KR20210098477A - 핵산 복합체 - Google Patents
핵산 복합체 Download PDFInfo
- Publication number
- KR20210098477A KR20210098477A KR1020217019004A KR20217019004A KR20210098477A KR 20210098477 A KR20210098477 A KR 20210098477A KR 1020217019004 A KR1020217019004 A KR 1020217019004A KR 20217019004 A KR20217019004 A KR 20217019004A KR 20210098477 A KR20210098477 A KR 20210098477A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- nucleic acid
- equation
- reference example
- mmol
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 311
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 311
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 311
- 102100036202 Serum amyloid P-component Human genes 0.000 claims abstract description 631
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 104
- 230000000692 anti-sense effect Effects 0.000 claims abstract description 78
- 239000002773 nucleotide Substances 0.000 claims abstract description 74
- 235000000346 sugar Nutrition 0.000 claims abstract description 57
- 239000003446 ligand Substances 0.000 claims abstract description 49
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 41
- 230000000295 complement effect Effects 0.000 claims abstract description 37
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 32
- 101001092910 Homo sapiens Serum amyloid P-component Proteins 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 205
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 47
- 201000010099 disease Diseases 0.000 claims description 41
- 125000004432 carbon atom Chemical group C* 0.000 claims description 36
- 125000002947 alkylene group Chemical group 0.000 claims description 33
- 230000014509 gene expression Effects 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 125000005647 linker group Chemical group 0.000 claims description 16
- 239000000835 fiber Substances 0.000 claims description 12
- 101150020229 Apcs gene Proteins 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 claims description 8
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 claims description 8
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 claims description 7
- 230000001404 mediated effect Effects 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 643
- 108010045517 Serum Amyloid P-Component Proteins 0.000 description 625
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 587
- 108020004459 Small interfering RNA Proteins 0.000 description 571
- 108091081021 Sense strand Proteins 0.000 description 559
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 132
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 114
- 239000000243 solution Substances 0.000 description 114
- 239000002904 solvent Substances 0.000 description 107
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 91
- 238000006243 chemical reaction Methods 0.000 description 89
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 87
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 87
- 238000004519 manufacturing process Methods 0.000 description 84
- 230000002829 reductive effect Effects 0.000 description 77
- 239000000203 mixture Substances 0.000 description 71
- 239000002585 base Substances 0.000 description 67
- -1 altose Chemical compound 0.000 description 63
- 238000003786 synthesis reaction Methods 0.000 description 60
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 54
- 230000008569 process Effects 0.000 description 54
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 52
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 52
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 51
- 230000036961 partial effect Effects 0.000 description 51
- 230000015572 biosynthetic process Effects 0.000 description 46
- 238000010898 silica gel chromatography Methods 0.000 description 36
- 239000012043 crude product Substances 0.000 description 34
- 239000000126 substance Substances 0.000 description 31
- 239000000047 product Substances 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 28
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 28
- 210000004027 cell Anatomy 0.000 description 28
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- 229910052739 hydrogen Inorganic materials 0.000 description 27
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 26
- 239000001257 hydrogen Substances 0.000 description 26
- 238000005160 1H NMR spectroscopy Methods 0.000 description 25
- 239000012044 organic layer Substances 0.000 description 25
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 25
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 23
- 239000012298 atmosphere Substances 0.000 description 22
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 22
- 239000000843 powder Substances 0.000 description 22
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 20
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
- 238000000605 extraction Methods 0.000 description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 16
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 15
- 241000282414 Homo sapiens Species 0.000 description 15
- 210000003494 hepatocyte Anatomy 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 14
- 229920000642 polymer Polymers 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 101100202395 Homo sapiens APCS gene Proteins 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 125000006239 protecting group Chemical group 0.000 description 13
- 125000001424 substituent group Chemical group 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 125000003277 amino group Chemical group 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 125000002652 ribonucleotide group Chemical group 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 108091028664 Ribonucleotide Proteins 0.000 description 11
- 238000009739 binding Methods 0.000 description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 11
- 239000002336 ribonucleotide Substances 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 229910019142 PO4 Inorganic materials 0.000 description 10
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 239000010452 phosphate Substances 0.000 description 10
- 239000007787 solid Chemical group 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000005547 deoxyribonucleotide Substances 0.000 description 9
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 125000001425 triazolyl group Chemical group 0.000 description 9
- 229940086542 triethylamine Drugs 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
- 235000015165 citric acid Nutrition 0.000 description 8
- 239000013065 commercial product Substances 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 150000002772 monosaccharides Chemical class 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000002194 synthesizing effect Effects 0.000 description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 108010006523 asialoglycoprotein receptor Proteins 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 229960002989 glutamic acid Drugs 0.000 description 6
- 235000018977 lysine Nutrition 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 230000002441 reversible effect Effects 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000012300 argon atmosphere Substances 0.000 description 5
- 235000003704 aspartic acid Nutrition 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000004494 ethyl ester group Chemical group 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000002953 preparative HPLC Methods 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- 239000012124 Opti-MEM Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000005251 capillar electrophoresis Methods 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 238000010511 deprotection reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 239000012096 transfection reagent Substances 0.000 description 4
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- UMKVNPJDILQVLF-UHFFFAOYSA-N [dimethylamino(triazolo[4,5-b]pyridin-3-yloxy)methylidene]-dimethylazanium fluoro(dioxido)phosphane Chemical compound [O-]P([O-])F.[O-]P([O-])F.[O-]P([O-])F.[O-]P([O-])F.[O-]P([O-])F.[O-]P([O-])F.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1.C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 UMKVNPJDILQVLF-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000003941 amyloidogenesis Effects 0.000 description 3
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 3
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- SMXMBXPLRFTROI-UHFFFAOYSA-N tert-butyl 2-[[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]acetate Chemical compound CC(C)(C)OC(=O)CNCC(=O)OC(C)(C)C SMXMBXPLRFTROI-UHFFFAOYSA-N 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- DQUHYEDEGRNAFO-QMMMGPOBSA-N (2s)-6-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCCCN DQUHYEDEGRNAFO-QMMMGPOBSA-N 0.000 description 2
- NTBYIQWZAVDRHA-KCDKBNATSA-N (2s,3s,4r,5s)-2-amino-3,4,5-trihydroxyhexanal Chemical compound C[C@H](O)[C@@H](O)[C@@H](O)[C@H](N)C=O NTBYIQWZAVDRHA-KCDKBNATSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- UOXJNGFFPMOZDM-UHFFFAOYSA-N 2-[di(propan-2-yl)amino]ethylsulfanyl-methylphosphinic acid Chemical compound CC(C)N(C(C)C)CCSP(C)(O)=O UOXJNGFFPMOZDM-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 2
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 2
- NZBKIOJQXNGENQ-UHFFFAOYSA-N 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium Chemical compound COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 NZBKIOJQXNGENQ-UHFFFAOYSA-N 0.000 description 2
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 2
- SFHYNDMGZXWXBU-LIMNOBDPSA-N 6-amino-2-[[(e)-(3-formylphenyl)methylideneamino]carbamoylamino]-1,3-dioxobenzo[de]isoquinoline-5,8-disulfonic acid Chemical compound O=C1C(C2=3)=CC(S(O)(=O)=O)=CC=3C(N)=C(S(O)(=O)=O)C=C2C(=O)N1NC(=O)N\N=C\C1=CC=CC(C=O)=C1 SFHYNDMGZXWXBU-LIMNOBDPSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 2
- 101100347612 Arabidopsis thaliana VIII-B gene Proteins 0.000 description 2
- 101100025412 Arabidopsis thaliana XI-A gene Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 125000004406 C3-C8 cycloalkylene group Chemical group 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- UNPLRYRWJLTVAE-UHFFFAOYSA-N Cloperastine hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 UNPLRYRWJLTVAE-UHFFFAOYSA-N 0.000 description 2
- JWFRNGYBHLBCMB-UHFFFAOYSA-N D-Canaytose Natural products CC(O)C(O)C(O)CC=O JWFRNGYBHLBCMB-UHFFFAOYSA-N 0.000 description 2
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 101100215371 Homo sapiens ACTB gene Proteins 0.000 description 2
- 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 2
- 101100281953 Homo sapiens GAPDH gene Proteins 0.000 description 2
- 101001066129 Homo sapiens Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- NSGDYZCDUPSTQT-UHFFFAOYSA-N N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide Chemical compound Cc1c(Br)cn(Cc2ccc(F)cc2)c(=O)c1NC(=O)C1CCCCCC1 NSGDYZCDUPSTQT-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 206010053159 Organ failure Diseases 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 2
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 230000006229 amino acid addition Effects 0.000 description 2
- 206010002022 amyloidosis Diseases 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
- 150000001555 benzenes Chemical class 0.000 description 2
- QNRYOQRUGRVBRL-UHFFFAOYSA-N benzyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC1=CC=CC=C1 QNRYOQRUGRVBRL-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229920001577 copolymer Chemical group 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 150000002337 glycosamines Chemical class 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 102000047486 human GAPDH Human genes 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 150000002431 hydrogen Chemical group 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- VUALREFPJJODHZ-WELRSGGNSA-N lactosediamine Chemical compound O=C[C@H](N)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1N VUALREFPJJODHZ-WELRSGGNSA-N 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 229940014800 succinic anhydride Drugs 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- AOCSUUGBCMTKJH-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCN AOCSUUGBCMTKJH-UHFFFAOYSA-N 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 150000004043 trisaccharides Chemical class 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FQORWEQXRQVPBZ-KCDKBNATSA-N (2r,3r,4r,5s)-5-aminohexane-1,2,3,4,6-pentol Chemical compound OC[C@H](N)[C@@H](O)[C@@H](O)[C@H](O)CO FQORWEQXRQVPBZ-KCDKBNATSA-N 0.000 description 1
- FDWRIIDFYSUTDP-KVTDHHQDSA-N (2r,4r,5s,6r)-6-methyloxane-2,4,5-triol Chemical compound C[C@H]1O[C@@H](O)C[C@@H](O)[C@@H]1O FDWRIIDFYSUTDP-KVTDHHQDSA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 1
- KYPWIZMAJMNPMJ-IANNHFEVSA-N (3r,5s,6r)-6-methyloxane-2,3,5-triol Chemical compound C[C@H]1OC(O)[C@H](O)C[C@@H]1O KYPWIZMAJMNPMJ-IANNHFEVSA-N 0.000 description 1
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- YQIGEJHOYBUSLR-UHFFFAOYSA-N 1-(1h-benzimidazol-2-yl)-n,n-bis(1h-benzimidazol-2-ylmethyl)methanamine Chemical compound C1=CC=C2NC(CN(CC=3NC4=CC=CC=C4N=3)CC=3NC4=CC=CC=C4N=3)=NC2=C1 YQIGEJHOYBUSLR-UHFFFAOYSA-N 0.000 description 1
- YNHKVOGCDPODMT-UHFFFAOYSA-N 1-(2-aminoethyl)pyrrole-2,5-dione;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.NCCN1C(=O)C=CC1=O YNHKVOGCDPODMT-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- JBWYRBLDOOOJEU-UHFFFAOYSA-N 1-[chloro-(4-methoxyphenyl)-phenylmethyl]-4-methoxybenzene Chemical compound C1=CC(OC)=CC=C1C(Cl)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 JBWYRBLDOOOJEU-UHFFFAOYSA-N 0.000 description 1
- FDWRIIDFYSUTDP-UHFFFAOYSA-N 102850-49-7 Natural products CC1OC(O)CC(O)C1O FDWRIIDFYSUTDP-UHFFFAOYSA-N 0.000 description 1
- ZDTVBXVYNIHVNR-UHFFFAOYSA-N 12-oxo-12-phenylmethoxydodecanoic acid Chemical compound OC(=O)CCCCCCCCCCC(=O)OCC1=CC=CC=C1 ZDTVBXVYNIHVNR-UHFFFAOYSA-N 0.000 description 1
- XGDRLCRGKUCBQL-UHFFFAOYSA-N 1h-imidazole-4,5-dicarbonitrile Chemical compound N#CC=1N=CNC=1C#N XGDRLCRGKUCBQL-UHFFFAOYSA-N 0.000 description 1
- WWSJZGAPAVMETJ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethoxypyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCC WWSJZGAPAVMETJ-UHFFFAOYSA-N 0.000 description 1
- MJLVLHNXEOQASX-UHFFFAOYSA-N 2-bromo-3,3-dimethylbutanoic acid Chemical compound CC(C)(C)C(Br)C(O)=O MJLVLHNXEOQASX-UHFFFAOYSA-N 0.000 description 1
- ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical group CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- VYWYYJYRVSBHJQ-UHFFFAOYSA-N 3,5-dinitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 VYWYYJYRVSBHJQ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- WCILBWLDYPEMNA-UHFFFAOYSA-N 3-(2,5-dioxopyrrol-3-yl)propanoic acid Chemical compound OC(=O)CCC1=CC(=O)NC1=O WCILBWLDYPEMNA-UHFFFAOYSA-N 0.000 description 1
- YHVUVJYEERGYNU-UHFFFAOYSA-N 4',8-Di-Me ether-5,7,8-Trihydroxy-3-(4-hydroxybenzyl)-4-chromanone Natural products COC1(C)CC(O)OC(C)C1O YHVUVJYEERGYNU-UHFFFAOYSA-N 0.000 description 1
- QSESWLKFTMBIPZ-UHFFFAOYSA-N 4'-O-glucosyl-beta-gentiobiose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OCC2C(C(O)C(O)C(O)O2)O)C(O)C1O QSESWLKFTMBIPZ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- QGHDLJAZIIFENW-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical group C1=C(CC=C)C(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C(CC=C)=C1 QGHDLJAZIIFENW-UHFFFAOYSA-N 0.000 description 1
- OCJFXVHDIVAONP-UHFFFAOYSA-N 4-nitroisophthalic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C(C(O)=O)=C1 OCJFXVHDIVAONP-UHFFFAOYSA-N 0.000 description 1
- QDOAWUCLBBYAGY-UHFFFAOYSA-N 4-phenylmethoxycarbonylcyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)O)CCC1C(=O)OCC1=CC=CC=C1 QDOAWUCLBBYAGY-UHFFFAOYSA-N 0.000 description 1
- GXGKKIPUFAHZIZ-UHFFFAOYSA-N 5-benzylsulfanyl-2h-tetrazole Chemical compound C=1C=CC=CC=1CSC=1N=NNN=1 GXGKKIPUFAHZIZ-UHFFFAOYSA-N 0.000 description 1
- GONFBOIJNUKKST-UHFFFAOYSA-N 5-ethylsulfanyl-2h-tetrazole Chemical compound CCSC=1N=NNN=1 GONFBOIJNUKKST-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- YOKDHMTZJSRRIQ-KZULUSFZSA-N 9h-fluoren-9-ylmethyl n-[(2r,3r)-1,3-dihydroxybutan-2-yl]carbamate Chemical compound C1=CC=C2C(COC(=O)N[C@H](CO)[C@H](O)C)C3=CC=CC=C3C2=C1 YOKDHMTZJSRRIQ-KZULUSFZSA-N 0.000 description 1
- 208000023769 AA amyloidosis Diseases 0.000 description 1
- 208000023761 AL amyloidosis Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002025 Amyloidosis senile Diseases 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 101100347605 Arabidopsis thaliana VIII-A gene Proteins 0.000 description 1
- YTXJRSMDAZJHQO-UHFFFAOYSA-N Br(=O)(=O)O.NCCC=1C(=O)NC(C1)=O Chemical compound Br(=O)(=O)O.NCCC=1C(=O)NC(C1)=O YTXJRSMDAZJHQO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- GNTQICZXQYZQNE-UHFFFAOYSA-N Colitose Natural products CC(O)C(O)CC(O)C=O GNTQICZXQYZQNE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- BBMKQGIZNKEDOX-UHFFFAOYSA-N D-Acosamin Natural products CC1OC(O)CC(N)C1O BBMKQGIZNKEDOX-UHFFFAOYSA-N 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-QTVWNMPRSA-N D-Mannose-6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O NBSCHQHZLSJFNQ-QTVWNMPRSA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- ZOYWWAGVGBSJDL-UHFFFAOYSA-N D-desosamine Natural products CC1CC(N(C)C)C(O)C(O)O1 ZOYWWAGVGBSJDL-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- BGWQRWREUZVRGI-OLLRPPRZSA-N D-glucoheptopyranose Chemical compound OC[C@H](O)[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O BGWQRWREUZVRGI-OLLRPPRZSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010064553 Dialysis amyloidosis Diseases 0.000 description 1
- OEKPKBBXXDGXNB-IBISWUOJSA-N Digitalose Natural products CO[C@H]1[C@@H](O)[C@@H](C)O[C@@H](O)[C@@H]1O OEKPKBBXXDGXNB-IBISWUOJSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-OBAJZVCXSA-N Gentianose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@H](O)[C@@H](CO)O2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-OBAJZVCXSA-N 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101001024703 Homo sapiens Nck-associated protein 5 Proteins 0.000 description 1
- 101000772194 Homo sapiens Transthyretin Proteins 0.000 description 1
- 208000005531 Immunoglobulin Light-chain Amyloidosis Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- OKPQBUWBBBNTOV-UHFFFAOYSA-N Kojibiose Natural products COC1OC(O)C(OC2OC(OC)C(O)C(O)C2O)C(O)C1O OKPQBUWBBBNTOV-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SKCKOFZKJLZSFA-UHFFFAOYSA-N L-Gulomethylit Natural products CC(O)C(O)C(O)C(O)CO SKCKOFZKJLZSFA-UHFFFAOYSA-N 0.000 description 1
- DBDJCJKVEBFXHG-UHFFFAOYSA-N L-Oleandrose Natural products COC1CC(O)OC(C)C1O DBDJCJKVEBFXHG-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- YPZMPEPLWKRVLD-UHFFFAOYSA-N L-glycero-D-manno-heptose Natural products OCC(O)C(O)C(O)C(O)C(O)C=O YPZMPEPLWKRVLD-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- SKCKOFZKJLZSFA-BXKVDMCESA-N L-rhamnitol Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO SKCKOFZKJLZSFA-BXKVDMCESA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- XXIHHRIZGBRENI-WDSKDSINSA-N L-rhodinose Chemical compound C[C@H](O)[C@@H](O)CCC=O XXIHHRIZGBRENI-WDSKDSINSA-N 0.000 description 1
- PNIWLNAGKUGXDO-UHFFFAOYSA-N Lactosamine Natural products OC1C(N)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 PNIWLNAGKUGXDO-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-KEWYIRBNSA-N N-acetyl-D-galactosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-KEWYIRBNSA-N 0.000 description 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 1
- CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 description 1
- 102100036946 Nck-associated protein 5 Human genes 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- DBDJCJKVEBFXHG-BNHYGAARSA-N Oleandrose Natural products O(C)[C@H]1[C@H](O)[C@H](C)O[C@H](O)C1 DBDJCJKVEBFXHG-BNHYGAARSA-N 0.000 description 1
- VBBVHUSSTYPTKK-UHFFFAOYSA-N P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C Chemical compound P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C VBBVHUSSTYPTKK-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- BNXOUFNLXOGIOT-UHFFFAOYSA-N Sarmentose Natural products CC1OC(O)CC(CO)C1O BNXOUFNLXOGIOT-UHFFFAOYSA-N 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 102100029290 Transthyretin Human genes 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
- LNRUEZIDUKQGRH-UHFFFAOYSA-N Umbelliferose Natural products OC1C(O)C(CO)OC1(CO)OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 LNRUEZIDUKQGRH-UHFFFAOYSA-N 0.000 description 1
- 101100463786 Zea mays PG14 gene Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YZGOWXGENSKDSE-XYPWUTKMSA-N [(1s,8r)-9-bicyclo[6.1.0]non-4-ynyl]methyl n-[2-[2-(2-aminoethoxy)ethoxy]ethyl]carbamate Chemical compound C1CC#CCC[C@@H]2C(COC(=O)NCCOCCOCCN)[C@@H]21 YZGOWXGENSKDSE-XYPWUTKMSA-N 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- WXIONIWNXBAHRU-UHFFFAOYSA-N [dimethylamino(triazolo[4,5-b]pyridin-3-yloxy)methylidene]-dimethylazanium Chemical compound C1=CN=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 WXIONIWNXBAHRU-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- WPJRFCZKZXBUNI-KVQBGUIXSA-N acosamine Chemical compound C[C@H](O)[C@@H](O)[C@H](N)CC=O WPJRFCZKZXBUNI-KVQBGUIXSA-N 0.000 description 1
- 150000001251 acridines Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- FBJQEBRMDXPWNX-SMGIPPFUSA-N alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-SMGIPPFUSA-N 0.000 description 1
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229940059260 amidate Drugs 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- ATPUSKUDFAGUJF-UHFFFAOYSA-N benzotriazol-1-yloxy(tripyrrolidin-1-yl)phosphanium fluoro(dioxido)phosphane Chemical compound P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.P([O-])([O-])F.N1(N=NC2=C1C=CC=C2)O[P+](N2CCCC2)(N2CCCC2)N2CCCC2.N2(N=NC1=C2C=CC=C1)O[P+](N1CCCC1)(N1CCCC1)N1CCCC1.N1(N=NC2=C1C=CC=C2)O[P+](N2CCCC2)(N2CCCC2)N2CCCC2.N2(N=NC1=C2C=CC=C1)O[P+](N1CCCC1)(N1CCCC1)N1CCCC1.N1(N=NC2=C1C=CC=C2)O[P+](N2CCCC2)(N2CCCC2)N2CCCC2.N2(N=NC1=C2C=CC=C1)O[P+](N1CCCC1)(N1CCCC1)N1CCCC1.N1(N=NC2=C1C=CC=C2)O[P+](N2CCCC2)(N2CCCC2)N2CCCC2.N2(N=NC1=C2C=CC=C1)O[P+](N1CCCC1)(N1CCCC1)N1CCCC1.N1(N=NC2=C1C=CC=C2)O[P+](N2CCCC2)(N2CCCC2)N2CCCC2.N2(N=NC1=C2C=CC=C1)O[P+](N1CCCC1)(N1CCCC1)N1CCCC1.N1(N=NC2=C1C=CC=C2)O[P+](N2CCCC2)(N2CCCC2)N2CCCC2.N2(N=NC1=C2C=CC=C1)O[P+](N1CCCC1)(N1CCCC1)N1CCCC1 ATPUSKUDFAGUJF-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- XXAYGJGDVLSEML-LBPRGKRZSA-N benzyl (2s)-2,6-diaminohexanoate Chemical compound NCCCC[C@H](N)C(=O)OCC1=CC=CC=C1 XXAYGJGDVLSEML-LBPRGKRZSA-N 0.000 description 1
- JHVLLYQQQYIWKX-UHFFFAOYSA-N benzyl 2-bromoacetate Chemical compound BrCC(=O)OCC1=CC=CC=C1 JHVLLYQQQYIWKX-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- HRSXWUSONDBHSP-UHFFFAOYSA-N benzyl hexanoate Chemical compound CCCCCC(=O)OCC1=CC=CC=C1 HRSXWUSONDBHSP-UHFFFAOYSA-N 0.000 description 1
- QMMFTRJQCCVPCE-UHFFFAOYSA-N benzyl n-(2-aminoethyl)carbamate Chemical compound NCCNC(=O)OCC1=CC=CC=C1 QMMFTRJQCCVPCE-UHFFFAOYSA-N 0.000 description 1
- NFPGZLVPTVWFSY-UHFFFAOYSA-N benzyl n-[2-(2-hydroxyethoxy)ethyl]carbamate Chemical compound OCCOCCNC(=O)OCC1=CC=CC=C1 NFPGZLVPTVWFSY-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- JWFRNGYBHLBCMB-SRQIZXRXSA-N boivinose Chemical compound C[C@@H](O)[C@H](O)[C@@H](O)CC=O JWFRNGYBHLBCMB-SRQIZXRXSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- AJSDVNKVGFVAQU-BIIVOSGPSA-N cladinose Chemical compound O=CC[C@@](C)(OC)[C@@H](O)[C@H](C)O AJSDVNKVGFVAQU-BIIVOSGPSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- WPJRFCZKZXBUNI-HCWXCVPCSA-N daunosamine Chemical compound C[C@H](O)[C@@H](O)[C@@H](N)CC=O WPJRFCZKZXBUNI-HCWXCVPCSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- VTJCSBJRQLZNHE-CSMHCCOUSA-N desosamine Chemical compound C[C@@H](O)C[C@H](N(C)C)[C@@H](O)C=O VTJCSBJRQLZNHE-CSMHCCOUSA-N 0.000 description 1
- 125000004431 deuterium atom Chemical group 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- MPQBLCRFUYGBHE-JRTVQGFMSA-N digitalose Chemical compound O=C[C@H](O)[C@@H](OC)[C@@H](O)[C@@H](C)O MPQBLCRFUYGBHE-JRTVQGFMSA-N 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- DOSDTCPDBPRFHQ-UHFFFAOYSA-N dimethyl 5-hydroxybenzene-1,3-dicarboxylate Chemical compound COC(=O)C1=CC(O)=CC(C(=O)OC)=C1 DOSDTCPDBPRFHQ-UHFFFAOYSA-N 0.000 description 1
- NTUGPDFKMVHCCJ-VIFPVBQESA-N ditert-butyl (2s)-2-aminopentanedioate Chemical compound CC(C)(C)OC(=O)CC[C@H](N)C(=O)OC(C)(C)C NTUGPDFKMVHCCJ-VIFPVBQESA-N 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- CJJCPDZKQKUXSS-JMSAOHGTSA-N fuculose Chemical compound C[C@@H]1OC(O)(CO)[C@H](O)[C@@H]1O CJJCPDZKQKUXSS-JMSAOHGTSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- VXWORWYFOFDZLY-FYBJJZIISA-N garosamine Chemical compound CN[C@@H]1[C@@H](O)C(O)OC[C@]1(C)O VXWORWYFOFDZLY-FYBJJZIISA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- MUPFEKGTMRGPLJ-WSCXOGSTSA-N gentianose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-WSCXOGSTSA-N 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- XPGRZDJXVKFLHQ-UHFFFAOYSA-N hydron;methyl 3-aminopropanoate;chloride Chemical compound Cl.COC(=O)CCN XPGRZDJXVKFLHQ-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002951 idosyl group Chemical class C1([C@@H](O)[C@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- FOMCONPAMXXLBX-MQHGYYCBSA-N isopanose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O)[C@H]([C@H](O)[C@@H](O)C=O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOMCONPAMXXLBX-MQHGYYCBSA-N 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- VYVWNADPXPVZPS-XAMCCFCMSA-N kansosamine Chemical compound CO[C@@H](C=O)[C@](C)(O)[C@@H](N)[C@H](C)O VYVWNADPXPVZPS-XAMCCFCMSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- PZDOWFGHCNHPQD-OQPGPFOOSA-N kojibiose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-OQPGPFOOSA-N 0.000 description 1
- DOVBXGDYENZJBJ-ONMPCKGSSA-N lactosamine Chemical compound O=C[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DOVBXGDYENZJBJ-ONMPCKGSSA-N 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- DTSSDPFTHGBSDX-KVTDHHQDSA-N mycosamine Chemical compound C[C@@H](O)[C@@H](O)[C@H](N)[C@H](O)C=O DTSSDPFTHGBSDX-KVTDHHQDSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229940060155 neuac Drugs 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- GOYBREOSJSERKM-ACZMJKKPSA-N oleandrose Chemical compound O=CC[C@H](OC)[C@@H](O)[C@H](C)O GOYBREOSJSERKM-ACZMJKKPSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 238000010397 one-hybrid screening Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000005053 phenanthridines Chemical class 0.000 description 1
- 150000002988 phenazines Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- SXADIBFZNXBEGI-UHFFFAOYSA-N phosphoramidous acid Chemical compound NP(O)O SXADIBFZNXBEGI-UHFFFAOYSA-N 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 208000022256 primary systemic amyloidosis Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- GOYBREOSJSERKM-VQVTYTSYSA-N sarmentose Chemical compound O=CC[C@H](OC)[C@@H](O)[C@@H](C)O GOYBREOSJSERKM-VQVTYTSYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- NMHIUKCEPXGTRP-HCWXCVPCSA-N streptose Chemical compound C[C@H](O)[C@](O)(C=O)[C@@H](O)C=O NMHIUKCEPXGTRP-HCWXCVPCSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- POHWAQLZBIMPRN-UHFFFAOYSA-N tert-butyl n-(3-aminopropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCN POHWAQLZBIMPRN-UHFFFAOYSA-N 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- LNRUEZIDUKQGRH-YZUCMPLFSA-N umbelliferose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 LNRUEZIDUKQGRH-YZUCMPLFSA-N 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229930028731 β-maltose Natural products 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3515—Lipophilic moiety, e.g. cholesterol
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 하기 식 1로 표시되는 핵산 복합체를 제공한다.
식 1:
(식 1 중, X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이고, 상기 이중 사슬 핵산은, 상기 안티센스 사슬 중의, 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이고, 상기 센스 사슬의 3' 말단 또는 5' 말단은 S3에 결합하고, L1 및 L2는 각각 독립적으로 당 리간드이고, S1, S2 및 S3은 각각 독립적으로 링커이다.)
식 1:
(식 1 중, X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이고, 상기 이중 사슬 핵산은, 상기 안티센스 사슬 중의, 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이고, 상기 센스 사슬의 3' 말단 또는 5' 말단은 S3에 결합하고, L1 및 L2는 각각 독립적으로 당 리간드이고, S1, S2 및 S3은 각각 독립적으로 링커이다.)
Description
본 발명은 핵산 복합체 및 이 핵산 복합체를 포함하는 의약 조성물 등에 관한 것이다.
핵산 의약으로서 압타머, 안티센스, 디코이 핵산, 리보자임, siRNA, miRNA 및 antimiRNA 등이 알려져 있다. 핵산 의약은 세포 내의 온갖 유전자를 제어할 수 있는 범용성이 높기 때문에, 지금까지 치료가 어렵다고 여겨져 온 다양한 질환에 대한 임상 응용이 기대되고 있다.
또한, 핵산 의약은 세포 내에 있어서의 표적 선택성과 활성이 높기 때문에, 항체, 저분자 의약에 이어지는 차세대 의약으로서 기대되고 있다.
그러나, 핵산 의약의 문제점으로서 표적 조직에의 송달이 곤란하다는 것을 들 수 있다.
인비보에 있어서의 효과적인 핵산 의약의 송달법의 하나로서, 표적화 화합물과 핵산의 핵산 복합체(콘쥬게이트)를 이용하는 것이 보고되어 있다. 표적화 화합물로서, 세포 밖으로 발현되는 수용체에 결합할 수 있는 리간드를 들 수 있다. 그 중에서도 특히 간세포에 매우 고발현인 아시알로당단백질 수용체(ASGPR)에 결합 가능한 리간드로서, N-아세틸-D-갈락토사민(GalNAc) 등을 이용한 핵산 복합체가 여러 개 보고되어 있다. 최근에는 이들 리간드와 siRNA류를 결합한 핵산 복합체가 간세포에 효율적으로 송달되는 것이 보고되어 있다(비특허문헌 1).
표적화 화합물과 올리고뉴클레오티드의 복합체로서, 예컨대 특허문헌 1 및 2에는 이하에 나타내는 핵산 복합체가 개시되어 있다.
(식 중, Ac는 아세틸기를 나타낸다. 이하, 본 명세서에 있어서 마찬가지다.)
또한, 특허문헌 3에는 특허문헌 1 및 2에 개시되는 핵산 복합체와 같은 당(糖) 리간드 테더 유닛을 갖는 이하에 나타내는 구조를 갖는 핵산 복합체가 개시되어 있다.
또한, 특허문헌 4에는 당 리간드 테더 유닛으로서 이하에 나타내는 구조를 갖는 핵산 복합체가 개시되어 있다.
APCS(amyloid P component, serum)(별칭 혈청 아밀로이드 P, SAP 혹은 펜트락신(Pentraxin)-2라고도 한다)는 223 아미노산으로 구성되는 당단백질의 5량체 구조를 갖는다. APCS는 간에서 생성되는 당 단백질이며, 혈중에 30∼50 μg/mL라는 비교적 고농도로 존재한다.
또한, APCS는 칼슘 의존적으로 모든 종류의 아밀로이드 섬유에 결합하는 생화학적 특성을 가지고, 아밀로이드를 갖는 환자의 아밀로이드 내에도 20,000 mg이나 되는 다량의 APCS가 포함되어 있는 것이 알려져 있다(비특허문헌 2).
APCS는 모든 아밀로이드 관련 질환 환자에게 있어서의 아밀로이드 내에 존재하므로, 아밀로이드 관련 질환 환자에게 있어서의 진단 마커로서 이용되고 있다(비특허문헌 3).
아밀로이드 관련 질환은, 아밀로이드 섬유로서 알려져 있는 이상한 불용성 단백질 섬유가 조직에 침착(沈着)되어 장기 장해가 야기되는 질환이다.
APCS가 아밀로이드에 결합함으로써 프로테아제에 의한 분해 내성이나 면역 세포에 의한 탐식에 대한 내성을 유도함으로써, APCS가 결합한 아밀로이드를 안정화할 수 있다는 것이 밝혀져 있고, 또한 APCS의 아밀로이드에의 결합을 저해함으로써, 장기에의 아밀로이드 침착 및 그것에 동반되는 조직 장해를 경감할 수 있다는 것이, 동물 모델을 이용한 연구 및 임상 연구로부터 강하게 시사되어 있다(비특허문헌 4 및 5).
APCS의 발현을 특이적으로 억제함으로써, 아밀로이드 관련 질환을 예방 또는 치료할 수 있다고 기대할 수 있지만, APCS의 발현을 특이적으로 억제하는 의약품은 지금까지 보고되지 않았다.
[비특허문헌 1] 저널 오브 아메리칸 케미컬 소사이어티(Journal of American Chemical Society), 2014년, 제136권, p 16958-16961
[비특허문헌 2] 아밀로이드(Amyloid) 1997년, 제4: 4권, p 274-295
[비특허문헌 3] 뉴잉글랜드 저널 오브 메디신(N. Engl. J. Med.) 1990년, 제323권, p 508-13
[비특허문헌 4] 네이처(Nature) 2010년, 제468권, p 93-97
[비특허문헌 5] 뉴잉글랜드 저널 오브 메디신(N. Engl. J. Med.) 2015년, 제373권, p 1106-1114
본 발명의 목적은 APCS의 발현을 억제할 수 있는 핵산 복합체를 제공하는 데에 있다.
본 발명은 이하에 관한 것이다.
[1]
하기 식 1로 표시되는 핵산 복합체.
식 1:
(식 1 중,
X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이고,
상기 이중 사슬 핵산은, 상기 안티센스 사슬 중의 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이고,
상기 센스 사슬의 3' 말단 또는 5' 말단은 S3에 결합하고,
L1 및 L2는 각각 독립적으로 당 리간드이고,
S1, S2 및 S3은 각각 독립적으로 링커이다.)
[2]
하기 식 2로 표시되는 구조를 갖는 [1]에 기재한 핵산 복합체.
식 2:
(식 2 중,
X, L1, L2 및 S3은 각각 상기와 동의이고,
P1, P2, P3, P4, P5 및 P6, 그리고 T1 및 T2는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q1, Q2, Q3 및 Q4는 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n-CH2CH2-이며, n은 0∼99의 정수이고,
B1 및 B2는 각각 독립적으로 결합수(結合手)이거나 또는 하기 식 2-1로 표시되는 어느 하나의 구조이고, 각 구조에 있어서의 말단의 둥근 흑점은 각각 P2 또는 P3 혹은 P5 또는 P6과의 결합점이며, m1, m2, m3 및 m4는 각각 독립적으로 0∼10의 정수이고,
식 2-1:
p1 및 p2는 각각 독립적으로 1, 2 또는 3의 정수이고,
q1, q2, q3 및 q4는 각각 독립적으로 0∼10의 정수이고,
단, p1 및 p2가 각각 2 또는 3의 정수일 때, 각각의 P3 및 P6, Q2 및 Q4, T1 및 T2, 그리고 L1 및 L2는 동일하거나 또는 다르더라도 좋으며, q1∼q4가 2∼10일 때, 각각의 -[P2-Q1]-, -[Q2-P3]-, -[P5-Q3]-, -[Q4-P6]-의 조합은 동일하거나 또는 다르더라도 좋다.)
[3]
P1 및 P4가 각각 독립적으로 -CO-NH-, -NH-CO- 또는 -O-인 [2]에 기재한 핵산 복합체.
[4]
-[P2-Q1]q1- 및 -[P5-Q3]q3-이 각각 독립적으로 존재하지 않거나 또는 하기 식 3-1∼식 3-3으로 표시되는 어느 하나의 구조인 [2] 또는 [3]에 기재한 핵산 복합체.
식 3-1:
식 3-2:
식 3-3:
(식 3-1∼식 3-3 중,
m5 및 m6은 각각 독립적으로 0∼10의 정수이고, 식 3-1∼식 3-3의 구조에 있어서의 말단의 둥근 흑점은 각각 B1 또는 B2 혹은 P1 또는 P4와의 결합점이다.)
[5]
하기 식 4-1∼식 4-9로 표시되는 어느 하나의 구조를 갖는 [2]∼[4]의 어느 한 항에 기재한 핵산 복합체.
식 4-1:
식 4-2:
식 4-3:
식 4-4:
식 4-5:
식 4-6:
식 4-7:
식 4-8:
식 4-9:
(식 4-1∼4-9 중,
X, L1, L2, S3, P3, P6, T1, T2, Q2, Q4, q2 및 q4는 각각 상기와 동의이다.)
[6]
하기 식 5로 표시되는 구조를 갖는 [1]에 기재한 핵산 복합체.
식 5:
(식 5 중,
X, S3, P1, P2, P3, Q1, Q2, B1, T1, L1, p1, q1 및 q2는 각각 상기와 동의이다.)
[7]
P1이 -CO-NH-, -NH-CO- 또는 -O-인 [6]에 기재한 핵산 복합체.
[8]
하기 식 6-1∼식 6-9로 표시되는 어느 하나의 구조를 갖는 [6] 또는 [7]에 기재한 핵산 복합체.
식 6-1:
식 6-2:
식 6-3:
식 6-4:
식 6-5:
식 6-6:
식 6-7:
식 6-8:
식 6-9:
(식 6-1∼6-9 중,
X, S3, P3, Q2, T1, L1 및 q2는 각각 상기와 동의이다.)
[9]
하기 식 7-1∼식 7-9로 표시되는 어느 하나의 구조를 갖는 [2]∼[5]의 어느 한 항에 기재한 핵산 복합체.
식 7-1:
식 7-2:
식 7-3:
식 7-4:
식 7-5:
식 7-6:
식 7-7:
식 7-8:
식 7-9:
(식 7-1∼7-9 중,
X, S3, L1 및 L2는 각각 상기와 동의이다.)
[10]
상기 당 리간드가 N-아세틸갈락토사민인 [1]∼[9]의 어느 한 항에 기재한 핵산 복합체.
[11]
상기 이중 사슬 핵산이 수식 뉴클레오티드를 포함하는 [1]∼[10]의 어느 한 항에 기재한 핵산 복합체.
[12]
센스 사슬의 3' 말단 및 안티센스 사슬의 5' 말단은 평활(平滑) 말단을 형성하는 [1]∼[11]의 어느 한 항에 기재한 핵산 복합체.
[13]
상기 이중 사슬 핵산이 당부(糖部) 수식 뉴클레오티드를 포함하는 [11]에 기재한 핵산 복합체.
[14]
하기 식 7-8-1로 표시되는 구조를 갖는 [1]∼[13]의 어느 한 항에 기재한 핵산 복합체.
식 7-8-1:
(식 7-8-1 중, X는 상기와 동의이다.)
[15]
X가 표 1-1∼표 1-13에 기재한 센스 사슬/안티센스 사슬로 이루어지는 군에서 선택되는 한 쌍의 센스 사슬/안티센스 사슬인 [1]∼[14]의 어느 한 항에 기재한 핵산 복합체.
[16]
X가 표 M1-1∼표 M1-3 및 표 R-1∼표 R-4에 기재한 센스 사슬/안티센스 사슬로 이루어지는 군에서 선택되는 한 쌍의 센스 사슬/안티센스 사슬인 [1]∼[14]의 어느 한 항에 기재한 핵산 복합체.
[16-A1]
X가 3' 말단이 S3에 결합하는 센스 사슬과 서열 번호 2126, 2144, 2146의 어느 하나의 안티센스 사슬을 포함하는 한 쌍의 센스 사슬/안티센스 사슬인 [1]∼[14]의 어느 한 항에 기재한 핵산 복합체.
[16-A2]
하기 식 6-1∼식 6-9로 표시되는 구조를 갖는 [16-A1]에 기재한 핵산 복합체.
식 6-7:
(식 6-7 중,
X, S3, P3, Q2, T1, L1 및 q2는 각각 상기와 동의이다.)
[16-A3]
하기 식 7-8로 표시되는 구조를 갖는 [16-A1]에 기재한 핵산 복합체.
식 7-8:
(식 7-8 중,
X, S3, L1 및 L2는 각각 상기와 동의이다.)
[16-A4]
하기 식 7-8-1로 표시되는 구조를 갖는 [16-A1]에 기재한 핵산 복합체.
식 7-8-1:
(식 7-8-1 중, X는 상기와 동의이다.)
[16-B1]
X가 서열 번호 2083의 센스 사슬과 서열 번호 2126의 안티센스 사슬, 서열 번호 2101의 센스 사슬과 서열 번호 2144의 안티센스 사슬, 또는 서열 번호 2103의 센스 사슬과 서열 번호 2146의 안티센스 사슬을 포함하는 한 쌍의 센스 사슬/안티센스 사슬인 [1]∼[14]의 어느 한 항에 기재한 핵산 복합체.
[16-B2]
하기 식 6-1∼식 6-9로 표시되는 구조를 갖는 [16-B1]에 기재한 핵산 복합체.
식 6-7:
(식 6-7 중,
X, S3, P3, Q2, T1, L1 및 q2는 각각 상기와 동의이다.)
[16-B3]
하기 식 7-8로 표시되는 구조를 갖는 [16-B1]에 기재한 핵산 복합체.
식 7-8:
(식 7-8 중,
X, S3, L1 및 L2는 각각 상기와 동의이다.)
[16-B4]
하기 식 7-8-1로 표시되는 구조를 갖는 [16-B1]에 기재한 핵산 복합체.
식 7-8-1:
(식 7-8-1 중, X는 상기와 동의이다.)
[17]
[1]∼[16]의 어느 한 항에 기재한 핵산 복합체를 포함하는 의약 조성물.
[18]
세포 내에 도입하기 위한 [17]에 기재한 의약 조성물.
[19]
정맥내 투여 또는 피하 투여되는 [17] 또는 [18]에 기재한 의약 조성물.
[20]
[1]∼[16]의 어느 한 항에 기재한 핵산 복합체 또는 [17]∼[19]의 어느 한 항에 기재한 의약 조성물을, 그것을 필요로 하는 환자에게 투여하는 것을 포함하는, 질환의 치료 또는 예방 방법.
[21]
[1]∼[16]의 어느 한 항에 기재한 핵산 복합체 또는 [17]∼[19]의 어느 한 항에 기재한 의약 조성물을 이용하여 이중 사슬 핵산을 세포 내에 도입하는 것을 포함하는, APCS 유전자의 발현을 억제하는 방법.
[22]
[1]∼[16]의 어느 한 항에 기재한 핵산 복합체 또는 [17]∼[19]의 어느 한 항에 기재한 의약 조성물을 포유동물에게 투여하는 것을 포함하는, 아밀로이드 관련 질환의 치료 방법.
[23]
[1]∼[16]의 어느 한 항에 기재한 핵산 복합체 또는 [17]∼[19]의 어느 한 항에 기재한 의약 조성물을 포함하는, 아밀로이드 관련 질환의 치료에 이용하기 위한 의약.
[24]
[1]∼[16]의 어느 한 항에 기재한 핵산 복합체 또는 [17]∼[19]의 어느 한 항에 기재한 의약 조성물을 포함하는, 아밀로이드 관련 질환의 치료제.
[25]
아밀로이드 관련 질환이 APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환인 [22]에 기재한 치료 방법.
[26]
아밀로이드 관련 질환이 APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환인 [23]에 기재한 의약.
[27]
아밀로이드 관련 질환이 APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환인 [24]에 기재한 치료제.
예컨대 본 발명의 핵산 복합체를 포함하는 의약 조성물을 포유동물에게 투여하여 생체 내에 있어서 각종 관련 질환을 치료할 수 있다.
도 1은 시험예 2에 있어서의 각 마우스군의 혈중 인간 APCS 농도의 추이를 도시하는 도면이다. 도면에서 Day0의 APCS 농도는 투여 6일 전의 값을 나타내고, 첫회 투여일을 Day0으로 했다. 횡축은 첫회 투여일을 0일째로 한 경과 일수, 종축은 혈중 인간 APCS 농도(μg/mL)를 나타낸다. ○는 컨트롤군, ▲은 화합물 5-2의 10 mg/kg 투여군을 나타낸다. 도면의 에러 바는 표준편차(SD)를 나타낸다.
본 발명의 핵산 복합체는 하기 식 1로 표시되는 핵산 복합체이다.
식 1:
식 1 중,
X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이고,
상기 이중 사슬 핵산은, 상기 안티센스 사슬 중의, 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이고,
상기 센스 사슬의 3' 말단 또는 5' 말단은 S3에 결합하고,
L1 및 L2는 각각 독립적으로 당 리간드이고,
S1, S2 및 S3은 각각 독립적으로 링커이다.
본 발명에 있어서, S1 및 S2는 S3의 벤젠환 상의 치환 위치에 대하여 각각 오르토 위치, 메타 위치, 파라 위치에서 벤젠환과 결합할 수 있지만, 하기 식 1-1로 표시되는 핵산 복합체인 것이 적합하다. 식 1에 있어서의 S1 및 S2의 벤젠환에의 결합수는, 벤젠환 상의 S3의 치환 위치 이외에 임의의 위치일 수 있다는 것을 의미한다.
식 1-1:
식 1-1 중,
X, L1, L2, S1, S2 및 S3은 각각 상기와 동의이다.
본 명세서에 있어서, 상기와 동의란, 식 1-1을 예시하여 설명하면, 식 1-1 중의 X, L1, L2, S1 및 S2 각각에 관해서, 식 1에 있어서 상기한 X, L1, L2, S1 및 S2 각각에 관한 정의와 같은 기일 수 있다는 것을 의미하고 있다.
본 발명에 있어서, X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이다.
또한, 상기 이중 사슬 핵산은, 상기 안티센스 사슬 중의, 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 후술하는 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이다.
또한, 상기 센스 사슬의 3' 말단 또는 5' 말단은 S3에 결합한다.
L1 및 L2는 각각 독립적으로 당 리간드이다.
본 발명에 있어서, 당 리간드란, 표적 세포에서 발현된 수용체에 결합할 수 있는 당류(단당, 이당, 삼당 및 다당 등)에서 유래하는 기를 의미한다. 또한, 본 발명에 있어서, 당 리간드가 O- 결합에 의해 S1 및 S2의 링커에 결합하고 있는 경우에는, 당 리간드란, 그것을 구성하는 당류의 결합에 관여하는 수산기를 제외한 부분이 당류에서 유래하는 기를 의미한다.
본 발명에서는, 올리고뉴클레오티드의 표적이 되는 당 리간드를 선택하면 된다.
단당으로서는, 예컨대 알로오스, 알토오스, 아라비노오스, 클라디노오스, 에리트로오스, 에리트룰로오스, 프럭토오스, D-푸시톨, L-푸시톨, 푸코사민, 푸코오스, 푸쿨로오스, 갈락토사민, D-갈락토사미니톨, N-아세틸-갈락토사민, 갈락토오스, 글루코사민, N-아세틸-글루코사민, 글루코사미니톨, 글루코오스, 글루코오스-6-인산, 글로오스, 글리세르알데히드, L-글리세로-D-만노-헵토오스, 글리세롤, 글리세론, 글로오스, 이도오스, 릭소오스, 만노사민, 만노오스, 만노오스-6-인산, 피시코오스, 퀴노보오스, 퀴노보사민, 람니톨, 람노사민, 람노오스, 리보오스, 리불로오스, 세도헵툴로오스, 소르보오스, 타가토오스, 타로오스, 타르타르산, 트레오스, 자일로오스 및 자일룰로오스 등을 들 수 있다.
이당, 삼당, 다당으로서는, 예컨대 아베크오스, 아클라보오스, 아미세토오스, 아밀로펙틴, 아밀로오스, 아피오스, 아르카노오스, 아스칼릴로오스, 아스코르빈산, 보이비노오스, 셀로비오스, 셀로트리오스, 셀룰로오스, 카코트리오스, 칼루코오스, 키틴, 코리토오스, 시클로덱스트린, 시마로오스, 덱스트린, 2-데옥시리보오스, 2-데옥시글루코오스, 디기노오스, 디기탈로오스, 디기톡소오스, 에발로오스, 에베미트로오스(evemitrose), 프럭토올리고당, 갈락토올리고당(galto-oligosaccharide, 겐티아노오스, 겐티오비오스, 글루칸, 글리코겐, 하마멜로오스, 헤파린, 이눌린, 이소레보글루코세논, 이소말토오스, 이소말토트리오스, 이소파노오스, 코지비오스, 락토오스, 락토사민, 락토오스디아민, 라미나라비오스, 레보글루코산, 레보글루코세논, β-말토스, 말토리오스, 만난올리고당, 만니노트리오스, 멜레치토오스, 멜리비오스, 무람산, 미카로오스, 미시노오스, 뉴라민산, 시알산 함유 당쇄, 니겔로오스, 노디리미신, 노비오스, 올레안드로오스, 파노오스, 파라토오스, 플란테오스, 프리메베로오스, 라피노오스, 로디노오스, 루티노오스, 사르멘토오스, 세도헵툴로오스, 세도헵툴로산, 솔라트리오스, 소포로오스, 스타키오스, 스트렙토오스, 수크로오스, α,α-트레할로오스, 트라할로사민, 투라노오스, 티벨로오스, 자일로비오스, 움벨리페로오스 등을 들 수 있다.
당류에 있어서의 각 단당은 D체 또는 L체라도 좋고, D체와 L체의 임의 비율에 의한 혼합물이라도 좋다.
당류는, 데옥시당(알코올히드록시기를 수소 원자로 치환한 것), 아미노당(알코올히드록시기를 아미노기로 치환한 것), 티오당(알코올히드록시기를 티올로 치환한 것, 또는 C=O를 C=S로 치환한 것, 또는 고리 산소를 황으로 치환한 것), 셀레노당, 텔룰로당, 아자당(고리 탄소를 질소로 치환한 것), 이미노당(고리 산소를 질소로 치환한 것), 포스파노당(고리 산소를 인으로 치환한 것), 포스파당(고리 탄소를 인으로 치환한 것), C- 치환 단당(비말단 탄소 원자에 있어서의 수소 원자를 탄소 원자로 치환한 것), 불포화 단당, 알디톨(카르보닐기를 CHOH기로 치환한 것), 알돈산(알데히드기를 카르복시기로 치환한 것), 케토알돈산, 우론산, 알다르산 등을 포함하고 있어도 좋다.
단당인 아미노당으로서, 갈락토사민, 글루코사민, 만노사민, 푸코사민, 퀴노보사민, 뉴라민산, 무라민산, 락토오스디아민, 아코사민, 바실로사민, 다우노사민, 데소사민, 포로사민, 가로사민, 카노사민, 칸소사민(kansosamine), 미카미노오스, 미코사민, 페로사민, 푸노이모사민, 푸르푸로사민(purpurosamine), 로도사민 등을 들 수 있다. 또한, 아미노당의 아미노기는 아세틸기 등으로 치환되어 있어도 좋다.
시알산 함유 당쇄로서는, NeuAc을 당쇄 비환원 말단에 함유하는 당쇄를 들 수 있고, 구체적으로는 NeuAc-Gal-GlcNAc을 함유하는 당쇄나 Neu5Acα(2-6)Galβ(1-3)GlcNAc 등을 들 수 있다.
당류에 있어서의 각 단당은, 표적 세포에 발현된 수용체에 결합 가능한 것을 한도로 하여, 치환기로 치환되어 있어도 좋으며, 예컨대 수산기가 치환되어 있어도 좋고, 각 단당에 있어서의 수소 원자가 아지드 및/또는 치환되어 있어도 좋은 아릴기로 하나∼복수 치환되어 있어도 좋다.
당 리간드로서는, 표적으로 하는 각 장기에 대응하여 표적 세포의 표면에 발현되는 수용체에 결합하는 당 리간드를 선택하는 것이 바람직하다. 예컨대 표적 세포가 간세포인 경우, 간세포 표면에 발현되는 수용체에 대한 당 리간드가 바람직하고, 아시알로당 단백질 수용체(ASGPR)에 대한 당 리간드가 보다 바람직하다.
ASGPR에 대한 당 리간드로서는, 만노오스 또는 N-아세틸갈락토사민이 바람직하고, N-아세틸갈락토사민이 보다 바람직하다.
ASGPR에 대하여 보다 친화성이 높은 당 리간드로서, 예컨대 Bioorganic Medicinal Chemistry, 17,7254(2009) 및 Journal of American Chemical Society, 134, 1978(2012) 등에 기재된 당 유도체가 알려져 있으며, 이들을 이용하여도 좋다.
본 발명에 있어서, S1, S2 및 S3은 링커이다.
S1과 S2는 당 리간드인 L1과 L2와 벤젠환을 연결하는 구조라면 특별히 한정되는 것은 아니며, 핵산 복합체에 있어서 이용되는 공지된 구조를 채용하여도 좋다. S1과 S2는 동일하더라도 좋고 다르더라도 좋다.
당 리간드인 L1과 L2는 S1 및 S2와 글리코시드 결합에 의해 연결되어 있는 것이 바람직하다. S1 및 S2는 벤젠환과 예컨대 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH- 결합에 의해 각각 연결되어 있어도 좋다.
S3은 이중 사슬 핵산인 X와 벤젠환을 연결하는 구조라면 특별히 한정되는 것은 아니며, 핵산 복합체에 있어서 이용되는 공지된 구조를 채용하여도 좋다.
올리고뉴클레오티드인 X는 S3과 포스포디에스테르 결합에 의해 연결되어 있는 것이 바람직하다. S3은 벤젠환과 예컨대 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH- 결합에 의해 연결되어 있어도 좋다.
S1, S2 및 S3의 링커는 예컨대 국제공개 제2009/073809호, 국제공개 제2013/075035호, 국제공개 제2015/105083호, 국제공개 제2014/179620호, 국제공개 제2015/006740호에 개시되는 구조를 채용하여도 좋다.
본 발명에 있어서, 핵산 복합체는 하기 식 2로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 2:
식 2 중,
X, L1, L2 및 S3은 각각 상기와 동의이고,
P1, P2, P3, P4, P5 및 P6, 그리고 T1 및 T2는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q1, Q2, Q3 및 Q4는 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n-CH2CH2-이며, n은 0∼99의 정수이다.
P1 및 P4는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이지만, -O-, -O-CO-, -NH-CO- 또는 -CO-NH-인 것이 바람직하고, -O-, -NH-CO- 또는 -CO-NH-인 것이 보다 바람직하고, -NH-CO-인 것이 더욱 바람직하다.
P1 또는 P4가 예컨대 -NH-CO-인 경우, -NH-CO- 벤젠환이라는 부분 구조를 갖는다.
Q1, Q2, Q3 및 Q4는 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n-CH2CH2-이고, n은 0∼99의 정수이지만, 치환 혹은 무치환의 탄소수 1∼12의 알킬렌인 것이 바람직하고, 무치환의 탄소수 1∼12의 알킬렌인 것이 보다 바람직하고, 무치환의 탄소수 1∼6의 알킬렌인 것이 더욱 바람직하고, 무치환의 탄소수 1∼4의 알킬렌인 것이 보다 더욱 바람직하다.
P2 및 P5는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이지만, 존재하지 않거나 -CO-O- 또는 -CO-NH-인 것이 바람직하고, 존재하지 않거나 -CO-NH-인 것이 보다 바람직하다. P2 및 P5가 예컨대 -CO-NH-인 경우, B1-CO-NH-Q1 및 B2-CO-NH-Q3이라는 부분 구조를 갖는다.
-[P2-Q1]q1- 및 -[P5-Q3]q3-이 각각 독립적으로 존재하지 않거나 또는 하기 식 3-1∼식 3-3으로 표시되는 어느 하나의 구조인 것이 적합하다.
식 3-1:
식 3-2:
식 3-3:
식 3-1∼3-3 중,
m5 및 m6은 각각 독립적으로 0∼10의 정수이고, 식 3-1∼식 3-3의 구조에 있어서의 말단의 둥근 흑점은 각각 B1 또는 B2 혹은 P1 또는 P4와의 결합점이다.
B1 및 B2는 각각 독립적으로 결합수이거나 또는 하기 식으로 표시되는 어느 하나의 구조이고, 각 구조에 있어서의 말단의 둥근 흑점은 각각 P2 또는 P3 혹은 P5 또는 P6과의 결합점이며, m1, m2, m3 및 m4는 각각 독립적으로 0∼10의 정수이다.
B1 및 B2는, 글루타민산, 아스파라긴산, 리신, 이미노이아세트산 등의 비천연 아미노산을 포함하는 아미노산, 또는 2-아미노-1,3-프로판디올 등의 아미노알코올에서 유래하는 기인 것이 바람직하고, B1 및 B2가 글루타민산 및 아스파라긴산에서 유래하는 기인 경우, 글루타민산 및 아스파라긴산의 아미노기가 각각 결합하며, P2 및 P5로서 -NH-CO- 결합인 것이 바람직하고, B1 및 B2가 리신에서 유래하는 기인 경우, 리신의 카르복실기가 각각 결합하며, P2 및 P5로서 -CO-NH- 결합인 것이 바람직하고, B1 및 B2가 이미노이아세트산에서 유래하는 기인 경우, 이미노이아세트산의 아미노기가 각각 결합하며, P2 및 P5로서 -CO- 결합이 되는 것이 바람직하다. B1 및 B2는 구체적으로는 이하의 구조를 갖는 것이 바람직하다.
p1 및 p2가 각각 2 또는 3의 정수일 때, 각각의 P3 및 P6, Q2 및 Q4, T1 및 T2, 그리고 L1 및 L2는 동일하더라도 또는 다르더라도 좋다.
q1∼q4가 2∼10일 때, 각각의 -[P2-Q1]-, -[Q2-P3]-, -[P5-Q3]-, -[Q4-P6]-의 조합은 동일하더라도 또는 다르더라도 좋다. 각각의 -[P2-Q1]-, -[Q2-P3]-, -[P5-Q3]- 및 -[Q4-P6]-의 조합이 동일하거나 또는 다르다는 것은 -[P2-Q1]-, -[Q2-P3]-, -[P5-Q3]- 및 -[Q4-P6]-으로 표시되는 각 2∼10의 단위가 동일한 경우와 다른 경우가 있다는 것을 의미한다.
본 발명에 있어서, 핵산 복합체는 하기 식 4-1∼4-9로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 4-1:
식 4-2:
식 4-3:
식 4-4:
식 4-5:
식 4-6:
식 4-7:
식 4-8:
식 4-9:
식 4-1∼4-9 중,
X, L1, L2, S3, P3, P6, T1, T2, Q2, Q4, q2 및 q4는 각각 상기와 동의이다.
P3 및 P6은 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이지만, -O-CO- 또는 -NH-CO-인 것이 바람직하고, -NH-CO-인 것이 보다 바람직하다. P3 및 P6이 예컨대 -NH-CO-인 경우, 각각 B1-NH-CO-Q2 및 B2-NH-CO-Q4라는 부분 구조를 갖는다.
T1 및 T2는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이지만, -O- 또는 -S-인 것이 바람직하고, -O-인 것이 보다 바람직하다.
본 발명에 있어서, 핵산 복합체는 하기 식 5로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 5에서는, 식 2에 있어서의 P1과 P4, P2와 P5, P3과 P6, Q1과 Q3, Q2와 Q4, B1과 B2, T1과 T2, L1과 L2, p1과 p2, q1과 q3 및 q2와 q4가 각각 동일하다.
식 5:
식 5 중,
X, S3, P1, P2, P3, Q1, Q2, B1, T1, L1, p1, q1 및 q2는 각각 상기와 동의이다.
또한, 식 5에 있어서의 X, S3, P1, P2, P3, Q1, Q2, B1, T1, L1, p1, q1 및 q2는 각각 상술한 적합한 기라도 좋지만, P1이 -CO-NH-, -NH-CO- 또는 -O-인 것이 바람직하다.
식 5에 있어서의 -(P2-Q1)q1-은 존재하지 않거나 또는 상기 식 3-1∼식 3-3으로 표시되는 어느 하나의 구조인 것이 적합하다.
본 발명에 있어서, 핵산 복합체는 하기 식 6-1∼6-9로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 6-1:
식 6-2:
식 6-3:
식 6-4:
식 6-5:
식 6-6:
식 6-7:
식 6-8:
식 6-9:
식 6-1∼식 6-9 중,
X, S3, P3, Q2, T1, L1 및 q2는 각각 상기와 동의이다.
본 발명에 있어서, 핵산 복합체는 하기 식 7-1∼식 7-9의 어느 하나로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 7-1:
식 7-2:
식 7-3:
식 7-4:
식 7-5:
식 7-6:
식 7-7:
식 7-8:
식 7-9:
식 7-1∼식 7-9 중,
X, L1, L2 및 S3은 각각 상기와 동의이다. L1과 L2는 동일하더라도 좋고, 다르더라도 좋으며, 동일한 것이 적합하다.
식 7-1∼식 7-9에 있어서, 각 알킬렌기 부분을 사슬 길이가 다른 알킬렌 사슬을 도입함으로써, 또한 아미드 결합 등을 다른 결합으로 치환함으로써, 식 7-1∼식 7-9로 표시되는 구조를 갖는 핵산 복합체 이외의 핵산 유도체를 제조할 수도 있다.
본 발명에 있어서, 핵산 복합체는 하기 식 11로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 11:
식 11 중,
L1, L2, S1, S2 및 X는 각각 상기와 동의이고,
P7 및 P8은 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q5, Q6 및 Q7은 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n8-CH2CH2-이며, n8은 0∼99의 정수이고,
B3은 본 명세서 내에서는 블랜처 유닛이라고 불리며, 하기 식 11-1로 표시되는 어느 하나의 구조이고, 파선은 각각 Q5 및 Q6과의 결합수를 의미한다.
식 11-1:
식 11-1 중, 트리아졸환을 갖는 기에 있어서의 치환은, 상기 트리아졸환의 1 위치 및 3 위치의 질소 원자의 어느 하나이다.
q5 및 q6은 각각 독립적으로 0∼10의 정수이다.
P7은 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이지만, -O-, -NH-CO- 또는 -CO-NH-인 것이 바람직하고, -O- 또는 -NH-CO-인 것이 보다 바람직하다. P7이 예컨대 -O-인 경우, 벤젠환-O-라는 부분 구조를 갖는다.
P8은 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이지만, 존재하는 경우, -CO-O- 또는 -CO-NH-인 것이 바람직하고, -CO-NH-인 것이 보다 바람직하다. P8이 예컨대 -CO-NH-인 경우, Q6-CO-NH-라는 부분 구조를 갖는다.
Q5, Q6 및 Q7은 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n8-CH2CH2-이며, n8은 0∼99의 정수이지만, 치환 혹은 무치환의 탄소수 1∼12의 알킬렌인 것이 바람직하고, 무치환의 탄소수 1∼12의 알킬렌인 것이 보다 바람직하고, 무치환의 탄소수 1∼6의 알킬렌인 것이 더욱 바람직하고, 무치환의 탄소수 1∼4의 알킬렌인 것이 보다 더욱 바람직하다.
-(P7-Q5)q5-는 -O-(CH2)m15-NH- 및 -NH-CO-(CH2)m16-NH이고, m15 및 m16은 각각 독립적으로 1∼10의 정수인 것이 적합하다.
본 발명에 있어서, 핵산 복합체는 하기 식 12-1∼식 12-12의 어느 하나로 표시되는 구조를 갖는 핵산 복합체인 것이 적합하다.
식 12-1:
식 12-2:
식 12-3:
식 12-4:
식 12-5:
식 12-6:
식 12-7:
식 12-8:
식 12-9:
식 12-10:
식 12-11:
식 12-12:
식 12-1∼12-12 중,
X, L1, L2, S1 및 S2는 각각 상기와 동의이고, n1'∼n12'는 각각 독립적으로 1∼10의 정수이다.
본 발명의 핵산 복합체는, 식 1로 표시되는 핵산 복합체에 있어서, S1 및 S2에 대응하는 식 2에 기재한 구조와 S3에 대응하는 식 11에 기재한 구조를 조합한 핵산 복합체인 것이 바람직하다. 식 2가 식 4-1∼식 4-9라도 좋고, 식 6-1∼식 6-9라도 좋고, 식 7-1∼식 7-9라도 좋으며, 식 2가 식 4-1∼식 4-9, 식 6-1∼식 6-9 혹은 식 7-1∼식 7-9인 경우에, 식 11이 식 12-1∼식 12-12라도 좋다. 본 발명의 핵산 복합체는, 식 1로 표시되는 핵산 복합체에 있어서, S1 및 S2에 대응하는 식 4-1∼식 4-9에 기재한 어느 하나의 구조 및 S3에 대응하는 식 12-1∼식 12-12에 기재한 어느 하나의 구조를 조합한 핵산 복합체, S1 및 S2에 대응하는 식 6-1∼식 6-9에 기재한 어느 하나의 구조 및 S3에 대응하는 식 12-1∼식 12-12에 기재한 어느 하나의 구조를 조합한 핵산 복합체, S1 및 S2에 대응하는 식 7-1∼식 7-9에 기재한 어느 하나의 구조 및 S3에 대응하는 식 12-1∼식 12-12에 기재한 어느 하나의 구조를 조합한 핵산 복합체인 것이 보다 적합하다.
본 발명의 핵산 복합체는 하기 식 7-8-1로 표시되는 것이 바람직하다.
식 7-8-1:
(식 7-8-1 중, X는 상기와 동의이다.)
식 1에 있어서의 X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이고, 이 이중 사슬 핵산은, 상기 안티센스 사슬 중의, 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이다. 센스 사슬의 3' 말단 또는 5' 말단이 S3에 결합하기 때문에, 식 1에 있어서, S3과 결합하는 X는 이중 사슬 핵산을 구성하는 센스 사슬이며, 후술하는 표 1-1∼표 1-13 또는 표 M1-1∼표 M1-3 및 표 R-1∼표 R-2 중의 센스 사슬 서열로 표시되는 센스 사슬이다.
본 발명에 있어서, APCS mRNA에 대하여 상보적인 염기 서열을 포함하는 핵산을 안티센스 사슬 핵산이라고 부르고, 안티센스 사슬 핵산의 염기 서열에 대하여 상보적인 염기 서열을 포함하는 핵산을 센스 사슬 핵산이라고도 부른다.
본 발명의 핵산 복합체를 구성하는 이중 사슬 핵산은, 포유동물 세포에 도입된 경우, APCS 유전자의 발현을 저하 또는 정지시키는 능력을 갖는 이중 사슬 핵산이며, 센스 사슬 및 안티센스 사슬을 갖는 이중 사슬 핵산이다. 또한, 상기 센스 사슬과 상기 안티센스 사슬은 적어도 11개의 염기쌍을 가지고, 상기 안티센스 사슬 중의, 적어도 17개의 뉴클레오티드 또한 많더라도 30개의, 즉 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬이, 표 1-1∼표 1-13에 기재된 군에서 선택되는 표적 APCS mRNA 서열과 상보적이다.
본 발명의 핵산 복합체를 구성하는 이중 사슬 핵산은, 뉴클레오티드 또는 이 뉴클레오티드와 동등한 기능을 갖는 분자가 중합된 중합체라면, 어떠한 이중 사슬 핵산이라도 좋다. 그와 같은 중합체로서는, 예컨대 리보뉴클레오티드의 중합체인 RNA, 데옥시리보뉴클레오티드의 중합체인 DNA, RNA와 DNA를 포함하는 키메라 핵산 및 이들 핵산의 적어도 하나의 뉴클레오티드가 이 뉴클레오티드와 동등한 기능을 갖는 분자로 치환된 뉴클레오티드 중합체를 들 수 있다. 또한, 이들 핵산 내에 뉴클레오티드와 동등한 기능을 갖는 분자를 적어도 하나 포함하는 유도체도 본 발명에서 이용되는 약물로서의 이중 사슬 핵산에 포함된다. 또한, 우라실(U)은 티민(T)으로 일의적으로 바꿔 읽을 수 있다.
뉴클레오티드와 동등한 기능을 갖는 분자로서는 예컨대 뉴클레오티드 유도체 등을 들 수 있다. 뉴클레오티드 유도체로서는, 뉴클레오티드에 수식을 행한 분자라면 어떠한 분자라도 좋지만, 예컨대 RNA 또는 DNA와 비교하여, 뉴클레아제 내성의 향상 혹은 안정화를 위해서, 상보 사슬 핵산과의 어피니티를 올리기 위해서, 세포 투과성을 올리기 위해서, 또는 가시화시키기 위해서, 리보뉴클레오티드 또는 데옥시리보뉴클레오티드에 수식을 행한 분자 등이 적합하게 이용된다.
뉴클레오티드에 수식을 행한 분자로서는, 예컨대 당부 수식 뉴클레오티드, 인산디에스테르 결합 수식 뉴클레오티드, 염기 수식 뉴클레오티드, 그리고 당부, 인산디에스테르 결합 및 염기의 적어도 하나가 수식된 뉴클레오티드 등을 들 수 있다.
당부 수식 뉴클레오티드로서는, 뉴클레오티드의 당의 화학 구조의 일부 혹은 전부에 대하여 임의의 치환기로 수식 혹은 치환한 것, 또는 임의의 원자로 치환한 것이라면 어떠한 것이라도 좋지만, 2'- 수식 뉴클레오티드가 바람직하게 이용된다.
2'- 수식 뉴클레오티드로서는, 예컨대 리보오스의 2'-OH기가 H, OR, R, R'OR, SH, SR, NH2, NHR, NR2, N3, CN, F, Cl, Br 및 I로 이루어지는 군(R은 알킬 또는 아릴, 바람직하게는 탄소수 1∼6의 알킬이고, R'은 알킬렌, 바람직하게는 탄소수 1∼6의 알킬렌이다)에서 선택되는 치환기로 치환된 뉴클레오티드이고, 보다 바람직하게는 2'-OH 기가 H, F 또는 메톡시기로 치환된 뉴클레오티드이고, 더욱 바람직하게는 2'-OH기가 F 또는 메톡시기로 치환된 뉴클레오티드이다. 또한, 2'-OH기가 2-(메톡시)에톡시기, 3-아미노프로폭시기, 2-[(N,N-디메틸아미노)옥시]에톡시기, 3-(N,N-디메틸아미노)프로폭시기, 2-[2-(N,N-디메틸아미노)에톡시]에톡시기, 2-(메틸아미노)-2-옥소에톡시기, 2-(N-메틸카르바모일)에톡시기 및 2-시아노에톡시기로 이루어지는 군에서 선택되는 치환기로 치환된 뉴클레오티드 등도 들 수 있다.
이중 사슬 핵산 영역 내의 뉴클레오티드에 대하여, 2'- 수식 뉴클레오티드는 50∼100% 포함되는 것이 바람직하고, 70∼100% 포함되는 것이 보다 바람직하고, 90∼100% 포함되는 것이 더욱 바람직하다. 또한, 센스 사슬의 뉴클레오티드에 대하여, 2'- 수식 뉴클레오티드는 20∼100% 포함되는 것이 바람직하고, 40∼100% 포함되는 것이 보다 바람직하고, 60%∼100% 포함되는 것이 더욱 바람직하다. 또한, 안티센스 사슬의 뉴클레오티드에 대하여, 2'- 수식 뉴클레오티드는 20∼100% 포함되는 것이 바람직하고, 40∼100% 포함되는 것이 보다 바람직하고, 60∼100% 포함되는 것이 더욱 바람직하다.
인산디에스테르 결합 수식 뉴클레오티드로서는, 뉴클레오티드의 인산디에스테르 결합의 화학 구조의 일부 혹은 전부에 대하여, 임의의 치환기로 수식 혹은 치환한 것, 또는 임의의 원자로 치환한 것이라면 어떠한 것이라도 좋으며, 예컨대 인산디에스테르 결합이 포스포로티오에이트 결합으로 치환된 뉴클레오티드, 인산디에스테르 결합이 포스포로디티오에이트 결합으로 치환된 뉴클레오티드, 인산디에스테르 결합이 알킬포스포네이트 결합으로 치환된 뉴클레오티드, 인산디에스테르 결합이 포스포로아미데이트 결합으로 치환된 뉴클레오티드 등을 들 수 있다.
염기 수식 뉴클레오티드로서는, 뉴클레오티드의 염기의 화학 구조의 일부 혹은 전부에 대하여, 임의의 치환기로 수식 혹은 치환한 것, 또는 임의의 원자로 치환한 것이라면 어떠한 것이라도 좋으며, 예컨대 염기 내의 산소 원자가 황 원자로 치환된 것, 수소 원자가 탄소수 1∼6의 알킬기, 할로겐 등으로 치환된 것, 메틸기가 수소, 히드록시메틸, 탄소수 2∼6의 알킬기 등으로 치환된 것, 아미노기가 탄소수 1∼6의 알킬기, 탄소수 1∼6의 알카노일기, 옥소기, 히드록시기 등으로 치환된 것을 들 수 있다.
뉴클레오티드 유도체로서는, 뉴클레오티드 또는 당부, 인산디에스테르 결합 혹은 염기의 적어도 하나가 수식된 뉴클레오티드 유도체에, 펩티드, 단백질, 당, 지질, 인지질, 페나진, 폴레이트, 페난트리딘, 안트라퀴논, 아크리딘, 플루오레세인, 로다민, 쿠마린, 색소 등, 별도의 화학 물질을 직접 또는 링커를 통해 부가한 것도 예로 들 수 있고, 구체적으로는 5'-폴리아민 부가 뉴클레오티드 유도체, 콜레스테롤 부가 뉴클레오티드 유도체, 스테로이드 부가 뉴클레오티드 유도체, 담즙산 부가 뉴클레오티드 유도체, 비타민 부가 뉴클레오티드 유도체, Cy5 부가 뉴클레오티드 유도체, Cy3 부가 뉴클레오티드 유도체, 6-FAM 부가 뉴클레오티드 유도체 및 비오틴 부가 뉴클레오티드 유도체 등을 들 수 있다.
뉴클레오티드 유도체는, 핵산 내의 다른 뉴클레오티드 또는 뉴클레오티드 유도체와 알킬렌 구조, 펩티드 구조, 뉴클레오티드 구조, 에테르 구조, 에스테르 구조 및 이들의 적어도 하나를 조합한 구조 등의 가교 구조를 형성하여도 좋다.
본 명세서에 있어서 「상보」란, 2개의 염기 사이에서 염기 짝짓기를 할 수 있는 관계를 의미하며, 예컨대 아데닌과 티민 또는 우라실과의 관계, 그리고 구아닌과 사이토신과의 관계와 같이 완만한 수소 결합을 통해 이중 사슬 영역 전체적으로 이중 나선 구조를 취하는 것을 말한다.
본 명세서에 있어서 「상보적」이란, 2개의 뉴클레오티드 서열이 완전히 상보하는 경우뿐만 아니라, 상기 뉴클레오티드 서열 사이에서 0∼30%, 0∼20% 또는 0∼10%의 미스매치 염기를 가질 수 있으며, 예컨대 APCS mRNA에 대하여 상보적인 안티센스 사슬은, 상기 mRNA의 부분 염기 서열과 완전히 상보하는 염기 서열에 있어서, 하나 또는 복수의 염기의 치환을 포함하여도 좋다는 것을 의미한다. 구체적으로는, 안티센스 사슬은 표적 유전자의 표적 서열에 대하여 1∼8개, 바람직하게는 1∼6개, 1∼4개, 1∼3개, 특히 2개 또는 1개의 미스매치 염기를 가지고 있어도 좋다. 예컨대 안티센스 사슬이 21 염기 길이인 경우에는, 표적 유전자의 표적 서열에 대하여 6개, 5개, 4개, 3개, 2개 또는 1개의 미스매치 염기를 갖더라도 좋으며, 그 미스매치의 위치는 각각의 서열의 5' 말단 또는 3' 말단이라도 좋다.
또한, 「상보적」이란, 한쪽의 뉴클레오티드 서열이 다른 쪽의 뉴클레오티드 서열과 완전히 상보하는 염기 서열에 있어서, 하나 또는 복수의 염기가 부가 및/또는 결손된 서열인 경우를 포함하는 의미이다. 예컨대 APCS mRNA와 본 발명의 안티센스 사슬 핵산은, 안티센스 사슬에 있어서의 염기의 부가 및/또는 결손에 의해, 안티센스 사슬 및/또는 표적 APCS mRNA 영역에 1개 또는 2개의 벌지 염기를 갖더라도 좋다.
본 발명에서 이용되는 약물로서의 이중 사슬 핵산은, APCS mRNA의 일부의 염기 서열에 대하여 상보적인 염기 서열을 포함하는 핵산 및/또는 이 핵산의 염기 서열에 대하여 상보적인 염기 서열을 포함하는 핵산이라면, 어느 뉴클레오티드 또는 그 유도체로 구성되어 있어도 좋다. 본 발명의 이중 사슬 핵산은, 표적 APCS mRNA 서열에 대하여 상보적인 염기 서열을 포함하는 핵산과 이 핵산의 염기 서열에 대하여 상보적인 염기 서열을 포함하는 핵산이 적어도 11개의 염기쌍의 이중 사슬을 형성할 수 있으면 어느 길이라도 좋지만, 이중 사슬을 형성할 수 있는 서열의 길이는 통상 11∼27 염기이며, 15∼25 염기가 바람직하고, 17∼23 염기가 보다 바람직하고, 19∼23 염기가 더욱 바람직하다.
본 발명의 핵산 복합체의 안티센스 사슬로서는, 표적 APCS mRNA 서열에 대하여 상보적인 염기 서열을 포함하는 핵산이 이용되지만, 상기 핵산 중 1∼3 염기, 바람직하게는 1∼2 염기, 보다 바람직하게는 1 염기가 결손, 치환 또는 부가된 것을 이용하여도 좋다.
APCS의 발현을 억제하는 핵산으로서는, 표적 APCS mRNA 서열에 대하여 상보적인 염기 서열을 포함하는 핵산이며 또한 APCS의 발현을 억제하는 단일 사슬 핵산, 혹은 표적 APCS mRNA 서열에 대하여 상보적인 염기 서열을 포함하는 핵산과 이 핵산의 염기 서열에 대하여 상보적인 염기 서열을 포함하는 핵산을 포함하며 또한 APCS의 발현을 억제하는 이중 사슬 핵산이 적합하게 이용된다.
이중 사슬 핵산을 구성하는 단일 사슬의 안티센스 사슬 핵산 및 센스 사슬 핵산은, 각각 동일하거나 또는 다르며, 통상 11∼30 염기를 포함하지만, 각각 동일하거나 또는 다르며, 17∼27 염기를 포함하는 것이 바람직하고, 17∼25 염기를 포함하는 것이 보다 바람직하고, 19∼25 염기를 포함하는 것이 더욱 바람직하고, 21 또는 23 염기를 포함하는 것이 보다 더욱 바람직하다.
본 발명에서 이용되는 약물로서의 이중 사슬 핵산에 있어서, 이중 사슬 영역에 이어지는 3' 측 또는 5' 측에 이중 사슬을 형성하지 않는 추가 뉴클레오티드 또는 뉴클레오티드 유도체를 갖는 경우에는, 이것을 돌출부(오버행)라고 부른다. 돌출부를 갖는 경우에는, 돌출부를 구성하는 뉴클레오티드는 리보뉴클레오티드, 데옥시리보뉴클레오티드 또는 이들의 유도체라도 좋다.
돌출부를 갖는 이중 사슬 핵산으로서는, 적어도 한쪽 사슬의 3' 말단 또는 5' 말단에 1∼6 염기, 통상은 1∼3 염기를 포함하는 돌출부를 갖는 것이 이용되지만, 2 염기를 포함하는 돌출부를 갖는 것이 바람직하게 이용되며, 예컨대 dTdT(dT는 데옥시티미딘을 나타낸다) 또는 UU(U는 우리딘을 나타낸다)을 포함하는 돌출부를 갖는 것을 예로 들 수 있다. 돌출부는, 안티센스 사슬에만, 센스 사슬에만 및 안티센스 사슬과 센스 사슬 양쪽에 가질 수 있지만, 본 발명에 있어서, 안티센스 사슬에 돌출부를 갖는 이중 사슬 핵산이 바람직하게 이용된다. 또한, 안티센스 사슬은, 이중 사슬 영역과 그것에 이어지는 돌출부를 포함하는, 17개∼30개의 뉴클레오티드를 포함하는 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 군에서 선택되는 표적 APCS mRNA 서열의 어느 하나와 충분히 상보적이다. 더욱이, 본 발명의 이중 사슬 핵산으로서는, 예컨대 Dicer 등의 리보뉴클레아제의 작용에 의해 이중 사슬 핵산을 생성하는 핵산 분자(WO2005/089287)나, 3' 말단이나 5' 말단의 돌출부를 갖지 않고서 평활 말단을 형성하는 이중 사슬 핵산, 센스 사슬만이 돌출된 이중 사슬 핵산(US2012/0040459) 등을 이용할 수도 있다.
본 발명의 핵산 복합체를 구성하는 이중 사슬 핵산으로서는, 표적 유전자의 염기 서열 또는 그 상보 사슬의 염기 서열과 동일한 서열을 포함하는 핵산을 이용하여도 좋지만, 상기 핵산의 적어도 한쪽 사슬의 5' 말단 또는 3' 말단이 1∼4 염기 삭제된 핵산과, 상기 핵산의 염기 서열에 대하여 상보적인 염기 서열을 포함하는 핵산을 포함하는 이중 사슬 핵산을 이용하여도 좋다.
본 발명의 핵산 복합체를 구성하는 이중 사슬 핵산은, RNA끼리 이중 사슬을 형성한 이중 사슬 RNA(dsRNA), DNA끼리 이중 사슬을 형성한 이중 사슬 DNA(dsDNA), 또는 RNA와 DNA가 이중 사슬을 형성한 하이브리드 핵산이라도 좋다. 혹은 이중 사슬 중 한쪽 혹은 양쪽의 사슬이 DNA와 RNA의 키메라 핵산이라도 좋다. 바람직하게는 이중 사슬 RNA(dsRNA)이다.
본 발명의 핵산 복합체의 안티센스 사슬의 5' 말단에서부터 2번째의 뉴클레오티드는, 표적 APCS mRNA 서열의 3' 말단에서부터 2번째의 데옥시리보뉴클레오티드와 상보인 것이 바람직하고, 안티센스 사슬의 5' 말단에서부터 2∼7번째의 뉴클레오티드가 표적 APCS mRNA 서열의 3' 말단에서부터 2∼7번째의 데옥시리보뉴클레오티드와 완전히 상보인 것이 보다 바람직하고, 안티센스 사슬의 5' 말단에서부터 2∼11번째의 뉴클레오티드가 표적 APCS mRNA 서열의 3' 말단에서부터 2∼11번째의 데옥시리보뉴클레오티드와 완전히 상보인 것이 더욱 바람직하다. 또한, 본 발명의 핵산에 있어서의 안티센스 사슬의 5' 말단에서부터 11번째의 뉴클레오티드가 표적 APCS mRNA 서열의 3' 말단에서부터 11번째의 데옥시리보뉴클레오티드와 상보인 것이 바람직하고, 안티센스 사슬의 5' 말단에서부터 9∼13번째의 뉴클레오티드가 표적 APCS mRNA 서열의 3' 말단에서부터 9∼13번째의 데옥시리보뉴클레오티드와 완전히 상보인 것이 보다 바람직하고, 안티센스 사슬의 5' 말단에서부터 7∼15번째의 뉴클레오티드가 표적 APCS mRNA 서열의 3' 말단에서부터 7∼15번째의 데옥시리보뉴클레오티드와 완전히 상보인 것이 더욱 바람직하다.
본 발명의 핵산 복합체의 안티센스 사슬 및 센스 사슬은, 예컨대 Genbank Accession No. NM_001639.3으로서 등록되어 있는 인간 APCS의 완전장(完全長) mRNA의 cDNA(센스 사슬)의 염기 서열(서열 번호 1)에 기초하여 설계할 수 있다.
이중 사슬 핵산은 APCS 유전자 서열 내의 표적 서열과 상호 작용하도록 설계할 수 있다.
이중 사슬 핵산의 하나의 사슬의 서열은 상기한 표적 부위 서열에 대하여 상보적이다. 이중 사슬 핵산은 본 명세서에 기술된 방법을 사용하여 화학적으로 합성할 수 있다.
RNA는 효소적 또는 부분/전체 유기 합성에 의해서 생성하여도 좋고, 또한 수식된 리보뉴클레오티드는 인비트로로 효소적 또는 유기 합성에 의해서 도입할 수 있다. 하나의 양태에 있어서, 각각의 사슬은 화학적으로 조제된다. RNA 분자를 화학적으로 합성하는 방법은 해당 기술 분야에서 공지되어 있다[뉴클레익 애시즈 리서치(Nucleic Acids Research), 1998년, 제32권, p. 936-948 참조]. 일반적으로, 이중 사슬 핵산은 고상(固相) 올리고뉴클레오티드 합성법을 사용함으로써 합성할 수 있다(예컨대 Usman et al., 미국 특허 제5,804,683호 명세서; 미국 특허 제5,831,071호 명세서; 미국 특허 제5,998,203호 명세서; 미국 특허 제6,117,657호 명세서; 미국 특허 제6,353,098호 명세서; 미국 특허 제6,362,323호 명세서; 미국 특허 제6,437,117호 명세서; 미국 특허 제6,469,158호 명세서; Scaringe et al., 미국 특허 제6,111,086호 명세서; 미국 특허 제6,008,400호 명세서; 미국 특허 제6,111,086호 명세서를 참조).
단일 사슬 핵산은 고상 포스포로아미다이트법(뉴클레익 애시즈 리서치(Nucleic Acids Research), 1993년, 제30권, p. 2435-2443 참조)을 사용하여 합성되고, 탈보호되고, 그리고 NAP-5 컬럼(Amersham Pharmacia Biotech, Piscataway, NJ) 상에서 탈염된다. 올리고머는, 15분 공정의 리니어 구배를 사용하는 Amersham Source 15Q 컬럼 -1.0 cm. 높이. 25 cm(Amersham Pharmacia Biotech, Piscataway, NJ)에서의 이온 교환 고성능 액체 크로마토그래피(IE-HPLC)를 사용하여 정제한다. 구배는 90:10의 완충액 A:B에서 52:48의 완충액 A:B로 변화되고, 완충액 A는 100 mmol/L Tris pH 8.5이며, 그리고 완충액 B는 100 mmol/L Tris pH 8.5(1 mol/L의 NaCl)이다. 시료는 260 nm로 모니터되고, 전장(全長) 올리고뉴클레오티드종에 대응하는 피크는 수집되고, 풀되고, NAP-5 컬럼으로 탈염되고, 그리고 동결 건조된다.
각 단일 사슬 핵산의 순도는, Beckman PACE 5000(Beckman Coulter, Inc., Fullerton, Calif)에서의 캐필러리 전기 영동(CE)에 의해서 결정된다. CE 캐필러리 는 100 ㎛의 내경을 가지고, ssDNA 100R Gel(Beckman-Coulter)을 포함한다. 전형적으로는, 약 0.6 nmole의 올리고뉴클레오티드를 캐필러리에 주사하고, 444 V/cm의 전계에 있어서 실행하여, 260 nm에 있어서의 UV 흡광도에 의해서 검출된다. 변성 트리스-붕산-7 mol/L-요소 영동 완충액은 Beckman-Coulter로부터 구입한다. 이하에 기술한 실험에 사용하기 위한, CE에 의해서 평가하는 적어도 90% 순수한 단일 사슬 핵산을 얻을 수 있다. 화합물 동일성은 제조업자의 장려 프로토콜에 따라서 Voyager DE. TM. Biospectometry 워크스테이션(Applied Biosystems, Foster City,, Calif.)에서의 매트릭스 지원 레이저 탈리 이온화-비행시간형(MALDI-TOF) 질량 분광법에 의해서 검증된다. 단일 사슬 핵산의 상대적인 분자 질량은 예상되는 분자 질량의 0.2% 이내로 얻을 수 있다.
단일 사슬 핵산은, 100 mmol/L 아세트산칼륨, 30 mmol/L HEPES, pH 7.5를 포함하는 완충액 중에 100 ㎛ol/L 농도로 재현탁시킨다. 상보적 센스 사슬 및 안티센스 사슬을 동등한 몰량으로 혼합하여, 50 ㎛ol/L 이중 사슬 핵산의 최종 용액을 얻는다. 시료를 95℃까지 5분간 가열하여, 사용 전에 실온으로 냉각시킨다. 이중 사슬 핵산은 -20℃에서 보존한다. 단일 사슬 핵산은 동결 건조시키거나 또는 뉴클레아제 프리 수중에 -80℃에서 저장한다.
본 발명에 있어서의 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하고, 상기 안티센스 사슬 중의, 11개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 후술하는 표 1-1∼표 1-13에 기재된 군에서 선택되는 표적 APCS mRNA 서열과 상보적인 이중 사슬 핵산으로서, 표 M1-1∼표 M1-3 및 표 R-3∼표 R-4, 그리고 표 1-1∼표 1-13에 기재된 안티센스 사슬로 이루어지는 군에서 선택되는 서열을 포함하는 이중 사슬 핵산이나, 후술하는 표 M1-1∼표 M1-3 및 표 R-1∼표 R-2, 그리고 표 1-1∼표 1-13에 기재된 센스 사슬로 이루어지는 군에서 선택되는 서열을 포함하는 이중 사슬 핵산이나, 혹은 표 M1-1∼표 M1-3 및 표 R-1∼표 R-4, 그리고 표 1-1∼표 1-13에 기재한 센스 사슬/안티센스 사슬로 이루어지는 군에서 선택되는 한 쌍의 센스 사슬/안티센스 사슬의 서열을 포함하는 이중 사슬 핵산을 이용하여도 좋다.
즉, 본 발명에서 이용되는 핵산 복합체를 구성하는 이중 사슬 핵산의 구체예는, 표 M1-1∼표 M1-3 및 표 R-1∼표 R-4, 그리고 표 1-1∼표 1-13 중의 센스 사슬 및 안티센스 사슬을 포함하는 이중 사슬 핵산이다. 또한, 표 M1-1∼표 M1-3 및 표 R-1∼표 R-4 중, N(M)은 2'-O-메틸 수식 RNA, N(F)는 2'-불소 수식 RNA, 그리고 ^은 포스포로티오에이트를 나타낸다. 또한, 표 1-1∼표 1-13 및 표 M1-1∼표 M1-3 및 표 R-3∼표 R-4에 기재한 안티센스 사슬 서열의 5' 말단 뉴클레오티드는, 5' 말단에 있어서 인산화되어 있어도 좋고, 인산화되어 있지 않아도 좋지만, 인산화되어 있는 것이 바람직하다.
표 1-1∼표 1-13에 기재한 센스 사슬/안티센스 사슬의 서열을 포함하는 이중 사슬 핵산은, 1 nM 첨가 시의 녹다운 활성의 측정에 있어서, 이중 사슬 핵산을 가하지 않은 조건에 대하여 이중 사슬 핵산을 가했을 때의, APCS의 상대적 발현량이 0.50 이하인 것이 바람직하고, 0.30 이하인 것이 보다 바람직하고, 0.20 이하인 것이 더욱 바람직하고, 0.10 이하인 것이 가장 바람직하다.
본 발명에 있어서의 올리고뉴클레오티드는, 2'- 수식 뉴클레오티드를 포함하는 이중 사슬 핵산이라도 좋으며, 표 M1∼표 M3에 기재한 것이 바람직하고, 1 nM 첨가 시의 녹다운 활성의 측정에 있어서, 이중 사슬 핵산을 가하지 않은 조건에 대하여 이중 사슬 핵산을 가했을 때의 APCS의 상대적 발현량이 0.10 이하인 것이 보다 바람직하다.
상기한 바람직한 이중 사슬 핵산과 공지된 리간드 링커를 조합한 핵산 복합체도 본 발명에 포함된다. 공지된 리간드 링커로서는 예컨대 국제공개 제2009/073809호 및 국제공개 제2013/075035호에 개시되어 있는 것을 들 수 있다.
본 발명의 핵산 복합체는, 표 S1에서 기재되어 있는 핵산 복합체(화합물 1-2∼화합물 43-2)가 바람직하고, 핵산 복합체를 종농도로 3 nM 첨가할 때의 녹다운 활성의 측정에 있어서, 핵산 복합체를 가하지 않은 음성 대조에 대하여 핵산 복합체를 가했을 때의 APCS의 상대적 발현량이 0.50 이하인 핵산 복합체가 보다 바람직하다. 핵산 복합체의 구체예로서는 화합물 1-2, 5-2, 9-2, 10-2, 15-2, 20-2, 33-2, 35-2를 들 수 있다.
본 발명의 핵산 복합체의 제조법에 관해서 설명한다. 또한, 이하에 나타내는 제조법에 있어서, 정의한 기가 상기 제조법의 조건 하에서 변화되거나 또는 상기 제조법을 실시하는 데 부적절한 경우, 유기합성화학에서 상용되는 보호기의 도입 및 제거 방법[예컨대 프로텍티브 그룹스 인 오가닉 신세시스 제3판(Protective Groups in Organic Synthesis, third edition), 그린(T. W. Greene) 저, John Wiley & Sons Inc.(1999년) 등에 기재된 방법] 등을 이용함으로써 목적 화합물을 제조할 수 있다. 또한, 필요에 따라서 치환기 도입 등의 반응 공정의 순서를 바꿀 수도 있다.
식 1로 표시되는 핵산 복합체는 고상 합성에 의해서도 합성할 수 있다.
식 1로 표시되는 핵산 복합체는 핵산 복합체로서 공지된 링커 구조의 합성 방법을 참고하여 합성할 수 있다.
식 1로 표시되는 핵산 복합체에 있어서의, S1을 링커로 한 L1-벤젠환 유닛이나 S2를 링커로 한 L2-벤젠환 유닛의 합성은, 식 2로 표시되는 핵산 복합체를 예로 들어 설명한다.
식 2로 표시되는 핵산 복합체에 있어서의 L1-벤젠환 유닛이나 L2-벤젠환 유닛은 P1, P2, P3, P4, P5 및 P6, 그리고 T1 및 T2에 의해 연결되어 있다.
P1, P2, P3, P4, P5 및 P6, 그리고 T1 및 T2의 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 또는 -CO-NH- 결합은, 예컨대 제4판 실험화학강좌 19 「유기 화합물의 합성 I」 마루젠(1992년), 제4판 실험화학강좌 20 「유기 화합물의 합성 II」, 마루젠(1992년) 등에 기재된 결합 반응의 방법을 참고하여, 식 2로 표시되는 구조를 형성하는 데 적절한 원료를 선택함으로써 적절하게 합성할 수 있다.
또한, 벤젠환에서부터 순차 Q1을 부분 구조로서 갖는 화합물, B1을 부분 구조로서 갖는 화합물을 결합시킴으로써, L1-벤젠환 유닛의 부분 구조를 제조할 수 있다.
L1과 Q2를 부분 구조로서 갖는 화합물을 별도 합성하여, L1과 Q2를 부분 구조로서 갖는 화합물을 벤젠환, Q1 및 B1을 부분 구조로서 갖는 L1-벤젠환 유닛의 부분 구조를 갖는 화합물과 결합시킴으로써, L1-벤젠환 유닛 구조를 제조할 수 있다.
L2-벤젠환 유닛에 관해서도 마찬가지로, 벤젠환에서부터 순차 Q3을 부분 구조로서 갖는 화합물, B2를 부분 구조로서 갖는 화합물을 결합시킴으로써, L2-벤젠환 유닛의 부분 구조를 제조할 수 있다.
L2와 Q4를 부분 구조로서 갖는 화합물을 별도 합성하여, L2와 Q4를 부분 구조로서 갖는 화합물을 벤젠환, Q3 및 B2를 부분 구조로서 갖는 L2-벤젠환 유닛의 부분 구조를 갖는 화합물과 결합시킴으로써, L2-벤젠환 유닛 구조를 제조할 수 있다.
Q1을 부분 구조로서 갖는 화합물, Q3을 부분 구조로서 갖는 화합물로서는, 탄소수 1∼10의 알킬렌 또는 -(CH2CH2O)n-CH2CH2-의 양 말단에 수산기, 카르복실기, 아미노기, 티올기를 갖는 화합물을 들 수 있다.
B1을 부분 구조로서 갖는 화합물, B2를 부분 구조로서 갖는 화합물로서는, 하기 식 2-1로 표시되는 어느 하나의 구조를 가지고, 각 구조에 있어서의 말단의 둥근 흑점에 있어서, 각각 수산기, 카르복실기, 아미노기 또는 티올기를 갖는 화합물을 들 수 있다.
식 2-1:
B1을 부분 구조로서 갖는 화합물, B2를 부분 구조로서 갖는 화합물의 구체예로서는, 글리콜, 글루타민산, 아스파라긴산, 리신, Tris, 이미노이아세트산, 2-아미노-1,3-프로판디올 등을 들 수 있고, 글루타민산, 아스파라긴산, 리신, 이미노이아세트산이 바람직하다. 구체적으로는 B1 및 B2는 이하의 구조가 바람직하다.
L1, Q2 및 B1을 부분 구조로서 갖는 화합물을 합성하고 나서, Q1과 벤젠환을 갖는 화합물과 결합함으로써, L1-벤젠환 유닛 구조를 제조하여도 좋다.
L2, Q4 및 B2를 부분 구조로서 갖는 화합물을 합성하고 나서, Q3과 벤젠환을 갖는 화합물과 결합함으로써, L2-벤젠환 유닛 구조를 제조하여도 좋다.
본 발명에서는, [L1-T1-(Q2-P3)q2-]p1-B1-(P2-Q1)q1-P1-인 부분 구조와 [L2-T2-(Q3-P6)q4-]p2-B2-(P5-Q3)q3-P2-인 부분 구조는, 동일하더라도 또는 다르더라도 좋지만, 동일한 것이 바람직하다.
당 리간드의 L1-T1-Q2에 상당하는 유닛으로서, 예컨대 L3-T1-Q2-COOH, L3-T1-(Q2-P3)q2-1-Q2-NH2 등을 들 수 있다. 구체적으로는 L3-O-탄소수 1∼12의 알킬렌-COOH나 L3-탄소수 1∼12의 알킬렌-CO-NH-탄소수 2∼12의 알킬렌-NH2 등을 들 수 있다.
L3은 탈보호함으로써 L1이 되는 당 리간드 유도체라면 특별히 한정되지 않는다. 당 리간드의 치환기로서는, 당질 화학 분야에서 범용되는 치환기라면 특별히 한정되지 않지만, Ac기가 바람직하다.
S1을 링커로 한 L1-벤젠환 유닛이나 S2를 링커로 한 L2-벤젠환 유닛의 합성은, 구체적으로는 실시예에 기재한 방법을 참고하여 알킬렌 사슬의 탄소수를 적절히 증감하고, 또한 말단 아미노기나 말단 카르복실기를 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 또는 -CO-NH- 결합을 형성할 수 있는 기로 변환한 화합물을 이용함으로써 합성할 수 있다. 또한, L1의 당 리간드에 관해서도 실시예에서는 만노오스 또는 N-아세틸갈락토사민을 예시하고 있지만, 다른 당 리간드로 변경하여 실시할 수 있다.
식 1로 표시되는 핵산 복합체에 있어서의, S3를 링커로 한 X-벤젠환 유닛의 합성은, 식 12로 표시되는 핵산 복합체를 예로 들어 설명한다.
식 12로 표시되는 핵산 복합체에 있어서의 X-벤젠환 유닛은, 올리고뉴클레오티드의 결합 이외에, P7 및 P8에 의해 표시되는 결합을 갖는다.
P7 및 P8의 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 또는 -CO-NH- 결합은, 예컨대 제4판 실험화학강좌 19 「유기 화합물의 합성 I」 마루젠(1992년), 제4판 실험화학강좌 20 「유기 화합물의 합성 II」, 마루젠(1992년)에 기재된 결합 반응의 방법을 참고하여 식 12로 표시되는 구조를 형성하는 데 적절한 원료를 선택함으로써 적절하게 합성할 수 있다.
또한, 벤젠환에서부터 순차 Q5를 부분 구조로서 갖는 화합물, B3을 부분 구조로서 갖는 화합물을 결합시킴으로써 X-벤젠환 유닛의 부분 구조를 제조할 수 있다.
X와 Q7을 부분 구조로서 갖는 화합물이나 X와 Q6을 부분 구조로서 갖는 화합물을 별도 합성하고, X와 Q7을 부분 구조로서 갖는 화합물이나 X와 Q6을 부분 구조로서 갖는 화합물을 벤젠환 및 Q5를 부분 구조로서 갖는 X-벤젠환 유닛의 부분 구조를 갖는 화합물과 결합시켜, B3 부분을 구축함으로써, X-벤젠환 유닛 구조를 제조할 수 있다.
구체적으로는, 벤젠환 및 Q5를 부분 구조로서 갖는 X-벤젠환 유닛의 부분 구조를 갖는 화합물의 말단에 아지드기를 갖는 경우를 예로 들면, 실시예에 개시하는 것과 같은 말단 결합성 작용기화한 올리고뉴클레오티드를 반응시킴으로써 고리화 부가시키고, 트리아졸환을 형성하게 하여 B3 부분을 구축함으로써 X-벤젠환 유닛 구조를 제조할 수 있다.
Q5를 부분 구조로서 갖는 화합물, Q6을 부분 구조로서 갖는 화합물, Q7을 부분 구조로서 갖는 화합물로서는, 탄소수 1∼10의 알킬렌 또는 -(CH2CH2O)n8-CH2CH2-의 양 말단에 수산기, 카르복실기, 아미노기, 티올기를 갖는 화합물을 들 수 있다.
L1-벤젠환 유닛 구조, L2-벤젠환 유닛 구조와 X-벤젠환 유닛 구조는, 각각 순차 제조해 나갈 수 있지만, L1-벤젠환 유닛 구조 및 L2-벤젠환 유닛 구조를 합성하고 나서 X-벤젠환 유닛 구조를 결합시키는 것이 바람직하다. 특히, 올리고뉴클레오티드 부분을 갖는 X에 관해서는, 당 리간드 복합체 합성의 최종 공정 근처에서 화합물 내에 도입하는 것이 바람직하다.
본 발명에서는, 하기 식 8∼식 10으로 표시되는 화합물을 합성 중간체로서 얻을 수 있다.
식 8:
(식 8 중,
R1 및 R2는 각각 독립적으로 수소 원자, t-부톡시카르보닐기(Boc기), 벤질옥시카르보닐기(Z기), 9-플루오레닐메틸옥시카르보닐기(Fmoc기), -CO-R4 또는 -CO-B4-[(P9-Q8)q7-T3-L3]p3이고,
P9 및 T3은 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q8은 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는-(CH2CH2O)n1-CH2CH2-이며, n1은 0∼99의 정수이고,
B4는 각각 독립적으로 결합수이거나 또는 하기 식 8-1로 표시되는 어느 하나의 구조이고, 각 구조에 있어서의 말단의 둥근 흑점은 각각 카르보닐기 또는 P9와의 결합점이며, m7, m8, m9 및 m10은 각각 독립적으로 0∼10의 정수이고,
식 8-1:
p3은 1, 2 또는 3의 정수이고,
q7은 0∼10의 정수이고,
L3은 당 리간드이고,
Y는 -O-(CH2)m11-NH- 및 -NH-CO-(CH2)m12-NH이며, m11 및 m12는 각각 독립적으로 1∼10의 정수이고,
R3은 수소 원자, t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기, -CO-R4, -CO-(CH2CH2O)n2-CH2CH2-N3 또는 -CO-Q9-B5-(Q10-P10)q8-X1이며, n2는 0∼99의 정수이고,
P10은 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q9 및 Q10은 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n3-CH2CH2-이며, n3은 0∼99의 정수이고,
B5는 하기 식 8-2로 표시되는 어느 하나의 구조이며, 파선에 있어서 각각 Q9 및 Q10과의 결합수를 의미하고,
식 8-2:
식 8-2 중, 트리아졸환을 갖는 기에 있어서의 치환은 상기 트리아졸환의 1 위치 및 3 위치의 질소 원자의 어느 하나이다.
q8은 0∼10의 정수이고,
X1은 수소 원자 또는 고상 담체이고,
R4는 t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기로 치환 혹은 무치환의 아미노기, 카르복시기, 말레이미드기 및 아랄킬옥시카르보닐기로 이루어지는 군에서 선택되는 1 또는 2개의 치환기로 치환된 탄소수 2∼10의 알킬기이다.)
식 9:
(식 9 중,
R5 및 R6은 각각 독립적으로 수소 원자, t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기, -CO-R4' 또는 -CO-Q11-(P11-Q11')q9-T4-L4이고,
P11 및 T4는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q11 및 Q11'은 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n4-CH2CH2-이며, n4는 0∼99의 정수이고,
q9는 0∼10의 정수이고,
L4는 당 리간드이고,
Y'는 -O-(CH2)m11'-NH- 및 -NH-CO-(CH2)m12'-NH이며, m11' 및 m12'는 각각 독립적으로 1∼10의 정수이고,
R3'은 수소 원자, t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기, -CO-R4', -CO-(CH2CH2O)n2'-CH2CH2-N3 또는 -CO-Q9'-B5'-(Q10'-P10')q8'-X1'이며, n2'는 0∼99의 정수이고,
P10'은 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q9' 및 Q10'은 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n3'-CH2CH2-이며, n3'은 0∼99의 정수이고,
B5'는 하기 식 9-1로 표시되는 어느 하나의 구조이며, 파선에 있어서 각각 Q9' 및 Q10'과의 결합수를 의미하고,
식 9-1:
식 9-1 중, 트리아졸환을 갖는 기에 있어서의 치환은 상기 트리아졸환의 1 위치 및 3 위치의 질소 원자의 어느 하나이다.
q8'은 0∼10의 정수이고,
X1'은 수소 원자 또는 고상 담체이고,
R4'는 t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기로 치환 혹은 무치환의 아미노기, 카르복시기, 말레이미드기 및 아랄킬옥시카르보닐기로 이루어지는 군에서 선택되는 1 또는 2개의 치환기로 치환된 탄소수 2∼10의 알킬기이다.)
식 10:
식 10 중,
R7 및 R8은 각각 독립적으로 히드록시기, t-부톡시기, 벤질옥시기, -NH-R10 또는 -NH-Q12-(P12-Q12')q10-T4-L4이고,
P12 및 T4는 각각 독립적으로 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q12 및 Q12'는 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n2-CH2CH2-이며, n2는 0∼99의 정수이고,
L4는 당 리간드이고,
Y2는 -O-(CH2)m9-NH- 및 -NH-CO-(CH2)m10-NH이며, m9, m10은 각각 독립적으로 1∼10의 정수이고,
q10은 0∼10의 정수이고,
R9는 수소 원자, t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기, -CO-R10, -CO-(CH2CH2O)n6-CH2CH2-N3 또는 -CO-Q13-B6-(Q14-P13)q11-X2이며, n6은 0∼99의 정수이고,
P13은 존재하지 않거나 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q13 및 Q14는 각각 독립적으로 존재하지 않거나 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n7-CH2CH2-이며, n7은 0∼99의 정수이고,
B6은 하기 식 10-1로 표시되는 어느 하나의 구조이며, 파선에 있어서 각각 Q13 및 Q14와의 결합수를 의미하고,
식 10-1:
식 10-1 중, 트리아졸환을 갖는 기에 있어서의 치환은 상기 트리아졸환의 1 위치 및 3 위치의 질소 원자의 어느 하나이다.
q11은 0∼10의 정수이고,
X2는 수소 원자 또는 고상 담체이고,
R10은 t-부톡시카르보닐기, 벤질옥시카르보닐기, 9-플루오레닐메틸옥시카르보닐기로 치환 혹은 무치환의 아미노기, 카르복시기, 말레이미드기 및 아랄킬옥시카르보닐기로 이루어지는 군에서 선택되는 1 또는 2개의 치환기로 치환된 탄소수 2∼10의 알킬기이다.)
이하, 본 발명과 관련하여 제조 방법을 일례로서 나타낸다. 또한, 이하의 제조 방법 1∼제조 방법 17에 관한 기재에 있어서, 본 발명의 핵산 유도체 등에 있어서의 식 1∼식 12로 표시되는 화합물에서, 기를 나타내는 기호로서 동일한 기호가 이용되고 있는 것이 있지만, 양자는 분리하여 이해되는 것이며, 제조 방법 1∼제조 방법 12에 대하여 기재되는 기의 설명에 의해 본 발명이 한정적으로 해석되는 것이 아니다. 또한, 본 발명에 있어서의 핵산 유도체에 관해서, 올리고뉴클레오티드를 나타내는 X를, 제조 방법 1∼제조 방법 17에서는 -O-X로서 기재한다.
제조 방법 1
본 발명에 있어서의 핵산 유도체는, 식 (I')로 표시되는 부분 구조를 갖는 화합물의 제조 방법으로서, 그 제조 방법을 예시할 수 있다.
(식 중, P1은 Fmoc 등의 염기에 의해 탈보호 가능한 보호기이고, DMTr은 p,p'-디메톡시트리틸기를 나타내고, R은 당 리간드 테더 유닛을 나타내고, R'은 R 중의 당 리간드의 각 수산기가 아세틸기 등의 염기로 탈보호 가능한 보호기로 보호된 기를 나타내고, Polymer는 고상 담체를 나타내고, Q'는 -CO-이다.)
공정 1
화합물 (I-B)는, 화합물 (I-A)와 p,p'-디메톡시트리틸클로리드를, 피리딘 등의 용매 중, 필요에 따라서 공용매의 존재 하에, 0℃와 100℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
공용매로서는, 예컨대 메탄올, 에탄올, 디클로로메탄, 클로로포름, 1,2-디클로로에탄, 톨루엔, 아세트산에틸, 아세토니트릴, 디에틸에테르, 테트라히드로푸란, 1,2-디메톡시에탄, 디옥산, N,N-디메틸포름아미드(DMF), N,N-디메틸아세트아미드, N-메틸피롤리돈, 피리딘, 물 등을 들 수 있으며, 이들은 단독으로 또는 혼합하여 이용된다.
공정 2
화합물 (I-C)는, 화합물 (I-B)를, 무용매로 또는 용매 중, 1∼1000 당량의 2급 아민 존재 하에, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는, 예컨대 메탄올, 에탄올, 디클로로메탄, 클로로포름, 1,2-디클로로에탄, 톨루엔, 아세트산에틸, 아세토니트릴, 디에틸에테르, 테트라히드로푸란, 1,2-디메톡시에탄, 디옥산, N,N-디메틸포름아미드(DMF), N,N-디메틸아세트아미드, N-메틸피롤리돈, 피리딘, 물 등을 들 수 있으며, 이들은 단독으로 또는 혼합하여 이용된다.
2급 아민으로서는 예컨대 디에틸아민, 피페리딘 등을 들 수 있다.
공정 3
화합물 (1-E)는, 화합물 (I-C)와 화합물 (I-D)를, 무용매로 또는 용매 중, 1∼30 당량의 염기, 축합제 및 필요에 따라서 0.01∼30 당량의 첨가제의 존재 하에, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 공정 2에서 예시한 것을 들 수 있다.
염기로서는, 예컨대 탄산세슘, 탄산칼륨, 수산화칼륨, 수산화나트륨, 나트륨메톡시드, 칼륨 tert-부톡시드, 트리에틸아민, 디이소프로필에틸아민, N-메틸모르폴린, 피리딘, 1,8-디아자비시클로[5.4.0]-7-운데센(DBU), N,N-디메틸-4-아미노피리딘(DMAP) 등을 들 수 있다.
축합제로서는, 예컨대 1,3-디시클로헥산카르보디이미드(DCC), 1-에틸-3-(3-디메틸아미노프로필)카르보디이미드·염산염(EDC), 카르보닐디이미다졸, 벤조트리아졸-1-일옥시트리스(디메틸아미노)포스포늄 헥사플루오로포스파이트, (벤조트리아졸-1-일옥시)트리피롤리디노포스포늄헥사플루오로포스파이트, O-(7-아자벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄 헥사플루오로포스파이트(HATU), O-(벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄 헥사플루오로포스파이트(HBTU), 요오드화 2-클로로-1-메틸피리디늄 등을 들 수 있다.
첨가제로서는 예컨대 1-히드록시벤조트리아졸(HOBt), 4-디메틸아미노피리딘(DMAP) 등을 들 수 있다.
화합물 (I-D)는 공지된 방법(예컨대 Journal of American Chemical Society, 136, 16958, (2014)를 참조) 혹은 그것에 준한 방법으로 얻을 수 있다.
공정 4
화합물 (I-F)는, 화합물 (I-E)와 숙신산무수물을, 용매 중, 1∼30 당량의 염기 존재 하에, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 공정 2에서 예시한 것을 들 수 있다.
염기로서는 공정 3에서 예시한 것을 들 수 있다.
공정 5
화합물 (I-G)는, 화합물 (I-F)와 말단이 아미노화된 고상 담체를, 무용매로 또는 용매 중, 1∼30 당량의 염기, 축합제 및 필요에 따라서 0.01∼30 당량의 첨가제의 존재 하에, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응한 후, 무수아세트산/피리딘 용액과, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 공정 2에서 예시한 것을 들 수 있다.
염기, 축합제 및 첨가제로서는 각각 공정 3에서 예시한 것을 들 수 있다.
아미노화된 고상 담체로서는, 예컨대 장쇄 알킬아민 세공성 유리(LCAA-CPG) 등을 들 수 있으며, 이들은 시판 제품으로서 얻을 수 있다.
공정 6
식 (I')로 표시되는 당 리간드 테더 블랜처 유닛을 갖는 핵산 복합체는, 화합물 (I-G)를 이용하여, 공지된 올리고뉴클레오티드 화학 합성법으로 대응하는 뉴클레오티드 사슬을 신장한 후에, 고상으로부터의 탈리, 보호기의 탈보호 및 정제를 행함으로써 제조할 수 있다.
공지된 올리고뉴클레오티드 화학 합성법으로서는, 포스포로아미다이트법, 포스포로티오에이트법, 포스포트리에스테르법, CEM법(Nucleic Acids Research, 35, 3287(2007)를 참조) 등을 들 수 있으며, 예컨대 ABI3900 하이 스루풋 핵산 합성기(어플라이드바이오시스템즈사 제조)에 의해 합성할 수 있다.
고상으로부터의 탈리, 탈보호는, 올리고뉴클레오티드 화학 합성 후, 용매 또는 무용매 중, -80℃에서부터 200℃ 사이의 온도에서 10초간부터 72시간 염기로 처리함으로써 제조할 수 있다.
염기로서는, 예컨대 암모니아, 메틸아민, 디메틸아민, 에틸아민, 디에틸아민, 이소프로필아민, 디이소프로필아민, 피페리딘, 트리에틸아민, 에틸렌디아민, 1,8-디아자비시클로[5.4.0]-7-운데센(DBU), 탄산칼륨 등을 들 수 있다.
용매로서는 물, 메탄올, 에탄올, THF 등을 들 수 있다.
올리고뉴클레오티드는, C18 역상 컬럼 혹은 음이온 교환 컬럼, 바람직하게는 상술한 2개의 수법을 조합하여 정제할 수 있다. 정제 후의 핵산 복합체 순도는 90% 이상, 바람직하게는 95% 이상으로 하는 것이 좋다.
또한, 상기 공정 3에 있어서, 필요에 따라 화합물 (I-D)를 2개의 유닛으로 분할하고, 2단계로 나눠 화합물 (I-C)와 축합함으로써 행할 수도 있다. 구체적으로는, 예컨대 R-Q'가 R-NH-CO-Q4'-CO-인 경우(Q4'는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌이다), 공정 3에 있어서 화합물 (I-C)와 CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의)를 공정 3과 같은 방법으로 축합시키고, 얻어진 화합물의 에틸에스테르를 에탄올이나 물 등의 용매 중, 수산화리튬 등의 염기로 가수분해한 후에, 또한 R'-NH2(R'는 상기와 동의)와 축합시킴으로써 목적으로 하는 화합물을 얻을 수 있다. 또한, CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의) 및 R'-NH2(R'은 상기와 동의)는 공지된 방법(예컨대 Journal of American Chemical Society, 136, 16958(2014)을 참조) 혹은 또한 그것에 준한 방법으로 얻을 수 있다. 여기서, Q4'에 있어서, 치환 혹은 무치환의 탄소수 1∼12의 알킬렌에 있어서의 치환기 및 알킬렌 부분은 상기와 마찬가지다.
Q가 -CO-인 경우를 예시하여 나타내고 있지만, Q가 -CO-가 아닌 경우의 화합물에 관해서도, Q의 구조를 적절하게 변경하고, 상기와 같은 방법, 공지된 방법 또는 이들을 조합하여, 적절하게 반응 조건을 변경함으로써 조제할 수 있다.
제조 방법 2
본 발명에 있어서의 핵산 유도체는, 식 (II')로 표시되는 부분 구조를 갖는 화합물의 제조 방법으로서, 그 제조 방법을 예시할 수 있다.
(식 중, DMTr, R, R', X, Q' 및 Polymer는 상기와 동의. TBDMS는 t-부틸디메틸실릴기, Fmoc는 9-플루오레닐메틸옥시카르보닐기를 나타낸다)
공정 7
화합물 (II-A)는, 화합물 (I-A), t-부틸디메틸실릴클로리드 및 디메틸아미노피리딘을 N,N-디메틸포름아미드(DMF) 등의 용매 중, 바람직하게는 2 등량의 염기의 존재 하에, 0℃∼100℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
염기로서는 제조 방법 1의 공정 3에서 예시한 것을 들 수 있다.
공정 8
화합물 (II-B)는, 화합물 (II-A)를 이용하여, 제조 방법 1의 공정 1과 같은 조건으로 제조할 수 있다.
공정 9
화합물 (II-C)는, 화합물 (II-B)와 불화n-테트라부틸암모늄(TBAF)을, 용매 중, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 공정 2에서 예시한 것을 들 수 있다.
공정 10
화합물 (II-D)는, 화합물 (II-C)를 이용하여, 제조 방법 1의 공정 2와 같은 조건으로 제조할 수 있다.
공정 11
화합물 (II-E)는, 화합물 (II-D) 및 화합물 (I-D)를 이용하여, 제조 방법 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 12∼14
화합물 (II')는, 화합물 (II-E)를 이용하여, 제조 방법 1의 공정 4∼공정 6과 같은 조건으로 제조할 수 있다.
또한, 상기 공정 11에 있어서, 필요에 따라 화합물 (I-D)를 2개의 유닛으로 분할하고, 2단계로 나눠 화합물 (II-C)와 축합함으로써 행할 수도 있다. 구체적으로는, 예컨대 R-Q'가 -NH-CO-Q4'-CO-인 경우(Q4'는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌), 공정 11에 있어서 화합물 (II-C)와 CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의)를 공정 11과 같은 방법으로 축합시키고, 얻어진 화합물의 에틸에스테르를 에탄올이나 물 등의 용매 중, 수산화리튬 등의 염기로 가수분해한 후에, 또한 R'-NH2(R'은 상기와 동의)와 축합시킴으로써 목적으로 하는 화합물을 얻을 수 있다. 또한, CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의) 및 R'-NH2(R'는 상기와 동의)는 공지된 방법(예컨대 Journal of American Chemical Society, 136, 16958(2014)를 참조) 혹은 그것에 준한 방법으로 얻을 수 있다.
Q가 -CO-인 경우를 예시하여 나타내고 있지만, Q가 -CO-가 아닌 경우의 화합물에 관해서도, Q의 구조를 적절하게 변경하고, 상기와 같은 방법, 공지된 방법 또는 이들을 조합하여, 적절하게 반응 조건을 변경함으로써 조제할 수 있다.
제조 방법 3
본 발명에 있어서의 핵산 유도체는, 식 (III')으로 표시되는 부분 구조를 갖는 화합물의 제조 방법으로서, 그 제조 방법을 예시할 수 있다.
(식 중, DMTr, Fmoc, R, R', Q', X 및 Polymer는 상기와 동의이다.)
화합물 (III')은, 화합물 (III-A)를 이용하여, 제조 방법 1의 공정 1∼공정 6과 같은 조건으로 제조할 수 있다. 또한, 화합물 (III-A)는 시판 제품으로서 얻을 수 있다.
공정 15
화합물 (III-B)는, 화합물 (III-A)를 이용하여, 제조법 1의 공정 1과 같은 조건으로 제조할 수 있다.
화합물 (III-A)는 시판 제품으로서 구입할 수 있다.
공정 16
화합물 (III-C)는, 화합물 (III-B)를 이용하여, 제조법 1의 공정 2와 같은 조건으로 제조할 수 있다.
공정 17
화합물 (III-E)는, 화합물 (III-C)를 이용하여, 제조법 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 18∼20
화합물 (III')은, 화합물 (III-E)를 이용하여, 제조 방법 1의 공정 4∼공정 6과 같은 조건으로 제조할 수 있다.
또한, 상기 공정 17에 있어서, 필요에 따라 화합물 (I-D)를 2개의 유닛으로 분할하고, 2단계로 나눠 화합물 (III-C)와 축합함으로써 행할 수도 있다. 구체적으로는, 예컨대 R-Q'가 -NH-CO-Q4'-CO-인 경우(Q4'는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌), 공정 17에 있어서 화합물 (III-C)와 CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의)를 공정 17과 같은 방법으로 축합시키고, 얻어진 화합물의 에틸에스테르를 에탄올이나 물 등의 용매 중, 수산화리튬 등의 염기로 가수분해한 후에, 또한 R'-NH2(R'은 상기와 동의)와 축합시킴으로써 목적으로 하는 화합물을 얻을 수 있다. 또한, CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의) 및 R'-NH2(R'은 상기와 동의)는 공지된 방법(예컨대 Journal of American Chemical Society, 136, 16958(2014)를 참조) 혹은 그것에 준한 방법으로 얻을 수 있다.
Q가 -CO-인 경우를 예시하여 나타내고 있지만, Q가 -CO-가 아닌 경우의 화합물에 관해서도, Q의 구조를 적절하게 변경하고, 상기와 같은 방법, 공지된 방법 또는 이들을 조합하여, 적절하게 반응 조건을 변경함으로써 조제할 수 있다.
제조 방법 4
본 발명에 있어서의 핵산 유도체는, 식 (IV')로 표시되는 부분 구조를 갖는 화합물의 제조 방법으로서, 그 제조 방법을 예시할 수 있다.
(식 중, DMTr, Fmoc, R, R', Q', X 및 Polymer는 상기와 동의이다.)
화합물 (IV')는, 화합물 (IV-A)를 이용하여, 제조 방법 1의 공정 1∼공정 6과 같은 조건으로 제조할 수 있다. 또한, 화합물 (IV-A)는 시판 제품으로서 얻을 수 있다.
또한, 상기 공정 23에 있어서, 필요에 따라 화합물 (I-D)를 2개의 유닛으로 분할하고, 2단계로 나눠 화합물 (IV-C)와 축합함으로써 행할 수도 있다. 구체적으로는, 예컨대 R'-Q'가 -NH-CO-Q4'-CO-인 경우(Q4'는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌이다), 공정 23에 있어서 화합물 (IV-C)와 CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의)를 공정 23과 같은 방법으로 축합시키고, 얻어진 화합물의 에틸에스테르를 에탄올이나 물 등의 용매 중, 수산화리튬 등의 염기로 가수분해한 후에, 또한 R'-NH2(R'은 상기와 동의)와 축합시킴으로써 목적으로 하는 화합물을 얻을 수 있다. 또한, CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의) 및 R'-NH2(R'은 상기와 동의)는 공지된 방법(예컨대 Journal of American Chemical Society, 136, 16958(2014)를 참조) 혹은 그것에 준한 방법으로 얻을 수 있다.
Q가 -CO-인 경우를 예시하여 나타내고 있지만, Q가 -CO-가 아닌 경우의 화합물에 관해서도, Q의 구조를 적절하게 변경하고, 상기와 같은 방법, 공지된 방법 또는 이들을 조합하여, 적절하게 반응 조건을 변경함으로써 조제할 수 있다.
제조 방법 5
본 발명에 있어서의 핵산 유도체는, 식 (V')로 표시되는 부분 구조를 갖는 화합물의 제조 방법으로서, 그 제조 방법을 예시할 수 있다.
(식 중, DMTr, R, R', X, Q', TBDMS, Fmoc 및 Polymer는 상기와 동의.)
화합물 (V')는, 화합물 (IV-A)를 이용하여, 제조 방법 2의 공정 1∼공정 7과 같은 조건으로 제조할 수 있다. 또한, 화합물 (IV-A)는 시판 제품으로서 얻을 수 있다.
또한, 상기 공정 31에 있어서, 필요에 따라 화합물 (I-D)를 2개의 유닛으로 분할하고, 2단계로 나눠 화합물 (V-D)와 축합함으로써 행할 수도 있다. 구체적으로는, 예컨대 R'-Q'가 -NH-CO-Q4'-CO-인 경우(Q4'는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌이다.), 공정 31에 있어서 화합물 (V-D)와 CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의)를 공정 31과 같은 방법으로 축합시키고, 얻어진 화합물의 에틸에스테르를 에탄올이나 물 등의 용매 중, 수산화리튬 등의 염기로 가수분해한 후에, 또한 R'-NH2(R'은 상기와 동의)와 축합시킴으로써 목적으로 하는 화합물을 얻을 수 있다. 또한, CH3CH2-O-CO-Q4'-CO-OH(Q4'는 상기와 동의) 및 R'-NH2(R'는 상기와 동의)는 공지된 방법(예컨대 Journal of American Chemical Society, 136, 16958(2014)를 참조) 혹은 그것에 준한 방법으로 얻을 수 있다.
Q가 -CO-인 경우를 예시하여 나타내고 있지만, Q가 -CO-가 아닌 경우의 화합물에 관해서도, Q-OH의 구조를 적절하게 변경하고, 상기와 같은 방법, 공지된 방법 또는 이들을 조합하여, 적절하게 반응 조건을 변경함으로써 조제할 수 있다.
제조 방법 6
올리고뉴클레오티드의 5' 말단에 당 리간드 테더 블랜처 유닛이 결합한 본 발명의 핵산 복합체의 제조 방법을 이하에 예시한다.
(식 중, R, R', Q', DMTr 및 X는 상기와 동의이다.)
공정 35
화합물 (I-H)는, 화합물 (II-E)와 2-시아노에틸-N,N,N',N'-테트라이소프로필포스포디아미다이트를, 무용매로 또는 용매 중, 염기 및 반응촉진제 공존 하에, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 제조 방법 1의 공정 2에서 예시한 것을 들 수 있다.
염기로서는 제조 방법 1의 공정 3에서 예시한 것을 들 수 있다.
반응촉진제로서는, 예컨대 1H-테트라졸, 4,5-디시아노이미다졸, 5-에틸티오테트라졸, 5-벤질티오테트라졸 등을 들 수 있으며, 시판 제품으로서 구입할 수 있다.
공정 36
올리고뉴클레오티드 사슬을 신장하고, 마지막으로 화합물 (I-H)를 이용하여, 올리고뉴클레오티드의 5' 말단을 당 리간드 테더 블랜처 유닛으로 수식한 후, 고상으로부터의 탈리 보호기의 탈보호 및 정제를 행함으로써 화합물 (I'')을 제조할 수 있다. 여기서, 고상으로부터의 탈리, 보호기의 탈보호 및 정제는 각각 제조 방법 1의 공정 7과 같은 식으로 하여 제조할 수 있다.
제조 방법 7
올리고뉴클레오티드의 5' 말단에 당 리간드 테더 블랜처 유닛이 결합한 본 발명의 핵산 복합체의 제조 방법을 이하에 예시한다.
제조 방법 6의 공정 35 및 36과 같은 조건으로 제조할 수 있다.
(식 중, R, R', Q', DMTr 및 X는 상기와 동의이다.)
제조 방법 8
올리고뉴클레오티드의 5' 말단에 당 리간드 테더 블랜처 유닛이 결합한 본 발명의 핵산 복합체의 제조 방법을 이하에 예시한다.
제조 방법 6의 공정 35 및 36과 같은 조건으로 제조할 수 있다.
(식 중, R, R', Q', DMTr 및 X는 상기와 동의이다.)
제조 방법 9
올리고뉴클레오티드의 5' 말단에 당 리간드 테더 블랜처 유닛이 결합한 본 발명의 핵산 복합체의 제조 방법을 이하에 예시한다.
제조 방법 6의 공정 35 및 36과 같은 조건으로 제조할 수 있다.
(식 중, R, R', Q', DMTr 및 X는 상기와 동의이다.)
제조 방법 10
올리고뉴클레오티드의 5' 말단에 당 리간드 테더 블랜처 유닛이 결합한 본 발명의 핵산 복합체의 제조 방법을 이하에 예시한다.
제조 방법 6의 공정 35 및 36과 같은 조건으로 제조할 수 있다.
(식 중, R, R', Q', DMTr 및 X는 상기와 동의이다.)
제조 방법 11
이중 사슬 핵산을 구성하는 센스 사슬의 3 말단' 또는 5' 말단에 당 리간드 테더 블랜처 유닛을 갖는 센스 사슬과, 이중 사슬 핵산을 구성하는 안티센스 사슬을, 물 또는 적당한 완충액에 각각 용해하여 혼합함으로써, 이중 사슬 핵산을 갖는 핵산 복합체를 얻을 수 있다.
완충액으로서는, 예컨대 아세트산 완충액, 트리스 완충액, 시트르산 완충액, 인산 완충액, 물 등을 들 수 있으며, 이들을 단독으로 또는 혼합하여 이용된다.
센스 사슬과 안티센스 사슬의 혼합비로서는, 센스 사슬 1 당량에 대하여 안티센스 사슬 0.5∼2 당량이 바람직하고, 0.9∼1.1 당량이 보다 바람직하고, 0.95 당량∼1.05 당량이 더욱 바람직하다.
또한, 상기 센스 사슬과 상기 안티센스 사슬을 혼합한 후, 적절하게 어닐링 처리를 행하여도 좋다. 어닐링 처리는, 센스 사슬과 안티센스 사슬의 혼합물을, 바람직하게는 50∼100℃, 보다 바람직하게는 60∼100℃, 더욱 바람직하게는 80∼100℃로 가열한 후에, 실온까지 서냉함으로써 행할 수 있다.
안티센스 사슬은 상기한 공지된 올리고뉴클레오티드 합성법에 준하여 얻을 수 있다.
제조 방법 12
본 발명에 있어서의 핵산 유도체는, 식 (VI')으로 표시되는 부분 구조를 갖는 화합물의 제조 방법으로서, 그 제조 방법을 예시할 수 있다.
(식 중, DMTr, R, R', X, Q', Polymer 및 Fmoc는 상기와 동의이고, TBS는 t-부틸디메틸실릴기를 나타내고, R0 및 Rx는 동일하거나 또는 다르며, 수소 원자, C1∼C10의 알킬렌 또는 C3-C8의 시클로알킬렌을 나타내고, W는 C1∼C10의 알킬렌, C3-C8의 시클로알킬렌이거나, R0와 함께 C4-C8의 함질소 복소환을 형성하여도 좋다.)
공정 45
화합물 (VI-B)는, 화합물 (VI-A)를 이용하여, 제조 방법 1의 공정 1과 같은 조건으로 제조할 수 있다.
화합물 (VI-A)는 시판 제품으로서 또는 공지된 방법(예컨대 바이오 오가닉 앤드 메디시날 케미스트리 레터즈, 제11권, 383-386 페이지) 혹은 그것에 준한 방법으로 얻을 수 있다.
공정 46
화합물 (VI-C)는, 화합물 (VI-B)를 이용하여, 제조 방법 1의 공정 2와 같은 조건으로 제조할 수 있다.
공정 47
화합물 (VI-D)는, 화합물 (VI-C)를 이용하여, 제조 방법 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 48
화합물 (VI-E)는, 화합물 (VI-D)를 이용하여, 제조 방법 1의 공정 2와 같은 조건으로 제조할 수 있다.
공정 49
화합물 (VI-G)는, 화합물 (VI-E)와 화합물 (VI-F)를 이용하여, 제조 방법 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 50
화합물 (VI-H)는, 화합물 (VI-G)를 이용하여, 제조 방법 2의 공정 9와 같은 조건으로 제조할 수 있다.
공정 51∼53
화합물 (VI')은, 화합물 (VI-H), 화합물 (VI-I) 및 화합물 (VI-J)를 이용하여, 제조 방법 1의 공정 4∼6과 같은 조건으로 제조할 수 있다.
공정 45∼53은 공지된 방법(예컨대 국제공개 제2015/105083호에 기재된 방법) 또는 그것에 준한 방법으로도 실시할 수 있다.
화합물 (VI-F)는 공지된 방법(예컨대 저널 오브 아메리칸 케미컬 소사이어티(Journal of American Chemical Society), 136권, 16958 페이지, 2014년에 기재된 방법) 또는 그것에 준한 방법으로 얻을 수 있다.
제조 방법 13
식 2에 있어서 P1 및 P4가 -NH-CO-, -O-CO- 또는 -S-CO-인 당 리간드 테더 유닛은 이하의 방법으로 제조할 수 있다.
(식 중, Q1, Q2, Q3, Q4, Q5, P2, P3, P5, P6, P7, T1, T2, L1, L2, q1, q2, q3 및 q4는 각각 상기와 동의이며, q2'는 q2보다 1작은 정수를 나타내고, q4'는 q4보다 1 작은 정수를 나타내고, P1' 및 P4'는 각각 독립적으로 -NH-CO-, -O-CO- 또는 -S-CO-를 나타내고, Z는 H, OH, NH2, SH, 염소 원자, 브롬 원자, 요오드 원자, 메탄술포닐옥시, p-톨루엔술포닐옥시 또는 카르복실산을 나타내고, B1' 및 B2'는 하기 식의 구조체의 어느 하나를 나타내고, PG1, PG2, PG3, PG4, PG5, PG6 및 PG7은 각각 적절한 보호기를 나타낸다.)
식:
m1, m2, m3 또는 m4는 각각 독립적으로 0∼10의 정수를 나타낸다.
공정 54
화합물 (VII-C)는, 화합물 (VII-A)와 화합물 (VII-B)를, 테트라히드로푸란 등의 용매 중, 트리페닐포스핀 폴리머 담지체를 가하여, 빙냉 하에 디이소프로필아조디카르복실레이트톨루엔 용액을 반응시킴으로써 제조할 수 있다.
용매로서는 제조 공정 1의 공정 2에서 예시한 것을 들 수 있다.
화합물 (VII-A)는 시판 제품으로서 얻을 수 있다.
공정 55
화합물 (VII-D)는, 화합물 (VII-C)를 이용하여, 메탄올 등의 용매 중, 빙냉 하, 염기의 존재 하에 반응시킴으로써 제조할 수 있다.
용매로서는 제조 공정 1의 공정 2에서 예시한 것을 들 수 있다.
염기로서는 제조 공정 1의 공정 3에서 예시한 것을 들 수 있다.
공정 56
화합물 (VII-F)는, 화합물 (VII-D) 및 화합물 (VII-E)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 57
화합물 (VII-H)는, 화합물 (VII-F) 및 화합물 (VII-G)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 58
화합물 (VII-J)는, 화합물 (VII-H) 및 화합물 (VII-I)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
또한, 하기 공정 DP1과 공정 58을 반복하여 행함으로써, 원하는 q1의 값을 갖는 화합물 (VII-J)를 제조할 수 있다.
공정 59
화합물 (VII-L)은, 화합물 (VII-J) 및 화합물 (VII-K)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 60
화합물 (VII-N)은, 화합물 (VII-L) 및 화합물 (VII-M)을 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 61∼63
화합물 (VII')은, 화합물 (VII-O), 화합물 (VII-P) 및 화합물 (VII-Q)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
또한, 하기 공정 DP1과 공정 61을 반복하여 행함으로써, 원하는 q3의 값을 갖는 화합물 (VII')을 제조할 수 있다.
공정 DP1
유기합성화학에서 상용되는 방법[예컨대 프로텍티브 그룹스 인 오가닉 신세시스 제3판(Protective Groups in Organic Synthesis, third edition), 그린(T. W. Greene) 저, John Wiley & Sons Inc.(1999년) 등에 기재된 방법 등]을 적절히 이용함으로써 원하는 화합물을 제조할 수 있다.
화합물 (VII-B), 화합물 (VII-E), 화합물 (VII-G), 화합물 (VII-I), 화합물 (VII-K), 화합물 (VII-M), 화합물 (VII-O), 화합물 (VII-P) 및 화합물 (VII-Q)는, 시판 제품으로서 또는 「실험화학강좌 제4판 유기합성, p. 258, 마루젠(1992년)」, 「March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 7th Edition」에 기재된 방법을 조합하거나 혹은 그것에 준한 방법으로 얻을 수 있다.
제조 방법 14
식 4에 있어서 P7이 -O-인 유닛은 이하의 방법으로 제조할 수 있다.
(식 중, Q5, P7, q5는 각각 상기와 동의이며, q5''는 q5보다 2 작은 정수를 나타내고, q5'는 q5보다 1 작은 정수를 나타내고, Z2는 H, OH, NH2 또는 SH를 나타내고, PG8 및 PG9는 각각 적절한 보호기를 나타내고, LC는 당 리간드 테더 유닛을 나타내고, E는 카르복실산 또는 말레이미드를 나타낸다.)
공정 64
화합물 (VIII-C)는, 화합물 (VIII-A) 및 화합물 (VIII-B)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
또한, 하기 공정 DP2와 공정 64를 반복하여 행함으로써 원하는 q5''의 값을 갖는 화합물 (VIII-C)를 제조할 수 있다. 화합물 (VIII-B)는, 시판 제품으로서 또는 「실험화학강좌 제4판 유기합성, p. 258, 마루젠(1992년)」, 「March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 7th Edition」에 기재된 방법을 조합하거나 혹은 그것에 준한 방법으로 얻을 수 있다.
공정 65
화합물 (VIII')은, 화합물 (VIII-C) 및 화합물 (VIII-D)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
화합물 (VIII-D)는, 시판 제품으로서 또는 「실험화학강좌 제4판 유기합성, p. 258, 마루젠(1992년)」, 「March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 7th Edition」에 기재된 방법을 조합하거나 혹은 그것에 준한 방법으로 얻을 수 있다.
공정 DP2
유기합성화학에서 상용되는 방법[예컨대 프로텍티브 그룹스 인 오가닉 신세시스 제3판(Protective Groups in Organic Synthesis, third edition), 그린(T. W. Greene) 저, John Wiley & Sons Inc.(1999년) 등에 기재된 방법 등]을 적절히 이용함으로써 원하는 화합물을 제조할 수 있다.
제조 방법 15
식 2에 있어서 P1 및 P4가 -O-인 당 리간드 테더 유닛은 이하의 방법으로 제조할 수 있다.
(식 중, Q1, Q2, Q3, Q4, P2, P3, P5, P6, T1, T2, L1, L2, q1, q2, q3, q4, q2', q4', Z, B1', B2'는 각각 상기와 동의이며, PG10, PG11, PG12, PG13, PG14 및 PG15는 각각 적절히 보호기를 나타낸다)
식:
m1, m2, m3 및 m4는 상기와 동의이다.
공정 66
화합물 (IX-C)는, 화합물 (IX-A)와 화합물 (IX-B)를 N,N'-디메틸포름아미드 등의 용매에 용해하고, 탄산수소칼륨 등의 염기를 가하여, 실온∼200℃에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 제조 공정 1의 공정 2에 예시한 것을 들 수 있다.
염기로서는 제조 공정 1의 공정 3에서 예시한 것을 들 수 있다.
공정 67
화합물 (IX-E)는, 화합물 (IX-C)와 화합물 (IX-D)를, N,N'-디메틸포름아미드 등의 용매에 용해하고, 탄산수소칼륨 등의 염기를 가하여, 실온∼200℃에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 제조 공정 1의 공정 2에서 예시한 것을 들 수 있다.
염기로서는 제조 공정 1의 공정 3에서 예시한 것을 들 수 있다.
화합물 (IX-A)는 시판 제품으로서 얻을 수 있다.
공정 68
화합물 (IX-G)는, 화합물 (IX-E) 및 화합물 (IX-F)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 69
화합물 (IX-I)는, 화합물 (IX-G) 및 화합물 (IX-H)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
또한, 공정 DP와 공정 69를 반복하여 행함으로써, 원하는 q1의 값을 갖는 화합물 (VII-J)를 제조할 수 있다.
공정 70
화합물 (IX-K)는, 화합물 (IX-I) 및 화합물 (IX-J)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 71
화합물 (IX-M)은, 화합물 (IX-K) 및 화합물 (IX-L)을 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
공정 72-74
화합물 (IX')는, 화합물 (IX-M), 화합물 (IX-N), 화합물 (IX-O) 및 화합물 (IX-P)를 이용하여, 제조 공정 1의 공정 3과 같은 조건으로 제조할 수 있다.
또한, 하기 공정 DP3과 공정 72를 반복하여 행함으로써, 원하는 q3의 값을 갖는 화합물 (IX')를 제조할 수 있다.
공정 DP3
유기합성화학에서 상용되는 방법[예컨대 프로텍티브 그룹스 인 오가닉 신세시스 제3판(Protective Groups in Organic Synthesis, third edition), 그린(T. W. Greene) 저, John Wiley & Sons Inc.(1999년) 등에 기재된 방법 등]을 적절히 이용함으로써 원하는 화합물을 제조할 수 있다.
화합물 (IX'-B), 화합물 (IX'-D), 화합물 (IX'-F), 화합물 (IX'-H), 화합물 (IX'-J), 화합물 (IX'-L), 화합물 (IX'-N), 화합물 (IX'-O) 및 화합물 (IX'-P)는, 시판 제품으로서 또는 「실험화학강좌 제4판 유기합성, p. 258, 마루젠(1992년)」, 「March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 7th Edition」에 기재된 방법을 조합하거나 혹은 그것에 준한 방법으로 얻을 수 있다.
제조 방법 16
식 1∼식 8의 핵산 복합체의 제조 방법으로서 이하의 방법도 이용할 수 있다.
(식 중, LC, Q5, Q6, Q7, P7, P8, q5', q6 및 X는 상기와 동의이다.)
공정 75
화합물 (X-B)는, 화합물 (XIII'')과 화합물 (X-A)를, 용매 중, 0℃∼100℃에서 10초간∼100시간 반응시킴으로써 제조할 수 있다.
용매로서는 물, 인산 완충액, 아세트산나트륨 완충액, 디메틸술폭시드 등을 들 수 있으며, 이들은 단독으로 또는 혼합하여 이용된다.
화합물 (VIII')은 제조법 14를 이용함으로써 얻을 수 있다.
화합물 (X-A)는 공지된 방법(예컨대 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제21권, 187-202 페이지, 2010년, 또는 커런트 프로토콜즈 인 뉴클레익 애시드 케미스트리(Current Protocols in Nucleic Acid Chemistry), 2010년, 9월; CHAPTER: Unit 4.41) 혹은 그것에 준한 방법으로 얻을 수 있다.
공정 76
화합물 (X')는, 화합물 (X-B)를 이용하여, 탄산나트륨 수용액 또는 암모니아수 중 등 pH 8 이상의 조건 하에, 실온과 200℃ 사이의 온도에서 5분간∼100시간 반응시킴으로써 제조할 수 있다.
제조 방법 17
식 1∼식 8의 핵산 복합체의 제조 방법으로서 이하의 방법도 이용할 수 있다.
(식 중, LC, Q5, Q6, Q7, P7, P8, q5', q6 및 X는 상기와 동의이다.)
공정 77
화합물 (XI-A)는, 화합물 (VIII'')을 이용하여, 공지된 방법(예컨대 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제26권, 1451-1455 페이지, 2015년에 기재된 방법) 또는 그것에 준한 방법으로 얻을 수 있다.
화합물 (VIII''')은 제조법 14를 이용함으로써 얻을 수 있다.
공정 78
화합물 (XI')은, 화합물 (XI-A)와 화합물 (XI-B)를 이용하여, 공지된 방법(예컨대 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제26권, 1451-1455 페이지, 2015년에 기재된 방법) 또는 그것에 준한 방법으로 얻을 수 있다.
화합물 (XI-B)는, 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제26권, 1451-1455 페이지, 2015년에 기재된 방법) 또는 그것에 준한 방법으로 얻을 수 있다.
공정 79
또 다른 방법으로서, 화합물 (XI')은, 공지된 방법(예컨대 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제22권, 1723-1728 페이지, 2011년을 참조) 혹은 그것에 준한 방법으로 화합물 (XI-A)로부터 직접 얻을 수 있다.
본 명세서에 있어서의 핵산 복합체는, 예컨대 산 부가염, 금속염, 암모늄염, 유기아민 부가염, 아미노산 부가염 등의 염으로서 얻을 수도 있다.
산 부가염으로서는, 예컨대 염산염, 황산염, 인산염 등의 무기산염, 아세트산염, 말레산염, 푸마르산염, 시트르산염, 메탄술폰산염 등의 유기산염을 들 수 있고, 금속염으로서는, 예컨대 나트륨염, 칼륨염 등의 알칼리 금속염, 마그네슘염, 칼슘염 등의 알칼리 토류 금속염, 알루미늄염, 아연염 등을 들 수 있고, 암모늄염으로서는, 예컨대 암모늄, 테트라메틸암모늄 등의 염을 들 수 있고, 유기아민 부가염으로서는, 예컨대 모르폴린, 피페리딘 등의 부가염을 들 수 있고, 아미노산 부가염으로서는, 예컨대 리신, 글리신, 페닐알라닌 등의 부가염을 들 수 있다.
본 명세서의 핵산 복합체의 염을 조제하고 싶은 경우에는, 상기 복합체를 원하는 염의 형태로 얻어질 때는 그대로 정제하면 되고, 또한 유리(遊離) 형태로 얻어질 때는, 상기 복합체를 적당한 용매에 용해 또는 현탁하고, 대응하는 산 또는 염기를 가하여, 단리·정제하면 된다. 또한, 상기 복합체염을 형성하는 카운터 이온을 다른 카운터 이온으로 변환할 때는, 상기 복합체염을 적당한 용매에 용해 또 는 현탁한 후, 산, 염기 및/또는 염(염화나트륨, 염화암모늄 등의 무기염 등)을 몇 당량∼매우 과잉량 가하여 단리, 정제하면 된다.
본 명세서의 핵산 복합체 중에는, 기하 이성체, 광학 이성체 등의 입체 이성체, 호변 이성체 등이 존재할 수 있는 것도 있는데, 모든 가능한 이성체 및 이들의 혼합물도 본 발명에 포함된다.
또한, 본 명세서의 핵산 복합체는, 물 또는 각종 용매와의 부가물 형태로 존재하는 경우도 있으며, 이들 부가물도 본 발명의 핵산 복합체에 포함된다.
더욱이, 본 발명의 핵산 복합체는, 분자 중의 일부 혹은 모든 원자가 질량수가 다른 원자(동위체)(예컨대 중수소 원자 등)로 치환된 것도 포함된다.
본 발명의 의약 조성물은 식 1로 표시되는 핵산 복합체를 포함한다. 본 발명의 핵산 복합체는, L1 및 L2의 당 리간드를 가짐으로써, 표적 세포에 인식되어, 세포 내에 도입된다.
본 발명의 핵산 복합체는, 포유동물에게 투여하여, 생체 내에 있어서 표적 유전자의 발현을 저하 또는 정지시킴으로써 억제하여, 표적 유전자와 관련된 질환의 치료에 이용할 수 있다.
본 발명의 핵산 복합체를 치료제 또는 예방제로서 사용하는 경우, 투여 경로로서는, 치료 시에 가장 효과적인 투여 경로를 사용하는 것이 바람직하며, 특별히 한정되는 것이 아니지만, 예컨대 정맥내 투여, 피하 투여, 근육내 투여 등을 들 수 있고, 바람직하게는 피하 투여이다.
투여량은, 투여 대상의 병상(病狀)이나 연령, 투여 경로 등에 따라 다르지만, 예컨대 이중 사슬의 올리고뉴클레오티드로 환산한 1일 투여량이 0.1 μg∼1000 mg이 되도록 투여하면 되며, 1일 투여량이 1∼100 mg이 되도록 투여하는 것이 보다 바람직하다.
정맥내 투여 또는 근육내 투여에 적당한 제제로서는, 예컨대 주사제를 들 수 있고, 조제한 액제를 그대로 예컨대 주사제 등의 형태로서 이용하는 것도 가능하지만, 상기 액제로부터 예컨대 여과, 원심분리 등에 의해서 용매를 제거하여 사용할 수도 있고, 상기 액제를 동결 건조하여 사용하고/거나 예컨대 만니톨, 락토오스, 트레할로스, 말토오스 혹은 글리신 등의 부형제를 가한 액제를 동결 건조하여 사용할 수도 있다.
주사제의 경우, 액제 또는 용매를 제거 또는 동결 건조한 조성물에, 예컨대 물, 산, 알칼리, 다양한 완충액, 생리식염수 또는 아미노산 수액 등을 혼합하여 주사제를 조제하는 것이 바람직하다. 또한, 예컨대 시트르산, 아스코르빈산, 시스테인 혹은 EDTA 등의 항산화제, 또는 글리세린, 포도당 혹은 염화나트륨 등의 등장화제 등을 첨가하여 주사제를 조제하는 것도 가능하다. 또한, 예컨대 글리세린 등의 동결보존제를 가하여 동결 보존할 수도 있다.
본 발명의 조성물을 포유동물의 세포에 투여함으로써, 본 발명의 조성물 중의 이중 사슬 핵산을 세포 내에 도입할 수 있다.
인비보에 있어서의 본 발명의 핵산 복합체를 포유동물의 세포에 도입하는 방법은, 인비보에 있어서 행할 수 있는 공지된 트랜스펙션의 수순에 따라서 행하면 된다. 본 발명의 조성물을 사람을 포함하는 포유동물에게 정맥내 투여함으로써 간에 송달되어, 간 또는 간세포 내에 본 발명의 조성물 중의 이중 사슬 핵산을 도입할 수 있다.
간 또는 간세포 내에 본 발명의 조성물 중의 이중 사슬 핵산이 도입되면, 그 간세포 내의 APCS 유전자의 발현을 저하시켜, 아밀로이드 관련 질환을 치료 혹은 예방할 수 있다. 아밀로이드 관련 질환으로서는, APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환을 들 수 있으며, 구체적으로는 아밀로이드 섬유로서 알려져 있는 이상한 불용성 단백질 섬유가 조직에 침착하여 장기(臟器) 장해가 야기되는 질환이다. 아밀로이드 관련 질환으로서 보다 구체적으로는, 전신성 아밀로이드시스인 AL 아밀로이드시스, AA 아밀로이드시스, ATTR 아밀로이드시스, 투석 아밀로이드시스, 아밀로이드 침착을 동반하는 심부전, 아밀로이드 침착을 동반하는 신증, 노년성 아밀로이드시스, 수근관증후군 등, 국한성 아밀로이드시스인 알츠하이머형 인지증, 뇌 아밀로이드 혈관병, II형 당뇨병 등을 들 수 있다. 본 발명의 핵산 복합체의 투여 대상은 포유동물이며, 인간인 것이 바람직하다.
본 발명의 핵산 복합체를 아밀로이드 관련 질환의 치료제 또는 예방제로서 사용하는 경우, 투여 경로로서는, 치료 시에 가장 효과적인 투여 경로를 사용하는 것이 바람직하며, 바람직하게는 정맥내 투여, 피하 투여 또는 근육내 투여를 들 수 있고, 보다 바람직하게는 피하 투여를 들 수 있다.
투여량은, 투여 대상의 병상이나 연령, 투여 경로 등에 따라 다르지만, 예컨대 이중 사슬 핵산으로 환산한 1일 투여량이 0.1 μg∼1000 mg이 되도록 투여하면 되고, 1일 투여량이 1∼100 mg이 되도록 투여하는 것이 바람직하다.
또한, 본 발명은, 질환의 치료에 사용하기 위한 핵산 복합체; 질환의 치료에 사용하기 위한 의약 조성물; 질환을 치료하기 위한 핵산 복합체의 용도; 질환의 치료용 의약의 제조에 있어서의 핵산 복합체의 용도; 질환의 치료용 의약의 제조에 사용하기 위한 핵산 복합체; 유효량의 핵산 복합체를, 그 필요가 있는 대상에게 투여하는 것을 포함하는, 질환의 치료 또는 예방 방법을 제공한다.
실시예
이어서, 참고예, 실시예 및 시험예에 의해 본 발명을 구체적으로 설명한다. 단, 본 발명은 이들 실시예 및 시험예에 한정되는 것은 아니다. 또한, 실시예 및 참고예에 기재된 프로톤 핵자기 공명 스펙트럼(1H NMR)은 270 MHz, 300 MHz 또는 400 MHz에서 측정된 것이며, 화합물 및 측정 조건에 따라서는 교환성 프로톤이 명료하게 관측되지 않는 경우가 있다. 또한, 시그널의 다중도 표기로서는 통상 이용되는 것을 이용하고 있지만, br은 broad를 의미하여, 외관상 폭넓은 시그널임을 나타낸다.
UPLC 분석은 이하의 조건을 이용했다.
이동상 A: 0.1% 포름산 함유 수용액, B: 아세토니트릴 용액
그래디언트: 이동상 B가 10%-90%인 리니어 그래디언트(3분간)
컬럼: Waters사 제조 ACQUITY UPLC BEH C18(1.7 ㎛, 내경 2.1x50 mm)
유속: 0.8 mL/min
PDA 검출 파장: 254 nm(검출 범위 190-800 nm)
표 X-1∼표 X-4에 참고예 화합물을 나타낸다.
참고예 1
화합물 RE1-2의 합성
참고예 1의 공정 1
저널 오브 아메리칸 케미컬 소사이어티(Journal of American Chemical Society), 제136권, 16958-16961 페이지, 2014년에 기재된 방법으로 합성한 화합물 RE1-1(0.8755 g, 1.9567 mmol)을 테트라히드로푸란(10 mL)에 용해하고, 1,3-디시클로헥산카르보디이미드(DCC, 0.4247 g, 2.0584 mmol)와 N-히드록시숙시미드(0.2412 g, 2.0958 mmol)를 가하여 실온에서 하룻밤 교반했다. 반응 혼합물로부터 석출된 고체를 제외하고, 감압 하에 용매를 유거(留去)했다. 얻어진 혼합물을 N,N'-디메틸포름아미드(DMF)에 용해하고, 2-아미노에틸말레이미드브롬산염(0.6479 g, 2.5491 mmol)과 디이소프로필에틸아민(1.7 mL, 9.7835 mmol)을 가한 후, 실온에서 하룻밤 교반했다. 감압 하에 반응액의 용매를 유거하고, 역상 컬럼 크로마토그래피(물/메탄올=80/20)로 용출시킴으로써, 화합물 RE1-2(0.8502 g, 수율 76%)를 얻었다.
ESI-MS m/z: 570(M+H)+;
1H-NMR(DMSO-D6) δ: 1.45-1.56(4H, m), 1.78(3H, s), 1.90(3H, s), 1.97(2H, t, J=7.0 Hz), 2.00(3H, s), 2.11(3H, s), 3.18-3.19(2H, m), 3.38-3.45(3H, m), 3.64-3.71(1H, m), 3.85-3.89(1H, m), 4.01-4.04(3H, m), 4.48(1H, d, J=8.6 Hz), 4.95-4.98(1H, m), 5.21(1H, d, J=3.5 Hz), 6.99(2H, s), 7.81-7.87(2H, m).
화합물 RE1-4의 합성
참고예 1의 공정 2
화합물 RE1-1(0.9602 g, 2.1460 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, N-Boc-에틸렌디아민(시그마알드리치사 제조, 0.6877 g, 4.292 mmol), 디이소프로필에틸아민(1.90 mL, 10.87 mmol) 및 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸유로늄 헥사플루오로인산염(와코쥰야쿠고교사 제조, 1.6437 g, 4.3229 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액에 물을 가하여, 클로로포름으로 2회 추출한 후, 유기층을 포화식염수로 세정하고, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 화합물 RE1-3의 조정제물(粗精製物)을 얻었다.
ESI-MS m/z: 590(M+H)+
참고예 1의 공정 3
화합물 RE1-4의 합성 공정 1에서 합성한 화합물 RE1-3(1.2654 g, 2.1460 mmol)을 디클로로메탄(15 mL)에 용해하고, 트리플루오로아세트산(4 mL)을 가하여, 실온에서 하룻밤 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 역상 컬럼 크로마토그래피(물/메탄올=80/20)로 용출시킴으로써, 화합물 RE1-4(0.3879 g, 수율 37%)를 얻었다.
ESI-MS m/z: 490(M+H)+;
1H-NMR(DMSO-D6) δ: 1.46-1.52(4H, m), 1.78(3H, s), 1.90(3H, s), 2.00(3H, s), 2.08(2H, t, J=7.4 Hz), 2.11(3H, s), 2.85(2H, t, J=6.3 Hz), 3.27(2H, dd, J=12.3, 6.2 Hz), 3.67-3.69(1H, m), 3.68-3.73(1H, m), 3.86-3.90(1H, m), 4.01-4.04(3H, m), 4.49(1H, d, J=8.4 Hz), 4.97(1H, dd, J=11.3, 3.4 Hz), 5.22(1H, d, J=3.5 Hz), 7.86(1H, d, J=9.1 Hz), 7.95-8.02(1H, m).
참고예 2
참고예 2의 공정 1
(9H-플루오렌-9-일)메틸((2R,3R)-1,3-디히드록시부탄-2-일)카르바메이트(화합물 RE2-1, Chem-Impex International, Inc사 제조, 1.50 g, 4.58 mmol)를 피리딘(20 mL)에 용해하고, 빙냉 하에 4,4'-디메톡시트리틸클로라이드(도쿄가세이고교사 제조, 1.71 g, 5.04 mmol)를 가한 후, 실온에서 2시간 교반했다. 반응액을 빙냉하고, 10% 시트르산 수용액을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헥산/아세트산에틸=90/10)로 정제함으로써, 화합물 RE2-2(1.07 g, 수율 37%)를 얻었다.
ESI-MS m/z: 630(M+H)+
참고예 2의 공정 2
참고예 2의 공정 1에서 합성한 화합물 RE2-2(1.07 g, 1.699 mmol)를 N,N-디메틸포름아미드(10 mL)에 용해하고, 실온에서 피페리딘(0.336 mL, 3.40 mmol)을 가하여 3시간 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 아미노 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제함으로써, 화합물 RE2-3(0.59 g, 수율 85%)을 얻었다.
ESI-MS m/z: 408(M+H)+
참고예 3
참고예 3의 공정 1
5-히드록시이소프탈산디메틸(화합물 RE3-1, 와코쥰야쿠고교사 제조, 5.0443 g, 24 mmol)을 테트라히드로푸란(와코쥰야쿠고교사 제조 25 mL)에 용해하고, 2-(tert-부톡시카르보닐아미노)-1-에탄올(도쿄가세이고교사 제조, 4.0343 g, 25.03 mmol) 및 트리페닐포스핀 폴리머 담지체(시그마알드리치사 제조, 6.61 g, 25.2 mmol)를 가한 후, 빙냉 하에 40% 디이소프로필아조디카르복실레이트(DIAD) 톨루엔 용액(도쿄가세이고교사 제조, 13.26 mL, 25.2 mmol)을 가하여, 실온에서 하룻밤 교반했다. 반응액을 여과하고, 감압 하에 여과액을 유거한 후, 잔사를 아미노 실리카겔 컬럼 크로마토그래피(헥산/아세트산에틸=95/5∼80/20)로 정제함으로써, 화합물 RE3-2(5.3071 g, 수율 63%)를 얻었다.
ESI-MS m/z: 254(M+H)+, 탈(脫)Boc체로서 검출
참고예 3의 공정 2
참고예 3의 공정 1에서 합성한 화합물 RE3-2(5.3071 g, 15.02 mmol)를 메탄올 (25 mL)에 용해하고, 빙냉 하에 2 mol/L 수산화나트륨 수용액(와코쥰야쿠고교사 제조, 13 mL)을 가하여, 실온에서 4시간 교반했다. 반응액을 빙냉하고, 10% 시트르산 수용액을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거함으로써, 화합물 RE3-3을 정량적으로 얻었다.
ESI-MS m/z: 324(M-H)-
참고예 3의 공정 3
참고예 3의 공정 2에서 합성한 화합물 RE3-3(1.9296 g, 5.93 mmol)을 N,N'-디메틸포름아미드(70 mL)에 용해하고, N-1-(9H-플루오렌-9-일메톡시카르보닐)-에틸렌디아민염산염(3.3493 g, 11.86 mmol), 디이소프로필에틸아민(5.18 mL, 29.7 mmol) 및 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸유로늄헥사플루오로인산염(4.5168 g, 11.88 mmol)을 가하여, 실온에서 4시간 교반했다. 반응액을 빙냉하고, 10% 시트르산 수용액을 가하여, 클로로포름으로 추출한 후, 유기층을 포화탄산수소나트륨 수용액 및 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하고, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올)로 정제함으로써, 화합물 RE3-4(3.4407 g, 수율 68%)를 얻었다.
ESI-MS m/z: 898(M+HCOO)-
참고예 3의 공정 4
참고예 3의 공정 3에서 합성한 화합물 RE3-4(1.6087 g, 1.884 mmol)를 디클로로메탄(20 mL)에 용해하고, 빙냉 하에 트리플루오로아세트산(5 mL, 64.9 mmol)을 가하여, 실온에서 4시간 교반했다. 반응액을 감압 하에 용매를 유거함으로써, 화합물 RE3-5(2.4079 g)를 정량적으로 얻었다.
ESI-MS m/z: 798(M+HCOO)-
참고예 3의 공정 5
참고예 3의 공정 4에서 합성한 화합물 RE3-5(386 mg, 0.512 mmol)를 테트라히드로푸란(10 mL)에 용해하고, 빙냉 하에 염화벤조일(175 mg, 1.024 mmol)을 가하여, 실온에서 1시간 교반했다. 반응액을 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올)로 정제함으로써, 화합물 RE3-6(373 mg, 수율 82%)을 얻었다.
ESI-MS m/z: 888(M+H)+
참고예 3의 공정 6
참고예 3의 공정 5에서 합성한 화합물 RE3-6(108 mg, 0.122 mmol)을 디클로로메탄(5 mL)에 용해하고, 실온에서 디에틸아민(0.5 mL, 4.8 mmol)을 가하여 1시간 교반했다. 감압 하에 용매를 유거함으로써, 화합물 RE3-7(54.9 mg)을 정량적으로 얻었다.
ESI-MS m/z: 444(M+H)+
참고예 3의 공정 7
참고예 3의 공정 6에서 합성한 화합물 RE3-7(180 mg, 0.406 mmol), Nα,Nε-비스(tert-부톡시카르보닐)-L-리신(노바바이오켐사 제조, 295 mg, 0.852 mmol), 디이소프로필에틸아민(0.354 mL, 2.029 mmol) 및 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸유로늄헥사플루오로인산염(324 mg, 0.852 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 빙냉하고, 10% 시트르산 수용액을 가하여, 클로로포름으로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 아미노 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올)로 정제함으로써, 화합물 RE3-8(450 mg)을 정량적으로 얻었다.
ESI-MS m/z: 1101(M+H)+
참고예 3의 공정 8
참고예 3의 공정 7에서 합성한 화합물 RE3-8(2.1558 g, 1.9593 mmol)을 디클로로메탄(20 mL)에 용해하고, 빙냉 하에 트리플루오로아세트산(5 mL)을 가하여, 실온에서 4시간 교반했다. 반응액을 감압 하에 용매를 유거함으로써, 화합물 RE3-9를 정량적으로 얻었다.
ESI-MS m/z: 700(M+H)+
참고예 4
(도면에서, Bn은 벤질기를 나타낸다.)
참고예 4의 공정 1
참고예 3에 기재한 방법으로 합성한 화합물 RE4-1(참고예 3에 있어서의 화합물 RE3-5, 0.5716 g, 0.7582 mmol), 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제22권, 690-699 페이지, 2011년에 기재된 방법으로 합성한 도데칸산모노벤질에스테르(0.4859 g, 1.5164 mmol), 디이소프로필에틸아민(0.662 mL, 3.79 mmol) 및 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸유로늄헥사플루오로인산염(0.5766 g, 1.516 mmol)을 N,N디메틸포름아미드(12 mL)에 용해하여, 실온에서 1시간 교반했다. 반응액을 빙냉하고, 포화시트르산 수용액을 가하여, 클로로포름으로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올)로 정제함으로써, 화합물 RE4-2(0.88 g, 수율 84%)를 얻었다.
ESI-MS m/z: 1057(M+H)+
참고예 4의 공정 2
참고예 4의 공정 1에서 합성한 화합물 RE4-2(0.7545 g, 0.714 mmol)를 디클로로메탄과 테트라히드로푸란의 혼합 용매(20 mL)에 용해하고, 실온에서 디에틸아민(5 mL, 47.9 mmol)을 가하여 밤새 교반했다. 감압 하에 용매를 유거함으로써, 화합물 RE4-3을 정량적으로 얻었다.
ESI-MS m/z: 612(M+H)+
참고예 4의 공정 3
참고예 4의 공정 2에서 합성한 화합물 RE4-3(0.437 g, 0.7143 mmol), Nα,Nε-비스(tert-부톡시카르보닐)-L-리신(노바바이오켐사 제조, 0.5483 g, 1.583 mmol), 디이소프로필에틸아민(0.624 mL, 3.57 mmol), 2-(1H-벤조트리아졸-1-일)-1,1,3,3-테트라메틸유로늄헥사플루오로인산염(0.5703 g, 1.5 mmol)을 가하여, 실온에서 2시간 교반했다. 반응액에 10% 시트르산 수용액을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거함으로써, 화합물 RE4-4의 조생성물(粗生成物)을 얻었다.
ESI-MS m/z: 1269(M+H)+
참고예 4의 공정 4
참고예 4의 공정 3에서 합성한 화합물 RE4-4(0.906 g, 0.7143 mmol)를 디클로로메탄(12 mL)에 용해하고, 빙냉 하에 트리플루오로아세트산(3 mL, 38.9 mmol)을 가하여, 실온에서 4시간 교반했다. 반응액을 감압 하에 용매를 유거함으로써, 화합물 RE4-5의 조생성물을 얻었다.
ESI-MS m/z: 869(M+H)+
참고예 5
참고예 5의 공정 1
참고예 3에 기재한 방법으로 합성한 화합물 RE5-1(참고예 3에 있어서의 RE3-8, 100 mg, 0.091 mmol)을 메탄올(3 mL)에 용해하고, 아세트산(2 μL)을 첨가한 후, 팔라듐/탄소에 의한 접촉 수소 환원을 행했다. 얻어진 용액 유분(留分)을 감압 하에 용매를 유거함으로써, 화합물 RE5-2를 정량적으로 얻었다.
ESI-MS m/z: 967(M+H)+
참고예 5의 공정 2
화합물 RE5-2(50 mg, 0.052 mmol) 및 N-(6-말레이미드카프로일옥시)숙시미드(48 mg, 0.155 mmol)를 테트라히드로푸란(2 mL)에 용해하고, 디이소프로필에틸아민(0.045 mL, 0.259 mmol)을 가하여, 실온에서 밤새 교반했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올)로 정제함으로써, 화합물 RE5-3(18 mg, 수율 30%)을 얻었다.
ESI-MS m/z: 1160(M+H)+
참고예 5의 공정 3
참고예 5의 공정 2에서 합성한 화합물 RE5-3(18 mg, 0.016 mmol)을 디클로로메탄(2 mL)에 용해하고, 빙냉 하에 트리플루오로아세트산(0.2 mL, 2.6 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 감압 하에 용매를 유거하여, 디에틸에테르로 정석한 후, 화합물 RE5-4(7.5 mg, 수율 64%)를 백색 고체로서 얻었다.
ESI-MS m/z: 759(M+H)+
참고예 6
참고예 6의 공정 1
참고예 3에 기재한 방법으로 합성한 화합물 RE6-1(참고예 3에 있어서의 화합물 RE3-2, 0.9372 g, 2.8809 mmol), β-알라닌메틸에스테르염산염(도쿄가세이고교가부시키가이샤 제조, 0.8082 g, 5.7902 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE6-2를 정량적으로 얻었다.
ESI-MS m/z: 495(M+H)+
참고예 6의 공정 2
참고예 6의 공정 1에서 합성한 화합물 RE6-2(0.9622 g, 1.952 mmol)를 이용하여, 참고예 3의 공정 4와 같은 방법으로 화합물 RE6-3을 정량적으로 얻었다.
ESI-MS m/z: 396(M+H)+
참고예 6의 공정 3
참고예 6의 공정 2에서 합성한 화합물 RE6-3(0.1146 g, 0.290 mmol) 및 N-숙신이미딜15-아지드-4,7,10,13-테트라옥사펜타데칸산(N3-PEG4-NHS, 도쿄가세이고교가부시키가이샤 제조, 0.0750 g, 0.1931 mmol)을 이용하여, 참고예 5의 공정 2와 같은 방법으로 화합물 RE6-4를 정량적으로 얻었다.
ESI-MS m/z: 669(M+H)+
참고예 6의 공정 4
참고예 6의 공정 3에서 합성한 화합물 RE6-4(0.1291 g, 0.193 mmol)를 이용하여, 참고예 3의 공정 2와 같은 방법으로 화합물 RE6-5를 정량적으로 얻었다.
ESI-MS m/z: 641(M+H)+
참고예 6의 공정 5
참고예 6의 공정 4에서 합성한 화합물 RE6-5(0.1252 g, 0.193 mmol) 및 L-글루타민산 디-tert-부틸에스테르(와타나베카가쿠가부시키가이샤 제조, 0.1180 g, 0.399 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE6-6(0.0521 g, 수율 24%)을 얻었다.
ESI-MS m/z: 1124(M+H)+
참고예 6의 공정 6
참고예 6의 공정 5에서 합성한 화합물 RE6-6(0.0521 g, 0.0464 mmol)을 이용하여, 참고예 3의 공정 4와 같은 방법으로 화합물 RE6-7(36 mg, 수율 86%)을 얻었다.
ESI-MS m/z: 899(M+H)+
참고예 7
참고예 7의 공정 1
참고예 3에 기재한 방법으로 합성한 화합물 RE7-1(참고예 3에 있어서의 RE3-9, 0.2586 g, 0.3695 mmol)과, 저널 오브 아메리칸 케미컬 소사이어티(Journal of American Chemical Society), 제136권, 16958-16961 페이지, 2014년에 기재된 방법으로 합성한 참고예 1에 기재한 화합물 RE-1(0.8559 g, 1.7927 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE7-2(0.5272 g, 수율 61%)를 얻었다.
ESI-MS m/z: 2418(M+H)+
참고예 7의 공정 2
참고예 7의 공정 1에서 합성한 화합물 RE7-2(0.2653 g, 0.1097 mmol)를 이용하여, 참고예 5의 공정 1과 같은 방법으로 화합물 RE7-3(0.1524 g, 수율 61%)을 얻었다.
ESI-MS m/z: 2284(M+H)+
참고예 8: 화합물 A1 및 B1의 합성
화합물 A1의 합성
참고예 7에 기재한 방법으로 합성한 화합물 RE8-1(참고예 7에 있어서의 화합물 RE7-3, 0.0152 g, 0.006657 mmol)을 이용하여, 참고예 5의 공정 2와 같은 방법으로 화합물 A1(0.0077 g, 수율 47%)을 얻었다.
ESI-MS m/z: 1239(M+2H)2+
1H-NMR(DMSO-D6) δ: 1.11-1.66(34H, m), 1.77(12H, d, J=1.5 Hz), 1.89(12H, s), 2.01-2.14(10H, m), 2.01(12H, s), 2.10(12H, s), 2.92-2.99(4H, m), 3.16-3.54(14H, m), 3.65-3.74(4H, m), 3.81-3.91(4H, m), 3.98-4.08(14H, m), 4.11-4.24(4H, m), 4.48(4H, dd, J=8.4, 1.8 Hz), 4.93-5.00(4H, m), 5.21(4H, d, J=3.5 Hz), 6.99(2H, s), 7.52(2H, s), 7.66-7.75(2H, m), 7.78-7.87(6H, m), 7.91(1H, br s), 8.01-8.08(3H, br m), 8.54-8.60(2H, br m).
화합물 B1의 합성
화합물 RE8-1(참고예 7에 있어서의 화합물 RE7-3, 0.0150 g, 0.00657 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 B1(0.0062 g, 수율 37%)을 얻었다.
ESI-MS m/z: 1279(M+2H)2+
1H-NMR(DMSO-D6) δ: 1.11-1.66(30H, m), 1.77(12H, s), 1.89(12H, s), 2.01-2.14(8H, m), 2.01(12H, s), 2.10(12H, s), 2.33-2.38(2H, m), 2.92-2.99(4H, m), 3.16-3.54(14H, m), 3.58-3.63(16H, m), 3.65-3.74(4H, m), 3.81-3.91(4H, m), 3.98-4.08(12H, m), 4.11-4.24(4H, m), 4.48(4H, dd, J=8.4, 1.8 Hz), 4.93-5.00(4H, m), 5.21(4H, d, J=3.5 Hz), 7.52(2H, s), 7.66-7.75(2H, m), 7.78-7.87(6H, m), 7.91(1H, br s), 8.01-8.08(3H, br m), 8.54-8.60(2H, br m).
참고예 9: 화합물 B2 및 B3의 합성
화합물 B2의 합성
참고예 6에 기재한 방법으로 합성한 화합물 RE9-1(참고예 6에 있어서의 화합물 RE6-5, 0.00436 g, 0.00681 mmol) 및 참고예 1의 화합물 RE1-4(0.010 g, 0.020 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 B2의 조생성물을 얻었다.
ESI-MS m/z: 1584(M+H)+
화합물 B3의 합성
참고예 6에 기재한 방법으로 합성한 화합물 RE9-2(참고예 6에 있어서의 화합물 RE6-7, 0.0100 g, 0.01112 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 B3(0.0223 g, 수율 72%)을 얻었다.
ESI-MS m/z: 1393(M+2H)2+
참고예 10: 화합물 C1 및 D1의 합성
참고예 10의 공정 1
참고예 4에 기재한 방법으로 합성한 화합물 RE10-1(참고예 4에 있어서의 화합물 RE4-5, 0.1952 g, 0.225 mmol)과, 저널 오브 아메리칸 케미컬 소사이어티(Journal of American Chemical Society), 제136권, 16958-16961 페이지, 2014년에 기재된 방법으로 합성한 참고예 1의 화합물 RE1-1(0.4162 g, 0.93 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE10-2(334.8 mg, 수율 58%)를 얻었다.
ESI-MS m/z: 1294(M+2H)2+
참고예 10의 공정 2
참고예 10의 공정 1에서 합성한 화합물 RE10-2(0.1459 g, 0.056 mmol)를 이용하여, 참고예 5의 공정 1과 같은 방법으로 화합물 D1(112 mg, 수율 80%)을 얻었다.
ESI-MS m/z: 1249(M+2H)2+
1H-NMR(DMSO-D6) δ: 1.11-1.66(44H, m), 1.77(12H, d, J=1.5 Hz), 1.89(12H, s), 2.01-2.20(12H, m), 2.01(12H, s), 2.10(12H, s), 2.92-2.99(4H, m), 3.16-3.54(10H, m), 3.58-3.64(4H, m), 3.65-3.74(4H, m), 3.81-3.91(4H, m), 3.98-4.08(12H, m), 4.11-4.24(4H, m), 4.48(4H, dd, J=8.4, 1.8 Hz), 4.93-5.00(4H, m), 5.21(4H, d, J=3.5 Hz), 6.99(2H, s), 7.52(2H, s), 7.66-7.75(2H, m), 7.78-7.87(6H, m), 7.91(1H, br s), 8.01-8.08(3H, br m), 8.54-8.60(2H, br m).
참고예 10의 공정 3
참고예 10의 공정 2에서 합성한 화합물 D1(0.1091 g, 0.044 mmol) 및 참고예 2의 화합물 RE2-3(0.0748 g, 0.184 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE10-3을 조생성물로서 얻었다.
ESI-MS m/z: 1292(M+2H)2+, 탈DMTr체로서 검출
참고예 10의 공정 4
참고예 10의 공정 3에서 합성한 화합물 RE10-3(0.161 g, 0.05586 mmol)을 디클로로메탄(5 mL)에 용해하고, 숙신산무수물(도쿄가세이고교사 제조, 0.1182 g, 1.181 mmol), N,N-디메틸아미노피리딘(0.0224 g, 0.183 mmol) 및 트리에틸아민(0.55 mL, 3.95 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 빙냉하고, 물을 가하여, 아세트산에틸로 2회 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거함으로써, 화합물 RE10-4의 조생성물을 얻었다.
ESI-MS m/z: 1342(M+2H)2+, 탈DMTr체로서 검출
참고예 10의 공정 5
참고예 10의 공정 4에서 합성한 화합물 RE10-4(0.0816 g, 0.02734 mmol), O-(벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄 헥사플루오로인산염(0.0221 g, 0.05827 mmol) 및 디이소프로필에틸아민(0.02 mL, 0.1094 mmol)을 N,N-디메틸포름아미드(4 mL)에 용해하고, LCAA-CPG(Chem Gene사 제조, 0.4882 g)를 가하여, 실온에서 밤새 교반했다. 혼합물을 여과 분별하고, 디클로로메탄, 10% 메탄올디클로로메탄 용액 및 디에틸에테르로 순차 세정한 후, 무수아세트산/피리딘 용액과 작용시킴으로써, 화합물 C1(49.5 ㎛ol/g, 수율 89%)을 얻었다. 또한, 수율은 1% 트리플루오로아세트산/디클로로메탄 용액을 고상 담지체에 첨가하여, DMTr기에서 유래하는 흡수로부터 계산할 수 있는 고상 담체에의 도입률로부터 산출했다.
참고예 11
화합물 RE11-1(1.200 g, 3.640 mmol)로부터 저널 오브 메디시날 케미스트리(Journal of Medicinal Chemistry), 제59권, 2718-2733 페이지, 2016년에 기재된 방법으로 화합물 RE11-2(1.050 g, 수율 50%)를 합성했다.
ESI-MS m/z: 582(M+H)+
참고예 12
화합물 RE12-1(4.000 g, 10.27 mmol)을 디클로로메탄(60 mL)에 용해하고, 벤질-2-(2-히드록시에톡시)에틸카르바메이트(2.700 g, 11.30 mmol) 및 트리플루오로메탄술폰산(0.1360 mL, 1.541 mmol)을 가하여, 환류 조건 하에서 밤새 교반했다. 반응액에 10 wt% 탄산칼륨 수용액을 가하여, 디클로로메탄과 분액한 후, 유기상을 물로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 2-메틸테트라히드로푸란으로 치환 농축했다. 잔사를 헵탄에 적하하여, 얻어진 결정을 여과함으로써, 화합물 RE12-2(5.130 g, 수율 88%)를 얻었다.
ESI-MS m/z: 570(M+H)+
참고예 13
화합물 RE13-1(참고예 1에 있어서의 화합물 RE1-1, 898.0 mg, 2.007 mmol)을 디클로로메탄(15 mL)에 용해하고, 1-히드록시벤조트리아졸일수화물(338.0 mg, 2.208 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(343 mg, 2.208 mmol) 및 N-1-Z-1,3-디아미노프로판염산염(0.4910 mL, 2.208 mmol)을 가하여, 실온에서 3시간 교반했다. 반응액에 물을 가하여, 디클로로메탄으로 분액한 후, 유기층을 포화탄산수소나트륨 수용액으로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제함으로써, 화합물 RE13-2(873.0 mg, 수율 68%)를 얻었다.
ESI-MS m/z: 639(M+H)+
참고예 14
참고예 14의 공정 1
화합물 RE14-1(참고예 1에 있어서의 화합물 RE1-1, 3.00 g, 6.70 mmol)을 디클로로메탄(60 mL)에 용해하고, 실온에서 L-리신벤질에스테르2p-톨루엔술폰산염(1.75 g, 3.02 mmol), 트리에틸아민(0.935 mL, 6.70 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(1.29 g, 6.70 mmol), 1-히드록시벤조트리아졸일수화물(103 mg, 0.670 mmol)을 가하여 2.5시간 교반했다. 반응액을 물과 포화탄산수소나트륨 수용액으로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제함으로써, 화합물 RE14-2를 정량적으로 얻었다.
ESI-MS m/z: 1096(M+H)+
참고예 14의 공정 2
화합물 RE14-2(2.30 g, 2.10 mmol)를 테트라히드로푸란(46 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 424 mg)을 가하여, 수소 분위기 하에서 밤새 교반했다. 반응액을 여과하여, 감압 하에 용매를 유거함으로써, 화합물 RE14-3을 정량적으로 얻었다.
ESI-MS m/z: 1006(M+H)+
참고예 15
참고예 15의 공정 1
이미노이아세트산(도쿄가세이고교사 제조, 1.5 g, 6.43 mmol)을 염화메틸렌(30 mL)에 용해하고, 펜타플루오로트리플루오로아세트산(도쿄가세이고교사 제조, 2.75 mL, 16.08 mmol), 트리에틸아민(4.48 mL, 32.2 mmol)을 가하여 4시간 교반했다. 반응액에 10% 시트르산 수용액을 가하여, 클로로포름으로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 거기에, 참고예 11에 기재한 방법으로 합성한 화합물 RE15-1(참고예 11에 있어서의 화합물 RE11-2, 2 g, 3.45 mmol)을 아세트산에틸(10 mL)과 아세토니트릴(10 mL)의 혼합액에 용해하여, 팔라듐/탄소에 의한 접촉 수소 환원을 행했다. 얻어진 용액 부분을 감압 하에 용매를 유거함으로써, 화합물 RE15-2의 조생성물을 얻었다.
ESI-MS m/z: 1091(M+H)+
참고예 15의 공정 2
화합물 RE15-2(1.5 g, 1.37 mmol)를 이용하여, 참고예 1의 공정 3과 같은 방법으로 화합물 RE15-3을 정량적으로 얻었다.
ESI-MS m/z: 990(M+H)+
참고예 16
참고예 16의 공정 1
N-(t-부톡시카르보닐)-L-글루타민산(도쿄가세이고교사 제조)을 이용하고, 참고예 11에 기재한 방법으로 합성한 화합물 RE16-1(1.855 g, 3.19 mmol)을 이용하여, 참고예 15의 공정 1과 같은 방법으로 화합물 RE16-2의 조정제물을 얻었다.
ESI-MS m/z: 1105(M+H)+
참고예 16의 공정 2
화합물 RE16-2(1.421 g, 1.2866 mmol)를 이용하여, 참고예 1의 공정 3과 같은 방법으로 화합물 RE16-3을 정량적으로 얻었다.
ESI-MS m/z: 1004(M+H)+
참고예 17
저널 오브 오가닉 케미스트리(Journal of Organic Chemistry), 제74권, 6837-6842 페이지, 2009년에 기재된 방법으로 합성한 화합물 RE17-1(90 mg, 0.173 mmol)을 테트라히드로푸란(1 mL)에 용해하고, 트리페닐포스핀, 폴리머 담지(시그마알드리치사 제조, 63 mg, 0.189 mmol)를 가하여, 가열 환류 하에 3시간 교반했다. 반응액을 여과하여, 감압 하에 용매를 유거함으로써, 화합물 RE17-2(70 mg, 수율 82%)를 얻었다.
ESI-MS m/z: 516(M+Na)+
1H-NMR(400 MHz, CDCl3): δ 0.89(3H, s), 1.42-1.48(2H, m), 1.52-1.61(2H, m), 1.85(1H, br s), 2.68(2H, t, J=7.2 Hz), 3.06-3.07(2H, m), 3.39-3.44(3H, m), 3.51-3.55(3H, m), 3.78(6H, s), 6.80-6.85(4H, m), 7.17-7.23(1H, m), 7.27-7.33(6H, m), 7.41-7.43(2H, m).
참고예 18
참고예 18의 공정 1
화합물 RE18-1(도쿄가세이고교사 제조, 0.500 g, 3.73 mmoL)을 이용하여, 참고예 2의 공정 1과 같은 방법으로 화합물 RE18-2의 조생성물(1.5 g)을 얻었다.
ESI-MS m/z: 435(M-H)-
참고예 18의 공정 2
화합물 RE18-2의 조생성물(1.5 g)과 1,4-디아미노부탄(도쿄가세이고교사 제조, 3.29 g, 37.3 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE18-3(0.18 g, 2단계 수율 10%)을 얻었다.
ESI-MS m/z: 551(M+HCOO)-
1H-NMR(400 MHz, MeOD): δ 1.09(3H, s), 1.45-1.52(4H, m), 2.80(2H, t, J=7.2 Hz), 2.91(2H, s), 3.05(1H, d, J=8.8 Hz), 3.12-3.16(4H, m), 3.24(1H, s), 3.43(1H, d, J=10.8 Hz), 3.62-3.66(7H, m), 6.71-6.76(4H, m), 7.05-7.11(1H, m), 7.12-7.20(6H, m), 7.28-7.32(2H, m).
참고예 19
저널 오브 오가닉 케미스트리(Journal of Organic Chemistry), 제74권, 6837-6842 페이지, 2009년에 기재된 방법으로 합성한 화합물 RE19-1(110 mg, 0.212 mmol)을 테트라히드로푸란(2 mL)에 용해하고, N-(1R,8S,9s)-비시클로[6.1.0]논-4-인-9-일메틸옥시카르보닐-1,8-디아미노-3,6-디옥사옥탄(도쿄가세이고교사 제조, 72 mg, 0.222 mmol)을 가하여, 실온에서 1시간 교반했다. 반응액에 물을 가하여, 클로로포름으로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 아미노 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제함으로써, 화합물 RE19-2(160 mg, 수율 90%)를 얻었다.
ESI-MS m/z: 845(M+H)+
1H-NMR(400 MHz, CDCl3): δ 0.88(3H, s), 0.91-1.09(3H, m), 1.20-1.25(1H, m), 1.52-1.59(4H, m), 1.80-1.85(2H, m), 2.19-2.25(4H, m), 2.59-2.68(1H, m), 2.84-2.90(4H, m), 3.02-3.11(3H, m), 3.35-3.44(5H, m), 3.49-3.53(5H, m), 3.54-3.58(2H, m), 3.62(5H, s), 3.78(6H, s), 4.13(2H, d, J=6.4 Hz), 4.21(2H, t, J=7.2 Hz), 6.79-6.84(4H, m), 7.18-7.21(1H, m), 7.24-7.27(2H, m), 7.28-7.32(4H, m), 7.39-7.44(2H, m).
참고예 20
참고예 20의 공정 1
화합물 RE20-1(AstaTech사 제조, 100 mg, 1.148 mmol) 및 Fmoc-Ser(tBuMe2Si)-OH(와타나베카가쿠고교사 제조, 532 mg, 1.205 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE20-2(410 mg, 수율 70%)를 얻었다.
ESI-MS m/z: 511(M+H)+
1H-NMR(400 MHz, CDCl3): δ 0.06(6H, s), 0.90(9H, s), 2.76-2.85(1H, m), 3.65-3.86(5H, m), 4.02-4.23(3H, m), 4.32-4.40(4H, m), 5.55(1H, d, J=8.0 Hz), 7.31(2H, t, J=7.6 Hz), 7.40(2H, t, J=7.6 Hz), 7.59(2H, d, J=7.6 Hz), 7.76(2H, d, J=7.6 Hz).
참고예 20의 공정 2
화합물 RE20-2(410 mg, 0.803 mmol)를 이용하여, 참고예 2의 공정 1과 같은 방법으로 화합물 RE20-3의 조생성물(680 mg)을 얻었다.
ESI-MS m/z: 814(M+H)+
참고예 20의 공정 3
화합물 RE20-3의 조생성물(680 mg)을 이용하여, 참고예 2의 공정 5와 같은 방법으로 화합물 RE20-4(330 mg, 2단계 수율 70%)를 얻었다.
ESI-MS m/z: 519(M+H)+
1H-NMR(400 MHz, CDCl3): δ 0.02-0.09(6H, m), 0.89(9H, d, J=28.8 Hz), 2.84-2.94(1H, m), 3.24-3.30(2H, m), 3.46(1H, t, J=7.2 Hz), 3.52-3.68(2H, m), 3.75-3.80(1H, m), 3.82(6H, d, J=2.4 Hz), 3.89-3.96(1H, m), 4.05-4.17(1H, m), 4.27-4.37(1H, m), 6.82-6.89(4H, m), 7.22-7.27(1H, m), 7.29-7.34(6H, m), 7.41-7.45(2H, m)
참고예 21
참고예 21의 공정 1
N-(Tert-부톡시카르보닐)-1,3-디아미노프로판(도쿄가세이고교사 제조, 1.788 g, 10.26 mmol)을 디클로로메탄(22.8 mL)에 용해하고, 트리에틸아민(1.907 mL, 13.68 mmol)을 가하여, 실온에서 15분 교반했다. 반응액에, 오가닉 레터(Organic Letter), 제16권, 6318-6321 페이지, 2014년에 기재된 방법으로 합성한 화합물 RE21-1(1.126 g, 6.84 mmol)의 디클로로메탄 용액(5 mL)을 적하하여, 실온에서 2시간 교반했다. 반응액에 물을 가하여, 클로로포름으로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산마그네슘으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=35/65)로 정제함으로써, 화합물 RE21-2(1.65 g, 수율 80%)를 얻었다.
ESI-MS m/z: 303(M+H)+
참고예 21의 공정 2
화합물 RE21-2(1.65 g, 5.46 mmol)를 이용하여, 참고예 1의 공정 2와 같은 방법으로 화합물 RE21-3(1.10 g, 수율 100%)을 얻었다.
ESI-MS m/z: 203(M+H)+
1H-NMR(400 MHz, CDCl3): δ 1.74(2H, dt, J=12.0, 6.0 Hz), 2.95(2H, t, J=6.0 Hz), 3.18(1H, s), 3.60(2H, td, J=6.0, 5.2 Hz), 7.54(2H, dt, J=8.4, 1.8 Hz), 7.76(2H, dt, J=8.4, 1.8 Hz), 7.97(1H, br s).
참고예 22
참고예 22의 공정 1
화합물 RE22-1(도쿄가세이사 제조, 1.2 g, 4.24 mmol)을 이용하여, 참고예 2의 공정 1과 같은 방법으로 화합물 RE22-2의 조생성물을 얻었다.
ESI-MS m/z: 608(M+Na)+
참고예 22의 공정 2
화합물 RE22-2의 조생성물을 이용하여, 참고예 2의 공정 5와 같은 방법으로 화합물 R22-3(1.34 g, 2단계 수율 52%)을 얻었다.
ESI-MS m/z: 386(M+Na)+
1H-NMR(400 MHz, CDCl3) :δ 3.34(2H, t, J=6.4 Hz), 3.47(2H, t, J=6.4 Hz), 3.79(6H, s), 6.78-6.84(4H, m), 7.17-7.21(1H, m), 7.27-7.35(6H, m), 7.42-7.46(2H, m).
참고예 22의 공정 3
화합물 RE22-3(1.15 g, 3.16 mmol) 및 Fmoc-Ser(tBuMe2Si)-OH(와타나베카가쿠고교사 제조, 1.677 g, 3.8 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 RE22-4(560 mg, 수율 31%)를 얻었다.
1H-NMR(400 MHz, CDCl3) δ: 0.00-0.07(6H, m), 0.83-0.89(9H, m), 3.18-3.26(2H, m), 3.39-3.46(2H, m), 3.61-3.68(1H, m), 3.76(6H, s), 3.89(1H, dd, J=10.0, 4.0 Hz), 4.03(1H, dd, J=10.0, 4.0 Hz), 4.15-4.20(1H, m), 4.22-4.28(1H, m), 4.32-4.40(2H, m), 5.65-5.88(1H, m), 6.76-6.85(4H, m), 7.16-7.23(1H, m), 7.25-7.34(8H, m), 7.36-7.44(4H, m), 7.50-7.64(2H, m), 7.72-7.79(2H, m).
참고예 23
표 Y-1에 기재된 화합물 RE23-1∼RE23-5 및 Fmoc-Ser(tBuMe2Si)-OH를 이용하여, 참고예 22와 같은 방법에 의해, 표 Y-2에 기재된 화합물 RE23-6∼RE23-10을 얻었다.
참고예 22의 화합물 RE22-3과 Fmoc-Thr(tBuMe2Si)-OH를 이용하여, 참고예 22와 같은 방법에 의해 표 Y-2에 기재한 화합물 RE23-11을 얻었다.
표 Y-1에 기재된 화합물 RE23-1과 Fmoc-Thr(tBuMe2Si)-OH를 이용하여, 참고예 22와 같은 방법에 의해 표 Y-2에 기재한 화합물 RE23-12를 얻었다.
본 실시예에 의해 합성한 화합물의 NMR 분석 데이터를 표 Y-3에 나타낸다.
참고예 24
참고예 22에 기재한 방법으로 합성한 화합물 RE24-1(참고예 22에 있어서의 화합물 RE22-4, 2.487 g, 3.16 mmol)을 이용하여, 참고예 2의 공정 2와 같은 방법으로 화합물 RE24-2를 얻었다(1.2 g, 수율 67%).
ESI-MS m/z: 587(M+Na)+
1H-NMR(400 MHz, CDCl3): δ-0.01-0.07(6H, m), 0.86-0.90(9H, m), 3.15-3.21(2H, m), 3.41-3.48(3H, m), 3.72(1H, dd, J=10.0, 6.4 Hz), 3.79(6H, s), 3.84(1H, dd, J=10.0, 4.8 Hz), 6.79-6.84(4H, m), 7.18-7.23(1H, m), 7.27-7.33(6H, m), 7.40-7.44(2H, m), 7.72-7.75(1H, br m).
참고예 25
표 Y-2에 기재한 화합물 RE23-6∼RE23-12를 이용하여, 참고예 24와 같은 방법에 의해 표 Z-1에 기재한 화합물 RE25-1∼RE25-7을 얻었다.
본 실시예에 의해 합성한 화합물의 질량 분석 결과를 표 Z-2에 나타낸다.
참고예 26
참고예 26의 공정 1
화합물 RE26-1(2.00 g, 9.47 mmol)을 N,N'-디메틸포름아미드(40 mL)에 용해하고, 실온에서 이미노이아세트산디-tert-부틸에스테르(5.11 g, 20.84 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(4.00 g, 20.84 mmol), 1-히드록시벤조트리아졸일수화물(145 mg, 0.947 mmol)을 가하여 2시간 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화탄산수소나트륨 수용액과 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=50/50)로 정제했다. 또한, 메탄올로 슬러리 정제함으로써, 화합물 RE26-2(4.07 g, 수율 65%)를 얻었다.
ESI-MS m/z: 664(M-H)-
참고예 26의 공정 2
화합물 RE26-2(2.66 g, 4.00 mmol)를 테트라히드로푸란(53 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 490 mg)을 가하여, 수소 분위기 하에서 3시간 교반했다. 반응액을 여과하여, 감압 하에 용매를 유거함으로써, 화합물 RE26-3(2.86 g, 수율 113%)을 얻었다.
ESI-MS m/z: 634(M-H)-
참고예 26의 공정 3
화합물 RE26-3(871.0 mg, 1.370 mmol)을 N,N'-디메틸포름아미드(17 mL)에 용해하고, O-(7-아자벤조트리아졸-1-인)-N,N,N',N'-테트라메틸유로늄헥사플루오로인산염(625.0 mg, 1.644 mmol), 디이소프로필에틸아민(0.5730 mL, 3.290 mmol) 및 도데칸이산모노벤질에스테르(527.0 mg, 1.644 mmol)를 가하여, 실온에서 밤새 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화탄산수소나트륨 수용액 및 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=60/40)로 정제함으로써, 화합물 RE26-4(1.030 g, 수율 80%)를 얻었다.
ESI-MS m/z: 939(M+H)+
참고예 26의 공정 4
화합물 RE26-4(1.030 g, 1.098 mmol)를 디클로로메탄(10 mL)에 용해하고, 트리플루오로아세트산(10.00 mL, 130.0 mmol)을 가하여, 실온에서 1시간 교반했다. 감압 하에 용매를 유거하여, 화합물 RE26-5의 조생성물을 얻었다.
ESI-MS m/z: 713(M-H)-
참고예 27
참고예 27의 공정 1
화합물 RE27-1(2.000 g, 12.98 mmol)을 N,N'-디메틸포름아미드(30 mL)에 용해하고, 탄산수소칼륨(1.559 g, 15.57 mmol) 및 염화벤질(2.328 mL, 19.47 mmol)을 가하여, 실온에서 4시간 교반했다. 반응액에 포화염화암모늄 수용액을 가하여, 디클로로메탄으로 추출한 후, 유기층을 물로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=50/50)로 정제함으로써, 화합물 RE27-2(2.850 g, 수율 90%)를 얻었다.
ESI-MS m/z: 243(M-H)-
참고예 27의 공정 2
화합물 RE27-2(2.500 g, 10.24 mmol)를 N,N'-디메틸포름아미드(30 mL)에 용해하고, 탄산칼륨(5.660 g, 40.90 mmol) 및 tert-부틸브로모아세트산(3.300 mL, 22.52 mmol)을 가하여, 90℃에서 4시간 교반했다. 반응액에 포화염화암모늄 수용액을 가하여, 디클로로메탄으로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=75/25)로 정제함으로써, 화합물 RE27-3(4.300 g, 수율 89%)을 얻었다.
ESI-MS m/z: 472(M-H)-
참고예 27의 공정 3
화합물 RE27-3(1.000 g, 2.116 mmol)을 디클로로메탄(10 mL)에 용해하고, 트리플루오로아세트산(10.00 mL, 130.0 mmol)을 가하여, 실온에서 6시간 교반했다. 감압 하에 용매를 유거하여, 화합물 RE27-4의 조생성물을 얻었다.
ESI-MS m/z: 359(M-H)-
참고예 27의 공정 4
화합물 RE27-4(350.0 mg, 0.9710 mmol)를 N,N'-디메틸포름아미드(7 mL)에 용해하고, 1-히드록시벤조트리아졸일수화물(327.0 mg, 2.137 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(410.0 mg, 2.137 mmol) 및 이미노디아세트산디-tert-부틸에스테르(524.0 mg, 2.137 mmol)를 가하여, 실온에서 5시간 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화탄산수소나트륨 수용액 및 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=60/40)로 정제함으로써, 화합물 RE27-5(617.0 mg, 수율 78%)를 얻었다.
ESI-MS m/z: 814(M-H)-
참고예 27의 공정 5
화합물 RE27-5(610.0 mg, 0.7490 mmol)를 디클로로메탄(6 mL)에 용해하고, 트리플루오로아세트산(6 mL, 78.00 mmol)을 가하여, 실온에서 1시간 교반했다. 감압 하에 용매를 유거하여, 화합물 RE27-6의 조생성물을 얻었다.
ESI-MS m/z: 590(M+H)+
참고예 28
참고예 28의 공정 1
참고예 26에 기재한 방법으로 합성한 화합물 RE28-1(참고예 26에 있어서의 화합물 RE26-3, 474 mg, 0.744 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, 실온에서 저널 오브 메디시날 케미스트리(Journal of Medicinal Chemistry), 제54권, 2433-2446 페이지, 2011년에 기재된 방법으로 합성한 trans-시클로헥산-1,4-디카르복실산모노벤질에스테르(0.234 mg, 0.893 mmol), 디이소프로필에틸아민(0.312 mL, 1.79 mmol), O-(7-아자벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄헥사플루오로포스파이트(339 mg, 0.893 mmol)를 가하여 6시간 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화탄산수소나트륨 수용액과 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=50/50)로 정제함으로써, 화합물 RE28-2(448 mg, 수율 68%)를 얻었다.
ESI-MS m/z: 879(M-H)-
참고예 28의 공정 2
화합물 RE28-2(341 mg, 0.387 mmol)를 디클로로메탄(3.4 mL)에 용해하고, 실온에서 트리플루오로아세트산(3.4 mL)을 가하여 밤새 교반했다. 반응액을 감압 농축하고, 아세트산에틸로 공비하여, 헵탄으로 슬러리 정제함으로써, 화합물 RE28-3(254 mg, 수율 100%)을 얻었다.
ESI-MS m/z: 656(M+H)+
참고예 29
참고예 29의 공정 1
화합물 RE29-1(500 mg, 2.75 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, 실온에서 이미노디아세트산디-tert-부틸에스테르(1.48 g, 6.04 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(1.16 g, 6.04 mmol), 1-히드록시벤조트리아졸일수화물(42.0 mg, 0.275 mmol)을 가하여 4시간 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=50/50)로 정제함으로써, 화합물 RE29-2(329 mg, 수율 19%)를 얻었다.
ESI-MS m/z: 635(M-H)-
참고예 29의 공정 2
화합물 RE29-2(323 mg, 0.507 mmol)를 N,N'-디메틸포름아미드(6.5 mL)에 용해하고, 실온에서 탄산칼륨(84.0 mg, 0.609 mmol), 브로모아세트산벤질(139 mg, 0.609 mmol)을 가하여 3시간 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=50/50)로 정제함으로써, 화합물 RE29-3(313 mg, 수율 79%)을 얻었다.
ESI-MS m/z: 783(M-H)-
참고예 29의 공정 3
화합물 RE29-3(312 mg, 0.398 mmol)을 디클로로메탄(3.1 mL)에 용해하고, 실온에서 트리플루오로아세트산(3.1 mL)을 가하여 밤새 교반했다. 반응액을 감압 농축하여, 아세트산에틸로 공비함으로써, 화합물 RE29-4(252 mg, 정량적)를 얻었다.
ESI-MS m/z: 561(M+H)+
참고예 30
참고예 30의 공정 1
화합물 RE30-1(2.00 g, 9.47 mmol)을 N,N'-디메틸포름아미드(40 mL)에 용해하고, 실온에서 2-아미노-1,3-프로판디올(1.90 g, 20.84 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(4.00 g, 20.84 mmol), 1-히드록시벤조트리아졸일수화물(145 mg, 0.947 mmol)을 가하여 2시간 교반했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(아세트산에틸/메탄올=70/30)로 정제했다. 또한, 아세트산에틸로 슬러리 정제함으로써, 화합물 RE30-2(2.68 g, 수율 79%)를 얻었다.
ESI-MS m/z: 356(M-H)-
참고예 30의 공정 2
화합물 RE30-2(500 mg, 1.40 mmol)를 아세토니트릴(10 mL)에 현탁하고, 실온에서 아크릴산tert-부틸에스테르(3.59 g, 28.0 mmol), 벤질트리메틸암모늄히드록시드(40% 수용액; 1.76 mL, 702 mmol)를 가하여 밤새 교반했다. 감압 하에 용매를 유거하고, 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=50/50)로 정제함으로써, 화합물 RE30-3(300 mg, 수율 24%)을 얻었다.
ESI-MS m/z: 871(M+H)+
참고예 30의 공정 3
화합물 RE30-3(340 mg, 0391 mmol)을 테트라히드로푸란(6.8 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 31.3 mg)을 가하여, 수소 분위기 하에서 6시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=30/70)로 정제함으로써, 화합물 RE30-4(235 mg, 수율 72%)를 얻었다.
ESI-MS m/z: 841(M+H)+
참고예 30의 공정 4
화합물 RE30-4(232 mg, 0.276 mmol)를 N,N'-디메틸포름아미드(4.6 mL)에 용해하고, 실온에서 도데칸산모노벤질에스테르(0.133 mg, 0.414 mmol), 디이소프로필에틸아민(0.145 mL, 0.829 mmol), O-(7-아자벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄헥사플루오로포스파이트(158 mg, 0.414 mmol)를 가하여 밤새 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화탄산수소나트륨 수용액과 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(헵탄/아세트산에틸=30/70)로 정제함으로써, 화합물 RE30-5(274 mg, 수율 87%)를 얻었다.
ESI-MS m/z: 1141(M-H)-
참고예 30의 공정 5
화합물 RE30-5(273 mg, 0.239 mmol)를 디클로로메탄(2.7 mL)에 용해하고, 실온에서 트리플루오로아세트산(2.7 mL)을 가하여 밤새 교반했다. 반응액을 감압 농축하여, 아세트산에틸로 공비함으로써, 화합물 RE30-6(231 mg, 정량적)을 얻었다.
ESI-MS m/z: 919(M+H)+
참고예 31
참고예 31의 공정 1
4-니트로이소프탈산 RE31-1(500 mg, 2.37 mmol) 및 N-Boc-에틸렌디아민(808 mg, 5.21 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, 실온에서 트리에틸아민(0.90 mL, 7.11 mmol), 1-히드록시벤조트리아졸일수화물(703 mg, 5.21 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(1.36 g, 7.11 mmol)을 가하여 16시간 교반했다. 반응액을 후처리하여, 조체(粗體)를 실리카겔 컬럼 크로마토그래피로 정제함으로써, 화합물 RE31-2(650 mg, 수율 55%)를 얻었다.
참고예 31의 공정 2
화합물 RE31-2(500 mg, 1.01 mmol) 및 아연 가루(330 mg, 5.05 mmol)를 메탄올(3.5 mL) 및 테트라히드로푸란(3.5 mL)에 현탁하고, 0℃에서 염화암모늄(378 mg, 7.07 mmol)의 수용액을 적하하여, 실온에서 24시간 교반했다. 반응액을 후처리하여, 조체를 실리카겔 컬럼 크로마토그래피로 정제함으로써, 화합물 RE31-3(160 mg, 수율 34%)을 얻었다.
참고예 31의 공정 3
화합물 RE31-3(200 mg, 0.430 mmol) 및 N-벤질옥시카르보닐-글리신(벤질옥시카르보닐을 Cbz라고도 기재한다.)(90.0 mg, 0.430 mmol)을 N,N'-디메틸포름아미드(2.0 mL)에 용해하고, 실온에서 디이소프로필에틸아민(0.220 mL, 1.29 mmol), O-(7-아자벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄헥사플루오로포스파이트(245 mg, 0.645 mmol)를 가하여 16시간 교반했다. 반응액을 후처리하여, 조체를 실리카겔 컬럼 크로마토그래피로 정제함으로써, 화합물 RE31-4(180 mg, 수율 64%)를 얻었다.
ESI-MS m/z: 657(M+H)+
참고예 32
참고예 32의 공정 1
3,5-디니트로안식향산 RE32-1(500 mg, 2.36 mmol) 및 N-Cbz-에틸렌디아민(588 mg, 2.83 mmol)을 N,N'-디메틸포름아미드(5.0 mL)에 용해하고, 실온에서 트리에틸아민(0.65 mL, 4.72 mmol), 1-히드록시벤조트리아졸일수화물(380 mg, 2.83 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(675 mg, 3.54 mmol)을 가하여 16시간 교반했다. 반응액을 후처리하여, 조체를 실리카겔 컬럼 크로마토그래피로 정제함으로써, 화합물 RE32-2(445 mg, 수율 48%)를 얻었다.
참고예 32의 공정 2
화합물 RE32-2(200 mg, 0.515 mmol)을 에탄올(5.0 mL)에 용해하고, 실온에서 염화주석(II)(584 mg, 3.09 mmol) 및 농염산(0.2 mL)을 가하여, 80℃에서 16시간 교반했다. 반응액을 후처리하여, 화합물 RE32-3(180 mg, 정량적)을 얻었다.
ESI-MS m/z: 329(M+H)+
참고예 33
참고예 33의 공정 1
참고예 3에 기재한 방법으로 합성한 화합물 RE33-1(참고예 3에 있어서의 화합물 RE3-2, 8.17 g, 23.12 mmol)을 이용하여, 참고예 3의 공정 4와 같은 방법으로 화합물 RE33-2(3.7 g, 수율 63%)를 얻었다.
ESI-MS m/z: 254(M+H)+
참고예 33의 공정 2
화합물 RE33-2(3.7 g, 14.63 mmol)를 이용하여, 참고예 3의 공정 5와 같은 방법으로 화합물 RE33-3(3.82 g, 수율 67%)을 얻었다.
ESI-MS m/z: 432(M+HCOO)-
참고예 33의 공정 3
화합물 RE33-3(3.82 g, 9.86 mmol)을 이용하여, 참고예 1의 공정 2와 같은 방법으로 화합물 RE33-4(3.08 g, 수율 87%)를 얻었다.
ESI-MS m/z: 360(M+H)+
참고예 34
참고예 34의 공정 1
화합물 RE34-1(2 g, 9.53 mmol)과 tert-부톡시카르보닐아미노)-1-펜탄올(도쿄가세이사 제조, 2 g, 10 mmol)을 이용하여, 참고예 3의 공정 1과 같은 방법으로 화합물 RE34-2(2.40 g, 수율 63%)를 얻었다.
ESI-MS m/z: 296(M+H)+, 탈Boc체로서 검출
참고예 34의 공정 2
화합물 RE34-2를 이용하여, 참고예 3의 공정 2∼4 및 참고예 4의 공정 1∼4와 같은 방법으로 화합물 RE34-3(1.579 g, 수율 21%)을 얻었다.
ESI-MS m/z: 910(M+H)+
참고예 35: 화합물 D2의 합성
참고예 35의 공정 1
참고예 11에 기재한 방법으로 합성한 화합물 RE35-1(참고예 11에 있어서의 화합물 RE11-2, 1.015 g, 1.748 mmol)을 N,N'-디메틸포름아미드(12 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 187 mg)을 가하여, 수소 분위기 하에서 6시간 교반했다. 반응액을 여과했다. 여과액에 참고예 26에서 합성한 화합물 RE26-5(250.0 mg, 0.350 mmol), 1-히드록시벤조트리아졸일수화물(26.80 mg, 0.1750 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(402.0 mg, 2.099 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액에 물을 가하여, 아세트산에틸로 추출한 후, 유기층을 포화탄산수소나트륨 수용액 및 포화식염수로 세정하여, 무수황산나트륨으로 건조했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=87/13)로 정제함으로써, 화합물 RE35-2(617.0 mg, 수율 88%)를 얻었다.
ESI-MS m/z: 1215(M+2H)2+
참고예 35의 공정 2
화합물 RE35-2(0.7380 g, 0.3040 mmol)를 테트라히드로푸란(7 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 135.90 mg)을 가하여, 수소 분위기 하에서 밤새 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=87/13)로 정제함으로써, 화합물 D2(581 mg, 수율 82%)를 얻었다.
ESI-MS m/z: 1170(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.12-2.36(106H, m), 2.91-3.19(8H, m), 3.23-3.55(14H, m), 3.60-3.76(4H, m), 3.78-3.94(8H, m), 3.95-4.10(16H, m), 4.47(4H, d, J=8.8 Hz), 4.92-5.01(4H, m), 5.17-5.24(4H, m), 6.98(1H, s), 7.64(2H, s), 7.81-7.95(4H, m), 8.28-8.38(2H, m), 8.44-8.56(2H, m), 10.13(1H, s)
참고예 36: 화합물 D3의 합성
참고예 36의 공정 1
참고예 12에 기재한 방법으로 합성한 화합물 RE36-1(참고예 12에 있어서의 화합물 RE12-2, 500 mg, 0.879 mmol)을 N,N'-디메틸포름아미드(6.5 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 94 mg)을 가하여, 수소 분위기 하에서 4시간 교반했다. 반응액을 여과했다. 여과액에 참고예 26에 있어서의 화합물 RE26-5(126.0 mg, 0.176 mmol), 1-히드록시벤조트리아졸일수화물(13.47 mg, 0.088 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(202.0 mg, 1.055 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 감압 하에 용매를 유거하여, 잔사를 역상 컬럼 크로마토그래피(물/아세토니트릴)로 정제함으로써, 화합물 RE36-2(249.7 mg, 수율 60%)를 얻었다.
ESI-MS m/z: 1191(M+2H)2+
참고예 36의 공정 2
화합물 RE36-2(0.242 g, 0.102 mmol)를 테트라히드로푸란(3.6 mL) 및 물(1.2 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 45 mg)을 가하여, 수소 분위기 하에서 4시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D3(216 mg, 수율 93%)을 얻었다.
ESI-MS m/z: 1146(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.15-1.65(20H, m), 1.68-2.15(52H, m), 3.13-3.29(6H, m), 3.40-3.67(16H, m), 3.71-3.96(11H, m), 3.98-4.14(16H, m), 4.55(4H, t, J=8.8 Hz), 4.93-5.06(4H, m), 5.12-5.28(4H, m), 6.56(1H, s), 6.98(1H. s), 7.64(2H, s), 7.77-7.93(4H, m), 8.26-8.49(3H, m), 10.10(1H, s)
참고예 37: 화합물 D4의 합성
참고예 37의 공정 1
참고예 13에 기재한 방법으로 합성한 화합물 RE37-1(참고예 13에 있어서의 화합물 RE13-2, 430 mg, 0.674 mmol)을 N,N'-디메틸포름아미드(6 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 79 mg)을 가하여, 수소 분위기 하에서 4시간 교반했다. 반응액을 여과했다. 여과액에 참고예 26에 있어서의 화합물 RE26-5(105.0 mg, 0.148 mmol), 1-히드록시벤조트리아졸일수화물(11.31 mg, 0.074 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(170.0.0 mg, 0.887 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 감압 하에 용매를 유거하여, 잔사를 역상 컬럼 크로마토그래피(물/아세토니트릴)로 정제함으로써, 화합물 RE37-2(218.1 mg, 수율 56%)를 얻었다.
ESI-MS m/z: 1329(M+2H)2+
참고예 37의 공정 2
화합물 RE37-2(0.210 g, 0.079 mmol)를 테트라히드로푸란(3.1 mL) 및 물(1.0 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 39 mg)을 가하여, 수소 분위기 하에서 4시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D4(192.7 mg, 수율 95%)를 얻었다.
ESI-MS m/z: 1284(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.17-1.65(42H, m), 1.69-2.13(61H, m), 2.95-3.17(16H, m), 3.65-3.77(3H, m), 3.79-3.94(6H, m), 3.96-4.10(16H, m), 4.48(4H, d, J=8.4 Hz), 4.96(4H, dd, J=2.4, 11.2 Hz), 5.21(4H, d, J=3.2 Hz), 7.01(1H, s), 7.64-7.92(11H, m), 8.26-8.48(4H, m), 10.14(1H, s)
참고예 38: 화합물 D5의 합성
참고예 38의 공정 1
참고예 12에 기재한 방법으로 합성한 화합물 RE38-1(참고예 12에 있어서의 화합물 RE12-2, 450 mg, 0.791 mmol)을 N,N'-디메틸포름아미드(6 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 85 mg)을 가하여, 수소 분위기 하에서 5시간 교반했다. 반응액을 여과했다. 여과액에 참고예 27에 있어서의 화합물 RE27-6(94 mg, 0.158 mmol), 1-히드록시벤조트리아졸일수화물(133.0 mg, 0.871 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(182.0 mg, 0.950 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 감압 하에 용매를 유거하여, 잔사를 역상 컬럼 크로마토그래피(물/아세토니트릴)로 정제함으로써, 화합물 RE38-2(99 mg, 수율 28%)를 얻었다.
ESI-MS m/z: 1129(M+2H)2+
참고예 38의 공정 2
화합물 RE38-2(80 mg, 0.035 mmol)를 테트라히드로푸란(1.7 mL) 및 물(0.85 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 26 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D5(57.5 mg, 수율 75%)를 얻었다.
ESI-MS m/z: 1084(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.69-2.21(46H, m), 3.14-3.65(28H, m), 3.67-4.22(27H, m), 4.43-4.66(4H, m), 4.69-4.88(4H, m), 4.89-5.08(4H, m), 5.12-5.32(4H, m), 6.54-6.68(1H, br), 7.01(2H, s), 7.78-8.09(3H, m), 8.13-8.31(2H, m), 8.58-8.75(2H, m)
참고예 39: 화합물 D6의 합성
참고예 39의 공정 1
참고예 13에 기재한 방법으로 합성한 화합물 RE39-1(참고예 13에 있어서의 화합물 RE13-2, 418 mg, 0.655 mmol)을 N,N'-디메틸포름아미드 (6 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 77 mg)을 가하여, 수소 분위기 하에서 5시간 교반했다. 반응액을 여과했다. 여과액에 참고예 27에서 합성한 화합물 RE27-6(85 mg, 0.144 mmol), 1-히드록시벤조트리아졸일수화물(121.0 mg, 0.791 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(165.0 mg, 0.863 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 감압 하에 용매를 유거하여, 잔사를 역상 컬럼 크로마토그래피(물/아세토니트릴)로 정제함으로써, 화합물 RE39-2(99 mg, 수율 28%)를 얻었다.
ESI-MS m/z: 1268(M+2H)2+
참고예 39의 공정 2
화합물 RE39-2(186 mg, 0.073 mmol)를 테트라히드로푸란(2.8 mL) 및 물(0.93 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 40 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D6(156.7 mg, 수율 87%)을 얻었다.
ESI-MS m/z: 1222(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.36-1.62(27H, m), 1.67-2.17(64H, m), 2.92-3.21(15H, m), 3.58-3.77(2H, m), 3.80-3.95(7H, m), 3.97-4.13(15H, m), 4.47(4H, d, J=8.8 Hz), 4.88-5.02(7H, m), 5.10-5.24(3H, m), 6.95-7.00(1H, m), 7.26-7.31(2H, m), 7.72-7.88(8H, m), 8.10-8.20(2H, m), 8.51-8.60(2H, m)
참고예 40
참고예 40의 공정 1
참고예 38에 기재한 방법으로 합성한 화합물 D5(171 mg, 0.079 mmol)를 N,N'-디메틸포름아미드(3.4 mL)에 용해하고, 글리신벤질 p-톨루엔술폰산염(32.0 mg, 0.095 mmol), 1-히드록시벤조트리아졸일수화물(12.09 mg, 0.079 mmol) 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(18.16 mg, 0.095 mmol)을 가하여, 실온에서 밤새 교반했다. 반응액을 감압 하에 용매를 유거하여, 잔사를 역상 컬럼 크로마토그래피(물/아세토니트릴)로 정제함으로써, 화합물 RE40-2(55.7 mg, 수율 31%)를 얻었다.
ESI-MS m/z: 1158(M+2H)2+
참고예 40의 공정 2
화합물 RE40-2(54 mg, 0.023 mmol)를 테트라히드로푸란(0.83 mL) 및 물(0.28 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 18 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 RE40-3(50.1 mg, 수율 97%)을 얻었다.
ESI-MS m/z: 1112(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 0.96-1.06(3H, m), 1.71-2.20(54H, m), 3.41-3.64(15H, m), 3.68-4.20(32H), 4.55(4H, d, J=8.4 Hz), 4.81(4H, s), 4.94-5.02(4H, m), 5.17-5.25(4H, m), 6.63-6.76(2H, m), 6.93-7.02(2H, m), 7.84-8.00(3H, m), 8.17-8.30(2H, m), 8.58-8.70(2H, m)
참고예 41: 화합물 D7의 합성
참고예 41의 공정 1
화합물 RE41-1(500 mg, 0.861 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 92.1 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 아르곤 분위기 하에, 실온에서 참고예 27에서 합성한 화합물 RE27-3(113 mg, 0.172 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(198 mg, 1.03 mmol), 1-히드록시벤조트리아졸일수화물(13.2 mg, 0.086 mmol)을 가하여 밤새 교반했다. 반응액을 셀라이트로 여과하고, 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제하고, 또한 역상 분취 HPLC(아세토니트릴/물)로 정제함으로써, 화합물 RE41-2(195 mg, 수율 48%)를 얻었다.
ESI-MS m/z: 1186(M+2H)2+
참고예 41의 공정 2
화합물 RE41-2(194 mg, 0.082 mmol)를 테트라히드로푸란(2.9 mg) 및 물(1.0 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 35.7 mg)을 가하여, 수소 분위기 하에서 8시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D7(183 mg, 수율 98%)을 얻었다.
ESI-MS m/z: 1141(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.21-1.45(m, 40H), 1.76-2.18(m, 50H), 3.00-3.09(m, 8H), 3.40-4.20(m, 32H), 4.47(d, J=8.5 Hz, 4H), 4.96(dd, J=3.1, 11.2 Hz, 4H), 5.21(d, J=3.1 Hz, 4H), 6.98(s, 1H), 7.65(s,2H), 7.84(d, J=9.0 Hz, 4H), 8.31(brs, 1H), 8.44(brs, 1H), 10.11(s, 1H).
참고예 42: 화합물 D8의 합성
참고예 42의 공정 1
참고예 11에 기재한 방법으로 합성한 화합물 RE42-1(참고예 11에 있어서의 화합물 RE11-2, 500 mg, 0.861 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 92.1 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 아르곤 분위기 하에, 실온에서 참고예 29에서 합성한 화합물 RE29-4(97.0 mg, 0.172 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(198 mg, 1.03 mmol), 1-히드록시벤조트리아졸일수화물(13.2 mg, 0.086 mmol)을 가하여 밤새 교반했다. 반응액을 셀라이트로 여과하고, 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=85/15)로 정제하고, 또한 역상 분취 HPLC(아세토니트릴/물)로 정제함으로써, 화합물 RE42-2(179 mg, 수율 46%)를 얻었다.
ESI-MS m/z: 1138(M+2H)2+
참고예 42의 공정 2
화합물 RE42-2(175 mg, 0.077 mmol)를 테트라히드로푸란(2.6 mg) 및 물(0.9 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 32.4 mg)을 가하여, 수소 분위기 하에서 1시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D8(160 mg, 수율 95%)을 얻었다.
ESI-MS m/z: 1093(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.23-1.45(m, 32H), 1.77(s, 12H), 1.89(s, 12H), 1.99(s, 12H), 2.10(s, 12H), 3.01-3.11(m, 8H), 3.69-4.02(m, 34H), 4.47-4.50(m, 4H), 4.94-4.98(m, 4H), 5.21(d, J=3.1 Hz, 4H), 6.92(s, 1H), 6.94(s,2H), 7.87(d, J=9.4 Hz, 2H), 7.92(d, J=8.5 Hz, 2H), 8.33(brs, 2H), 8.50(brs, 2H).
참고예 43: 화합물 D9의 합성
참고예 43의 공정 1
참고예 13에 기재한 방법으로 합성한 화합물 RE43-1(참고예 13에 있어서의 화합물 RE13-2, 500 mg, 0.784 mmol)을 N,N'-디메틸포름아미드(10 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 92.1 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 아르곤 분위기 하에, 실온에서 참고예 30에서 합성한 화합물 RE30-6(144 mg, 0.157 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(180 mg, 0.941 mmol), 1-히드록시벤조트리아졸일수화물(12.0 mg, 0.078 mmol)을 가하여 밤새 교반했다. 반응액을 셀라이트로 여과하고, 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=80/20)로 정제하고, 또한 역상 분취 HPLC(아세토니트릴/물)로 정제함으로써, 화합물 RE43-2(191 mg, 수율 43%)를 얻었다.
ESI-MS m/z: 1431(M+2H)2+
참고예 43의 공정 2
화합물 RE43-2(186 mg, 0.065 mmol)를 테트라히드로푸란(2.8 mg) 및 물(0.9 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 34.3 mg)을 가하여, 수소 분위기 하에서 1시간 교반했다. 반응액을 여과하고, 감압 하에 용매를 유거하여, 화합물 D9(174 mg, 수율 97%)를 얻었다.
ESI-MS m/z: 1386(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.25-4.02(m, 164H), 4.18-4.26(m,2H), 4.47(d, J=8.1 Hz, 4H), 4.96(dd, J=3.1, 11.2 Hz, 4H), 5.21(d, J=3.6 Hz, 4H), 7.74-7.91(m, 13H), 8.18(s, 2H), 8.36(d, J=7.2 Hz, 2H), 10.27(brs, 1H).
참고예 44: 화합물 A2의 합성
참고예 44의 공정 1
참고예 31에 기재한 방법으로 합성한 화합물 RE44-1(참고예 31에 있어서의 화합물 RE31-4, 150 mg, 0.228 mmol)을 디클로로메탄(1.5 mL)에 용해하고, 실온에서 트리플루오로아세트산(1.5 mL)을 가하여 4시간 교반했다. 반응액을 감압 농축하여, 아세트산에틸로 공비했다. 잔사를 N,N'-디메틸포름아미드(3 mL)에 용해하고, 실온에서 참고예 14의 화합물 RE14-3(574 mg, 0.571 mmol), 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드염산염(109 mg, 0.571 mmol), 트리에틸아민(0.159 mL, 1.14 mmol), 1-히드록시벤조트리아졸일수화물(3.50 mg, 0.023 mmol)을 가하여 밤새 교반했다. 반응액을 감압 농축하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제하고, 또한 역상 분취 HPLC(아세토니트릴/물)로 정제함으로써, 화합물 RE44-2(242 mg, 수율 44%)를 얻었다.
ESI-MS m/z: 1216(M+2H)2+
참고예 44의 공정 2
화합물 RE44-2(242 mg, 0.100 mmol)를 테트라히드로푸란/물(4/1; 12 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 44.6 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 아르곤 분위기 하에, 실온에서 6-말레이미드헥산산(23.2 mg, 0.110 mmol), 4-(4,6-디메톡시-1,3,5-트리아진-2-일)-4-메틸모르폴리늄클로리드(55.2 mg, 0.199 mmol)를 가하여 밤새 교반했다. 반응액을 셀라이트로 여과하고, 감압 하에 용매를 유거하여, 잔사를 HP20 레진(아세톤/물)으로 정제함으로써, 화합물 A2(97.4 mg, 수율 39%)를 얻었다.
ESI-MS m/z: 1245(M+2H)2+
1H-NMR(400 MHz, DMSO-d6, δ): 1.14-2.16(100H, m), 2.96-2.98(4H, m), 3.24-3.41(18H, m), 3.69-3.73(4H, m), 3.83-3.91(6H, m), 4.14-4.16(2H, m), 4.47(4H, d, J=8.6 Hz), 4.96(4H, dd, J=3.6, 11.3 Hz), 5.21(4H, d, J=3.2 Hz), 7.01(2H, s), 7.73-7.75(2H, m), 7.83-7.94(7H, m), 8.05-8.08(2H, m), 8.14-8.20(3H, m), 8.55-8.56(2H, m), 10.24(1H, brs).
참고예 45: 화합물 A3의 합성
참고예 45의 공정 1
참고예 32에 기재한 방법으로 합성한 화합물 RE45-1(참고예 32에 있어서의 화합물 RE32-3, 75.0 mg, 0.228 mmol)을 N,N'-디메틸포름아미드(3.0 mL)에 용해하고, 실온에서 참고예 14의 화합물 RE14-3(574 mg, 0.571 mmol), 디이소프로필에틸아민(0.199 mL, 1.14 mmol), O-(7-아자벤조트리아졸-1-일)-N,N,N',N'-테트라메틸유로늄헥사플루오로포스파이트(217 mg, 0.571 mmol)를 가하여 밤새 교반했다. 감압 하에 용매를 유거하여, 잔사를 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=90/10)로 정제하고, 또한 역상 분취 HPLC(아세토니트릴/물)로 정제함으로써, 화합물 RE45-2(202 mg, 수율 38%)를 얻었다.
ESI-MS m/z: 1152(M+2H)2+
참고예 45의 공정 2
화합물 RE45-2(196 mg, 0.085 mmol)를 테트라히드로푸란/물(4/1; 10 mL)에 용해하고, 실온에서 10% 팔라듐카본 분말(함수 제품, 54.29%; 36.1 mg)을 가하여, 수소 분위기 하에서 2시간 교반했다. 아르곤 분위기 하에, 실온에서 6-말레이미드헥산산(19.8 mg, 0.094 mmol), 4-(4,6-디메톡시-1,3,5-트리아진-2-일)-4-메틸모르폴리늄클로리드(47.0 mg, 0.170 mmol)를 가하여 밤새 교반했다. 반응액을 셀라이트로 여과하고, 감압 하에 용매를 유거하여, 잔사를 HP20 레진(아세톤/물)으로 정제함으로써, 화합물 A3(42.4 mg, 수율 21%)을 얻었다.
ESI-MS m/z: 1182(M+2H)2+
참고예 46: 화합물 D10
참고예 34에 기재한 방법으로 합성한 화합물 RE46-1(참고예 34에 있어서의 화합물 RE34-3)을 이용하여, 참고예 10의 공정 1 및 2와 같은 방법으로 화합물 D10(2.2 g, 수율 58%)을 얻었다.
ESI-MS m/z: 2437(M+H)+
참고예 47: 화합물 A4의 합성
참고예 47의 공정 1
참고예 33에 기재한 방법으로 합성한 화합물 RE47-1(참고예 33에 있어서의 화합물 RE33-4, 0.101 g, 0.282 mmol)을 이용하고, 참고예 15의 화합물 RE15-2(0.607 g, 0.613 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법에 의해서 화합물 RE47-2(0.25 g, 수율 39%)를 얻었다.
ESI-MS m/z: 2304(M+H)+
참고예 47의 공정 2
화합물 RE47-2(0.255 g, 0.111 mmol)를 이용하여, 참고예 3의 공정 2와 같은 방법에 의해서 화합물 RE47-3(0.15 g, 수율 63%)을 얻었다.
ESI-MS m/z: 2170(M+H)+
참고예 47의 공정 3
화합물 RE47-3(20.8 mg, 9.59 ㎛ol)을 이용하여, 참고예 5의 공정 2와 같은 방법에 의해서 화합물 A4(5.5 mg, 수율 24%)를 얻었다.
ESI-MS m/z: 1182(M+2H)2+
참고예 48: 화합물 A5의 합성
참고예 48의 공정 1
참고예 33에 기재한 방법으로 합성한 화합물 RE48-1(참고예 33에 있어서의 화합물 RE33-4, 0.099 g, 0.277 mmol)을 이용하고, 참고예 16의 공정 2에서 합성한 화합물 RE16-3(0.618 g, 0.615 mmol)을 이용하여, 참고예 3의 공정 3과 같은 방법에 의해서 화합물 RE48-2(0.343 g, 수율 53%)를 얻었다.
ESI-MS m/z: 2333(M+H)+
참고예 48의 공정 2
화합물 RE48-2를 이용하여, 참고예 10의 공정 1 및 2와 같은 방법으로 화합물 A5(6.9 mg, 수율 28%)를 얻었다.
ESI-MS m/z: 2392(M+H)+
참고예 49: 화합물 A6의 합성
화합물 RE49-1(0.048 g, 0.021 mmol)과 3-말레이미드프로피온산 N-숙신이미딜(도쿄가세이사 제조, 0.017 g, 0.064 mmol)을 이용하여, 참고예 8의 화합물 A1의 합성과 같은 방법으로 화합물 A6(0.040 g, 수율 78%)을 얻었다.
ESI-MS m/z: 2480(M+HCOO)-
참고예 50: 화합물 A7의 합성
공정 131
참고예 10에 기재한 방법으로 합성한 화합물 D1(23.6 mg, 9.46 ㎛ol)과 N-(2-아미노에틸)말레이미드 트리플루오로아세트산염(시그마알드리치사 제조, 7.21 mg, 0.028 ㎛ol)을 이용하여, 참고예 3의 공정 3과 같은 방법으로 화합물 A7(9.1 mg, 수율 36%)을 얻었다.
ESI-MS m/z: 1310(M+2H)2+
참고예 51
참고예 51의 공정 1
참고예 7에 기재한 방법으로 합성한 화합물 RE51-1(0.122 g, 0.054 mmol)과 바이오콘쥬게이트 케미스트리(Bioconjugate Chemistry), 제22권, 690-699 페이지, 2011년에 기재된 방법과 같은 방법을 이용하여 합성한 헥산산모노벤질에스테르를 이용하여, 참고예 4의 공정 1과 같은 방법으로 화합물 RE51-2(0.076 g, 수율 56%)를 얻었다.
ESI-MS m/z: 2503(M+H)+
참고예 51의 공정 2
화합물 RE51-2(0.076 g, 0.03 mmol)를 이용하여, 참고예 3의 공정 1과 같은 방법으로 화합물 RE51-3(0.030 g, 수율 40%)을 얻었다.
ESI-MS m/z: 2412(M+H)+
참고예 52
참고예 6에 기재한 방법으로 합성한 화합물 RE52-1(참고예 6에 있어서의 화합물 RE6-5, 4.36 mg, 0.006 mmol)과 참고예 1의 화합물 RE1-4(10 mg, 0.02 mmol) 를 이용하여, 참고예 3의 공정 7과 같은 방법으로 화합물 RE52-2(7 mg, 수율 65%)를 얻었다.
ESI-MS m/z: 1581(M-H)-
참고예 53: 화합물 C2의 합성
참고예 53의 공정 1
참고예 46에 기재한 방법으로 합성한 화합물 D10(0.2011 g, 0.079 mmol)을 이용하여, 참고예 10의 공정 3과 같은 방법으로 화합물 RE53-1(0.129 g, 수율 55%)을 얻었다.
ESI-MS m/z: 2972(M+HCOO)-
참고예 53의 공정 2
화합물 RE53-1(0.129 g, 0.044 mmol)을 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE53-2의 조생생물을 얻었다.
ESI-MS m/z: 1535(M+HCOOH-2H)2-
참고예 53의 공정 3
화합물 RE53-2(0.0467 g, 0.013 mmol)를 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C2(19.4 ㎛ol/g, 수율 35%)를 얻었다.
참고예 54: 화합물 C3의 합성
참고예 54의 공정 1
참고예 10에 기재한 방법으로 합성한 화합물 D1(100 mg, 0.040 mmol) 및 참고예 17의 화합물 RE17-2를 이용하여, 참고예 10의 공정 3과 같은 방법으로 화합물 RE54-1(90 mg, 수율 76%)을 얻었다.
ESI-MS m/z: 1335(M-DMTr+2H)2+
참고예 54의 공정 2
화합물 RE54-1(90 mg, 0.030 mmol)을 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE54-2의 조생성물을 얻었다.
ESI-MS m/z: 1558(M+HCOOH-2H)2-
참고예 54의 공정 3
화합물 RE54-2의 조생성물을 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C3(21.5 ㎛ol/g, 2단계 수율 32%)을 얻었다.
참고예 55: 화합물 C4의 합성
참고예 55의 공정 1
참고예 46에 기재한 방법으로 합성한 화합물 D10(100 mg, 0.039 mmol) 및 참고예 17에서 합성한 화합물 RE17-2를 이용하여, 참고예 10의 공정 3과 같은 방법으로 화합물 RE55-1(90 mg, 수율 76%)을 얻었다.
ESI-MS m/z: 1356(M+2H)2+ 탈DMTr체로서 검출
참고예 55의 공정 2
화합물 RE55-1(90 mg, 0.030 mmol)을 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE55-2의 조생성물을 얻었다.
ESI-MS m/z: 1579(M+HCOOH-2H)2-
참고예 55의 공정 3
화합물 RE55-2의 조생성물을 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C4(17.0 ㎛ol/g, 2단계 수율 26%)를 얻었다.
참고예 56: 화합물 C5의 합성
참고예 56의 공정 1
참고예 46에 기재한 방법으로 합성한 화합물 D10(100 mg, 0.039 mmol) 및 참고예 18의 공정 2에서 합성한 화합물 RE18-3을 이용하여, 참고예 10의 공정 3과 같은 방법으로 화합물 RE56-1(50 mg, 수율 42%)을 얻었다.
ESI-MS m/z: 1363(M+2H)2+ 탈DMTr체로서 검출
참고예 56의 공정 2
화합물 RE56-1(50 mg, 0.017 mmol)을 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE56-2의 조생성물을 얻었다.
ESI-MS m/z: 1587(M+HCOOH-2H)2-
참고예 56의 공정 3
화합물 RE56-2의 조생성물을 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C5(0.5 ㎛ol/g, 2단계 수율 1%)를 얻었다.
참고예 57: 화합물 C6의 합성
참고예 57의 공정 1
참고예 46에 기재한 방법으로 합성한 화합물 D10(100 mg, 0.039 mmol) 및 참고예 19의 화합물 RE19-2를 이용하여, 참고예 10의 공정 3과 같은 방법으로 화합물 RE57-1(40 mg, 수율 30%)을 얻었다.
ESI-MS m/z: 1532(M+2H)2+ 탈DMTr체로서 검출
참고예 57의 공정 2
화합물 RE57-1(40 mg, 0.012 mmol)을 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE57-2의 조생성물을 얻었다.
ESI-MS m/z: 1582(M+2H)2+ 탈DMTr체로서 검출
참고예 57의 공정 3
화합물 RE57-2의 조생성물을 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C6(0.2 ㎛ol/g, 2단계 수율 1%)을 얻었다.
참고예 58: 화합물 C7의 합성
참고예 58의 공정 1
참고예 10에 기재한 방법으로 합성한 화합물 D1(70 mg, 0.028 mmol) 및 참고예 21의 화합물 RE21-3을 이용하여, 참고예 10의 공정 3과 같은 방법으로 화합물 RE58-1(58 mg, 수율 77%)을 얻었다.
ESI-MS m/z: 1341(M+2H)2+
참고예 58의 공정 2
화합물 RE58-1(58 mg, 0.022 mmol)을 메탄올(0.15 mL)에 용해하고, 저널 오브 오가닉 케미스트리(Journal of Organic Chemistry), 제74권, 6837-6842 페이지, 2009년에 기재된 방법으로 합성한 참고예 17의 화합물 RE17-1(16.9 mg, 0.032 mmol), 1 mol/L 소듐 L-아스코르베이트 수용액(0.022 mL, 0.022 mmol), 20 mmol/L 황산구리(II) 수용액(0.011 mL, 0.22 ㎛ol) 및 10 mmol/L 트리스(2-벤즈이미다졸릴메틸)아민/DMSO 용액(0.022 mL, 0.22 ㎛ol)을 가하여, 실온에서 3시간 교반했다. 반응액을 실리카겔 컬럼 크로마토그래피(클로로포름/메탄올=80/20)로 정제하여, 화합물 RE58-2(7 mg, 수율 10%)를 얻었다.
ESI-MS m/z: 1450(M+2H)2+ 탈DMTr체로서 검출
참고예 58의 공정 3
화합물 RE58-2(10 mg, 3.13 ㎛ol)를 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE58-3의 조생성물을 얻었다.
ESI-MS m/z: 1500(M+2H)2+ 탈DMTr체로서 검출
참고예 58의 공정 4
화합물 RE58-3의 조생성물을 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C7(8.4 ㎛ol/g, 수율 27%)을 얻었다.
참고예 59
참고예 59의 공정 1
참고예 46에 기재한 방법으로 합성한 화합물 D10(74.1 mg, 0.029 mmol)과 참고예 22의 화합물 RE22-2(15 mg, 0.027 mmol)를 이용하여, 참고예 3의 공정 3과 같은 방법, 또는 바이오콘쥬게이트 케미스트리, 제26권, 1451-1455 페이지, 2015년에 기재된 방법으로 화합물 RE59-1의 조생성물을 얻었다.
ESI-MS m/z: 1392(M+H)+, 탈DMTr체로서 검출
참고예 59의 공정 2
화합물 RE59-1(0.083 g, 0.027 mmol)을 이용하여, 국제공개공보 2015105083호에 기재된 방법에 의해 화합물 RE59-2의 조생성물을 얻었다.
ESI-MS m/z: 2669(M+H)+, 탈DMTr체로서 검출
참고예 59의 공정 3
화합물 RE59-2(0.08 g, 0.027 mmol)을 이용하여, 참고예 10의 공정 4와 같은 방법으로 화합물 RE59-3의 조생성물을 얻었다.
ESI-MS m/z: 1556(M+HOOH-2H)2-
1H-NMR(400 MHz, MeOD): δ 1.45-1.86(48H, m), 1.93(12H, s), 1.94(12H, s), 2.02(12H, s), 2.13(12H, s), 2.16-2.28(17H, m), 2.48(4H, s), 3.10-3.16(6H, m), 3.36-3.56(19H, m), 3.77(6H, s), 3.80-3.89(6H, m), 3.98-4.35(30H, m), 4.53-4.59(4H, m), 4.66-4.72(1H, m), 5.04-5.10(4H, m), 5.31-5.36(4H, m), 6.81-6.88(4H, m), 7.17-7.23(1H, m), 7.26-7.32(6H, m), 7.38-7.44(2H, m), 7.54(2H, br s), 7.90(1H, br s).
참고예 60
화합물 D1 및 표 Z-1에 기재한 구조 또는 참고예 20의 화합물 RE20-4를 이용하여, 참고예 59의 공정 1 및 공정 2와 같은 방법으로 표 P-1 및 표 P-2에 기재한 화합물을 얻었다.
본 실시예에 의해 합성한 화합물의 질량 분석 결과를 표 P-3에 나타낸다.
참고예 61: 화합물 C8의 합성
참고예 59에 기재한 화합물 RE59-3을 이용하여, 참고예 10의 공정 5와 같은 방법으로 화합물 C8(10.0 ㎛ol/g)을 얻었다.
참고예 62: C9∼C17의 합성
표 P-1 및 표 P-2에 기재한 화합물을 이용하여, 참고예 61과 같은 방법으로 표 Q-1 및 표 Q-2에 기재한 화합물을 얻었다.
본 실시예에 의해 합성한 화합물의 담지량을 표 Q-3에 나타낸다.
실시예 1: 화합물 1-1 및 1-2의 합성
공정 1
참고예 화합물 A1과, 몰레큘즈(Molecules), 제17권, 13825-13843 페이지, 2012년에 기재된 방법으로 합성한 말단 티올화된 올리고뉴클레오티드를 가하여, 실온에서 4시간 정치했다. 반응 혼합물에 탄산나트륨을 가하여, 4℃에서 하룻밤 정치했다. 음이온 교환 크로마토그래피(GE Healthcare, MonoQ 5/50GL, 10 ㎛, 5.0 mmx50 mm, A액: 10 mmol/L Tris 완충액/30% 아세토니트릴, B액: 10 mmol/L Tris 완충액/30% 아세토니트릴/1 mol/L NaBr에 의한 그래디언트) 혹은 역상 액체 크로마토그래피(워터즈, X BridgeC18, 5 ㎛, 4.6 mmx250 mm, 0.1 mol/L 아세트산트리에틸암모늄 완충액, B액: 아세토니트릴에 의한 그래디언트)의 어느 하나의 방법으로 정제함으로써 화합물 1-1을 얻었다. 센스 사슬 서열은 표 R-1∼표 R-2에 기재되어 있는 것과 같다.
공정 2
공정 1에서 합성한 화합물 1-1(3'-APCS-ssRNA)을, 혼합 완충액(100 mmol/L 아세트산칼륨, 30 mmol/L 2-[4-(2-히드록시에틸)피페라진-1-일]에탄술폰산, HEPES)-KOH(pH 7.4), 2 mmol/L 아세트산마그네슘)으로 농도 조정(50 ㎛ol/L)했다. 상술한 센스 사슬과 안티센스 사슬(50 ㎛ol/L)을 각각 등량 혼합하여, 80℃에서 10분간 정치했다. 안티센스 사슬 서열은 표 R-3∼표 R-4에 기재되어 있는 것과 같다. 서서히 온도를 내리고, 37℃에서 1시간 정치하여, 이중 사슬의 화합물 1-2를 얻었다.
실시예 2∼10: 화합물 2-1∼10-1 및 화합물 2-2∼10-2의 합성
실시예 1과는 염기 서열이 다른 올리고뉴클레오티드를 이용하여, 실시예 1과 같은 식으로 하여, 화합물 2-1∼10-1 및 화합물 2-2∼10-2를 합성했다.
실시예 11: 화합물 11-1 및 화합물 11-2의 합성
공정 1
참고예 화합물 D5를 이용하여, 몰레큘즈(Molecules), 제17권, 13825-13843 페이지, 2012년에 기재된 방법으로 합성한 말단이 아미노기로 수식된 올리고뉴클레오티드를 가하여, 바이오콘쥬게이트 케미스트리, 제22권, 1723-1728 페이지, 2011년 혹은 바이오콘쥬게이트 케미스트리, 제26권, 1451-1455 페이지, 2015년에 기재된 방법으로 반응시켰다. 실시예 1에 기재한 방법으로 정제함으로써 화합물 11-1을 얻었다.
공정 2
실시예 1의 공정 2와 같은 방법으로 화합물 11-2를 얻었다.
실시예 12∼43: 화합물 12-1∼43-1 및 화합물 12-2∼43-2의 합성
실시예 11과는 염기 서열이 다른 올리고뉴클레오티드를 이용하여, 실시예 11과 같은 식으로 화합물 12-1∼43-1 및 화합물 12-2∼43-2를 합성했다.
본 실시예에 의해 합성한 화합물의 리간드 링커 구조를 이하에 나타낸다.
본 실시예에 의해 합성한 핵산 복합체의 서열(센스 사슬) 및 질량 분석 결과를 표 R-1∼표 R-2에 나타낸다. 또한, 표 R-1∼표 R-2 중, N(M)은 2'-O-메틸 수식 RNA, N(F)는 2'-불소 수식 RNA, p는 5' 말단에 있어서의 인산화, ^는 포스포로티오에이트, X는 참고예 화합물 A1의 잔기 및 Y는 참고예 화합물 D5의 잔기를 나타낸다. 서열 번호 2069∼∼2111에 나타내는 리보뉴클레오티드를 포함하는 센스 사슬과, 서열 번호 2112∼2154에 나타내는 리보뉴클레오티드를 포함하는 안티센스 사슬의 이중 사슬 핵산으로 구성된다(서열 번호 n(n=2069∼∼2111)에 나타내는 센스 사슬과 서열 번호 [n+43]에 나타내는 안티센스 사슬이 쌍을 이룬다).
본 실시예에 의해 합성한 핵산 복합체의 서열을 표 R-3∼표 R-4에 나타낸다. 또한, 표 R-3∼표 R-4 중, N(M)은 2'-O-메틸 수식 RNA, N(F)는 2'-불소 수식 RNA, p는 5' 말단에 있어서의 인산화 및 ^은 포스포로티오에이트를 나타낸다.
참고 시험예 1: siRNA의 인간 세포에 있어서의 APCS mRNA의 녹다운 활성의 측정
이중 사슬 핵산은 표 1-1∼표 1∼13에 기재한 것을 시그마알드리치사에서 합성하여 이용했다. 구체적으로는 서열 번호 2∼644에 나타내는 리보뉴클레오티드를 포함하는 센스 사슬, 서열 번호 645∼1287에 나타내는 리보뉴클레오티드를 포함하는 안티센스 사슬을 어닐링시킨 이중 사슬 핵산으로 구성된다(서열 번호 n(n=2∼644)에 나타내는 센스 사슬과 서열 번호 [n+643]에 나타내는 안티센스 사슬이 쌍을 이룬다). 384 웰의 배양 플레이트에, 이중 사슬 핵산과 RNAiMax 트랜스펙션 시약(Thermo Fisher Scientific사 제조, 카탈로그 번호 13778150)을 Opti-MEM I Reduced Serum Medium 배지(Thermo Fisher Scientific사 제조, 카탈로그 번호31985070)로 희석한 siRNA/RNAiMax 혼합액 20 μL를 첨가했다. 인간 난소암 유래의 세포주인 RMG-I 세포(JCRB 세포뱅크, JCRB0172)를, 10,000 세포/40 μL/웰이 되도록 각각 384 웰의 배양 플레이트에 파종하고, 37℃, 5% CO2 조건 하에서 24시간 배양했다. 배지는, 10% 소 태아 혈청(Thermo Fisher Scientific사 제조, 카탈로그 번호 10091-148)을 포함하는 Ham's F-12 Nutrient Mix 배지(Thermo Fisher Scientific사 제조, 카탈로그 번호 11765-047)를 이용했다. 이중 사슬 핵산의 종농도는 1 nM이 되게 했다. 그 후, 세포를 DPBS, 칼슘 무함유, 마그네슘 무함유(Thermo Fisher Scientific사 제조, 카탈로그 번호 14190-144)으로 세정하고, 각각의 플레이트로부터 TaqMan(등록상표) Fast Cells-to-CT(상표) 키트(Thermo Fisher Scientific사 제조, 카탈로그 번호 4399003)를 이용하여 이하의 방법으로 cDNA를 합성했다. 용해(Lysis)액(키트 내용물)과 DNase I(키트 내용물)을 100:1로 혼합한 용액을 10 μL씩 첨가하여, 5분간 혼합했다. 정지액(키트 내용물)을 1 μL씩 첨가, 2분간 혼합하여, RNA 추출액으로 했다. 5 μL의 2×RT 버퍼(키트 내용물), 0.5 μL의 20×RT Enzyme Mix(키트 내용물), 2.5 μL의 뉴클레아제-프리 워터, 2 μL의 RNA 추출액을 혼합하고, 이것을 37℃, 60분간, 95℃, 5분간으로 반응시켜, cDNA를 합성했다. 이 cDNA 2 μL를 MicroAmp(등록상표) EnduraPlate(상표) 바코드가 부착된 광학 384-웰 클리어 반응 플레이트(Thermo Fisher Scientific사 제조, 카탈로그 번호 4483285)에 가하고, 또한 5 μL의 TaqMan(등록상표) Fast Universal PCR Master Mix(Thermo Fisher Scientific사 제조, 카탈로그 번호 4352042), 2.5 μL의 증류수(초고순도)(Thermo Fisher Scientific사 제조, 카탈로그 번호 10977015), 0.25 μL의 인간 APCS 프로브, 0.25 μL의 인간 ACTB 프로브를 첨가했다. QuantStudio(상표) 7 Flex를 이용하여, 인간 APCS 유전자 및 인간 ACTB(액틴 베타) 유전자의 리얼타임 PCR을 행했다. ACTB는 구성적 발현 유전자이며 내부 대조로서 측정하여, APCS 유전자 발현량을 보정했다. siRNA를 첨가하지 않고서 트랜스펙션 시약만으로 RMG-I 세포를 처리했을 때의 APCS mRNA량을 1.0으로 하여, 각 siRNA를 도입했을 때의 APCS mRNA 상대 발현량의 값을 산출했다. 본 실험을 2회 행하여, APCS mRNA 상대 발현량 값의 최소치를 표 1-1∼표 1-13에 나타냈다.
또한, APCS 제2 가닥 cDNA의 전장의 염기 서열을 표 2에 나타낸다.
참고 시험예 2: 수식 siRNA의 인간 세포에 있어서의 APCS mRNA의 녹다운 활성의 측정 1
진디자인사에 의뢰하여, 서열 번호 1931∼1974에 나타내는 리보뉴클레오티드를 포함하는 센스 사슬 핵산, 서열 번호 1975∼2018에 나타내는 리보뉴클레오티드를 포함하는 안티센스 사슬 핵산 및 이들을 어닐링시킨 이중 사슬 핵산(서열 번호 n(n=1931∼1974)에 나타내는 센스 사슬과 서열 번호 [n+44]에 나타내는 안티센스 사슬이 쌍을 이룬다)을 합성했다.
합성한 이중 사슬 핵산의 종농도는 1 nM 또는 0.1 nM이 되게 하고, 상기 이중 사슬 핵산을 RMG-1 세포에 도입하여, 24시간 배양한 것 이외에는, 참고 시험예 1과 같은 조작을 행하여, APCS mRNA 상대 발현량을 산출했다. 본 실험을 4회 행하여, APCS mRNA 상대 발현량 값의 중앙치를 표 M1-1∼표 M1-2에 나타냈다. 표 M1-1∼표 M1-2에 있어서, N(M)은 2'-O-메틸-RNA를, N(F)는 2'-F-RNA를 나타낸다.
참고
시험예
3 수식
siRNA의
인간
세포에 있어서의
APCS
mRNA의
녹다운 활성의 측정 2
이중 사슬 핵산은, 표 M1-3에 기재한 것을 진디자인사에서 합성하여 이용했다. 구체적으로는 서열 번호 2019∼2043에 나타내는 리보뉴클레오티드를 포함하는 센스 사슬, 서열 번호 2044∼2068에 나타내는 리보뉴클레오티드를 포함하는 안티센스 사슬을 어닐링시킨 이중 사슬 핵산으로 구성된다(서열 번호 n(n=2019∼2043)에 나타내는 센스 사슬과 서열 번호 [n+25]에 나타내는 안티센스 사슬이 쌍을 이룬다). 96 웰의 배양 플레이트에, 각 이중 사슬 핵산과 RNAiMax 트랜스펙션 시약(Thermo Fisher Scientific사 제조, 카탈로그 번호 13778150)을 Opti-MEM I Reduced Serum Medium 배지(Thermo Fisher Scientific사 제조, 카탈로그 번호 31985070)로 희석한 siRNA/RNAiMax 혼합액 20 μL를 첨가했다. 인간 난소암 유래의 세포주인 RMG-I 세포(JCRB 세포뱅크, JCRB0172)를, 10,000 세포/60 μL/웰이 되도록 각각 96 웰의 배양 플레이트에 파종하고, 37℃, 5% CO2 조건 하에서 24시간 배양했다. 배지는, 10% 소 태아 혈청(Thermo Fisher Scientific사 제조, 카탈로그 번호 10091-148)을 포함하는 Ham's F-12 Nutrient Mix 배지(Thermo Fisher Scientific사 제조, 카탈로그 번호 11765-047)를 이용했다. 이중 사슬 핵산의 종농도는 1 또는 0.1 nM이 되게 했다. 그 후, 세포를 DPBS, 칼슘 무함유, 마그네슘 무함유(Thermo Fisher Scientific사 제조, 카탈로그 번호 14190-144)으로 세정하고, 각각의 플레이트로부터 슈퍼프렙 셀 라이시스 앤드 알티 키트 포 큐피씨알(도요보세키사 제조, 카탈로그 번호 SCQ-101)을 이용하여, 제품에 첨부된 설명서에 기재된 방법에 따라서 전체 RNA를 회수하고, 얻어진 전체 RNA를 주형으로 하는 역전사 반응에 의한 cDNA를 제작했다. 이 cDNA 3 μL를 MicroAmpOptical 384 웰 플레이트(어플라이드바이오시스템즈사 제조, 카탈로그 번호 : 4309849)에 가하고, 또한 10 μL의 TaqMan Gene Expression Master Mix(어플라이드바이오시스템즈사 제조, 카탈로그 번호 4369016), 6 μL의 초고순도 증류수(서모피셔사이엔티픽사 제조, 카탈로그 번호 : 10977-015), 1 μL의 인간 APCS 프로브 혹은 1 μL의 인간 GAPDH(D-글리세르알데히드-3-포스페이트데히드로게나아제) 프로브를 첨가하고, 콴트스튜디오 12케이 플렉스 리얼타임 피씨알 시스템(서모피셔사이엔티픽사 제조)을 이용하여, 인간 APCS 유전자 및 인간 GAPDH 유전자의 리얼타임 PCR을 행했다. GAPDH는 구성적 발현 유전자이며 내부 대조로서 측정하여, APCS 유전자 발현량을 보정했다. siRNA를 첨가하지 않고서 트랜스펙션 시약만으로 RMG-I 세포를 처리했을 때의 APCS mRNA량을 1.0으로 하여, 각 siRNA를 도입했을 때의 APCS mRNA 상대 발현량의 값을 산출했다. 본 실험을 2회 행하여, APCS mRNA 상대 발현량 값의 평균치를 표 M1-3에 나타냈다. 또한, 표 M1-3 중, N(M)은 2'-O-메틸 수식 RNA, N(F)는 2'-불소 수식 RNA를 나타낸다.
시험예 1 핵산 복합체의 인간 초대 간세포에 대한 APCS mRNA의 녹다운 시험
실시예 1∼43에서 얻어진 각 핵산 복합체에 관해서, 인간 초대 간세포에 있어서의 인비트로 녹다운 활성을 측정했다. 이 핵산 복합체의 종농도가 300, 30, 3 또는 0.3 nmol/L가 되도록 옵티멤(Opti-MEM)(서모피셔사이엔티픽사 제조, 카탈로그 번호 31985)으로 희석한 각 핵산 복합체를, 96 웰의 콜라겐 I 코트 배양 플레이트 (코닝사 제조, 카탈로그 번호 : 356407)에 20 μL씩 분주한 후, 플레이팅 미디엄(바이오프레딕인터내셔날사 제조, 카탈로그 번호 LV0304-2)에 현탁시킨 인간 초대 간세포(바이오프레딕인터내셔날사 제조, 카탈로그 번호 HEP187)를, 10,000 세포/80 μL/웰이 되도록 파종하고, 37℃, 5% CO2 조건 하에서 6시간 배양한 후에, 배양 상청을 주의 깊게 제거하고, 인큐베이션 미디엄(바이오프레딕인터내셔날사 제조, 카탈로그 번호 LV0304-2)을 첨가하여, 각 핵산 복합체를 인간 초대 간세포에 제공했다. 또한, 음성 대조군으로서 20 μL의 옵티멤을 제공한 인간 초대 간세포를 이용한 각 핵산 복합체를 첨가한 세포를 37℃의 5% CO2 인큐베이터 내에서 18시간 배양하고, 빙냉한 인산 완충화 생리식염수(DPBS)(나카라이테스크사 제조, 카탈로그 번호 14249-95)로 세정하고, 각각의 플레이트로부터 슈퍼프렙 셀 라이시스 앤드 알티 키트 포 큐피씨알(도요보세키 제조, 카탈로그 번호 SCQ-101)을 이용하여, 제품에 첨부된 설명서에 기재된 방법에 따라서 전체 RNA를 회수하고, 얻어진 전체 RNA를 주형으로 하는 역전사 반응에 의한 cDNA를 제작했다. 이 cDNA 3 μL를 MicroAmpOptical 384 웰 플레이트(어플라이드바이오시스템즈사 제조, 카탈로그 번호 : 4309849)에 가하고, 또한 10 μL의 TaqMan Gene Expression Master Mix(어플라이드바이오시스템즈사 제조, 카탈로그 번호 4369016), 6 μL의 초고순도 증류수(서모피셔사이엔티픽사 제조, 카탈로그 번호 : 10977-015), 1 μL의 인간 APCS 프로브(어플라이드바이오시스템즈사 제조) 혹은 1 μL의 인간 GAPDH 프로브(어플라이드바이오시스템즈사 제조)를 첨가하고, 콴트스튜디오 12케이 플렉스 리얼타임 피씨알 시스템(서모피셔사이엔티픽사 제조)를 이용하여, 첨부된 사용설명서에 기재된 방법에 따라서 인간 APCS 유전자 및 인간 GAPDH 유전자의 리얼타임 PCR을 행했다. GAPDH는 구성적 발현 유전자이며 내부 대조로서 측정하여, APCS 발현량을 보정했다. 마찬가지로 측정한 음성 대조에 있어서의 APCS의 mRNA의 준정량치를 1.0으로 하여, 각 핵산 복합체를 도입했을 때의 APCS mRNA 상대 발현량을 산출했다. 본 실험을 2회 행하여, APCS mRNA 상대 발현량의 평균치를 표 S1에 나타냈다.
표 S1로부터 분명한 것과 같이, 각 핵산 복합체는 인간 초대 간세포에 첨가한 후, APCS 유전자의 mRNA의 발현을 억제했다.
시험예 2 핵산 복합체의 마우스에 있어서의 인비보 녹다운 시험
실시예 1∼43에서 얻어진 핵산 복합체에 관해서 이하의 방법에 의해 인비보 녹다운 시험을 실시했다. 또한, 각 핵산 복합체는 시험에 맞춰 인산 완충화 생리식염수(DPBS)(나카라이테스크사 제조)로 희석하여 이용했다. 마우스는 인간 간세포가 이식된 PXB 마우스(PXB/human Hepatocyte repopulated cDNA-uPA/SCID Tg, 페닉스바이오사로부터 입수)를 사용하여, 인간 APCS에 대한 핵산 복합체의 효과를 평가했다. PXB 마우스를 순화 사육한 후, 각 핵산 복합체를 마우스에게 피하 투여했다. 투여 용량은 10 mg/kg이고, 투여 용량은 5 mL/kg으로 했다. 컨트롤군으로서는 DPBS만을 마우스에게 피하 투여했다. 투여 6일 전 및 투여 후 1, 2, 3, 6, 10, 13일에 채혈을 하여, 1500×g으로 원심분리함으로써 혈청을 얻었다. 이들 혈청을 인간 SAP ELISA(SAP, 인간, ELISA 키트, HycultBiotech사 제조, #HK331-02)를 이용하여, 혈중 인간 APCS량을 평가했다. ELISA는 부속된 메뉴얼에 따라 실시했다. 각 마우스군의 혈중 인간 APCS 농도 추이를 도 1에 도시했다. DPBS 투여군에 대한 핵산 복합체 투여군에 있어서의 APCS 발현 비율(%)을 표 S2에 나타낸다.
표 S2로부터 분명한 것과 같이, 본 발명의 핵산 복합체를, 인간 APCS를 발현하는 마우스에게 투여하여, 마우스 말초혈 중의 APCS 단백질 발현을 저하시킨다는 것이 분명하게 되었다.
본 발명의 핵산 복합체는, 포유동물에게 투여하여, 생체 내에 있어서 아밀로이드 관련 질환을 치료하기 위해서 이용할 수 있다.
SEQUENCE LISTING
<110> KYOWA KIRIN CO., LTD.
<120> Nucleic acid complexes
<130> K1635AKP0009
<150> JP 2018-225829
<151> 2018-11-30
<160> 2154
<170> PatentIn version 3.5
<210> 1
<211> 960
<212> DNA
<213> Homo sapiens
<400> 1
gggcatgaat atcagacgct agggggacag ccactgtgtt gtctgctacc ctcatcctgg 60
tcactgcttc tgctataaca gccctaggcc aggaatatga acaagccgct gctttggatc 120
tctgtcctca ccagcctcct ggaagccttt gctcacacag acctcagtgg gaaggtgttt 180
gtatttccta gagaatctgt tactgatcat gtaaacttga tcacaccgct ggagaagcct 240
ctacagaact ttaccttgtg ttttcgagcc tatagtgatc tctctcgtgc ctacagcctc 300
ttctcctaca atacccaagg cagggataat gagctactag tttataaaga aagagttgga 360
gagtatagtc tatacattgg aagacacaaa gttacatcca aagttatcga aaagttcccg 420
gctccagtgc acatctgtgt gagctgggag tcctcatcag gtattgctga attttggatc 480
aatgggacac ctttggtgaa aaagggtctg cgacagggtt actttgtaga agctcagccc 540
aagattgtcc tggggcagga acaggattcc tatgggggca agtttgatag gagccagtcc 600
tttgtgggag agattgggga tttgtacatg tgggactctg tgctgccccc agaaaatatc 660
ctgtctgcct atcagggtac ccctctccct gccaatatcc tggactggca ggctctgaac 720
tatgaaatca gaggatatgt catcatcaaa cccttggtgt gggtctgagg tcttgactca 780
acgagagcac ttgaaaatga aatgactgtc taagagatct ggtcaaagca actggatact 840
agatcttaca tctgcagctc tttcttcttt gaatttccta tctgtatgtc tgcctaatta 900
aaaaaatata tattgtatta tgctacctgc aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 960
<210> 2
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 2
gcaugaauau cagacgcuag g 21
<210> 3
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 3
caugaauauc agacgcuagg g 21
<210> 4
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 4
auaucagacg cuagggggac a 21
<210> 5
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 5
cuagggggac agccacugug u 21
<210> 6
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 6
agggggacag ccacuguguu g 21
<210> 7
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 7
ggggacagcc acuguguugu c 21
<210> 8
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 8
gggacagcca cuguguuguc u 21
<210> 9
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 9
ggacagccac uguguugucu g 21
<210> 10
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 10
gacagccacu guguugucug c 21
<210> 11
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 11
gccacugugu ugucugcuac c 21
<210> 12
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 12
ccacuguguu gucugcuacc c 21
<210> 13
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 13
cacuguguug ucugcuaccc u 21
<210> 14
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 14
cuguguuguc ugcuacccuc a 21
<210> 15
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 15
uguguugucu gcuacccuca u 21
<210> 16
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 16
guguugucug cuacccucau c 21
<210> 17
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 17
uguugucugc uacccucauc c 21
<210> 18
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 18
guugucugcu acccucaucc u 21
<210> 19
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 19
gucugcuacc cucauccugg u 21
<210> 20
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 20
cugcuacccu cauccugguc a 21
<210> 21
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 21
gcuacccuca uccuggucac u 21
<210> 22
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 22
cuacccucau ccuggucacu g 21
<210> 23
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 23
uacccucauc cuggucacug c 21
<210> 24
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 24
acccucaucc uggucacugc u 21
<210> 25
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 25
cccucauccu ggucacugcu u 21
<210> 26
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 26
ccucauccug gucacugcuu c 21
<210> 27
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 27
cucauccugg ucacugcuuc u 21
<210> 28
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 28
cauccugguc acugcuucug c 21
<210> 29
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 29
auccugguca cugcuucugc u 21
<210> 30
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 30
uccuggucac ugcuucugcu a 21
<210> 31
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 31
ccuggucacu gcuucugcua u 21
<210> 32
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 32
cuggucacug cuucugcuau a 21
<210> 33
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 33
uggucacugc uucugcuaua a 21
<210> 34
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 34
ggucacugcu ucugcuauaa c 21
<210> 35
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 35
gucacugcuu cugcuauaac a 21
<210> 36
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 36
cacugcuucu gcuauaacag c 21
<210> 37
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 37
acugcuucug cuauaacagc c 21
<210> 38
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 38
cugcuucugc uauaacagcc c 21
<210> 39
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 39
gcuucugcua uaacagcccu a 21
<210> 40
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 40
cuucugcuau aacagcccua g 21
<210> 41
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 41
uucugcuaua acagcccuag g 21
<210> 42
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 42
ucugcuauaa cagcccuagg c 21
<210> 43
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 43
cugcuauaac agcccuaggc c 21
<210> 44
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 44
ugcuauaaca gcccuaggcc a 21
<210> 45
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 45
gcuauaacag cccuaggcca g 21
<210> 46
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 46
cuauaacagc ccuaggccag g 21
<210> 47
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 47
uauaacagcc cuaggccagg a 21
<210> 48
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 48
auaacagccc uaggccagga a 21
<210> 49
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 49
uaacagcccu aggccaggaa u 21
<210> 50
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 50
acagcccuag gccaggaaua u 21
<210> 51
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 51
cagcccuagg ccaggaauau g 21
<210> 52
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 52
agcccuaggc caggaauaug a 21
<210> 53
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 53
gcccuaggcc aggaauauga a 21
<210> 54
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 54
cccuaggcca ggaauaugaa c 21
<210> 55
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 55
ccuaggccag gaauaugaac a 21
<210> 56
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 56
cuaggccagg aauaugaaca a 21
<210> 57
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 57
uaggccagga auaugaacaa g 21
<210> 58
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 58
aggccaggaa uaugaacaag c 21
<210> 59
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 59
ggccaggaau augaacaagc c 21
<210> 60
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 60
gccaggaaua ugaacaagcc g 21
<210> 61
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 61
ccaggaauau gaacaagccg c 21
<210> 62
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 62
caggaauaug aacaagccgc u 21
<210> 63
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 63
aggaauauga acaagccgcu g 21
<210> 64
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 64
ggaauaugaa caagccgcug c 21
<210> 65
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 65
gaauaugaac aagccgcugc u 21
<210> 66
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 66
aauaugaaca agccgcugcu u 21
<210> 67
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 67
auaugaacaa gccgcugcuu u 21
<210> 68
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 68
uaugaacaag ccgcugcuuu g 21
<210> 69
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 69
augaacaagc cgcugcuuug g 21
<210> 70
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 70
ugaacaagcc gcugcuuugg a 21
<210> 71
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 71
gaacaagccg cugcuuugga u 21
<210> 72
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 72
aacaagccgc ugcuuuggau c 21
<210> 73
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 73
acaagccgcu gcuuuggauc u 21
<210> 74
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 74
caagccgcug cuuuggaucu c 21
<210> 75
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 75
aagccgcugc uuuggaucuc u 21
<210> 76
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 76
agccgcugcu uuggaucucu g 21
<210> 77
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 77
gccgcugcuu uggaucucug u 21
<210> 78
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 78
ccgcugcuuu ggaucucugu c 21
<210> 79
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 79
cgcugcuuug gaucucuguc c 21
<210> 80
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 80
gcugcuuugg aucucugucc u 21
<210> 81
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 81
cugcuuugga ucucuguccu c 21
<210> 82
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 82
ugcuuuggau cucuguccuc a 21
<210> 83
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 83
gcuuuggauc ucuguccuca c 21
<210> 84
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 84
cuuuggaucu cuguccucac c 21
<210> 85
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 85
uuuggaucuc uguccucacc a 21
<210> 86
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 86
ggaucucugu ccucaccagc c 21
<210> 87
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 87
gaucucuguc cucaccagcc u 21
<210> 88
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 88
cucuguccuc accagccucc u 21
<210> 89
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 89
cuguccucac cagccuccug g 21
<210> 90
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 90
uguccucacc agccuccugg a 21
<210> 91
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 91
guccucacca gccuccugga a 21
<210> 92
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 92
uccucaccag ccuccuggaa g 21
<210> 93
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 93
cucaccagcc uccuggaagc c 21
<210> 94
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 94
ucaccagccu ccuggaagcc u 21
<210> 95
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 95
accagccucc uggaagccuu u 21
<210> 96
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 96
ccagccuccu ggaagccuuu g 21
<210> 97
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 97
cagccuccug gaagccuuug c 21
<210> 98
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 98
agccuccugg aagccuuugc u 21
<210> 99
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 99
gccuccugga agccuuugcu c 21
<210> 100
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 100
ccuccuggaa gccuuugcuc a 21
<210> 101
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 101
cuccuggaag ccuuugcuca c 21
<210> 102
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 102
uccuggaagc cuuugcucac a 21
<210> 103
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 103
ccuggaagcc uuugcucaca c 21
<210> 104
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 104
cuggaagccu uugcucacac a 21
<210> 105
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 105
ggaagccuuu gcucacacag a 21
<210> 106
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 106
gaagccuuug cucacacaga c 21
<210> 107
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 107
aagccuuugc ucacacagac c 21
<210> 108
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 108
agccuuugcu cacacagacc u 21
<210> 109
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 109
gccuuugcuc acacagaccu c 21
<210> 110
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 110
ccuuugcuca cacagaccuc a 21
<210> 111
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 111
cuuugcucac acagaccuca g 21
<210> 112
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 112
uuugcucaca cagaccucag u 21
<210> 113
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 113
ugcucacaca gaccucagug g 21
<210> 114
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 114
cucacacaga ccucaguggg a 21
<210> 115
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 115
cacacagacc ucagugggaa g 21
<210> 116
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 116
acacagaccu cagugggaag g 21
<210> 117
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 117
cacagaccuc agugggaagg u 21
<210> 118
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 118
agaccucagu gggaaggugu u 21
<210> 119
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 119
gaccucagug ggaagguguu u 21
<210> 120
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 120
accucagugg gaagguguuu g 21
<210> 121
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 121
ccucaguggg aagguguuug u 21
<210> 122
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 122
cucaguggga agguguuugu a 21
<210> 123
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 123
ucagugggaa gguguuugua u 21
<210> 124
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 124
cagugggaag guguuuguau u 21
<210> 125
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 125
agugggaagg uguuuguauu u 21
<210> 126
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 126
gugggaaggu guuuguauuu c 21
<210> 127
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 127
ugggaaggug uuuguauuuc c 21
<210> 128
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 128
gggaaggugu uuguauuucc u 21
<210> 129
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 129
ggaagguguu uguauuuccu a 21
<210> 130
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 130
gaagguguuu guauuuccua g 21
<210> 131
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 131
aagguguuug uauuuccuag a 21
<210> 132
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 132
agguguuugu auuuccuaga g 21
<210> 133
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 133
gguguuugua uuuccuagag a 21
<210> 134
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 134
guguuuguau uuccuagaga a 21
<210> 135
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 135
uguuuguauu uccuagagaa u 21
<210> 136
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 136
guuuguauuu ccuagagaau c 21
<210> 137
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 137
uuuguauuuc cuagagaauc u 21
<210> 138
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 138
uuguauuucc uagagaaucu g 21
<210> 139
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 139
uguauuuccu agagaaucug u 21
<210> 140
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 140
guauuuccua gagaaucugu u 21
<210> 141
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 141
uauuuccuag agaaucuguu a 21
<210> 142
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 142
auuuccuaga gaaucuguua c 21
<210> 143
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 143
uuuccuagag aaucuguuac u 21
<210> 144
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 144
uccuagagaa ucuguuacug a 21
<210> 145
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 145
ccuagagaau cuguuacuga u 21
<210> 146
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 146
cuagagaauc uguuacugau c 21
<210> 147
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 147
uagagaaucu guuacugauc a 21
<210> 148
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 148
agagaaucug uuacugauca u 21
<210> 149
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 149
gagaaucugu uacugaucau g 21
<210> 150
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 150
agaaucuguu acugaucaug u 21
<210> 151
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 151
gaaucuguua cugaucaugu a 21
<210> 152
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 152
aaucuguuac ugaucaugua a 21
<210> 153
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 153
aucuguuacu gaucauguaa a 21
<210> 154
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 154
ucuguuacug aucauguaaa c 21
<210> 155
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 155
cuguuacuga ucauguaaac u 21
<210> 156
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 156
uguuacugau cauguaaacu u 21
<210> 157
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 157
guuacugauc auguaaacuu g 21
<210> 158
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 158
acugaucaug uaaacuugau c 21
<210> 159
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 159
cugaucaugu aaacuugauc a 21
<210> 160
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 160
ugaucaugua aacuugauca c 21
<210> 161
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 161
gaucauguaa acuugaucac a 21
<210> 162
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 162
ucauguaaac uugaucacac c 21
<210> 163
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 163
cauguaaacu ugaucacacc g 21
<210> 164
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 164
uaaacuugau cacaccgcug g 21
<210> 165
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 165
aaacuugauc acaccgcugg a 21
<210> 166
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 166
acuugaucac accgcuggag a 21
<210> 167
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 167
uugaucacac cgcuggagaa g 21
<210> 168
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 168
ugaucacacc gcuggagaag c 21
<210> 169
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 169
gaucacaccg cuggagaagc c 21
<210> 170
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 170
cacaccgcug gagaagccuc u 21
<210> 171
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 171
acaccgcugg agaagccucu a 21
<210> 172
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 172
caccgcugga gaagccucua c 21
<210> 173
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 173
accgcuggag aagccucuac a 21
<210> 174
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 174
ccgcuggaga agccucuaca g 21
<210> 175
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 175
cgcuggagaa gccucuacag a 21
<210> 176
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 176
gcuggagaag ccucuacaga a 21
<210> 177
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 177
cuggagaagc cucuacagaa c 21
<210> 178
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 178
uggagaagcc ucuacagaac u 21
<210> 179
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 179
ggagaagccu cuacagaacu u 21
<210> 180
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 180
gagaagccuc uacagaacuu u 21
<210> 181
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 181
agaagccucu acagaacuuu a 21
<210> 182
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 182
gaagccucua cagaacuuua c 21
<210> 183
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 183
aagccucuac agaacuuuac c 21
<210> 184
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 184
agccucuaca gaacuuuacc u 21
<210> 185
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 185
gccucuacag aacuuuaccu u 21
<210> 186
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 186
ccucuacaga acuuuaccuu g 21
<210> 187
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 187
cucuacagaa cuuuaccuug u 21
<210> 188
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 188
ucuacagaac uuuaccuugu g 21
<210> 189
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 189
cuacagaacu uuaccuugug u 21
<210> 190
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 190
uacagaacuu uaccuugugu u 21
<210> 191
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 191
acagaacuuu accuuguguu u 21
<210> 192
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 192
cagaacuuua ccuuguguuu u 21
<210> 193
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 193
agaacuuuac cuuguguuuu c 21
<210> 194
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 194
gaacuuuacc uuguguuuuc g 21
<210> 195
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 195
aacuuuaccu uguguuuucg a 21
<210> 196
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 196
cuuuaccuug uguuuucgag c 21
<210> 197
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 197
accuuguguu uucgagccua u 21
<210> 198
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 198
ccuuguguuu ucgagccuau a 21
<210> 199
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 199
cuuguguuuu cgagccuaua g 21
<210> 200
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 200
uuguguuuuc gagccuauag u 21
<210> 201
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 201
guguuuucga gccuauagug a 21
<210> 202
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 202
guuuucgagc cuauagugau c 21
<210> 203
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 203
uuuucgagcc uauagugauc u 21
<210> 204
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 204
cgagccuaua gugaucucuc u 21
<210> 205
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 205
gagccuauag ugaucucucu c 21
<210> 206
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 206
agccuauagu gaucucucuc g 21
<210> 207
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 207
gccuauagug aucucucucg u 21
<210> 208
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 208
ccuauaguga ucucucucgu g 21
<210> 209
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 209
cuauagugau cucucucgug c 21
<210> 210
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 210
uauagugauc ucucucgugc c 21
<210> 211
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 211
agugaucucu cucgugccua c 21
<210> 212
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 212
gugaucucuc ucgugccuac a 21
<210> 213
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 213
ugaucucucu cgugccuaca g 21
<210> 214
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 214
gaucucucuc gugccuacag c 21
<210> 215
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 215
cucucgugcc uacagccucu u 21
<210> 216
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 216
ucucgugccu acagccucuu c 21
<210> 217
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 217
cucgugccua cagccucuuc u 21
<210> 218
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 218
cgugccuaca gccucuucuc c 21
<210> 219
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 219
gugccuacag ccucuucucc u 21
<210> 220
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 220
gccuacagcc ucuucuccua c 21
<210> 221
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 221
ccuacagccu cuucuccuac a 21
<210> 222
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 222
cuacagccuc uucuccuaca a 21
<210> 223
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 223
uacagccucu ucuccuacaa u 21
<210> 224
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 224
acagccucuu cuccuacaau a 21
<210> 225
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 225
cagccucuuc uccuacaaua c 21
<210> 226
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 226
agccucuucu ccuacaauac c 21
<210> 227
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 227
gccucuucuc cuacaauacc c 21
<210> 228
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 228
ccucuucucc uacaauaccc a 21
<210> 229
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 229
ucuucuccua caauacccaa g 21
<210> 230
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 230
ucuccuacaa uacccaaggc a 21
<210> 231
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 231
cuccuacaau acccaaggca g 21
<210> 232
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 232
uccuacaaua cccaaggcag g 21
<210> 233
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 233
ccuacaauac ccaaggcagg g 21
<210> 234
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 234
cuacaauacc caaggcaggg a 21
<210> 235
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 235
caauacccaa ggcagggaua a 21
<210> 236
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 236
auacccaagg cagggauaau g 21
<210> 237
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 237
uacccaaggc agggauaaug a 21
<210> 238
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 238
ccaaggcagg gauaaugagc u 21
<210> 239
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 239
aaggcaggga uaaugagcua c 21
<210> 240
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 240
aggcagggau aaugagcuac u 21
<210> 241
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 241
gcagggauaa ugagcuacua g 21
<210> 242
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 242
cagggauaau gagcuacuag u 21
<210> 243
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 243
agggauaaug agcuacuagu u 21
<210> 244
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 244
gggauaauga gcuacuaguu u 21
<210> 245
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 245
ggauaaugag cuacuaguuu a 21
<210> 246
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 246
gauaaugagc uacuaguuua u 21
<210> 247
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 247
auaaugagcu acuaguuuau a 21
<210> 248
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 248
uaaugagcua cuaguuuaua a 21
<210> 249
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 249
augagcuacu aguuuauaaa g 21
<210> 250
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 250
ugagcuacua guuuauaaag a 21
<210> 251
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 251
gagcuacuag uuuauaaaga a 21
<210> 252
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 252
agcuacuagu uuauaaagaa a 21
<210> 253
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 253
gcuacuaguu uauaaagaaa g 21
<210> 254
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 254
cuacuaguuu auaaagaaag a 21
<210> 255
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 255
aguuuauaaa gaaagaguug g 21
<210> 256
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 256
aagaaagagu uggagaguau a 21
<210> 257
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 257
agaaagaguu ggagaguaua g 21
<210> 258
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 258
gaaagaguug gagaguauag u 21
<210> 259
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 259
aagaguugga gaguauaguc u 21
<210> 260
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 260
agaguuggag aguauagucu a 21
<210> 261
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 261
gaguuggaga guauagucua u 21
<210> 262
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 262
aguuggagag uauagucuau a 21
<210> 263
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 263
guuggagagu auagucuaua c 21
<210> 264
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 264
uuggagagua uagucuauac a 21
<210> 265
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 265
uggagaguau agucuauaca u 21
<210> 266
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 266
ggagaguaua gucuauacau u 21
<210> 267
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 267
gagaguauag ucuauacauu g 21
<210> 268
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 268
agaguauagu cuauacauug g 21
<210> 269
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 269
gaguauaguc uauacauugg a 21
<210> 270
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 270
aguauagucu auacauugga a 21
<210> 271
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 271
guauagucua uacauuggaa g 21
<210> 272
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 272
gucuauacau uggaagacac a 21
<210> 273
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 273
cuauacauug gaagacacaa a 21
<210> 274
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 274
uauacauugg aagacacaaa g 21
<210> 275
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 275
auacauugga agacacaaag u 21
<210> 276
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 276
acauuggaag acacaaaguu a 21
<210> 277
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 277
cauuggaaga cacaaaguua c 21
<210> 278
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 278
auuggaagac acaaaguuac a 21
<210> 279
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 279
uggaagacac aaaguuacau c 21
<210> 280
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 280
ggaagacaca aaguuacauc c 21
<210> 281
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 281
gaagacacaa aguuacaucc a 21
<210> 282
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 282
aagacacaaa guuacaucca a 21
<210> 283
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 283
agacacaaag uuacauccaa a 21
<210> 284
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 284
gacacaaagu uacauccaaa g 21
<210> 285
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 285
acacaaaguu acauccaaag u 21
<210> 286
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 286
cacaaaguua cauccaaagu u 21
<210> 287
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 287
caaaguuaca uccaaaguua u 21
<210> 288
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 288
aaaguuacau ccaaaguuau c 21
<210> 289
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 289
aaguuacauc caaaguuauc g 21
<210> 290
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 290
aguuacaucc aaaguuaucg a 21
<210> 291
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 291
guuacaucca aaguuaucga a 21
<210> 292
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 292
uuacauccaa aguuaucgaa a 21
<210> 293
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 293
uacauccaaa guuaucgaaa a 21
<210> 294
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 294
acauccaaag uuaucgaaaa g 21
<210> 295
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 295
cauccaaagu uaucgaaaag u 21
<210> 296
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 296
auccaaaguu aucgaaaagu u 21
<210> 297
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 297
uccaaaguua ucgaaaaguu c 21
<210> 298
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 298
ccaaaguuau cgaaaaguuc c 21
<210> 299
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 299
caaaguuauc gaaaaguucc c 21
<210> 300
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 300
cgaaaaguuc ccggcuccag u 21
<210> 301
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 301
aaaaguuccc ggcuccagug c 21
<210> 302
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 302
cccggcucca gugcacaucu g 21
<210> 303
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 303
cggcuccagu gcacaucugu g 21
<210> 304
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 304
ggcuccagug cacaucugug u 21
<210> 305
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 305
gcuccagugc acaucugugu g 21
<210> 306
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 306
cuccagugca caucugugug a 21
<210> 307
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 307
ccagugcaca ucugugugag c 21
<210> 308
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 308
gugcacaucu gugugagcug g 21
<210> 309
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 309
gcacaucugu gugagcuggg a 21
<210> 310
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 310
acaucugugu gagcugggag u 21
<210> 311
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 311
aucuguguga gcugggaguc c 21
<210> 312
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 312
ugugugagcu gggaguccuc a 21
<210> 313
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 313
gugugagcug ggaguccuca u 21
<210> 314
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 314
agcugggagu ccucaucagg u 21
<210> 315
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 315
gcugggaguc cucaucaggu a 21
<210> 316
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 316
cugggagucc ucaucaggua u 21
<210> 317
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 317
ugggaguccu caucagguau u 21
<210> 318
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 318
gggaguccuc aucagguauu g 21
<210> 319
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 319
ggaguccuca ucagguauug c 21
<210> 320
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 320
gaguccucau cagguauugc u 21
<210> 321
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 321
guccucauca gguauugcug a 21
<210> 322
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 322
uccucaucag guauugcuga a 21
<210> 323
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 323
ccucaucagg uauugcugaa u 21
<210> 324
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 324
cucaucaggu auugcugaau u 21
<210> 325
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 325
ucaucaggua uugcugaauu u 21
<210> 326
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 326
caucagguau ugcugaauuu u 21
<210> 327
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 327
aucagguauu gcugaauuuu g 21
<210> 328
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 328
ucagguauug cugaauuuug g 21
<210> 329
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 329
cagguauugc ugaauuuugg a 21
<210> 330
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 330
agguauugcu gaauuuugga u 21
<210> 331
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 331
gguauugcug aauuuuggau c 21
<210> 332
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 332
guauugcuga auuuuggauc a 21
<210> 333
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 333
auugcugaau uuuggaucaa u 21
<210> 334
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 334
ugcugaauuu uggaucaaug g 21
<210> 335
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 335
gcugaauuuu ggaucaaugg g 21
<210> 336
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 336
cugaauuuug gaucaauggg a 21
<210> 337
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 337
gaauuuugga ucaaugggac a 21
<210> 338
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 338
ggaucaaugg gacaccuuug g 21
<210> 339
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 339
caaugggaca ccuuugguga a 21
<210> 340
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 340
aaugggacac cuuuggugaa a 21
<210> 341
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 341
augggacacc uuuggugaaa a 21
<210> 342
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 342
ugggacaccu uuggugaaaa a 21
<210> 343
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 343
gggacaccuu uggugaaaaa g 21
<210> 344
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 344
ggacaccuuu ggugaaaaag g 21
<210> 345
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 345
accuuuggug aaaaaggguc u 21
<210> 346
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 346
ccuuugguga aaaagggucu g 21
<210> 347
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 347
cuuuggugaa aaagggucug c 21
<210> 348
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 348
ggugaaaaag ggucugcgac a 21
<210> 349
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 349
gugaaaaagg gucugcgaca g 21
<210> 350
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 350
ugaaaaaggg ucugcgacag g 21
<210> 351
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 351
gaaaaagggu cugcgacagg g 21
<210> 352
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 352
aaagggucug cgacaggguu a 21
<210> 353
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 353
aagggucugc gacaggguua c 21
<210> 354
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 354
agggucugcg acaggguuac u 21
<210> 355
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 355
gggucugcga caggguuacu u 21
<210> 356
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 356
ggucugcgac aggguuacuu u 21
<210> 357
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 357
gucugcgaca ggguuacuuu g 21
<210> 358
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 358
ucugcgacag gguuacuuug u 21
<210> 359
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 359
cugcgacagg guuacuuugu a 21
<210> 360
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 360
ugcgacaggg uuacuuugua g 21
<210> 361
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 361
gcgacagggu uacuuuguag a 21
<210> 362
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 362
cgacaggguu acuuuguaga a 21
<210> 363
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 363
gacaggguua cuuuguagaa g 21
<210> 364
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 364
acaggguuac uuuguagaag c 21
<210> 365
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 365
caggguuacu uuguagaagc u 21
<210> 366
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 366
aggguuacuu uguagaagcu c 21
<210> 367
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 367
ggguuacuuu guagaagcuc a 21
<210> 368
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 368
gguuacuuug uagaagcuca g 21
<210> 369
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 369
guuacuuugu agaagcucag c 21
<210> 370
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 370
agaagcucag cccaagauug u 21
<210> 371
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 371
gaagcucagc ccaagauugu c 21
<210> 372
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 372
aagcucagcc caagauuguc c 21
<210> 373
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 373
agcucagccc aagauugucc u 21
<210> 374
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 374
cucagcccaa gauuguccug g 21
<210> 375
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 375
agcccaagau uguccugggg c 21
<210> 376
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 376
ccaagauugu ccuggggcag g 21
<210> 377
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 377
caagauuguc cuggggcagg a 21
<210> 378
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 378
agauuguccu ggggcaggaa c 21
<210> 379
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 379
gauuguccug gggcaggaac a 21
<210> 380
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 380
uuguccuggg gcaggaacag g 21
<210> 381
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 381
uccuggggca ggaacaggau u 21
<210> 382
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 382
cuggggcagg aacaggauuc c 21
<210> 383
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 383
uggggcagga acaggauucc u 21
<210> 384
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 384
ggggcaggaa caggauuccu a 21
<210> 385
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 385
ggcaggaaca ggauuccuau g 21
<210> 386
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 386
gcaggaacag gauuccuaug g 21
<210> 387
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 387
caggaacagg auuccuaugg g 21
<210> 388
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 388
ggaacaggau uccuaugggg g 21
<210> 389
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 389
gaacaggauu ccuauggggg c 21
<210> 390
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 390
acaggauucc uaugggggca a 21
<210> 391
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 391
caggauuccu augggggcaa g 21
<210> 392
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 392
ggauuccuau gggggcaagu u 21
<210> 393
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 393
gauuccuaug ggggcaaguu u 21
<210> 394
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 394
auuccuaugg gggcaaguuu g 21
<210> 395
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 395
uuccuauggg ggcaaguuug a 21
<210> 396
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 396
uccuaugggg gcaaguuuga u 21
<210> 397
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 397
ccuauggggg caaguuugau a 21
<210> 398
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 398
cuaugggggc aaguuugaua g 21
<210> 399
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 399
uaugggggca aguuugauag g 21
<210> 400
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 400
gggggcaagu uugauaggag c 21
<210> 401
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 401
ggggcaaguu ugauaggagc c 21
<210> 402
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 402
gggcaaguuu gauaggagcc a 21
<210> 403
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 403
ggcaaguuug auaggagcca g 21
<210> 404
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 404
gcaaguuuga uaggagccag u 21
<210> 405
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 405
caaguuugau aggagccagu c 21
<210> 406
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 406
aaguuugaua ggagccaguc c 21
<210> 407
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 407
uugauaggag ccaguccuuu g 21
<210> 408
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 408
ugauaggagc caguccuuug u 21
<210> 409
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 409
gauaggagcc aguccuuugu g 21
<210> 410
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 410
auaggagcca guccuuugug g 21
<210> 411
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 411
aggagccagu ccuuuguggg a 21
<210> 412
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 412
ggagccaguc cuuuguggga g 21
<210> 413
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 413
gagccagucc uuugugggag a 21
<210> 414
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 414
agccaguccu uugugggaga g 21
<210> 415
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 415
gccaguccuu ugugggagag a 21
<210> 416
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 416
ccaguccuuu gugggagaga u 21
<210> 417
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 417
caguccuuug ugggagagau u 21
<210> 418
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 418
aguccuuugu gggagagauu g 21
<210> 419
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 419
guccuuugug ggagagauug g 21
<210> 420
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 420
uccuuugugg gagagauugg g 21
<210> 421
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 421
ccuuuguggg agagauuggg g 21
<210> 422
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 422
cuuuguggga gagauugggg a 21
<210> 423
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 423
uugugggaga gauuggggau u 21
<210> 424
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 424
ugugggagag auuggggauu u 21
<210> 425
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 425
gugggagaga uuggggauuu g 21
<210> 426
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 426
ugggagagau uggggauuug u 21
<210> 427
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 427
gggagagauu ggggauuugu a 21
<210> 428
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 428
ggagagauug gggauuugua c 21
<210> 429
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 429
gagagauugg ggauuuguac a 21
<210> 430
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 430
agagauuggg gauuuguaca u 21
<210> 431
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 431
gagauugggg auuuguacau g 21
<210> 432
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 432
agauugggga uuuguacaug u 21
<210> 433
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 433
ggggauuugu acauguggga c 21
<210> 434
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 434
gggauuugua caugugggac u 21
<210> 435
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 435
ggauuuguac augugggacu c 21
<210> 436
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 436
gauuuguaca ugugggacuc u 21
<210> 437
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 437
uguacaugug ggacucugug c 21
<210> 438
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 438
guacaugugg gacucugugc u 21
<210> 439
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 439
acauguggga cucugugcug c 21
<210> 440
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 440
gggacucugu gcugccccca g 21
<210> 441
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 441
ggacucugug cugcccccag a 21
<210> 442
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 442
acucugugcu gcccccagaa a 21
<210> 443
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 443
cucugugcug cccccagaaa a 21
<210> 444
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 444
cugugcugcc cccagaaaau a 21
<210> 445
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 445
ugugcugccc ccagaaaaua u 21
<210> 446
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 446
gugcugcccc cagaaaauau c 21
<210> 447
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 447
gcugccccca gaaaauaucc u 21
<210> 448
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 448
cccccagaaa auauccuguc u 21
<210> 449
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 449
cccagaaaau auccugucug c 21
<210> 450
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 450
ccagaaaaua uccugucugc c 21
<210> 451
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 451
cagaaaauau ccugucugcc u 21
<210> 452
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 452
gaaaauaucc ugucugccua u 21
<210> 453
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 453
aaaauauccu gucugccuau c 21
<210> 454
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 454
aaauauccug ucugccuauc a 21
<210> 455
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 455
ccugucugcc uaucagggua c 21
<210> 456
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 456
cugucugccu aucaggguac c 21
<210> 457
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 457
gucugccuau caggguaccc c 21
<210> 458
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 458
ugccuaucag gguaccccuc u 21
<210> 459
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 459
gccuaucagg guaccccucu c 21
<210> 460
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 460
ccuaucaggg uaccccucuc c 21
<210> 461
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 461
cuaucagggu accccucucc c 21
<210> 462
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 462
caggguaccc cucucccugc c 21
<210> 463
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 463
ggguaccccu cucccugcca a 21
<210> 464
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 464
gguaccccuc ucccugccaa u 21
<210> 465
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 465
guaccccucu cccugccaau a 21
<210> 466
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 466
uaccccucuc ccugccaaua u 21
<210> 467
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 467
ccccucuccc ugccaauauc c 21
<210> 468
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 468
cccucucccu gccaauaucc u 21
<210> 469
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 469
cugccaauau ccuggacugg c 21
<210> 470
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 470
ccaauauccu ggacuggcag g 21
<210> 471
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 471
caauauccug gacuggcagg c 21
<210> 472
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 472
uccuggacug gcaggcucug a 21
<210> 473
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 473
ccuggacugg caggcucuga a 21
<210> 474
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 474
cuggacuggc aggcucugaa c 21
<210> 475
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 475
uggacuggca ggcucugaac u 21
<210> 476
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 476
ggacuggcag gcucugaacu a 21
<210> 477
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 477
gacuggcagg cucugaacua u 21
<210> 478
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 478
acuggcaggc ucugaacuau g 21
<210> 479
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 479
cuggcaggcu cugaacuaug a 21
<210> 480
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 480
uggcaggcuc ugaacuauga a 21
<210> 481
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 481
ggcaggcucu gaacuaugaa a 21
<210> 482
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 482
gcaggcucug aacuaugaaa u 21
<210> 483
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 483
caggcucuga acuaugaaau c 21
<210> 484
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 484
aggcucugaa cuaugaaauc a 21
<210> 485
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 485
ggcucugaac uaugaaauca g 21
<210> 486
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 486
gcucugaacu augaaaucag a 21
<210> 487
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 487
cucugaacua ugaaaucaga g 21
<210> 488
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 488
ucugaacuau gaaaucagag g 21
<210> 489
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 489
gaacuaugaa aucagaggau a 21
<210> 490
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 490
aacuaugaaa ucagaggaua u 21
<210> 491
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 491
acuaugaaau cagaggauau g 21
<210> 492
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 492
cuaugaaauc agaggauaug u 21
<210> 493
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 493
uaugaaauca gaggauaugu c 21
<210> 494
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 494
ugaaaucaga ggauauguca u 21
<210> 495
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 495
gaaaucagag gauaugucau c 21
<210> 496
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 496
aaaucagagg auaugucauc a 21
<210> 497
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 497
aaucagagga uaugucauca u 21
<210> 498
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 498
cagaggauau gucaucauca a 21
<210> 499
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 499
agaggauaug ucaucaucaa a 21
<210> 500
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 500
gaggauaugu caucaucaaa c 21
<210> 501
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 501
aggauauguc aucaucaaac c 21
<210> 502
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 502
ggauauguca ucaucaaacc c 21
<210> 503
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 503
gauaugucau caucaaaccc u 21
<210> 504
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 504
augucaucau caaacccuug g 21
<210> 505
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 505
caucaucaaa cccuuggugu g 21
<210> 506
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 506
ucaucaaacc cuuggugugg g 21
<210> 507
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 507
acccuuggug ugggucugag g 21
<210> 508
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 508
cccuuggugu gggucugagg u 21
<210> 509
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 509
ccuuggugug ggucugaggu c 21
<210> 510
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 510
cuuggugugg gucugagguc u 21
<210> 511
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 511
uggugugggu cugaggucuu g 21
<210> 512
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 512
gguguggguc ugaggucuug a 21
<210> 513
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 513
gugugggucu gaggucuuga c 21
<210> 514
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 514
ugugggucug aggucuugac u 21
<210> 515
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 515
gugggucuga ggucuugacu c 21
<210> 516
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 516
gggucugagg ucuugacuca a 21
<210> 517
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 517
ggucugaggu cuugacucaa c 21
<210> 518
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 518
gucugagguc uugacucaac g 21
<210> 519
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 519
cugaggucuu gacucaacga g 21
<210> 520
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 520
ugaggucuug acucaacgag a 21
<210> 521
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 521
gaggucuuga cucaacgaga g 21
<210> 522
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 522
aggucuugac ucaacgagag c 21
<210> 523
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 523
ggucuugacu caacgagagc a 21
<210> 524
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 524
gucuugacuc aacgagagca c 21
<210> 525
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 525
ucuugacuca acgagagcac u 21
<210> 526
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 526
cuugacucaa cgagagcacu u 21
<210> 527
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 527
uugacucaac gagagcacuu g 21
<210> 528
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 528
ugacucaacg agagcacuug a 21
<210> 529
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 529
gacucaacga gagcacuuga a 21
<210> 530
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 530
acucaacgag agcacuugaa a 21
<210> 531
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 531
cucaacgaga gcacuugaaa a 21
<210> 532
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 532
ucaacgagag cacuugaaaa u 21
<210> 533
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 533
caacgagagc acuugaaaau g 21
<210> 534
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 534
aacgagagca cuugaaaaug a 21
<210> 535
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 535
acgagagcac uugaaaauga a 21
<210> 536
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 536
cgagagcacu ugaaaaugaa a 21
<210> 537
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 537
gagagcacuu gaaaaugaaa u 21
<210> 538
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 538
agagcacuug aaaaugaaau g 21
<210> 539
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 539
gagcacuuga aaaugaaaug a 21
<210> 540
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 540
agcacuugaa aaugaaauga c 21
<210> 541
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 541
gcacuugaaa augaaaugac u 21
<210> 542
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 542
cacuugaaaa ugaaaugacu g 21
<210> 543
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 543
acuugaaaau gaaaugacug u 21
<210> 544
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 544
cuugaaaaug aaaugacugu c 21
<210> 545
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 545
uugaaaauga aaugacuguc u 21
<210> 546
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 546
ugaaaaugaa augacugucu a 21
<210> 547
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 547
gaaaaugaaa ugacugucua a 21
<210> 548
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 548
aaaaugaaau gacugucuaa g 21
<210> 549
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 549
aaaugaaaug acugucuaag a 21
<210> 550
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 550
aaugaaauga cugucuaaga g 21
<210> 551
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 551
augaaaugac ugucuaagag a 21
<210> 552
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 552
ugaaaugacu gucuaagaga u 21
<210> 553
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 553
gaaaugacug ucuaagagau c 21
<210> 554
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 554
aaaugacugu cuaagagauc u 21
<210> 555
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 555
augacugucu aagagaucug g 21
<210> 556
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 556
ugacugucua agagaucugg u 21
<210> 557
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 557
gacugucuaa gagaucuggu c 21
<210> 558
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 558
acugucuaag agaucugguc a 21
<210> 559
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 559
cugucuaaga gaucugguca a 21
<210> 560
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 560
ugucuaagag aucuggucaa a 21
<210> 561
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 561
gucuaagaga ucuggucaaa g 21
<210> 562
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 562
ucuaagagau cuggucaaag c 21
<210> 563
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 563
cuaagagauc uggucaaagc a 21
<210> 564
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 564
uaagagaucu ggucaaagca a 21
<210> 565
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 565
aagagaucug gucaaagcaa c 21
<210> 566
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 566
agagaucugg ucaaagcaac u 21
<210> 567
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 567
gagaucuggu caaagcaacu g 21
<210> 568
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 568
agaucugguc aaagcaacug g 21
<210> 569
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 569
gaucugguca aagcaacugg a 21
<210> 570
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 570
aucuggucaa agcaacugga u 21
<210> 571
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 571
ucuggucaaa gcaacuggau a 21
<210> 572
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 572
cuggucaaag caacuggaua c 21
<210> 573
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 573
uggucaaagc aacuggauac u 21
<210> 574
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 574
ggucaaagca acuggauacu a 21
<210> 575
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 575
gucaaagcaa cuggauacua g 21
<210> 576
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 576
ucaaagcaac uggauacuag a 21
<210> 577
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 577
caaagcaacu ggauacuaga u 21
<210> 578
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 578
aaagcaacug gauacuagau c 21
<210> 579
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 579
aagcaacugg auacuagauc u 21
<210> 580
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 580
agcaacugga uacuagaucu u 21
<210> 581
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 581
gcaacuggau acuagaucuu a 21
<210> 582
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 582
caacuggaua cuagaucuua c 21
<210> 583
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 583
aacuggauac uagaucuuac a 21
<210> 584
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 584
acuggauacu agaucuuaca u 21
<210> 585
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 585
cuggauacua gaucuuacau c 21
<210> 586
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 586
uggauacuag aucuuacauc u 21
<210> 587
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 587
ggauacuaga ucuuacaucu g 21
<210> 588
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 588
gauacuagau cuuacaucug c 21
<210> 589
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 589
auacuagauc uuacaucugc a 21
<210> 590
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 590
acuagaucuu acaucugcag c 21
<210> 591
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 591
cuagaucuua caucugcagc u 21
<210> 592
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 592
agaucuuaca ucugcagcuc u 21
<210> 593
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 593
gaucuuacau cugcagcucu u 21
<210> 594
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 594
aucuuacauc ugcagcucuu u 21
<210> 595
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 595
ucuuacaucu gcagcucuuu c 21
<210> 596
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 596
cuuacaucug cagcucuuuc u 21
<210> 597
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 597
uuacaucugc agcucuuucu u 21
<210> 598
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 598
uacaucugca gcucuuucuu c 21
<210> 599
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 599
acaucugcag cucuuucuuc u 21
<210> 600
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 600
caucugcagc ucuuucuucu u 21
<210> 601
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 601
aucugcagcu cuuucuucuu u 21
<210> 602
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 602
ucugcagcuc uuucuucuuu g 21
<210> 603
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 603
cugcagcucu uucuucuuug a 21
<210> 604
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 604
ugcagcucuu ucuucuuuga a 21
<210> 605
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 605
gcagcucuuu cuucuuugaa u 21
<210> 606
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 606
cagcucuuuc uucuuugaau u 21
<210> 607
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 607
agcucuuucu ucuuugaauu u 21
<210> 608
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 608
gcucuuucuu cuuugaauuu c 21
<210> 609
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 609
cucuuucuuc uuugaauuuc c 21
<210> 610
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 610
ucuuucuucu uugaauuucc u 21
<210> 611
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 611
cuuucuucuu ugaauuuccu a 21
<210> 612
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 612
uuucuucuuu gaauuuccua u 21
<210> 613
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 613
uucuucuuug aauuuccuau c 21
<210> 614
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 614
ucuucuuuga auuuccuauc u 21
<210> 615
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 615
uucuuugaau uuccuaucug u 21
<210> 616
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 616
ucuuugaauu uccuaucugu a 21
<210> 617
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 617
cuuugaauuu ccuaucugua u 21
<210> 618
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 618
uuugaauuuc cuaucuguau g 21
<210> 619
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 619
uugaauuucc uaucuguaug u 21
<210> 620
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 620
ugaauuuccu aucuguaugu c 21
<210> 621
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 621
gaauuuccua ucuguauguc u 21
<210> 622
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 622
auuuccuauc uguaugucug c 21
<210> 623
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 623
uuuccuaucu guaugucugc c 21
<210> 624
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 624
uuccuaucug uaugucugcc u 21
<210> 625
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 625
uccuaucugu augucugccu a 21
<210> 626
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 626
ccuaucugua ugucugccua a 21
<210> 627
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 627
cuaucuguau gucugccuaa u 21
<210> 628
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 628
uaucuguaug ucugccuaau u 21
<210> 629
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 629
aucuguaugu cugccuaauu a 21
<210> 630
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 630
ucuguauguc ugccuaauua a 21
<210> 631
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 631
cuguaugucu gccuaauuaa a 21
<210> 632
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 632
uguaugucug ccuaauuaaa a 21
<210> 633
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 633
guaugucugc cuaauuaaaa a 21
<210> 634
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 634
uaugucugcc uaauuaaaaa a 21
<210> 635
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 635
augucugccu aauuaaaaaa a 21
<210> 636
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 636
ugucugccua auuaaaaaaa u 21
<210> 637
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 637
gucugccuaa uuaaaaaaau a 21
<210> 638
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 638
ucugccuaau uaaaaaaaua u 21
<210> 639
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 639
cugccuaauu aaaaaaauau a 21
<210> 640
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 640
ugccuaauua aaaaaauaua u 21
<210> 641
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 641
gccuaauuaa aaaaauauau a 21
<210> 642
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 642
ccuaauuaaa aaaauauaua u 21
<210> 643
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 643
cuaauuaaaa aaauauauau u 21
<210> 644
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 644
uaaaaaaaua uauauuguau u 21
<210> 645
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 645
uagcgucuga uauucaugcc c 21
<210> 646
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 646
cuagcgucug auauucaugc c 21
<210> 647
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 647
ucccccuagc gucugauauu c 21
<210> 648
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 648
acaguggcug ucccccuagc g 21
<210> 649
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 649
acacaguggc ugucccccua g 21
<210> 650
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 650
caacacagug gcuguccccc u 21
<210> 651
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 651
acaacacagu ggcugucccc c 21
<210> 652
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 652
gacaacacag uggcuguccc c 21
<210> 653
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 653
agacaacaca guggcugucc c 21
<210> 654
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 654
uagcagacaa cacaguggcu g 21
<210> 655
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 655
guagcagaca acacaguggc u 21
<210> 656
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 656
gguagcagac aacacagugg c 21
<210> 657
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 657
aggguagcag acaacacagu g 21
<210> 658
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 658
gaggguagca gacaacacag u 21
<210> 659
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 659
ugaggguagc agacaacaca g 21
<210> 660
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 660
augaggguag cagacaacac a 21
<210> 661
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 661
gaugagggua gcagacaaca c 21
<210> 662
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 662
caggaugagg guagcagaca a 21
<210> 663
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 663
accaggauga ggguagcaga c 21
<210> 664
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 664
ugaccaggau gaggguagca g 21
<210> 665
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 665
gugaccagga ugaggguagc a 21
<210> 666
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 666
agugaccagg augaggguag c 21
<210> 667
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 667
cagugaccag gaugagggua g 21
<210> 668
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 668
gcagugacca ggaugagggu a 21
<210> 669
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 669
agcagugacc aggaugaggg u 21
<210> 670
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 670
aagcagugac caggaugagg g 21
<210> 671
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 671
agaagcagug accaggauga g 21
<210> 672
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 672
cagaagcagu gaccaggaug a 21
<210> 673
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 673
gcagaagcag ugaccaggau g 21
<210> 674
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 674
agcagaagca gugaccagga u 21
<210> 675
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 675
uagcagaagc agugaccagg a 21
<210> 676
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 676
auagcagaag cagugaccag g 21
<210> 677
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 677
uauagcagaa gcagugacca g 21
<210> 678
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 678
uuauagcaga agcagugacc a 21
<210> 679
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 679
uguuauagca gaagcaguga c 21
<210> 680
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 680
cuguuauagc agaagcagug a 21
<210> 681
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 681
gcuguuauag cagaagcagu g 21
<210> 682
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 682
gggcuguuau agcagaagca g 21
<210> 683
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 683
agggcuguua uagcagaagc a 21
<210> 684
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 684
uagggcuguu auagcagaag c 21
<210> 685
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 685
cuagggcugu uauagcagaa g 21
<210> 686
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 686
ccuagggcug uuauagcaga a 21
<210> 687
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 687
gccuagggcu guuauagcag a 21
<210> 688
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 688
ggccuagggc uguuauagca g 21
<210> 689
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 689
uggccuaggg cuguuauagc a 21
<210> 690
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 690
cuggccuagg gcuguuauag c 21
<210> 691
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 691
ccuggccuag ggcuguuaua g 21
<210> 692
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 692
uccuggccua gggcuguuau a 21
<210> 693
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 693
auuccuggcc uagggcuguu a 21
<210> 694
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 694
uauuccuggc cuagggcugu u 21
<210> 695
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 695
auauuccugg ccuagggcug u 21
<210> 696
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 696
cauauuccug gccuagggcu g 21
<210> 697
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 697
ucauauuccu ggccuagggc u 21
<210> 698
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 698
uucauauucc uggccuaggg c 21
<210> 699
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 699
guucauauuc cuggccuagg g 21
<210> 700
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 700
uguucauauu ccuggccuag g 21
<210> 701
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 701
uuguucauau uccuggccua g 21
<210> 702
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 702
cuuguucaua uuccuggccu a 21
<210> 703
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 703
gcuuguucau auuccuggcc u 21
<210> 704
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 704
ggcuuguuca uauuccuggc c 21
<210> 705
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 705
cggcuuguuc auauuccugg c 21
<210> 706
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 706
gcggcuuguu cauauuccug g 21
<210> 707
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 707
agcggcuugu ucauauuccu g 21
<210> 708
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 708
cagcggcuug uucauauucc u 21
<210> 709
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 709
gcagcggcuu guucauauuc c 21
<210> 710
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 710
agcagcggcu uguucauauu c 21
<210> 711
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 711
aagcagcggc uuguucauau u 21
<210> 712
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 712
aaagcagcgg cuuguucaua u 21
<210> 713
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 713
caaagcagcg gcuuguucau a 21
<210> 714
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 714
ccaaagcagc ggcuuguuca u 21
<210> 715
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 715
uccaaagcag cggcuuguuc a 21
<210> 716
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 716
auccaaagca gcggcuuguu c 21
<210> 717
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 717
gauccaaagc agcggcuugu u 21
<210> 718
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 718
agauccaaag cagcggcuug u 21
<210> 719
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 719
gagauccaaa gcagcggcuu g 21
<210> 720
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 720
agagauccaa agcagcggcu u 21
<210> 721
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 721
cagagaucca aagcagcggc u 21
<210> 722
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 722
acagagaucc aaagcagcgg c 21
<210> 723
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 723
gacagagauc caaagcagcg g 21
<210> 724
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 724
ggacagagau ccaaagcagc g 21
<210> 725
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 725
aggacagaga uccaaagcag c 21
<210> 726
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 726
gaggacagag auccaaagca g 21
<210> 727
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 727
ugaggacaga gauccaaagc a 21
<210> 728
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 728
gugaggacag agauccaaag c 21
<210> 729
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 729
cuggugagga cagagaucca a 21
<210> 730
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 730
gcuggugagg acagagaucc a 21
<210> 731
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 731
gaggcuggug aggacagaga u 21
<210> 732
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 732
aggaggcugg ugaggacaga g 21
<210> 733
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 733
caggaggcug gugaggacag a 21
<210> 734
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 734
ccaggaggcu ggugaggaca g 21
<210> 735
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 735
uccaggaggc uggugaggac a 21
<210> 736
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 736
cuuccaggag gcuggugagg a 21
<210> 737
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 737
gcuuccagga ggcuggugag g 21
<210> 738
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 738
aggcuuccag gaggcuggug a 21
<210> 739
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 739
aaggcuucca ggaggcuggu g 21
<210> 740
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 740
aaaggcuucc aggaggcugg u 21
<210> 741
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 741
caaaggcuuc caggaggcug g 21
<210> 742
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 742
gcaaaggcuu ccaggaggcu g 21
<210> 743
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 743
agcaaaggcu uccaggaggc u 21
<210> 744
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 744
gagcaaaggc uuccaggagg c 21
<210> 745
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 745
ugagcaaagg cuuccaggag g 21
<210> 746
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 746
gugagcaaag gcuuccagga g 21
<210> 747
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 747
ugugagcaaa ggcuuccagg a 21
<210> 748
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 748
ugugugagca aaggcuucca g 21
<210> 749
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 749
cugugugagc aaaggcuucc a 21
<210> 750
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 750
ucugugugag caaaggcuuc c 21
<210> 751
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 751
gucuguguga gcaaaggcuu c 21
<210> 752
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 752
ggucugugug agcaaaggcu u 21
<210> 753
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 753
aggucugugu gagcaaaggc u 21
<210> 754
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 754
gaggucugug ugagcaaagg c 21
<210> 755
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 755
ugaggucugu gugagcaaag g 21
<210> 756
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 756
acugaggucu gugugagcaa a 21
<210> 757
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 757
ccacugaggu cugugugagc a 21
<210> 758
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 758
ucccacugag gucuguguga g 21
<210> 759
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 759
uucccacuga ggucugugug a 21
<210> 760
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 760
cuucccacug aggucugugu g 21
<210> 761
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 761
caccuuccca cugaggucug u 21
<210> 762
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 762
acaccuuccc acugaggucu g 21
<210> 763
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 763
aacaccuucc cacugagguc u 21
<210> 764
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 764
aaacaccuuc ccacugaggu c 21
<210> 765
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 765
caaacaccuu cccacugagg u 21
<210> 766
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 766
acaaacaccu ucccacugag g 21
<210> 767
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 767
uacaaacacc uucccacuga g 21
<210> 768
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 768
auacaaacac cuucccacug a 21
<210> 769
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 769
aauacaaaca ccuucccacu g 21
<210> 770
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 770
aaauacaaac accuucccac u 21
<210> 771
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 771
gaaauacaaa caccuuccca c 21
<210> 772
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 772
ggaaauacaa acaccuuccc a 21
<210> 773
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 773
aggaaauaca aacaccuucc c 21
<210> 774
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 774
uaggaaauac aaacaccuuc c 21
<210> 775
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 775
cuaggaaaua caaacaccuu c 21
<210> 776
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 776
ucuaggaaau acaaacaccu u 21
<210> 777
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 777
cucuaggaaa uacaaacacc u 21
<210> 778
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 778
ucucuaggaa auacaaacac c 21
<210> 779
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 779
uucucuagga aauacaaaca c 21
<210> 780
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 780
auucucuagg aaauacaaac a 21
<210> 781
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 781
gauucucuag gaaauacaaa c 21
<210> 782
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 782
agauucucua ggaaauacaa a 21
<210> 783
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 783
cagauucucu aggaaauaca a 21
<210> 784
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 784
acagauucuc uaggaaauac a 21
<210> 785
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 785
aacagauucu cuaggaaaua c 21
<210> 786
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 786
uaacagauuc ucuaggaaau a 21
<210> 787
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 787
aguaacagau ucucuaggaa a 21
<210> 788
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 788
caguaacaga uucucuagga a 21
<210> 789
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 789
ucaguaacag auucucuagg a 21
<210> 790
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 790
aucaguaaca gauucucuag g 21
<210> 791
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 791
gaucaguaac agauucucua g 21
<210> 792
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 792
ugaucaguaa cagauucucu a 21
<210> 793
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 793
augaucagua acagauucuc u 21
<210> 794
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 794
caugaucagu aacagauucu c 21
<210> 795
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 795
acaugaucag uaacagauuc u 21
<210> 796
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 796
uacaugauca guaacagauu c 21
<210> 797
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 797
uuacaugauc aguaacagau u 21
<210> 798
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 798
uuuacaugau caguaacaga u 21
<210> 799
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 799
guuuacauga ucaguaacag a 21
<210> 800
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 800
aguuuacaug aucaguaaca g 21
<210> 801
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 801
ucaaguuuac augaucagua a 21
<210> 802
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 802
aucaaguuua caugaucagu a 21
<210> 803
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 803
gaucaaguuu acaugaucag u 21
<210> 804
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 804
ugaucaaguu uacaugauca g 21
<210> 805
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 805
ugugaucaag uuuacaugau c 21
<210> 806
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 806
gugugaucaa guuuacauga u 21
<210> 807
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 807
agcgguguga ucaaguuuac a 21
<210> 808
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 808
cagcggugug aucaaguuua c 21
<210> 809
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 809
uccagcggug ugaucaaguu u 21
<210> 810
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 810
ucuccagcgg ugugaucaag u 21
<210> 811
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 811
uucuccagcg gugugaucaa g 21
<210> 812
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 812
cuucuccagc ggugugauca a 21
<210> 813
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 813
aggcuucucc agcgguguga u 21
<210> 814
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 814
gaggcuucuc cagcggugug a 21
<210> 815
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 815
agaggcuucu ccagcggugu g 21
<210> 816
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 816
uagaggcuuc uccagcggug u 21
<210> 817
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 817
guagaggcuu cuccagcggu g 21
<210> 818
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 818
uguagaggcu ucuccagcgg u 21
<210> 819
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 819
cuguagaggc uucuccagcg g 21
<210> 820
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 820
ucuguagagg cuucuccagc g 21
<210> 821
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 821
uucuguagag gcuucuccag c 21
<210> 822
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 822
guucuguaga ggcuucucca g 21
<210> 823
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 823
aguucuguag aggcuucucc a 21
<210> 824
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 824
aaguucugua gaggcuucuc c 21
<210> 825
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 825
aaaguucugu agaggcuucu c 21
<210> 826
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 826
uaaaguucug uagaggcuuc u 21
<210> 827
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 827
guaaaguucu guagaggcuu c 21
<210> 828
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 828
gguaaaguuc uguagaggcu u 21
<210> 829
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 829
agguaaaguu cuguagaggc u 21
<210> 830
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 830
aagguaaagu ucuguagagg c 21
<210> 831
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 831
caagguaaag uucuguagag g 21
<210> 832
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 832
acaagguaaa guucuguaga g 21
<210> 833
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 833
cacaagguaa aguucuguag a 21
<210> 834
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 834
acacaaggua aaguucugua g 21
<210> 835
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 835
aacacaaggu aaaguucugu a 21
<210> 836
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 836
aaacacaagg uaaaguucug u 21
<210> 837
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 837
aaaacacaag guaaaguucu g 21
<210> 838
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 838
gaaaacacaa gguaaaguuc u 21
<210> 839
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 839
ucgaaaacac aagguaaagu u 21
<210> 840
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 840
aggcucgaaa acacaaggua a 21
<210> 841
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 841
uaggcucgaa aacacaaggu a 21
<210> 842
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 842
auaggcucga aaacacaagg u 21
<210> 843
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 843
uauaggcucg aaaacacaag g 21
<210> 844
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 844
acuauaggcu cgaaaacaca a 21
<210> 845
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 845
ucacuauagg cucgaaaaca c 21
<210> 846
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 846
aucacuauag gcucgaaaac a 21
<210> 847
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 847
agagaucacu auaggcucga a 21
<210> 848
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 848
gagagaucac uauaggcucg a 21
<210> 849
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 849
agagagauca cuauaggcuc g 21
<210> 850
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 850
gagagagauc acuauaggcu c 21
<210> 851
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 851
cgagagagau cacuauaggc u 21
<210> 852
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 852
acgagagaga ucacuauagg c 21
<210> 853
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 853
cacgagagag aucacuauag g 21
<210> 854
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 854
aggcacgaga gagaucacua u 21
<210> 855
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 855
uaggcacgag agagaucacu a 21
<210> 856
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 856
guaggcacga gagagaucac u 21
<210> 857
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 857
uguaggcacg agagagauca c 21
<210> 858
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 858
gaggcuguag gcacgagaga g 21
<210> 859
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 859
agaggcugua ggcacgagag a 21
<210> 860
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 860
aagaggcugu aggcacgaga g 21
<210> 861
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 861
agaagaggcu guaggcacga g 21
<210> 862
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 862
gagaagaggc uguaggcacg a 21
<210> 863
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 863
aggagaagag gcuguaggca c 21
<210> 864
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 864
uaggagaaga ggcuguaggc a 21
<210> 865
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 865
guaggagaag aggcuguagg c 21
<210> 866
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 866
uguaggagaa gaggcuguag g 21
<210> 867
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 867
uuguaggaga agaggcugua g 21
<210> 868
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 868
auuguaggag aagaggcugu a 21
<210> 869
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 869
uauuguagga gaagaggcug u 21
<210> 870
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 870
guauuguagg agaagaggcu g 21
<210> 871
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 871
gguauuguag gagaagaggc u 21
<210> 872
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 872
uggguauugu aggagaagag g 21
<210> 873
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 873
ccuuggguau uguaggagaa g 21
<210> 874
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 874
gccuugggua uuguaggaga a 21
<210> 875
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 875
ugccuugggu auuguaggag a 21
<210> 876
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 876
cugccuuggg uauuguagga g 21
<210> 877
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 877
ccugccuugg guauuguagg a 21
<210> 878
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 878
aucccugccu uggguauugu a 21
<210> 879
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 879
uuaucccugc cuuggguauu g 21
<210> 880
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 880
auuaucccug ccuuggguau u 21
<210> 881
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 881
cucauuaucc cugccuuggg u 21
<210> 882
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 882
agcucauuau cccugccuug g 21
<210> 883
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 883
uagcucauua ucccugccuu g 21
<210> 884
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 884
aguagcucau uaucccugcc u 21
<210> 885
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 885
uaguagcuca uuaucccugc c 21
<210> 886
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 886
cuaguagcuc auuaucccug c 21
<210> 887
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 887
acuaguagcu cauuaucccu g 21
<210> 888
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 888
aacuaguagc ucauuauccc u 21
<210> 889
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 889
aaacuaguag cucauuaucc c 21
<210> 890
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 890
uaaacuagua gcucauuauc c 21
<210> 891
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 891
auaaacuagu agcucauuau c 21
<210> 892
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 892
uuauaaacua guagcucauu a 21
<210> 893
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 893
uuuauaaacu aguagcucau u 21
<210> 894
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 894
cuuuauaaac uaguagcuca u 21
<210> 895
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 895
ucuuuauaaa cuaguagcuc a 21
<210> 896
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 896
uucuuuauaa acuaguagcu c 21
<210> 897
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 897
uuucuuuaua aacuaguagc u 21
<210> 898
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 898
aacucuuucu uuauaaacua g 21
<210> 899
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 899
uacucuccaa cucuuucuuu a 21
<210> 900
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 900
auacucucca acucuuucuu u 21
<210> 901
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 901
uauacucucc aacucuuucu u 21
<210> 902
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 902
acuauacucu ccaacucuuu c 21
<210> 903
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 903
gacuauacuc uccaacucuu u 21
<210> 904
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 904
agacuauacu cuccaacucu u 21
<210> 905
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 905
uagacuauac ucuccaacuc u 21
<210> 906
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 906
auagacuaua cucuccaacu c 21
<210> 907
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 907
uauagacuau acucuccaac u 21
<210> 908
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 908
guauagacua uacucuccaa c 21
<210> 909
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 909
uguauagacu auacucucca a 21
<210> 910
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 910
auguauagac uauacucucc a 21
<210> 911
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 911
aauguauaga cuauacucuc c 21
<210> 912
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 912
caauguauag acuauacucu c 21
<210> 913
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 913
ccaauguaua gacuauacuc u 21
<210> 914
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 914
uccaauguau agacuauacu c 21
<210> 915
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 915
ugucuuccaa uguauagacu a 21
<210> 916
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 916
ugugucuucc aauguauaga c 21
<210> 917
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 917
uugugucuuc caauguauag a 21
<210> 918
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 918
uuugugucuu ccaauguaua g 21
<210> 919
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 919
acuuuguguc uuccaaugua u 21
<210> 920
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 920
aacuuugugu cuuccaaugu a 21
<210> 921
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 921
uaacuuugug ucuuccaaug u 21
<210> 922
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 922
uguaacuuug ugucuuccaa u 21
<210> 923
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 923
auguaacuuu gugucuucca a 21
<210> 924
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 924
gauguaacuu ugugucuucc a 21
<210> 925
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 925
ggauguaacu uugugucuuc c 21
<210> 926
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 926
uggauguaac uuugugucuu c 21
<210> 927
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 927
uuggauguaa cuuugugucu u 21
<210> 928
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 928
uuuggaugua acuuuguguc u 21
<210> 929
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 929
cuuuggaugu aacuuugugu c 21
<210> 930
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 930
aacuuuggau guaacuuugu g 21
<210> 931
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 931
uaacuuugga uguaacuuug u 21
<210> 932
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 932
auaacuuugg auguaacuuu g 21
<210> 933
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 933
gauaacuuug gauguaacuu u 21
<210> 934
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 934
cgauaacuuu ggauguaacu u 21
<210> 935
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 935
ucgauaacuu uggauguaac u 21
<210> 936
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 936
uucgauaacu uuggauguaa c 21
<210> 937
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 937
uuucgauaac uuuggaugua a 21
<210> 938
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 938
uuuucgauaa cuuuggaugu a 21
<210> 939
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 939
cuuuucgaua acuuuggaug u 21
<210> 940
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 940
acuuuucgau aacuuuggau g 21
<210> 941
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 941
aacuuuucga uaacuuugga u 21
<210> 942
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 942
gaacuuuucg auaacuuugg a 21
<210> 943
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 943
uggagccggg aacuuuucga u 21
<210> 944
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 944
acuggagccg ggaacuuuuc g 21
<210> 945
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 945
gaugugcacu ggagccggga a 21
<210> 946
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 946
cagaugugca cuggagccgg g 21
<210> 947
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 947
acagaugugc acuggagccg g 21
<210> 948
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 948
cacagaugug cacuggagcc g 21
<210> 949
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 949
acacagaugu gcacuggagc c 21
<210> 950
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 950
ucacacagau gugcacugga g 21
<210> 951
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 951
agcucacaca gaugugcacu g 21
<210> 952
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 952
ccagcucaca cagaugugca c 21
<210> 953
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 953
ucccagcuca cacagaugug c 21
<210> 954
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 954
acucccagcu cacacagaug u 21
<210> 955
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 955
aggacuccca gcucacacag a 21
<210> 956
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 956
gaggacuccc agcucacaca g 21
<210> 957
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 957
cugaugagga cucccagcuc a 21
<210> 958
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 958
ccugaugagg acucccagcu c 21
<210> 959
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 959
accugaugag gacucccagc u 21
<210> 960
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 960
uaccugauga ggacucccag c 21
<210> 961
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 961
auaccugaug aggacuccca g 21
<210> 962
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 962
aauaccugau gaggacuccc a 21
<210> 963
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 963
caauaccuga ugaggacucc c 21
<210> 964
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 964
agcaauaccu gaugaggacu c 21
<210> 965
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 965
cagcaauacc ugaugaggac u 21
<210> 966
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 966
ucagcaauac cugaugagga c 21
<210> 967
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 967
uucagcaaua ccugaugagg a 21
<210> 968
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 968
auucagcaau accugaugag g 21
<210> 969
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 969
aauucagcaa uaccugauga g 21
<210> 970
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 970
aaauucagca auaccugaug a 21
<210> 971
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 971
aaaauucagc aauaccugau g 21
<210> 972
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 972
caaaauucag caauaccuga u 21
<210> 973
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 973
ccaaaauuca gcaauaccug a 21
<210> 974
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 974
uccaaaauuc agcaauaccu g 21
<210> 975
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 975
auccaaaauu cagcaauacc u 21
<210> 976
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 976
ugauccaaaa uucagcaaua c 21
<210> 977
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 977
auugauccaa aauucagcaa u 21
<210> 978
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 978
cauugaucca aaauucagca a 21
<210> 979
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 979
ccauugaucc aaaauucagc a 21
<210> 980
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 980
ucccauugau ccaaaauuca g 21
<210> 981
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 981
aaaggugucc cauugaucca a 21
<210> 982
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 982
caccaaaggu gucccauuga u 21
<210> 983
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 983
ucaccaaagg ugucccauug a 21
<210> 984
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 984
uucaccaaag gugucccauu g 21
<210> 985
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 985
uuucaccaaa ggugucccau u 21
<210> 986
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 986
uuuucaccaa agguguccca u 21
<210> 987
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 987
uuuuucacca aagguguccc a 21
<210> 988
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 988
acccuuuuuc accaaaggug u 21
<210> 989
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 989
gacccuuuuu caccaaaggu g 21
<210> 990
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 990
agacccuuuu ucaccaaagg u 21
<210> 991
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 991
ucgcagaccc uuuuucacca a 21
<210> 992
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 992
gucgcagacc cuuuuucacc a 21
<210> 993
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 993
ugucgcagac ccuuuuucac c 21
<210> 994
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 994
cugucgcaga cccuuuuuca c 21
<210> 995
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 995
acccugucgc agacccuuuu u 21
<210> 996
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 996
aacccugucg cagacccuuu u 21
<210> 997
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 997
uaacccuguc gcagacccuu u 21
<210> 998
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 998
guaacccugu cgcagacccu u 21
<210> 999
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 999
aguaacccug ucgcagaccc u 21
<210> 1000
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1000
aaguaacccu gucgcagacc c 21
<210> 1001
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1001
aaaguaaccc ugucgcagac c 21
<210> 1002
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1002
caaaguaacc cugucgcaga c 21
<210> 1003
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1003
acaaaguaac ccugucgcag a 21
<210> 1004
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1004
uacaaaguaa cccugucgca g 21
<210> 1005
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1005
cuacaaagua acccugucgc a 21
<210> 1006
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1006
ucuacaaagu aacccugucg c 21
<210> 1007
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1007
uucuacaaag uaacccuguc g 21
<210> 1008
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1008
cuucuacaaa guaacccugu c 21
<210> 1009
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1009
gcuucuacaa aguaacccug u 21
<210> 1010
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1010
agcuucuaca aaguaacccu g 21
<210> 1011
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1011
gagcuucuac aaaguaaccc u 21
<210> 1012
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1012
ugagcuucua caaaguaacc c 21
<210> 1013
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1013
aaucuugggc ugagcuucua c 21
<210> 1014
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1014
caaucuuggg cugagcuucu a 21
<210> 1015
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1015
acaaucuugg gcugagcuuc u 21
<210> 1016
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1016
gacaaucuug ggcugagcuu c 21
<210> 1017
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1017
aggacaaucu ugggcugagc u 21
<210> 1018
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1018
cccaggacaa ucuugggcug a 21
<210> 1019
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1019
ugccccagga caaucuuggg c 21
<210> 1020
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1020
cugccccagg acaaucuugg g 21
<210> 1021
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1021
uccugcccca ggacaaucuu g 21
<210> 1022
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1022
uuccugcccc aggacaaucu u 21
<210> 1023
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1023
uguuccugcc ccaggacaau c 21
<210> 1024
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1024
uccuguuccu gccccaggac a 21
<210> 1025
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1025
aauccuguuc cugccccagg a 21
<210> 1026
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1026
gaauccuguu ccugccccag g 21
<210> 1027
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1027
ggaauccugu uccugcccca g 21
<210> 1028
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1028
uaggaauccu guuccugccc c 21
<210> 1029
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1029
auaggaaucc uguuccugcc c 21
<210> 1030
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1030
cauaggaauc cuguuccugc c 21
<210> 1031
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1031
cccauaggaa uccuguuccu g 21
<210> 1032
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1032
ccccauagga auccuguucc u 21
<210> 1033
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1033
gcccccauag gaauccuguu c 21
<210> 1034
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1034
ugcccccaua ggaauccugu u 21
<210> 1035
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1035
cuugccccca uaggaauccu g 21
<210> 1036
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1036
acuugccccc auaggaaucc u 21
<210> 1037
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1037
aacuugcccc cauaggaauc c 21
<210> 1038
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1038
aaacuugccc ccauaggaau c 21
<210> 1039
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1039
caaacuugcc cccauaggaa u 21
<210> 1040
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1040
ucaaacuugc ccccauagga a 21
<210> 1041
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1041
aucaaacuug cccccauagg a 21
<210> 1042
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1042
uaucaaacuu gcccccauag g 21
<210> 1043
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1043
uccuaucaaa cuugccccca u 21
<210> 1044
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1044
cuccuaucaa acuugccccc a 21
<210> 1045
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1045
gcuccuauca aacuugcccc c 21
<210> 1046
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1046
ggcuccuauc aaacuugccc c 21
<210> 1047
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1047
uggcuccuau caaacuugcc c 21
<210> 1048
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1048
cuggcuccua ucaaacuugc c 21
<210> 1049
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1049
acuggcuccu aucaaacuug c 21
<210> 1050
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1050
aaggacuggc uccuaucaaa c 21
<210> 1051
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1051
aaaggacugg cuccuaucaa a 21
<210> 1052
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1052
caaaggacug gcuccuauca a 21
<210> 1053
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1053
acaaaggacu ggcuccuauc a 21
<210> 1054
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1054
ccacaaagga cuggcuccua u 21
<210> 1055
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1055
cccacaaagg acuggcuccu a 21
<210> 1056
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1056
ucccacaaag gacuggcucc u 21
<210> 1057
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1057
cucccacaaa ggacuggcuc c 21
<210> 1058
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1058
ucucccacaa aggacuggcu c 21
<210> 1059
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1059
cucucccaca aaggacuggc u 21
<210> 1060
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1060
ucucucccac aaaggacugg c 21
<210> 1061
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1061
aucucuccca caaaggacug g 21
<210> 1062
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1062
aaucucuccc acaaaggacu g 21
<210> 1063
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1063
caaucucucc cacaaaggac u 21
<210> 1064
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1064
ccaaucucuc ccacaaagga c 21
<210> 1065
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1065
cccaaucucu cccacaaagg a 21
<210> 1066
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1066
uccccaaucu cucccacaaa g 21
<210> 1067
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1067
auccccaauc ucucccacaa a 21
<210> 1068
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1068
aauccccaau cucucccaca a 21
<210> 1069
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1069
aaauccccaa ucucucccac a 21
<210> 1070
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1070
caaaucccca aucucuccca c 21
<210> 1071
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1071
acaaaucccc aaucucuccc a 21
<210> 1072
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1072
uacaaauccc caaucucucc c 21
<210> 1073
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1073
guacaaaucc ccaaucucuc c 21
<210> 1074
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1074
uguacaaauc cccaaucucu c 21
<210> 1075
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1075
auguacaaau ccccaaucuc u 21
<210> 1076
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1076
cccacaugua caaaucccca a 21
<210> 1077
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1077
ucccacaugu acaaaucccc a 21
<210> 1078
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1078
gucccacaug uacaaauccc c 21
<210> 1079
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1079
agucccacau guacaaaucc c 21
<210> 1080
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1080
acagaguccc acauguacaa a 21
<210> 1081
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1081
cacagagucc cacauguaca a 21
<210> 1082
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1082
agcacagagu cccacaugua c 21
<210> 1083
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1083
gggggcagca cagaguccca c 21
<210> 1084
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1084
ugggggcagc acagaguccc a 21
<210> 1085
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1085
ucugggggca gcacagaguc c 21
<210> 1086
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1086
uucugggggc agcacagagu c 21
<210> 1087
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1087
uuuucugggg gcagcacaga g 21
<210> 1088
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1088
auuuucuggg ggcagcacag a 21
<210> 1089
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1089
uauuuucugg gggcagcaca g 21
<210> 1090
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1090
gauauuuucu gggggcagca c 21
<210> 1091
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1091
acaggauauu uucugggggc a 21
<210> 1092
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1092
agacaggaua uuuucugggg g 21
<210> 1093
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1093
cagacaggau auuuucuggg g 21
<210> 1094
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1094
gcagacagga uauuuucugg g 21
<210> 1095
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1095
aggcagacag gauauuuucu g 21
<210> 1096
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1096
uaggcagaca ggauauuuuc u 21
<210> 1097
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1097
auaggcagac aggauauuuu c 21
<210> 1098
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1098
acccugauag gcagacagga u 21
<210> 1099
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1099
uacccugaua ggcagacagg a 21
<210> 1100
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1100
gguacccuga uaggcagaca g 21
<210> 1101
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1101
agggguaccc ugauaggcag a 21
<210> 1102
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1102
gagggguacc cugauaggca g 21
<210> 1103
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1103
agagggguac ccugauaggc a 21
<210> 1104
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1104
gagaggggua cccugauagg c 21
<210> 1105
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1105
cagggagagg gguacccuga u 21
<210> 1106
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1106
ggcagggaga gggguacccu g 21
<210> 1107
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1107
uggcagggag agggguaccc u 21
<210> 1108
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1108
uuggcaggga gagggguacc c 21
<210> 1109
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1109
auuggcaggg agagggguac c 21
<210> 1110
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1110
auauuggcag ggagaggggu a 21
<210> 1111
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1111
gauauuggca gggagagggg u 21
<210> 1112
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1112
caguccagga uauuggcagg g 21
<210> 1113
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1113
ugccagucca ggauauuggc a 21
<210> 1114
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1114
cugccagucc aggauauugg c 21
<210> 1115
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1115
agagccugcc aguccaggau a 21
<210> 1116
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1116
cagagccugc caguccagga u 21
<210> 1117
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1117
ucagagccug ccaguccagg a 21
<210> 1118
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1118
uucagagccu gccaguccag g 21
<210> 1119
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1119
guucagagcc ugccagucca g 21
<210> 1120
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1120
aguucagagc cugccagucc a 21
<210> 1121
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1121
uaguucagag ccugccaguc c 21
<210> 1122
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1122
auaguucaga gccugccagu c 21
<210> 1123
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1123
cauaguucag agccugccag u 21
<210> 1124
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1124
ucauaguuca gagccugcca g 21
<210> 1125
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1125
uucauaguuc agagccugcc a 21
<210> 1126
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1126
uuucauaguu cagagccugc c 21
<210> 1127
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1127
auuucauagu ucagagccug c 21
<210> 1128
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1128
gauuucauag uucagagccu g 21
<210> 1129
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1129
ugauuucaua guucagagcc u 21
<210> 1130
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1130
cugauuucau aguucagagc c 21
<210> 1131
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1131
ucugauuuca uaguucagag c 21
<210> 1132
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1132
uccucugauu ucauaguuca g 21
<210> 1133
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1133
auccucugau uucauaguuc a 21
<210> 1134
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1134
uauccucuga uuucauaguu c 21
<210> 1135
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1135
auauccucug auuucauagu u 21
<210> 1136
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1136
cauauccucu gauuucauag u 21
<210> 1137
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1137
gacauauccu cugauuucau a 21
<210> 1138
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1138
ugacauaucc ucugauuuca u 21
<210> 1139
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1139
augacauauc cucugauuuc a 21
<210> 1140
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1140
gaugacauau ccucugauuu c 21
<210> 1141
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1141
gaugaugaca uauccucuga u 21
<210> 1142
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1142
ugaugaugac auauccucug a 21
<210> 1143
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1143
uugaugauga cauauccucu g 21
<210> 1144
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1144
uuugaugaug acauauccuc u 21
<210> 1145
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1145
guuugaugau gacauauccu c 21
<210> 1146
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1146
gguuugauga ugacauaucc u 21
<210> 1147
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1147
aaggguuuga ugaugacaua u 21
<210> 1148
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1148
caccaagggu uugaugauga c 21
<210> 1149
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1149
cacaccaagg guuugaugau g 21
<210> 1150
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1150
ucagacccac accaaggguu u 21
<210> 1151
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1151
cucagaccca caccaagggu u 21
<210> 1152
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1152
ccucagaccc acaccaaggg u 21
<210> 1153
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1153
accucagacc cacaccaagg g 21
<210> 1154
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1154
agaccucaga cccacaccaa g 21
<210> 1155
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1155
aagaccucag acccacacca a 21
<210> 1156
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1156
caagaccuca gacccacacc a 21
<210> 1157
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1157
ucaagaccuc agacccacac c 21
<210> 1158
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1158
gucaagaccu cagacccaca c 21
<210> 1159
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1159
gagucaagac cucagaccca c 21
<210> 1160
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1160
ugagucaaga ccucagaccc a 21
<210> 1161
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1161
uugagucaag accucagacc c 21
<210> 1162
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1162
cguugaguca agaccucaga c 21
<210> 1163
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1163
ucguugaguc aagaccucag a 21
<210> 1164
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1164
cucguugagu caagaccuca g 21
<210> 1165
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1165
ucucguugag ucaagaccuc a 21
<210> 1166
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1166
cucucguuga gucaagaccu c 21
<210> 1167
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1167
gcucucguug agucaagacc u 21
<210> 1168
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1168
ugcucucguu gagucaagac c 21
<210> 1169
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1169
gugcucucgu ugagucaaga c 21
<210> 1170
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1170
agugcucucg uugagucaag a 21
<210> 1171
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1171
aagugcucuc guugagucaa g 21
<210> 1172
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1172
caagugcucu cguugaguca a 21
<210> 1173
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1173
ucaagugcuc ucguugaguc a 21
<210> 1174
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1174
uucaagugcu cucguugagu c 21
<210> 1175
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1175
uuucaagugc ucucguugag u 21
<210> 1176
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1176
uuuucaagug cucucguuga g 21
<210> 1177
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1177
auuuucaagu gcucucguug a 21
<210> 1178
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1178
cauuuucaag ugcucucguu g 21
<210> 1179
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1179
ucauuuucaa gugcucucgu u 21
<210> 1180
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1180
uucauuuuca agugcucucg u 21
<210> 1181
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1181
uuucauuuuc aagugcucuc g 21
<210> 1182
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1182
auuucauuuu caagugcucu c 21
<210> 1183
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1183
cauuucauuu ucaagugcuc u 21
<210> 1184
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1184
ucauuucauu uucaagugcu c 21
<210> 1185
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1185
gucauuucau uuucaagugc u 21
<210> 1186
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1186
agucauuuca uuuucaagug c 21
<210> 1187
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1187
cagucauuuc auuuucaagu g 21
<210> 1188
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1188
acagucauuu cauuuucaag u 21
<210> 1189
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1189
gacagucauu ucauuuucaa g 21
<210> 1190
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1190
agacagucau uucauuuuca a 21
<210> 1191
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1191
uagacaguca uuucauuuuc a 21
<210> 1192
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1192
uuagacaguc auuucauuuu c 21
<210> 1193
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1193
cuuagacagu cauuucauuu u 21
<210> 1194
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1194
ucuuagacag ucauuucauu u 21
<210> 1195
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1195
cucuuagaca gucauuucau u 21
<210> 1196
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1196
ucucuuagac agucauuuca u 21
<210> 1197
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1197
aucucuuaga cagucauuuc a 21
<210> 1198
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1198
agaucucuua gacagucauu u 21
<210> 1199
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1199
cagaucucuu agacagucau u 21
<210> 1200
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1200
ccagaucucu uagacaguca u 21
<210> 1201
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1201
accagaucuc uuagacaguc a 21
<210> 1202
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1202
gaccagaucu cuuagacagu c 21
<210> 1203
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1203
ugaccagauc ucuuagacag u 21
<210> 1204
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1204
uugaccagau cucuuagaca g 21
<210> 1205
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1205
uuugaccaga ucucuuagac a 21
<210> 1206
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1206
cuuugaccag aucucuuaga c 21
<210> 1207
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1207
gcuuugacca gaucucuuag a 21
<210> 1208
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1208
ugcuuugacc agaucucuua g 21
<210> 1209
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1209
uugcuuugac cagaucucuu a 21
<210> 1210
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1210
guugcuuuga ccagaucucu u 21
<210> 1211
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1211
aguugcuuug accagaucuc u 21
<210> 1212
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1212
caguugcuuu gaccagaucu c 21
<210> 1213
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1213
ccaguugcuu ugaccagauc u 21
<210> 1214
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1214
uccaguugcu uugaccagau c 21
<210> 1215
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1215
auccaguugc uuugaccaga u 21
<210> 1216
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1216
uauccaguug cuuugaccag a 21
<210> 1217
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1217
guauccaguu gcuuugacca g 21
<210> 1218
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1218
aguauccagu ugcuuugacc a 21
<210> 1219
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1219
uaguauccag uugcuuugac c 21
<210> 1220
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1220
cuaguaucca guugcuuuga c 21
<210> 1221
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1221
ucuaguaucc aguugcuuug a 21
<210> 1222
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1222
aucuaguauc caguugcuuu g 21
<210> 1223
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1223
gaucuaguau ccaguugcuu u 21
<210> 1224
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1224
agaucuagua uccaguugcu u 21
<210> 1225
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1225
aagaucuagu auccaguugc u 21
<210> 1226
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1226
uaagaucuag uauccaguug c 21
<210> 1227
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1227
guaagaucua guauccaguu g 21
<210> 1228
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1228
uguaagaucu aguauccagu u 21
<210> 1229
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1229
auguaagauc uaguauccag u 21
<210> 1230
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1230
gauguaagau cuaguaucca g 21
<210> 1231
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1231
agauguaaga ucuaguaucc a 21
<210> 1232
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1232
cagauguaag aucuaguauc c 21
<210> 1233
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1233
ugcagaugua agaucuagua u 21
<210> 1234
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1234
cugcagaugu aagaucuagu a 21
<210> 1235
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1235
agcugcagau guaagaucua g 21
<210> 1236
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1236
gagcugcaga uguaagaucu a 21
<210> 1237
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1237
agagcugcag auguaagauc u 21
<210> 1238
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1238
aagagcugca gauguaagau c 21
<210> 1239
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1239
aaagagcugc agauguaaga u 21
<210> 1240
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1240
gaaagagcug cagauguaag a 21
<210> 1241
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1241
agaaagagcu gcagauguaa g 21
<210> 1242
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1242
aagaaagagc ugcagaugua a 21
<210> 1243
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1243
gaagaaagag cugcagaugu a 21
<210> 1244
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1244
agaagaaaga gcugcagaug u 21
<210> 1245
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1245
aagaagaaag agcugcagau g 21
<210> 1246
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1246
aaagaagaaa gagcugcaga u 21
<210> 1247
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1247
caaagaagaa agagcugcag a 21
<210> 1248
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1248
ucaaagaaga aagagcugca g 21
<210> 1249
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1249
uucaaagaag aaagagcugc a 21
<210> 1250
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1250
auucaaagaa gaaagagcug c 21
<210> 1251
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1251
aauucaaaga agaaagagcu g 21
<210> 1252
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1252
aaauucaaag aagaaagagc u 21
<210> 1253
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1253
gaaauucaaa gaagaaagag c 21
<210> 1254
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1254
ggaaauucaa agaagaaaga g 21
<210> 1255
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1255
aggaaauuca aagaagaaag a 21
<210> 1256
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1256
uaggaaauuc aaagaagaaa g 21
<210> 1257
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1257
auaggaaauu caaagaagaa a 21
<210> 1258
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1258
agauaggaaa uucaaagaag a 21
<210> 1259
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1259
cagauaggaa auucaaagaa g 21
<210> 1260
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1260
acagauagga aauucaaaga a 21
<210> 1261
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1261
uacagauagg aaauucaaag a 21
<210> 1262
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1262
auacagauag gaaauucaaa g 21
<210> 1263
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1263
cauacagaua ggaaauucaa a 21
<210> 1264
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1264
acauacagau aggaaauuca a 21
<210> 1265
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1265
agacauacag auaggaaauu c 21
<210> 1266
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1266
cagacauaca gauaggaaau u 21
<210> 1267
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1267
gcagacauac agauaggaaa u 21
<210> 1268
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1268
ggcagacaua cagauaggaa a 21
<210> 1269
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1269
aggcagacau acagauagga a 21
<210> 1270
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1270
uaggcagaca uacagauagg a 21
<210> 1271
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1271
uuaggcagac auacagauag g 21
<210> 1272
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1272
auuaggcaga cauacagaua g 21
<210> 1273
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1273
aauuaggcag acauacagau a 21
<210> 1274
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1274
uaauuaggca gacauacaga u 21
<210> 1275
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1275
uuaauuaggc agacauacag a 21
<210> 1276
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1276
uuuaauuagg cagacauaca g 21
<210> 1277
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1277
uuuuaauuag gcagacauac a 21
<210> 1278
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1278
uuuuuaauua ggcagacaua c 21
<210> 1279
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1279
uuuuuuaauu aggcagacau a 21
<210> 1280
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1280
uuuuuuuaau uaggcagaca u 21
<210> 1281
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1281
auuuuuuuaa uuaggcagac a 21
<210> 1282
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1282
uauuuuuuua auuaggcaga c 21
<210> 1283
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1283
auauuuuuuu aauuaggcag a 21
<210> 1284
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1284
uauauuuuuu uaauuaggca g 21
<210> 1285
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1285
auauauuuuu uuaauuaggc a 21
<210> 1286
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1286
uauauauuuu uuuaauuagg c 21
<210> 1287
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 1287
uacaauauau auuuuuuuaa u 21
<210> 1288
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1288
gcaugaauau cagacgcua 19
<210> 1289
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1289
caugaauauc agacgcuag 19
<210> 1290
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1290
auaucagacg cuaggggga 19
<210> 1291
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1291
cuagggggac agccacugu 19
<210> 1292
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1292
agggggacag ccacugugu 19
<210> 1293
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1293
ggggacagcc acuguguug 19
<210> 1294
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1294
gggacagcca cuguguugu 19
<210> 1295
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1295
ggacagccac uguguuguc 19
<210> 1296
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1296
gacagccacu guguugucu 19
<210> 1297
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1297
gccacugugu ugucugcua 19
<210> 1298
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1298
ccacuguguu gucugcuac 19
<210> 1299
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1299
cacuguguug ucugcuacc 19
<210> 1300
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1300
cuguguuguc ugcuacccu 19
<210> 1301
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1301
uguguugucu gcuacccuc 19
<210> 1302
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1302
guguugucug cuacccuca 19
<210> 1303
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1303
uguugucugc uacccucau 19
<210> 1304
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1304
guugucugcu acccucauc 19
<210> 1305
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1305
gucugcuacc cucauccug 19
<210> 1306
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1306
cugcuacccu cauccuggu 19
<210> 1307
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1307
gcuacccuca uccugguca 19
<210> 1308
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1308
cuacccucau ccuggucac 19
<210> 1309
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1309
uacccucauc cuggucacu 19
<210> 1310
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1310
acccucaucc uggucacug 19
<210> 1311
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1311
cccucauccu ggucacugc 19
<210> 1312
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1312
ccucauccug gucacugcu 19
<210> 1313
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1313
cucauccugg ucacugcuu 19
<210> 1314
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1314
cauccugguc acugcuucu 19
<210> 1315
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1315
auccugguca cugcuucug 19
<210> 1316
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1316
uccuggucac ugcuucugc 19
<210> 1317
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1317
ccuggucacu gcuucugcu 19
<210> 1318
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1318
cuggucacug cuucugcua 19
<210> 1319
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1319
uggucacugc uucugcuau 19
<210> 1320
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1320
ggucacugcu ucugcuaua 19
<210> 1321
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1321
gucacugcuu cugcuauaa 19
<210> 1322
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1322
cacugcuucu gcuauaaca 19
<210> 1323
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1323
acugcuucug cuauaacag 19
<210> 1324
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1324
cugcuucugc uauaacagc 19
<210> 1325
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1325
gcuucugcua uaacagccc 19
<210> 1326
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1326
cuucugcuau aacagcccu 19
<210> 1327
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1327
uucugcuaua acagcccua 19
<210> 1328
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1328
ucugcuauaa cagcccuag 19
<210> 1329
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1329
cugcuauaac agcccuagg 19
<210> 1330
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1330
ugcuauaaca gcccuaggc 19
<210> 1331
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1331
gcuauaacag cccuaggcc 19
<210> 1332
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1332
cuauaacagc ccuaggcca 19
<210> 1333
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1333
uauaacagcc cuaggccag 19
<210> 1334
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1334
auaacagccc uaggccagg 19
<210> 1335
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1335
uaacagcccu aggccagga 19
<210> 1336
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1336
acagcccuag gccaggaau 19
<210> 1337
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1337
cagcccuagg ccaggaaua 19
<210> 1338
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1338
agcccuaggc caggaauau 19
<210> 1339
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1339
gcccuaggcc aggaauaug 19
<210> 1340
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1340
cccuaggcca ggaauauga 19
<210> 1341
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1341
ccuaggccag gaauaugaa 19
<210> 1342
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1342
cuaggccagg aauaugaac 19
<210> 1343
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1343
uaggccagga auaugaaca 19
<210> 1344
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1344
aggccaggaa uaugaacaa 19
<210> 1345
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1345
ggccaggaau augaacaag 19
<210> 1346
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1346
gccaggaaua ugaacaagc 19
<210> 1347
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1347
ccaggaauau gaacaagcc 19
<210> 1348
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1348
caggaauaug aacaagccg 19
<210> 1349
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1349
aggaauauga acaagccgc 19
<210> 1350
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1350
ggaauaugaa caagccgcu 19
<210> 1351
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1351
gaauaugaac aagccgcug 19
<210> 1352
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1352
aauaugaaca agccgcugc 19
<210> 1353
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1353
auaugaacaa gccgcugcu 19
<210> 1354
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1354
uaugaacaag ccgcugcuu 19
<210> 1355
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1355
augaacaagc cgcugcuuu 19
<210> 1356
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1356
ugaacaagcc gcugcuuug 19
<210> 1357
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1357
gaacaagccg cugcuuugg 19
<210> 1358
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1358
aacaagccgc ugcuuugga 19
<210> 1359
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1359
acaagccgcu gcuuuggau 19
<210> 1360
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1360
caagccgcug cuuuggauc 19
<210> 1361
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1361
aagccgcugc uuuggaucu 19
<210> 1362
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1362
agccgcugcu uuggaucuc 19
<210> 1363
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1363
gccgcugcuu uggaucucu 19
<210> 1364
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1364
ccgcugcuuu ggaucucug 19
<210> 1365
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1365
cgcugcuuug gaucucugu 19
<210> 1366
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1366
gcugcuuugg aucucuguc 19
<210> 1367
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1367
cugcuuugga ucucugucc 19
<210> 1368
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1368
ugcuuuggau cucuguccu 19
<210> 1369
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1369
gcuuuggauc ucuguccuc 19
<210> 1370
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1370
cuuuggaucu cuguccuca 19
<210> 1371
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1371
uuuggaucuc uguccucac 19
<210> 1372
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1372
ggaucucugu ccucaccag 19
<210> 1373
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1373
gaucucuguc cucaccagc 19
<210> 1374
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1374
cucuguccuc accagccuc 19
<210> 1375
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1375
cuguccucac cagccuccu 19
<210> 1376
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1376
uguccucacc agccuccug 19
<210> 1377
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1377
guccucacca gccuccugg 19
<210> 1378
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1378
uccucaccag ccuccugga 19
<210> 1379
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1379
cucaccagcc uccuggaag 19
<210> 1380
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1380
ucaccagccu ccuggaagc 19
<210> 1381
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1381
accagccucc uggaagccu 19
<210> 1382
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1382
ccagccuccu ggaagccuu 19
<210> 1383
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1383
cagccuccug gaagccuuu 19
<210> 1384
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1384
agccuccugg aagccuuug 19
<210> 1385
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1385
gccuccugga agccuuugc 19
<210> 1386
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1386
ccuccuggaa gccuuugcu 19
<210> 1387
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1387
cuccuggaag ccuuugcuc 19
<210> 1388
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1388
uccuggaagc cuuugcuca 19
<210> 1389
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1389
ccuggaagcc uuugcucac 19
<210> 1390
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1390
cuggaagccu uugcucaca 19
<210> 1391
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1391
ggaagccuuu gcucacaca 19
<210> 1392
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1392
gaagccuuug cucacacag 19
<210> 1393
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1393
aagccuuugc ucacacaga 19
<210> 1394
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1394
agccuuugcu cacacagac 19
<210> 1395
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1395
gccuuugcuc acacagacc 19
<210> 1396
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1396
ccuuugcuca cacagaccu 19
<210> 1397
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1397
cuuugcucac acagaccuc 19
<210> 1398
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1398
uuugcucaca cagaccuca 19
<210> 1399
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1399
ugcucacaca gaccucagu 19
<210> 1400
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1400
cucacacaga ccucagugg 19
<210> 1401
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1401
cacacagacc ucaguggga 19
<210> 1402
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1402
acacagaccu cagugggaa 19
<210> 1403
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1403
cacagaccuc agugggaag 19
<210> 1404
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1404
agaccucagu gggaaggug 19
<210> 1405
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1405
gaccucagug ggaaggugu 19
<210> 1406
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1406
accucagugg gaagguguu 19
<210> 1407
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1407
ccucaguggg aagguguuu 19
<210> 1408
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1408
cucaguggga agguguuug 19
<210> 1409
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1409
ucagugggaa gguguuugu 19
<210> 1410
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1410
cagugggaag guguuugua 19
<210> 1411
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1411
agugggaagg uguuuguau 19
<210> 1412
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1412
gugggaaggu guuuguauu 19
<210> 1413
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1413
ugggaaggug uuuguauuu 19
<210> 1414
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1414
gggaaggugu uuguauuuc 19
<210> 1415
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1415
ggaagguguu uguauuucc 19
<210> 1416
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1416
gaagguguuu guauuuccu 19
<210> 1417
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1417
aagguguuug uauuuccua 19
<210> 1418
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1418
agguguuugu auuuccuag 19
<210> 1419
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1419
gguguuugua uuuccuaga 19
<210> 1420
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1420
guguuuguau uuccuagag 19
<210> 1421
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1421
uguuuguauu uccuagaga 19
<210> 1422
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1422
guuuguauuu ccuagagaa 19
<210> 1423
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1423
uuuguauuuc cuagagaau 19
<210> 1424
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1424
uuguauuucc uagagaauc 19
<210> 1425
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1425
uguauuuccu agagaaucu 19
<210> 1426
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1426
guauuuccua gagaaucug 19
<210> 1427
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1427
uauuuccuag agaaucugu 19
<210> 1428
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1428
auuuccuaga gaaucuguu 19
<210> 1429
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1429
uuuccuagag aaucuguua 19
<210> 1430
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1430
uccuagagaa ucuguuacu 19
<210> 1431
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1431
ccuagagaau cuguuacug 19
<210> 1432
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1432
cuagagaauc uguuacuga 19
<210> 1433
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1433
uagagaaucu guuacugau 19
<210> 1434
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1434
agagaaucug uuacugauc 19
<210> 1435
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1435
gagaaucugu uacugauca 19
<210> 1436
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1436
agaaucuguu acugaucau 19
<210> 1437
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1437
gaaucuguua cugaucaug 19
<210> 1438
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1438
aaucuguuac ugaucaugu 19
<210> 1439
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1439
aucuguuacu gaucaugua 19
<210> 1440
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1440
ucuguuacug aucauguaa 19
<210> 1441
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1441
cuguuacuga ucauguaaa 19
<210> 1442
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1442
uguuacugau cauguaaac 19
<210> 1443
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1443
guuacugauc auguaaacu 19
<210> 1444
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1444
acugaucaug uaaacuuga 19
<210> 1445
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1445
cugaucaugu aaacuugau 19
<210> 1446
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1446
ugaucaugua aacuugauc 19
<210> 1447
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1447
gaucauguaa acuugauca 19
<210> 1448
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1448
ucauguaaac uugaucaca 19
<210> 1449
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1449
cauguaaacu ugaucacac 19
<210> 1450
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1450
uaaacuugau cacaccgcu 19
<210> 1451
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1451
aaacuugauc acaccgcug 19
<210> 1452
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1452
acuugaucac accgcugga 19
<210> 1453
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1453
uugaucacac cgcuggaga 19
<210> 1454
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1454
ugaucacacc gcuggagaa 19
<210> 1455
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1455
gaucacaccg cuggagaag 19
<210> 1456
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1456
cacaccgcug gagaagccu 19
<210> 1457
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1457
acaccgcugg agaagccuc 19
<210> 1458
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1458
caccgcugga gaagccucu 19
<210> 1459
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1459
accgcuggag aagccucua 19
<210> 1460
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1460
ccgcuggaga agccucuac 19
<210> 1461
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1461
cgcuggagaa gccucuaca 19
<210> 1462
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1462
gcuggagaag ccucuacag 19
<210> 1463
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1463
cuggagaagc cucuacaga 19
<210> 1464
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1464
uggagaagcc ucuacagaa 19
<210> 1465
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1465
ggagaagccu cuacagaac 19
<210> 1466
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1466
gagaagccuc uacagaacu 19
<210> 1467
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1467
agaagccucu acagaacuu 19
<210> 1468
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1468
gaagccucua cagaacuuu 19
<210> 1469
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1469
aagccucuac agaacuuua 19
<210> 1470
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1470
agccucuaca gaacuuuac 19
<210> 1471
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1471
gccucuacag aacuuuacc 19
<210> 1472
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1472
ccucuacaga acuuuaccu 19
<210> 1473
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1473
cucuacagaa cuuuaccuu 19
<210> 1474
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1474
ucuacagaac uuuaccuug 19
<210> 1475
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1475
cuacagaacu uuaccuugu 19
<210> 1476
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1476
uacagaacuu uaccuugug 19
<210> 1477
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1477
acagaacuuu accuugugu 19
<210> 1478
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1478
cagaacuuua ccuuguguu 19
<210> 1479
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1479
agaacuuuac cuuguguuu 19
<210> 1480
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1480
gaacuuuacc uuguguuuu 19
<210> 1481
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1481
aacuuuaccu uguguuuuc 19
<210> 1482
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1482
cuuuaccuug uguuuucga 19
<210> 1483
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1483
accuuguguu uucgagccu 19
<210> 1484
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1484
ccuuguguuu ucgagccua 19
<210> 1485
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1485
cuuguguuuu cgagccuau 19
<210> 1486
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1486
uuguguuuuc gagccuaua 19
<210> 1487
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1487
guguuuucga gccuauagu 19
<210> 1488
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1488
guuuucgagc cuauaguga 19
<210> 1489
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1489
uuuucgagcc uauagugau 19
<210> 1490
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1490
cgagccuaua gugaucucu 19
<210> 1491
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1491
gagccuauag ugaucucuc 19
<210> 1492
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1492
agccuauagu gaucucucu 19
<210> 1493
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1493
gccuauagug aucucucuc 19
<210> 1494
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1494
ccuauaguga ucucucucg 19
<210> 1495
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1495
cuauagugau cucucucgu 19
<210> 1496
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1496
uauagugauc ucucucgug 19
<210> 1497
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1497
agugaucucu cucgugccu 19
<210> 1498
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1498
gugaucucuc ucgugccua 19
<210> 1499
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1499
ugaucucucu cgugccuac 19
<210> 1500
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1500
gaucucucuc gugccuaca 19
<210> 1501
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1501
cucucgugcc uacagccuc 19
<210> 1502
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1502
ucucgugccu acagccucu 19
<210> 1503
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1503
cucgugccua cagccucuu 19
<210> 1504
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1504
cgugccuaca gccucuucu 19
<210> 1505
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1505
gugccuacag ccucuucuc 19
<210> 1506
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1506
gccuacagcc ucuucuccu 19
<210> 1507
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1507
ccuacagccu cuucuccua 19
<210> 1508
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1508
cuacagccuc uucuccuac 19
<210> 1509
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1509
uacagccucu ucuccuaca 19
<210> 1510
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1510
acagccucuu cuccuacaa 19
<210> 1511
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1511
cagccucuuc uccuacaau 19
<210> 1512
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1512
agccucuucu ccuacaaua 19
<210> 1513
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1513
gccucuucuc cuacaauac 19
<210> 1514
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1514
ccucuucucc uacaauacc 19
<210> 1515
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1515
ucuucuccua caauaccca 19
<210> 1516
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1516
ucuccuacaa uacccaagg 19
<210> 1517
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1517
cuccuacaau acccaaggc 19
<210> 1518
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1518
uccuacaaua cccaaggca 19
<210> 1519
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1519
ccuacaauac ccaaggcag 19
<210> 1520
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1520
cuacaauacc caaggcagg 19
<210> 1521
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1521
caauacccaa ggcagggau 19
<210> 1522
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1522
auacccaagg cagggauaa 19
<210> 1523
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1523
uacccaaggc agggauaau 19
<210> 1524
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1524
ccaaggcagg gauaaugag 19
<210> 1525
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1525
aaggcaggga uaaugagcu 19
<210> 1526
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1526
aggcagggau aaugagcua 19
<210> 1527
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1527
gcagggauaa ugagcuacu 19
<210> 1528
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1528
cagggauaau gagcuacua 19
<210> 1529
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1529
agggauaaug agcuacuag 19
<210> 1530
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1530
gggauaauga gcuacuagu 19
<210> 1531
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1531
ggauaaugag cuacuaguu 19
<210> 1532
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1532
gauaaugagc uacuaguuu 19
<210> 1533
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1533
auaaugagcu acuaguuua 19
<210> 1534
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1534
uaaugagcua cuaguuuau 19
<210> 1535
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1535
augagcuacu aguuuauaa 19
<210> 1536
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1536
ugagcuacua guuuauaaa 19
<210> 1537
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1537
gagcuacuag uuuauaaag 19
<210> 1538
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1538
agcuacuagu uuauaaaga 19
<210> 1539
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1539
gcuacuaguu uauaaagaa 19
<210> 1540
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1540
cuacuaguuu auaaagaaa 19
<210> 1541
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1541
aguuuauaaa gaaagaguu 19
<210> 1542
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1542
aagaaagagu uggagagua 19
<210> 1543
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1543
agaaagaguu ggagaguau 19
<210> 1544
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1544
gaaagaguug gagaguaua 19
<210> 1545
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1545
aagaguugga gaguauagu 19
<210> 1546
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1546
agaguuggag aguauaguc 19
<210> 1547
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1547
gaguuggaga guauagucu 19
<210> 1548
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1548
aguuggagag uauagucua 19
<210> 1549
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1549
guuggagagu auagucuau 19
<210> 1550
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1550
uuggagagua uagucuaua 19
<210> 1551
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1551
uggagaguau agucuauac 19
<210> 1552
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1552
ggagaguaua gucuauaca 19
<210> 1553
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1553
gagaguauag ucuauacau 19
<210> 1554
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1554
agaguauagu cuauacauu 19
<210> 1555
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1555
gaguauaguc uauacauug 19
<210> 1556
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1556
aguauagucu auacauugg 19
<210> 1557
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1557
guauagucua uacauugga 19
<210> 1558
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1558
gucuauacau uggaagaca 19
<210> 1559
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1559
cuauacauug gaagacaca 19
<210> 1560
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1560
uauacauugg aagacacaa 19
<210> 1561
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1561
auacauugga agacacaaa 19
<210> 1562
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1562
acauuggaag acacaaagu 19
<210> 1563
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1563
cauuggaaga cacaaaguu 19
<210> 1564
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1564
auuggaagac acaaaguua 19
<210> 1565
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1565
uggaagacac aaaguuaca 19
<210> 1566
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1566
ggaagacaca aaguuacau 19
<210> 1567
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1567
gaagacacaa aguuacauc 19
<210> 1568
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1568
aagacacaaa guuacaucc 19
<210> 1569
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1569
agacacaaag uuacaucca 19
<210> 1570
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1570
gacacaaagu uacauccaa 19
<210> 1571
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1571
acacaaaguu acauccaaa 19
<210> 1572
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1572
cacaaaguua cauccaaag 19
<210> 1573
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1573
caaaguuaca uccaaaguu 19
<210> 1574
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1574
aaaguuacau ccaaaguua 19
<210> 1575
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1575
aaguuacauc caaaguuau 19
<210> 1576
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1576
aguuacaucc aaaguuauc 19
<210> 1577
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1577
guuacaucca aaguuaucg 19
<210> 1578
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1578
uuacauccaa aguuaucga 19
<210> 1579
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1579
uacauccaaa guuaucgaa 19
<210> 1580
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1580
acauccaaag uuaucgaaa 19
<210> 1581
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1581
cauccaaagu uaucgaaaa 19
<210> 1582
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1582
auccaaaguu aucgaaaag 19
<210> 1583
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1583
uccaaaguua ucgaaaagu 19
<210> 1584
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1584
ccaaaguuau cgaaaaguu 19
<210> 1585
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1585
caaaguuauc gaaaaguuc 19
<210> 1586
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1586
cgaaaaguuc ccggcucca 19
<210> 1587
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1587
aaaaguuccc ggcuccagu 19
<210> 1588
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1588
cccggcucca gugcacauc 19
<210> 1589
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1589
cggcuccagu gcacaucug 19
<210> 1590
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1590
ggcuccagug cacaucugu 19
<210> 1591
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1591
gcuccagugc acaucugug 19
<210> 1592
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1592
cuccagugca caucugugu 19
<210> 1593
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1593
ccagugcaca ucuguguga 19
<210> 1594
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1594
gugcacaucu gugugagcu 19
<210> 1595
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1595
gcacaucugu gugagcugg 19
<210> 1596
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1596
acaucugugu gagcuggga 19
<210> 1597
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1597
aucuguguga gcugggagu 19
<210> 1598
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1598
ugugugagcu gggaguccu 19
<210> 1599
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1599
gugugagcug ggaguccuc 19
<210> 1600
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1600
agcugggagu ccucaucag 19
<210> 1601
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1601
gcugggaguc cucaucagg 19
<210> 1602
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1602
cugggagucc ucaucaggu 19
<210> 1603
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1603
ugggaguccu caucaggua 19
<210> 1604
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1604
gggaguccuc aucagguau 19
<210> 1605
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1605
ggaguccuca ucagguauu 19
<210> 1606
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1606
gaguccucau cagguauug 19
<210> 1607
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1607
guccucauca gguauugcu 19
<210> 1608
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1608
uccucaucag guauugcug 19
<210> 1609
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1609
ccucaucagg uauugcuga 19
<210> 1610
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1610
cucaucaggu auugcugaa 19
<210> 1611
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1611
ucaucaggua uugcugaau 19
<210> 1612
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1612
caucagguau ugcugaauu 19
<210> 1613
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1613
aucagguauu gcugaauuu 19
<210> 1614
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1614
ucagguauug cugaauuuu 19
<210> 1615
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1615
cagguauugc ugaauuuug 19
<210> 1616
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1616
agguauugcu gaauuuugg 19
<210> 1617
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1617
gguauugcug aauuuugga 19
<210> 1618
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1618
guauugcuga auuuuggau 19
<210> 1619
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1619
auugcugaau uuuggauca 19
<210> 1620
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1620
ugcugaauuu uggaucaau 19
<210> 1621
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1621
gcugaauuuu ggaucaaug 19
<210> 1622
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1622
cugaauuuug gaucaaugg 19
<210> 1623
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1623
gaauuuugga ucaauggga 19
<210> 1624
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1624
ggaucaaugg gacaccuuu 19
<210> 1625
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1625
caaugggaca ccuuuggug 19
<210> 1626
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1626
aaugggacac cuuugguga 19
<210> 1627
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1627
augggacacc uuuggugaa 19
<210> 1628
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1628
ugggacaccu uuggugaaa 19
<210> 1629
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1629
gggacaccuu uggugaaaa 19
<210> 1630
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1630
ggacaccuuu ggugaaaaa 19
<210> 1631
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1631
accuuuggug aaaaagggu 19
<210> 1632
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1632
ccuuugguga aaaaggguc 19
<210> 1633
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1633
cuuuggugaa aaagggucu 19
<210> 1634
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1634
ggugaaaaag ggucugcga 19
<210> 1635
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1635
gugaaaaagg gucugcgac 19
<210> 1636
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1636
ugaaaaaggg ucugcgaca 19
<210> 1637
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1637
gaaaaagggu cugcgacag 19
<210> 1638
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1638
aaagggucug cgacagggu 19
<210> 1639
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1639
aagggucugc gacaggguu 19
<210> 1640
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1640
agggucugcg acaggguua 19
<210> 1641
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1641
gggucugcga caggguuac 19
<210> 1642
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1642
ggucugcgac aggguuacu 19
<210> 1643
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1643
gucugcgaca ggguuacuu 19
<210> 1644
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1644
ucugcgacag gguuacuuu 19
<210> 1645
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1645
cugcgacagg guuacuuug 19
<210> 1646
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1646
ugcgacaggg uuacuuugu 19
<210> 1647
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1647
gcgacagggu uacuuugua 19
<210> 1648
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1648
cgacaggguu acuuuguag 19
<210> 1649
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1649
gacaggguua cuuuguaga 19
<210> 1650
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1650
acaggguuac uuuguagaa 19
<210> 1651
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1651
caggguuacu uuguagaag 19
<210> 1652
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1652
aggguuacuu uguagaagc 19
<210> 1653
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1653
ggguuacuuu guagaagcu 19
<210> 1654
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1654
gguuacuuug uagaagcuc 19
<210> 1655
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1655
guuacuuugu agaagcuca 19
<210> 1656
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1656
agaagcucag cccaagauu 19
<210> 1657
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1657
gaagcucagc ccaagauug 19
<210> 1658
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1658
aagcucagcc caagauugu 19
<210> 1659
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1659
agcucagccc aagauuguc 19
<210> 1660
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1660
cucagcccaa gauuguccu 19
<210> 1661
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1661
agcccaagau uguccuggg 19
<210> 1662
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1662
ccaagauugu ccuggggca 19
<210> 1663
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1663
caagauuguc cuggggcag 19
<210> 1664
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1664
agauuguccu ggggcagga 19
<210> 1665
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1665
gauuguccug gggcaggaa 19
<210> 1666
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1666
uuguccuggg gcaggaaca 19
<210> 1667
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1667
uccuggggca ggaacagga 19
<210> 1668
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1668
cuggggcagg aacaggauu 19
<210> 1669
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1669
uggggcagga acaggauuc 19
<210> 1670
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1670
ggggcaggaa caggauucc 19
<210> 1671
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1671
ggcaggaaca ggauuccua 19
<210> 1672
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1672
gcaggaacag gauuccuau 19
<210> 1673
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1673
caggaacagg auuccuaug 19
<210> 1674
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1674
ggaacaggau uccuauggg 19
<210> 1675
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1675
gaacaggauu ccuaugggg 19
<210> 1676
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1676
acaggauucc uaugggggc 19
<210> 1677
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1677
caggauuccu augggggca 19
<210> 1678
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1678
ggauuccuau gggggcaag 19
<210> 1679
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1679
gauuccuaug ggggcaagu 19
<210> 1680
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1680
auuccuaugg gggcaaguu 19
<210> 1681
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1681
uuccuauggg ggcaaguuu 19
<210> 1682
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1682
uccuaugggg gcaaguuug 19
<210> 1683
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1683
ccuauggggg caaguuuga 19
<210> 1684
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1684
cuaugggggc aaguuugau 19
<210> 1685
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1685
uaugggggca aguuugaua 19
<210> 1686
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1686
gggggcaagu uugauagga 19
<210> 1687
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1687
ggggcaaguu ugauaggag 19
<210> 1688
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1688
gggcaaguuu gauaggagc 19
<210> 1689
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1689
ggcaaguuug auaggagcc 19
<210> 1690
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1690
gcaaguuuga uaggagcca 19
<210> 1691
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1691
caaguuugau aggagccag 19
<210> 1692
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1692
aaguuugaua ggagccagu 19
<210> 1693
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1693
uugauaggag ccaguccuu 19
<210> 1694
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1694
ugauaggagc caguccuuu 19
<210> 1695
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1695
gauaggagcc aguccuuug 19
<210> 1696
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1696
auaggagcca guccuuugu 19
<210> 1697
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1697
aggagccagu ccuuugugg 19
<210> 1698
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1698
ggagccaguc cuuuguggg 19
<210> 1699
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1699
gagccagucc uuuguggga 19
<210> 1700
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1700
agccaguccu uugugggag 19
<210> 1701
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1701
gccaguccuu ugugggaga 19
<210> 1702
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1702
ccaguccuuu gugggagag 19
<210> 1703
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1703
caguccuuug ugggagaga 19
<210> 1704
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1704
aguccuuugu gggagagau 19
<210> 1705
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1705
guccuuugug ggagagauu 19
<210> 1706
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1706
uccuuugugg gagagauug 19
<210> 1707
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1707
ccuuuguggg agagauugg 19
<210> 1708
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1708
cuuuguggga gagauuggg 19
<210> 1709
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1709
uugugggaga gauugggga 19
<210> 1710
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1710
ugugggagag auuggggau 19
<210> 1711
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1711
gugggagaga uuggggauu 19
<210> 1712
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1712
ugggagagau uggggauuu 19
<210> 1713
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1713
gggagagauu ggggauuug 19
<210> 1714
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1714
ggagagauug gggauuugu 19
<210> 1715
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1715
gagagauugg ggauuugua 19
<210> 1716
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1716
agagauuggg gauuuguac 19
<210> 1717
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1717
gagauugggg auuuguaca 19
<210> 1718
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1718
agauugggga uuuguacau 19
<210> 1719
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1719
ggggauuugu acauguggg 19
<210> 1720
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1720
gggauuugua cauguggga 19
<210> 1721
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1721
ggauuuguac augugggac 19
<210> 1722
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1722
gauuuguaca ugugggacu 19
<210> 1723
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1723
uguacaugug ggacucugu 19
<210> 1724
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1724
guacaugugg gacucugug 19
<210> 1725
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1725
acauguggga cucugugcu 19
<210> 1726
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1726
gggacucugu gcugccccc 19
<210> 1727
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1727
ggacucugug cugccccca 19
<210> 1728
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1728
acucugugcu gcccccaga 19
<210> 1729
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1729
cucugugcug cccccagaa 19
<210> 1730
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1730
cugugcugcc cccagaaaa 19
<210> 1731
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1731
ugugcugccc ccagaaaau 19
<210> 1732
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1732
gugcugcccc cagaaaaua 19
<210> 1733
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1733
gcugccccca gaaaauauc 19
<210> 1734
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1734
cccccagaaa auauccugu 19
<210> 1735
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1735
cccagaaaau auccugucu 19
<210> 1736
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1736
ccagaaaaua uccugucug 19
<210> 1737
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1737
cagaaaauau ccugucugc 19
<210> 1738
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1738
gaaaauaucc ugucugccu 19
<210> 1739
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1739
aaaauauccu gucugccua 19
<210> 1740
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1740
aaauauccug ucugccuau 19
<210> 1741
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1741
ccugucugcc uaucagggu 19
<210> 1742
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1742
cugucugccu aucagggua 19
<210> 1743
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1743
gucugccuau caggguacc 19
<210> 1744
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1744
ugccuaucag gguaccccu 19
<210> 1745
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1745
gccuaucagg guaccccuc 19
<210> 1746
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1746
ccuaucaggg uaccccucu 19
<210> 1747
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1747
cuaucagggu accccucuc 19
<210> 1748
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1748
caggguaccc cucucccug 19
<210> 1749
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1749
ggguaccccu cucccugcc 19
<210> 1750
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1750
gguaccccuc ucccugcca 19
<210> 1751
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1751
guaccccucu cccugccaa 19
<210> 1752
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1752
uaccccucuc ccugccaau 19
<210> 1753
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1753
ccccucuccc ugccaauau 19
<210> 1754
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1754
cccucucccu gccaauauc 19
<210> 1755
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1755
cugccaauau ccuggacug 19
<210> 1756
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1756
ccaauauccu ggacuggca 19
<210> 1757
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1757
caauauccug gacuggcag 19
<210> 1758
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1758
uccuggacug gcaggcucu 19
<210> 1759
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1759
ccuggacugg caggcucug 19
<210> 1760
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1760
cuggacuggc aggcucuga 19
<210> 1761
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1761
uggacuggca ggcucugaa 19
<210> 1762
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1762
ggacuggcag gcucugaac 19
<210> 1763
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1763
gacuggcagg cucugaacu 19
<210> 1764
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1764
acuggcaggc ucugaacua 19
<210> 1765
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1765
cuggcaggcu cugaacuau 19
<210> 1766
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1766
uggcaggcuc ugaacuaug 19
<210> 1767
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1767
ggcaggcucu gaacuauga 19
<210> 1768
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1768
gcaggcucug aacuaugaa 19
<210> 1769
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1769
caggcucuga acuaugaaa 19
<210> 1770
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1770
aggcucugaa cuaugaaau 19
<210> 1771
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1771
ggcucugaac uaugaaauc 19
<210> 1772
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1772
gcucugaacu augaaauca 19
<210> 1773
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1773
cucugaacua ugaaaucag 19
<210> 1774
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1774
ucugaacuau gaaaucaga 19
<210> 1775
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1775
gaacuaugaa aucagagga 19
<210> 1776
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1776
aacuaugaaa ucagaggau 19
<210> 1777
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1777
acuaugaaau cagaggaua 19
<210> 1778
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1778
cuaugaaauc agaggauau 19
<210> 1779
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1779
uaugaaauca gaggauaug 19
<210> 1780
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1780
ugaaaucaga ggauauguc 19
<210> 1781
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1781
gaaaucagag gauauguca 19
<210> 1782
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1782
aaaucagagg auaugucau 19
<210> 1783
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1783
aaucagagga uaugucauc 19
<210> 1784
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1784
cagaggauau gucaucauc 19
<210> 1785
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1785
agaggauaug ucaucauca 19
<210> 1786
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1786
gaggauaugu caucaucaa 19
<210> 1787
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1787
aggauauguc aucaucaaa 19
<210> 1788
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1788
ggauauguca ucaucaaac 19
<210> 1789
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1789
gauaugucau caucaaacc 19
<210> 1790
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1790
augucaucau caaacccuu 19
<210> 1791
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1791
caucaucaaa cccuuggug 19
<210> 1792
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1792
ucaucaaacc cuuggugug 19
<210> 1793
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1793
acccuuggug ugggucuga 19
<210> 1794
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1794
cccuuggugu gggucugag 19
<210> 1795
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1795
ccuuggugug ggucugagg 19
<210> 1796
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1796
cuuggugugg gucugaggu 19
<210> 1797
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1797
uggugugggu cugaggucu 19
<210> 1798
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1798
gguguggguc ugaggucuu 19
<210> 1799
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1799
gugugggucu gaggucuug 19
<210> 1800
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1800
ugugggucug aggucuuga 19
<210> 1801
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1801
gugggucuga ggucuugac 19
<210> 1802
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1802
gggucugagg ucuugacuc 19
<210> 1803
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1803
ggucugaggu cuugacuca 19
<210> 1804
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1804
gucugagguc uugacucaa 19
<210> 1805
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1805
cugaggucuu gacucaacg 19
<210> 1806
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1806
ugaggucuug acucaacga 19
<210> 1807
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1807
gaggucuuga cucaacgag 19
<210> 1808
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1808
aggucuugac ucaacgaga 19
<210> 1809
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1809
ggucuugacu caacgagag 19
<210> 1810
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1810
gucuugacuc aacgagagc 19
<210> 1811
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1811
ucuugacuca acgagagca 19
<210> 1812
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1812
cuugacucaa cgagagcac 19
<210> 1813
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1813
uugacucaac gagagcacu 19
<210> 1814
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1814
ugacucaacg agagcacuu 19
<210> 1815
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1815
gacucaacga gagcacuug 19
<210> 1816
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1816
acucaacgag agcacuuga 19
<210> 1817
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1817
cucaacgaga gcacuugaa 19
<210> 1818
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1818
ucaacgagag cacuugaaa 19
<210> 1819
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1819
caacgagagc acuugaaaa 19
<210> 1820
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1820
aacgagagca cuugaaaau 19
<210> 1821
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1821
acgagagcac uugaaaaug 19
<210> 1822
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1822
cgagagcacu ugaaaauga 19
<210> 1823
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1823
gagagcacuu gaaaaugaa 19
<210> 1824
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1824
agagcacuug aaaaugaaa 19
<210> 1825
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1825
gagcacuuga aaaugaaau 19
<210> 1826
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1826
agcacuugaa aaugaaaug 19
<210> 1827
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1827
gcacuugaaa augaaauga 19
<210> 1828
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1828
cacuugaaaa ugaaaugac 19
<210> 1829
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1829
acuugaaaau gaaaugacu 19
<210> 1830
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1830
cuugaaaaug aaaugacug 19
<210> 1831
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1831
uugaaaauga aaugacugu 19
<210> 1832
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1832
ugaaaaugaa augacuguc 19
<210> 1833
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1833
gaaaaugaaa ugacugucu 19
<210> 1834
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1834
aaaaugaaau gacugucua 19
<210> 1835
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1835
aaaugaaaug acugucuaa 19
<210> 1836
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1836
aaugaaauga cugucuaag 19
<210> 1837
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1837
augaaaugac ugucuaaga 19
<210> 1838
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1838
ugaaaugacu gucuaagag 19
<210> 1839
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1839
gaaaugacug ucuaagaga 19
<210> 1840
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1840
aaaugacugu cuaagagau 19
<210> 1841
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1841
augacugucu aagagaucu 19
<210> 1842
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1842
ugacugucua agagaucug 19
<210> 1843
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1843
gacugucuaa gagaucugg 19
<210> 1844
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1844
acugucuaag agaucuggu 19
<210> 1845
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1845
cugucuaaga gaucugguc 19
<210> 1846
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1846
ugucuaagag aucugguca 19
<210> 1847
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1847
gucuaagaga ucuggucaa 19
<210> 1848
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1848
ucuaagagau cuggucaaa 19
<210> 1849
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1849
cuaagagauc uggucaaag 19
<210> 1850
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1850
uaagagaucu ggucaaagc 19
<210> 1851
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1851
aagagaucug gucaaagca 19
<210> 1852
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1852
agagaucugg ucaaagcaa 19
<210> 1853
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1853
gagaucuggu caaagcaac 19
<210> 1854
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1854
agaucugguc aaagcaacu 19
<210> 1855
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1855
gaucugguca aagcaacug 19
<210> 1856
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1856
aucuggucaa agcaacugg 19
<210> 1857
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1857
ucuggucaaa gcaacugga 19
<210> 1858
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1858
cuggucaaag caacuggau 19
<210> 1859
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1859
uggucaaagc aacuggaua 19
<210> 1860
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1860
ggucaaagca acuggauac 19
<210> 1861
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1861
gucaaagcaa cuggauacu 19
<210> 1862
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1862
ucaaagcaac uggauacua 19
<210> 1863
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1863
caaagcaacu ggauacuag 19
<210> 1864
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1864
aaagcaacug gauacuaga 19
<210> 1865
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1865
aagcaacugg auacuagau 19
<210> 1866
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1866
agcaacugga uacuagauc 19
<210> 1867
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1867
gcaacuggau acuagaucu 19
<210> 1868
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1868
caacuggaua cuagaucuu 19
<210> 1869
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1869
aacuggauac uagaucuua 19
<210> 1870
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1870
acuggauacu agaucuuac 19
<210> 1871
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1871
cuggauacua gaucuuaca 19
<210> 1872
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1872
uggauacuag aucuuacau 19
<210> 1873
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1873
ggauacuaga ucuuacauc 19
<210> 1874
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1874
gauacuagau cuuacaucu 19
<210> 1875
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1875
auacuagauc uuacaucug 19
<210> 1876
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1876
acuagaucuu acaucugca 19
<210> 1877
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1877
cuagaucuua caucugcag 19
<210> 1878
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1878
agaucuuaca ucugcagcu 19
<210> 1879
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1879
gaucuuacau cugcagcuc 19
<210> 1880
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1880
aucuuacauc ugcagcucu 19
<210> 1881
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1881
ucuuacaucu gcagcucuu 19
<210> 1882
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1882
cuuacaucug cagcucuuu 19
<210> 1883
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1883
uuacaucugc agcucuuuc 19
<210> 1884
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1884
uacaucugca gcucuuucu 19
<210> 1885
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1885
acaucugcag cucuuucuu 19
<210> 1886
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1886
caucugcagc ucuuucuuc 19
<210> 1887
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1887
aucugcagcu cuuucuucu 19
<210> 1888
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1888
ucugcagcuc uuucuucuu 19
<210> 1889
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1889
cugcagcucu uucuucuuu 19
<210> 1890
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1890
ugcagcucuu ucuucuuug 19
<210> 1891
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1891
gcagcucuuu cuucuuuga 19
<210> 1892
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1892
cagcucuuuc uucuuugaa 19
<210> 1893
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1893
agcucuuucu ucuuugaau 19
<210> 1894
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1894
gcucuuucuu cuuugaauu 19
<210> 1895
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1895
cucuuucuuc uuugaauuu 19
<210> 1896
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1896
ucuuucuucu uugaauuuc 19
<210> 1897
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1897
cuuucuucuu ugaauuucc 19
<210> 1898
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1898
uuucuucuuu gaauuuccu 19
<210> 1899
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1899
uucuucuuug aauuuccua 19
<210> 1900
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1900
ucuucuuuga auuuccuau 19
<210> 1901
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1901
uucuuugaau uuccuaucu 19
<210> 1902
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1902
ucuuugaauu uccuaucug 19
<210> 1903
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1903
cuuugaauuu ccuaucugu 19
<210> 1904
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1904
uuugaauuuc cuaucugua 19
<210> 1905
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1905
uugaauuucc uaucuguau 19
<210> 1906
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1906
ugaauuuccu aucuguaug 19
<210> 1907
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1907
gaauuuccua ucuguaugu 19
<210> 1908
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1908
auuuccuauc uguaugucu 19
<210> 1909
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1909
uuuccuaucu guaugucug 19
<210> 1910
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1910
uuccuaucug uaugucugc 19
<210> 1911
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1911
uccuaucugu augucugcc 19
<210> 1912
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1912
ccuaucugua ugucugccu 19
<210> 1913
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1913
cuaucuguau gucugccua 19
<210> 1914
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1914
uaucuguaug ucugccuaa 19
<210> 1915
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1915
aucuguaugu cugccuaau 19
<210> 1916
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1916
ucuguauguc ugccuaauu 19
<210> 1917
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1917
cuguaugucu gccuaauua 19
<210> 1918
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1918
uguaugucug ccuaauuaa 19
<210> 1919
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1919
guaugucugc cuaauuaaa 19
<210> 1920
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1920
uaugucugcc uaauuaaaa 19
<210> 1921
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1921
augucugccu aauuaaaaa 19
<210> 1922
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1922
ugucugccua auuaaaaaa 19
<210> 1923
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1923
gucugccuaa uuaaaaaaa 19
<210> 1924
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1924
ucugccuaau uaaaaaaau 19
<210> 1925
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1925
cugccuaauu aaaaaaaua 19
<210> 1926
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1926
ugccuaauua aaaaaauau 19
<210> 1927
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1927
gccuaauuaa aaaaauaua 19
<210> 1928
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1928
ccuaauuaaa aaaauauau 19
<210> 1929
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1929
cuaauuaaaa aaauauaua 19
<210> 1930
<211> 19
<212> RNA
<213> Homo sapiens
<400> 1930
uaaaaaaaua uauauugua 19
<210> 1931
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1931
uaccuugugu uuucgagccu a 21
<210> 1932
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1932
ugccuacagc cucuucuccu a 21
<210> 1933
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1933
acagccucuu cuccuacaau a 21
<210> 1934
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1934
guccucauca gguauugcug a 21
<210> 1935
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1935
aggagccagu ccuuuguggg a 21
<210> 1936
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1936
gagccagucc uuugugggag a 21
<210> 1937
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1937
ccaguccuuu gugggagaga u 21
<210> 1938
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1938
caguccuuug ugggagagau u 21
<210> 1939
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1939
ugggagagau uggggauuug u 21
<210> 1940
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1940
gggagagauu ggggauuugu a 21
<210> 1941
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1941
gagagauugg ggauuuguac a 21
<210> 1942
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1942
uccugucugc cuaucagggu a 21
<210> 1943
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<400> 1943
caggcucuga acuaugaaau c 21
<210> 1944
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<400> 1944
gaggauaugu caucaucaaa c 21
<210> 1945
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1945
ugggucugag gucuugacuc a 21
<210> 1946
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1946
acucaacgag agcacuugaa a 21
<210> 1947
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1947
cucaacgaga gcacuugaaa a 21
<210> 1948
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1948
ucaacgagag cacuugaaaa u 21
<210> 1949
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1949
aacgagagca cuugaaaaug a 21
<210> 1950
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1950
acgagagcac uugaaaauga a 21
<210> 1951
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1951
cgagagcacu ugaaaaugaa a 21
<210> 1952
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1952
gagagcacuu gaaaaugaaa u 21
<210> 1953
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 1953
agagcacuug aaaaugaaau g 21
<210> 1954
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1954
cuaagagauc uggucaaagc a 21
<210> 1955
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<400> 1955
cuggucaaag caacuggaua c 21
<210> 1956
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1956
aagcaacugg auacuagauc u 21
<210> 1957
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1957
agcaacugga uacuagaucu u 21
<210> 1958
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1958
gcaacuggau acuagaucuu a 21
<210> 1959
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1959
aucuuacauc ugcagcucuu u 21
<210> 1960
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<400> 1960
uacaucugca gcucuuucuu c 21
<210> 1961
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1961
acaucugcag cucuuucuuc u 21
<210> 1962
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1962
caucugcagc ucuuucuucu u 21
<210> 1963
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1963
aucugcagcu cuuucuucuu u 21
<210> 1964
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 1964
ucugcagcuc uuucuucuuu g 21
<210> 1965
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1965
cugcagcucu uucuucuuug a 21
<210> 1966
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1966
ugcagcucuu ucuucuuuga a 21
<210> 1967
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1967
gcagcucuuu cuucuuugaa u 21
<210> 1968
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1968
cagcucuuuc uucuuugaau u 21
<210> 1969
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 1969
uugaauuucc uaucuguaug u 21
<210> 1970
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1970
uccuaucugu augucugccu a 21
<210> 1971
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1971
aucuguaugu cugccuaauu a 21
<210> 1972
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1972
ucuguauguc ugccuaauua a 21
<210> 1973
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1973
cuguaugucu gccuaauuaa a 21
<210> 1974
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 1974
gucugccuaa uuaaaaaaau a 21
<210> 1975
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 1975
uaggcucgaa aacacaaggu aaa 23
<210> 1976
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 1976
uaggagaaga ggcuguaggc acg 23
<210> 1977
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 1977
uauuguagga gaagaggcug uag 23
<210> 1978
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1978
ucagcaauac cugaugagga cuc 23
<210> 1979
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1979
ucccacaaag gacuggcucc uau 23
<210> 1980
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1980
ucucccacaa aggacuggcu ccu 23
<210> 1981
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1981
aucucuccca caaaggacug gcu 23
<210> 1982
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1982
aaucucuccc acaaaggacu ggc 23
<210> 1983
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 1983
acaaaucccc aaucucuccc aca 23
<210> 1984
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1984
uacaaauccc caaucucucc cac 23
<210> 1985
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1985
uguacaaauc cccaaucucu ccc 23
<210> 1986
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 1986
uacccugaua ggcagacagg aua 23
<210> 1987
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1987
gauuucauag uucagagccu gcc 23
<210> 1988
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 1988
guuugaugau gacauauccu cug 23
<210> 1989
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 1989
ugagucaaga ccucagaccc aca 23
<210> 1990
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 1990
uuucaagugc ucucguugag uca 23
<210> 1991
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1991
uuuucaagug cucucguuga guc 23
<210> 1992
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1992
auuuucaagu gcucucguug agu 23
<210> 1993
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 1993
ucauuuucaa gugcucucgu uga 23
<210> 1994
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 1994
uucauuuuca agugcucucg uug 23
<210> 1995
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1995
uuucauuuuc aagugcucuc guu 23
<210> 1996
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1996
auuucauuuu caagugcucu cgu 23
<210> 1997
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 1997
cauuucauuu ucaagugcuc ucg 23
<210> 1998
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 1998
ugcuuugacc agaucucuua gac 23
<210> 1999
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 1999
guauccaguu gcuuugacca gau 23
<210> 2000
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2000
agaucuagua uccaguugcu uug 23
<210> 2001
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2001
aagaucuagu auccaguugc uuu 23
<210> 2002
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2002
uaagaucuag uauccaguug cuu 23
<210> 2003
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2003
aaagagcugc agauguaaga ucu 23
<210> 2004
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2004
gaagaaagag cugcagaugu aag 23
<210> 2005
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2005
agaagaaaga gcugcagaug uaa 23
<210> 2006
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2006
aagaagaaag agcugcagau gua 23
<210> 2007
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2007
aaagaagaaa gagcugcaga ugu 23
<210> 2008
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2008
caaagaagaa agagcugcag aug 23
<210> 2009
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> gm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2009
ucaaagaaga aagagcugca gau 23
<210> 2010
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2010
uucaaagaag aaagagcugc aga 23
<210> 2011
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2011
auucaaagaa gaaagagcug cag 23
<210> 2012
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2012
aauucaaaga agaaagagcu gca 23
<210> 2013
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2013
acauacagau aggaaauuca aag 23
<210> 2014
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2014
uaggcagaca uacagauagg aaa 23
<210> 2015
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2015
uaauuaggca gacauacaga uag 23
<210> 2016
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2016
uuaauuaggc agacauacag aua 23
<210> 2017
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2017
uuuaauuagg cagacauaca gau 23
<210> 2018
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2018
uauuuuuuua auuaggcaga cau 23
<210> 2019
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<400> 2019
uaccuugugu uuucgagccu a 21
<210> 2020
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2020
uaccuugugu uuucgagccu a 21
<210> 2021
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2021
uaccuugugu uuucgagccu a 21
<210> 2022
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> um
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> cm
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2022
ugggucugag gucuugacuc a 21
<210> 2023
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> cm
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2023
ugggucugag gucuugacuc a 21
<210> 2024
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroguanine
<400> 2024
agagcacuug aaaaugaaau g 21
<210> 2025
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(14)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2025
agagcacuug aaaaugaaau g 21
<210> 2026
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2026
agagcacuug aaaaugaaau g 21
<210> 2027
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroguanine
<400> 2027
ucugcagcuc uuucuucuuu g 21
<210> 2028
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> um
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(16)
<223> um
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2028
ucugcagcuc uuucuucuuu g 21
<210> 2029
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2029
ucugcagcuc uuucuucuuu g 21
<210> 2030
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> gm
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> gm
<220>
<221> modified_base
<222> (19)..(20)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2030
gcagcucuuu cuucuuugaa u 21
<210> 2031
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> gm
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> gm
<220>
<221> modified_base
<222> (19)..(20)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2031
gcagcucuuu cuucuuugaa u 21
<210> 2032
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> gm
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> um
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(16)
<223> um
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(21)
<223> um
<400> 2032
cagcucuuuc uucuuugaau u 21
<210> 2033
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(21)
<223> um
<400> 2033
cagcucuuuc uucuuugaau u 21
<210> 2034
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> gm
<220>
<221> modified_base
<222> (4)..(5)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2034
uugaauuucc uaucuguaug u 21
<210> 2035
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2035
uugaauuucc uaucuguaug u 21
<210> 2036
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 2036
agagcacuug aaaaugaaau a 21
<210> 2037
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2037
agagcacuug aaaaugaaau a 21
<210> 2038
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(14)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2038
agagcacuug aaaaugaaau a 21
<210> 2039
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2039
agagcacuug aaaaugaaau a 21
<210> 2040
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<400> 2040
ucugcagcuc uuucuucuuu a 21
<210> 2041
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2041
ucugcagcuc uuucuucuuu a 21
<210> 2042
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> um
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(16)
<223> um
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2042
ucugcagcuc uuucuucuuu a 21
<210> 2043
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2043
ucugcagcuc uuucuucuuu a 21
<210> 2044
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2044
uaggcucgaa aacacaaggu aaa 23
<210> 2045
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(4)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(17)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (18)..(19)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2045
uaggcucgaa aacacaaggu aaa 23
<210> 2046
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(23)
<223> 2'-O-methyladenosine
<400> 2046
uaggcucgaa aacacaaggu aaa 23
<210> 2047
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(8)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (18)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2047
ugagucaaga ccucagaccc aca 23
<210> 2048
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2048
ugagucaaga ccucagaccc aca 23
<210> 2049
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2049
cauuucauuu ucaagugcuc ucg 23
<210> 2050
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2050
cauuucauuu ucaagugcuc ucg 23
<210> 2051
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2051
cauuucauuu ucaagugcuc ucg 23
<210> 2052
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2052
caaagaagaa agagcugcag aug 23
<210> 2053
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(4)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2053
caaagaagaa agagcugcag aug 23
<210> 2054
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> um
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2054
caaagaagaa agagcugcag aug 23
<210> 2055
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (5)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2055
auucaaagaa gaaagagcug cag 23
<210> 2056
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2056
auucaaagaa gaaagagcug cag 23
<210> 2057
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(4)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(8)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2057
aauucaaaga agaaagagcu gca 23
<210> 2058
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2058
aauucaaaga agaaagagcu gca 23
<210> 2059
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (20)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2059
acauacagau aggaaauuca aag 23
<210> 2060
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(22)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2060
acauacagau aggaaauuca aag 23
<210> 2061
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 2061
uauuucauuu ucaagugcuc ucg 23
<210> 2062
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2062
uauuucauuu ucaagugcuc ucg 23
<210> 2063
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2063
uauuucauuu ucaagugcuc ucg 23
<210> 2064
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2064
uauuucauuu ucaagugcuc ucg 23
<210> 2065
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<400> 2065
uaaagaagaa agagcugcag aug 23
<210> 2066
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2066
uaaagaagaa agagcugcag aug 23
<210> 2067
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(4)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2067
uaaagaagaa agagcugcag aug 23
<210> 2068
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(22)
<223> um
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2068
uaaagaagaa agagcugcag aug 23
<210> 2069
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2069
uaccuugugu uuucgagccu a 21
<210> 2070
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2070
ccaguccuuu gugggagaga u 21
<210> 2071
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2071
gagagauugg ggauuuguac a 21
<210> 2072
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2072
ugggucugag gucuugacuc a 21
<210> 2073
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2073
agagcacuug aaaaugaaau g 21
<210> 2074
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2074
gcaacuggau acuagaucuu a 21
<210> 2075
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2075
ucugcagcuc uuucuucuuu g 21
<210> 2076
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2076
gcagcucuuu cuucuuugaa u 21
<210> 2077
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2077
cagcucuuuc uucuuugaau u 21
<210> 2078
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2078
uugaauuucc uaucuguaug u 21
<210> 2079
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2079
uaccuugugu uuucgagccu a 21
<210> 2080
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2080
ccaguccuuu gugggagaga u 21
<210> 2081
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2081
gagagauugg ggauuuguac a 21
<210> 2082
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2082
ugggucugag gucuugacuc a 21
<210> 2083
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2083
agagcacuug aaaaugaaau g 21
<210> 2084
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2084
gcaacuggau acuagaucuu a 21
<210> 2085
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2085
ucugcagcuc uuucuucuuu g 21
<210> 2086
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2086
gcagcucuuu cuucuuugaa u 21
<210> 2087
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2087
cagcucuuuc uucuuugaau u 21
<210> 2088
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2088
uugaauuucc uaucuguaug u 21
<210> 2089
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<400> 2089
uaccuugugu uuucgagccu a 21
<210> 2090
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2090
uaccuugugu uuucgagccu a 21
<210> 2091
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2091
uaccuugugu uuucgagccu a 21
<210> 2092
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> um
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> cm
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2092
ugggucugag gucuugacuc a 21
<210> 2093
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> cm
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2093
ugggucugag gucuugacuc a 21
<210> 2094
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroguanine
<400> 2094
agagcacuug aaaaugaaau g 21
<210> 2095
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(14)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2095
agagcacuug aaaaugaaau g 21
<210> 2096
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2096
agagcacuug aaaaugaaau g 21
<210> 2097
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroguanine
<400> 2097
ucugcagcuc uuucuucuuu g 21
<210> 2098
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> um
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(16)
<223> um
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2098
ucugcagcuc uuucuucuuu g 21
<210> 2099
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<400> 2099
ucugcagcuc uuucuucuuu g 21
<210> 2100
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> gm
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> gm
<220>
<221> modified_base
<222> (19)..(20)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2100
gcagcucuuu cuucuuugaa u 21
<210> 2101
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> gm
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> gm
<220>
<221> modified_base
<222> (19)..(20)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2101
gcagcucuuu cuucuuugaa u 21
<210> 2102
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> gm
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> um
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(16)
<223> um
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(21)
<223> um
<400> 2102
cagcucuuuc uucuuugaau u 21
<210> 2103
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(21)
<223> um
<400> 2103
cagcucuuuc uucuuugaau u 21
<210> 2104
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(2)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (3)..(3)
<223> gm
<220>
<221> modified_base
<222> (4)..(5)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2104
uugaauuucc uaucuguaug u 21
<210> 2105
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(2)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<400> 2105
uugaauuucc uaucuguaug u 21
<210> 2106
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2106
agagcacuug aaaaugaaau a 21
<210> 2107
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(14)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> gm
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2107
agagcacuug aaaaugaaau a 21
<210> 2108
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2108
agagcacuug aaaaugaaau a 21
<210> 2109
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2109
ucugcagcuc uuucuucuuu a 21
<210> 2110
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> um
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> cm
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> cm
<220>
<221> modified_base
<222> (15)..(16)
<223> um
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2110
ucugcagcuc uuucuucuuu a 21
<210> 2111
<211> 21
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA sense strand against APCS
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (11)..(12)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> um
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<400> 2111
ucugcagcuc uuucuucuuu a 21
<210> 2112
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2112
uaggcucgaa aacacaaggu aaa 23
<210> 2113
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2113
aucucuccca caaaggacug gcu 23
<210> 2114
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 2114
uguacaaauc cccaaucucu ccc 23
<210> 2115
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2115
ugagucaaga ccucagaccc aca 23
<210> 2116
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2116
cauuucauuu ucaagugcuc ucg 23
<210> 2117
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2117
uaagaucuag uauccaguug cuu 23
<210> 2118
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2118
caaagaagaa agagcugcag aug 23
<210> 2119
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2119
auucaaagaa gaaagagcug cag 23
<210> 2120
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2120
aauucaaaga agaaagagcu gca 23
<210> 2121
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2121
acauacagau aggaaauuca aag 23
<210> 2122
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2122
uaggcucgaa aacacaaggu aaa 23
<210> 2123
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> cm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2123
aucucuccca caaaggacug gcu 23
<210> 2124
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(10)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> cm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> cm
<400> 2124
uguacaaauc cccaaucucu ccc 23
<210> 2125
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> gm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2125
ugagucaaga ccucagaccc aca 23
<210> 2126
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2126
cauuucauuu ucaagugcuc ucg 23
<210> 2127
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> gm
<220>
<221> modified_base
<222> (11)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> um
<400> 2127
uaagaucuag uauccaguug cuu 23
<210> 2128
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2128
caaagaagaa agagcugcag aug 23
<210> 2129
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> um
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2129
auucaaagaa gaaagagcug cag 23
<210> 2130
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2130
aauucaaaga agaaagagcu gca 23
<210> 2131
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (2)..(2)
<223> cm
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2131
acauacagau aggaaauuca aag 23
<210> 2132
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2132
uaggcucgaa aacacaaggu aaa 23
<210> 2133
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(4)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(17)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (18)..(19)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2133
uaggcucgaa aacacaaggu aaa 23
<210> 2134
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> um
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> cm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> gm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(23)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<400> 2134
uaggcucgaa aacacaaggu aaa 23
<210> 2135
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(8)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (18)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2135
ugagucaaga ccucagaccc aca 23
<210> 2136
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> gm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> cm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> um
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2136
ugagucaaga ccucagaccc aca 23
<210> 2137
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2137
cauuucauuu ucaagugcuc ucg 23
<210> 2138
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2138
cauuucauuu ucaagugcuc ucg 23
<210> 2139
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2139
cauuucauuu ucaagugcuc ucg 23
<210> 2140
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2140
caaagaagaa agagcugcag aug 23
<210> 2141
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(4)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2141
caaagaagaa agagcugcag aug 23
<210> 2142
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> cm
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> um
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2142
caaagaagaa agagcugcag aug 23
<210> 2143
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (5)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2143
auucaaagaa gaaagagcug cag 23
<210> 2144
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> cm
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> gm
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> cm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2144
auucaaagaa gaaagagcug cag 23
<210> 2145
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(4)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(8)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(10)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2145
aauucaaaga agaaagagcu gca 23
<210> 2146
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(20)
<223> um
<220>
<221> modified_base
<222> (21)..(21)
<223> gm
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> 2'-O-methyladenosine
<400> 2146
aauucaaaga agaaagagcu gca 23
<210> 2147
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (20)..(22)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2147
acauacagau aggaaauuca aag 23
<210> 2148
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(10)
<223> um
<220>
<221> modified_base
<222> (11)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> gm
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (17)..(17)
<223> um
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (19)..(19)
<223> cm
<220>
<221> modified_base
<222> (20)..(22)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2148
acauacagau aggaaauuca aag 23
<210> 2149
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2149
uauuucauuu ucaagugcuc ucg 23
<210> 2150
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2150
uauuucauuu ucaagugcuc ucg 23
<210> 2151
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (4)..(4)
<223> um
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (6)..(6)
<223> cm
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> um
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (10)..(11)
<223> um
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (15)..(15)
<223> gm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> um
<220>
<221> modified_base
<222> (20)..(20)
<223> cm
<220>
<221> modified_base
<222> (21)..(21)
<223> um
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> cm
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2151
uauuucauuu ucaagugcuc ucg 23
<210> 2152
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (2)..(2)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (3)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2152
uaaagaagaa agagcugcag aug 23
<210> 2153
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(4)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (20)..(20)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2153
uaaagaagaa agagcugcag aug 23
<210> 2154
<211> 23
<212> RNA
<213> Artificial Sequence
<220>
<223> siRNA antisense strand against APCS
<220>
<221> modified_base
<222> (1)..(3)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (1)..(1)
<223> um
<220>
<221> modified_base
<222> (2)..(3)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (4)..(4)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (5)..(5)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (6)..(6)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (7)..(7)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (8)..(8)
<223> gm
<220>
<221> modified_base
<222> (9)..(9)
<223> 2'-fluoroadenine
<220>
<221> modified_base
<222> (10)..(11)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (12)..(12)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (13)..(13)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (14)..(14)
<223> 2'-fluoroguanine
<220>
<221> modified_base
<222> (15)..(15)
<223> cm
<220>
<221> modified_base
<222> (16)..(16)
<223> 2'-fluorouracil
<220>
<221> modified_base
<222> (17)..(17)
<223> gm
<220>
<221> modified_base
<222> (18)..(18)
<223> 2'-fluorocytosine
<220>
<221> modified_base
<222> (19)..(19)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (20)..(20)
<223> gm
<220>
<221> modified_base
<222> (21)..(21)
<223> 2'-O-methyladenosine
<220>
<221> modified_base
<222> (22)..(23)
<223> 5'-phosphonothioate
<220>
<221> modified_base
<222> (22)..(22)
<223> um
<220>
<221> modified_base
<222> (23)..(23)
<223> gm
<400> 2154
uaaagaagaa agagcugcag aug 23
Claims (27)
- 하기 식 1로 표시되는 핵산 복합체.
식 1:
(식 1 중,
X는 센스 사슬 및 안티센스 사슬을 포함하며, 적어도 11개의 염기쌍의 이중 사슬 영역을 포함하는 이중 사슬 핵산이고,
상기 이중 사슬 핵산은, 상기 안티센스 사슬 중의, 17개∼30개의 뉴클레오티드 사슬 길이의 올리고뉴클레오티드 사슬에 있어서, 표 1-1∼표 1-13에 기재된 표적 APCS mRNA 서열의 어느 하나와 상보적이고,
상기 센스 사슬의 3' 말단 또는 5' 말단은 S3에 결합하고,
L1 및 L2는 각각 독립적으로 당(糖) 리간드이고,
S1, S2 및 S3은 각각 독립적으로 링커이다.) - 제1항에 있어서, 하기 식 2로 표시되는 구조를 갖는 핵산 복합체.
식 2:
(식 2 중,
X, L1, L2 및 S3은 각각 상기와 동의이고,
P1, P2, P3, P4, P5 및 P6, 그리고 T1 및 T2는 각각 독립적으로 존재하지 않거나, 또는 -CO-, -NH-, -O-, -S-, -O-CO-, -S-CO-, -NH-CO-, -CO-O-, -CO-S- 혹은 -CO-NH-이고,
Q1, Q2, Q3 및 Q4는 각각 독립적으로 존재하지 않거나, 또는 치환 혹은 무치환의 탄소수 1∼12의 알킬렌 또는 -(CH2CH2O)n-CH2CH2-이며, n은 0∼99의 정수이고,
B1 및 B2는 각각 독립적으로 결합수(結合手)이거나 또는 하기 식 2-1로 표시되는 어느 하나의 구조이고, 각 구조에 있어서의 말단의 둥근 흑점은 각각 P2 또는 P3 혹은 P5 또는 P6과의 결합점이며, m1, m2, m3 및 m4는 각각 독립적으로 0∼10의 정수이고,
식 2-1:
p1 및 p2는 각각 독립적으로 1, 2 또는 3의 정수이고,
q1, q2, q3 및 q4는 각각 독립적으로 0∼10의 정수이고,
단, p1 및 p2가 각각 2 또는 3의 정수일 때, 각각의 P3 및 P6, Q2 및 Q4, T1 및 T2, 그리고 L1 및 L2는 동일하더라도 또는 다르더라도 좋으며, q1∼q4가 2∼10일 때, 각각의 -[P2-Q1]-, -[Q2-P3]-, -[P5-Q3]-, -[Q4-P6]-의 조합은 동일하더라도 또는 다르더라도 좋다.) - 제2항에 있어서, P1 및 P4가 각각 독립적으로 -CO-NH-, -NH-CO- 또는 -O-인 핵산 복합체.
- 제6항에 있어서, P1이 -CO-NH-, -NH-CO- 또는 -O-인 핵산 복합체.
- 제1항 내지 제9항 중 어느 한 항에 있어서, 상기 당 리간드가 N-아세틸갈락토사민인 핵산 복합체.
- 제1항 내지 제10항 중 어느 한 항에 있어서, 상기 이중 사슬 핵산이 수식 뉴클레오티드를 포함하는 핵산 복합체.
- 제1항 내지 제11항 중 어느 한 항에 있어서, 센스 사슬의 3' 말단 및 안티센스 사슬의 5' 말단은 평활 말단을 형성하는 핵산 복합체.
- 제11항에 있어서, 상기 이중 사슬 핵산이 당부(糖部) 수식 뉴클레오티드를 포함하는 핵산 복합체.
- 제1항 내지 제14항 중 어느 한 항에 있어서, X가 표 1-1∼표 1-13에 기재한 센스 사슬/안티센스 사슬로 이루어진 군에서 선택되는 한 쌍의 센스 사슬/안티센스 사슬인 핵산 복합체.
- 제1항 내지 제14항 중 어느 한 항에 있어서, X가 표 M1-1∼표 M1-3, 표 R-1∼표 R-2 및 표 R-3∼표 R-4에 기재한 센스 사슬/안티센스 사슬로 이루어진 군에서 선택되는 한 쌍의 센스 사슬/안티센스 사슬인 핵산 복합체.
- 제1항 내지 제16항 중 어느 한 항에 기재한 핵산 복합체를 포함하는 의약 조성물.
- 제17항에 있어서, 세포 내에 도입하기 위한 의약 조성물.
- 제17항 또는 제18항에 있어서, 정맥내 투여 또는 피하 투여되는 의약 조성물.
- 제1항 내지 제16항 중 어느 한 항에 기재한 핵산 복합체 또는 제17항 내지 제19항 중 어느 한 항에 기재한 의약 조성물을, 그것을 필요로 하는 환자에게 투여하는 것을 포함하는, 질환의 치료 또는 예방 방법.
- 제1항 내지 제16항 중 어느 한 항에 기재한 핵산 복합체 또는 제17항 내지 제19항 중 어느 한 항에 기재한 의약 조성물을 이용하여 이중 사슬 핵산을 세포 내에 도입하는 것을 포함하는, APCS 유전자의 발현을 억제하는 방법.
- 제1항 내지 제16항 중 어느 한 항에 기재한 핵산 복합체 또는 제17항 내지 제19항 중 어느 한 항에 기재한 의약 조성물을 포유동물에게 투여하는 것을 포함하는, 아밀로이드 관련 질환의 치료 방법.
- 제1항 내지 제16항 중 어느 한 항에 기재한 핵산 복합체 또는 제17항 내지 제19항 중 어느 한 항에 기재한 의약 조성물을 포함하는, 아밀로이드 관련 질환의 치료에 이용하기 위한 의약.
- 제1항 내지 제16항 중 어느 한 항에 기재한 핵산 복합체 또는 제17항 내지 제19항 중 어느 한 항에 기재한 의약 조성물을 포함하는, 아밀로이드 관련 질환의 치료제.
- 제22항에 있어서, 아밀로이드 관련 질환이 APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환인 치료 방법.
- 제23항에 있어서, 아밀로이드 관련 질환이 APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환인 의약.
- 제24항에 있어서, 아밀로이드 관련 질환이 APCS를 포함한 아밀로이드 섬유에 의해 매개되는 장해에 의해서 야기되는 질환인 치료제.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2018-225829 | 2018-11-30 | ||
JP2018225829 | 2018-11-30 | ||
PCT/JP2019/047044 WO2020111280A1 (ja) | 2018-11-30 | 2019-12-02 | 核酸複合体 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210098477A true KR20210098477A (ko) | 2021-08-10 |
Family
ID=70853262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217019004A KR20210098477A (ko) | 2018-11-30 | 2019-12-02 | 핵산 복합체 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220127605A1 (ko) |
EP (1) | EP3888663A1 (ko) |
JP (1) | JPWO2020111280A1 (ko) |
KR (1) | KR20210098477A (ko) |
CN (1) | CN113286600A (ko) |
AU (1) | AU2019390097A1 (ko) |
CA (1) | CA3121449A1 (ko) |
WO (1) | WO2020111280A1 (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118591552A (zh) * | 2022-01-30 | 2024-09-03 | 成都凌泰氪生物技术有限公司 | 一种配体、其制备方法及应用 |
WO2024172057A1 (ja) * | 2023-02-15 | 2024-08-22 | 国立大学法人 東京医科歯科大学 | 人工miRNA構築物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009073809A2 (en) | 2007-12-04 | 2009-06-11 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
KR20130075035A (ko) | 2011-12-27 | 2013-07-05 | 주식회사 케이씨씨 | 외관이 향상된 박막형 전착 도료용 변성 폴리에폭사이드-아민 수지, 그 제조 방법 및 이를 포함하는 전착 도료 조성물 |
JP2014179620A (ja) | 2008-07-18 | 2014-09-25 | Beijing Boe Optoelectronics Technology Co Ltd | フォトレジストの縁部のバリの形成方法とアレイ基板の製造方法 |
KR20150105083A (ko) | 2014-03-07 | 2015-09-16 | 한국해양과학기술원 | 다층 지반의 관입을 위한 석션파일 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6469158B1 (en) | 1992-05-14 | 2002-10-22 | Ribozyme Pharmaceuticals, Incorporated | Synthesis, deprotection, analysis and purification of RNA and ribozymes |
US5977343A (en) | 1992-05-14 | 1999-11-02 | Ribozyme Pharmaceuticals, Inc. | Synthesis, deprotection, analysis and purification of RNA and ribozymes |
US5804683A (en) | 1992-05-14 | 1998-09-08 | Ribozyme Pharmaceuticals, Inc. | Deprotection of RNA with alkylamine |
JPH09502092A (ja) | 1993-09-02 | 1997-03-04 | リボザイム・ファーマシューティカルズ・インコーポレイテッド | 非ヌクレオチドを含有する酵素性核酸 |
US5889136A (en) | 1995-06-09 | 1999-03-30 | The Regents Of The University Of Colorado | Orthoester protecting groups in RNA synthesis |
US5998203A (en) | 1996-04-16 | 1999-12-07 | Ribozyme Pharmaceuticals, Inc. | Enzymatic nucleic acids containing 5'-and/or 3'-cap structures |
US6111086A (en) | 1998-02-27 | 2000-08-29 | Scaringe; Stephen A. | Orthoester protecting groups |
CA2559955C (en) | 2004-03-15 | 2016-02-16 | City Of Hope | Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
JP6209309B2 (ja) | 2008-09-22 | 2017-10-04 | アールエックスアイ ファーマシューティカルズ コーポレーション | サイズが減少した自己送達用RNAi化合物 |
PE20142362A1 (es) | 2011-11-18 | 2015-01-30 | Alnylam Pharmaceuticals Inc | Agentes de iarn, composiciones y metodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr) |
RU2686080C2 (ru) | 2013-05-01 | 2019-04-24 | Ионис Фармасьютикалз, Инк. | Композиции и способы |
EP4039278A1 (en) | 2013-07-11 | 2022-08-10 | Alnylam Pharmaceuticals, Inc. | Oligonucleotide-ligand conjugates and process for their preparation |
JP6482475B2 (ja) | 2014-01-07 | 2019-03-13 | レナセラピューティクス株式会社 | アンチセンスオリゴヌクレオチド及び糖誘導体を含む二本鎖オリゴヌクレオチド |
ES2858090T3 (es) * | 2016-01-29 | 2021-09-29 | Kyowa Kirin Co Ltd | Complejo de ácidos nucleicos |
AU2018277476A1 (en) * | 2017-05-31 | 2020-01-02 | Kyowa Kirin Co., Ltd. | APCS-expression-suppressing nucleic acids |
TW201920668A (zh) * | 2017-08-02 | 2019-06-01 | 日商協和醱酵麒麟有限公司 | 核酸複合體 |
WO2019027015A1 (ja) * | 2017-08-02 | 2019-02-07 | 協和発酵キリン株式会社 | 核酸複合体 |
WO2019100039A1 (en) * | 2017-11-20 | 2019-05-23 | Alnylam Pharmaceuticals, Inc. | Serum amyloid p component (apcs) irna compositions and methods of use thereof |
-
2019
- 2019-12-02 AU AU2019390097A patent/AU2019390097A1/en not_active Abandoned
- 2019-12-02 WO PCT/JP2019/047044 patent/WO2020111280A1/ja unknown
- 2019-12-02 EP EP19890058.1A patent/EP3888663A1/en not_active Withdrawn
- 2019-12-02 US US17/298,185 patent/US20220127605A1/en active Pending
- 2019-12-02 KR KR1020217019004A patent/KR20210098477A/ko unknown
- 2019-12-02 CN CN201980065564.4A patent/CN113286600A/zh active Pending
- 2019-12-02 CA CA3121449A patent/CA3121449A1/en active Pending
- 2019-12-02 JP JP2020557890A patent/JPWO2020111280A1/ja not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009073809A2 (en) | 2007-12-04 | 2009-06-11 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
JP2014179620A (ja) | 2008-07-18 | 2014-09-25 | Beijing Boe Optoelectronics Technology Co Ltd | フォトレジストの縁部のバリの形成方法とアレイ基板の製造方法 |
KR20130075035A (ko) | 2011-12-27 | 2013-07-05 | 주식회사 케이씨씨 | 외관이 향상된 박막형 전착 도료용 변성 폴리에폭사이드-아민 수지, 그 제조 방법 및 이를 포함하는 전착 도료 조성물 |
KR20150105083A (ko) | 2014-03-07 | 2015-09-16 | 한국해양과학기술원 | 다층 지반의 관입을 위한 석션파일 |
Non-Patent Citations (5)
Title |
---|
[비특허문헌 1] 저널 오브 아메리칸 케미컬 소사이어티(Journal of American Chemical Society), 2014년, 제136권, p 16958-16961 |
[비특허문헌 2] 아밀로이드(Amyloid) 1997년, 제4: 4권, p 274-295 |
[비특허문헌 3] 뉴잉글랜드 저널 오브 메디신(N. Engl. J. Med.) 1990년, 제323권, p 508-13 |
[비특허문헌 4] 네이처(Nature) 2010년, 제468권, p 93-97 |
[비특허문헌 5] 뉴잉글랜드 저널 오브 메디신(N. Engl. J. Med.) 2015년, 제373권, p 1106-1114 |
Also Published As
Publication number | Publication date |
---|---|
CA3121449A1 (en) | 2020-06-04 |
EP3888663A1 (en) | 2021-10-06 |
CN113286600A (zh) | 2021-08-20 |
JPWO2020111280A1 (ja) | 2021-10-14 |
US20220127605A1 (en) | 2022-04-28 |
WO2020111280A1 (ja) | 2020-06-04 |
AU2019390097A1 (en) | 2021-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI733751B (zh) | 核酸複合體 | |
JP7296916B2 (ja) | オリゴヌクレオチド-リガンドコンジュゲートおよびそれらの調製方法 | |
WO2019027015A1 (ja) | 核酸複合体 | |
CN109415401B (zh) | 核酸复合物 | |
JPWO2017010575A1 (ja) | β2GPI遺伝子発現抑制核酸複合体 | |
KR20210098477A (ko) | 핵산 복합체 | |
JP6667179B2 (ja) | オリゴヌクレオチド誘導体及びそれを用いたオリゴヌクレオチド構築物並びにそれらの製造方法 | |
WO2019027009A1 (ja) | 核酸複合体 | |
WO2018110678A1 (ja) | ヌクレオシド誘導体及びその利用 | |
KR20240070519A (ko) | 1'-알킬 개질된 리보스 유도체 및 사용 방법 | |
JP2019024444A (ja) | 核酸複合体 | |
RU2816898C2 (ru) | Нуклеиновая кислота, фармацевтическая композиция и конъюгат, способ получения и применение | |
JP2024528270A (ja) | 治療活性剤の送達のためのリガンド共役体 |